Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts.org |
| Table |
 |   | |
| Symptoms | Count | Percent |
| 3-Dimensional vasculography | 1 | 0% |
| 5'nucleotidase | 3 | 0% |
| 5-alpha reductase inhibition therapy | 1 | 0% |
| 5-hydroxyindolacetic acid | 4 | 0% |
| 5-hydroxyindolacetic acid in urine | 5 | 0% |
| 5q minus syndrome | 2 | 0% |
| 17-hydroxyprogesterone | 15 | 0% |
| Abdomen crushing | 2 | 0% |
| Abdomen scan | 267 | 0.02% |
| Abdomen scan normal | 18 | 0% |
| Abdominal abscess | 60 | 0% |
| Abdominal adhesions | 20 | 0% |
| Abdominal bruit | 1 | 0% |
| Abdominal cavity drainage | 21 | 0% |
| Abdominal discomfort | 9,138 | 0.56% |
| Abdominal distension | 3,586 | 0.22% |
| Abdominal exploration | 66 | 0% |
| Abdominal fat apron | 2 | 0% |
| Abdominal hernia | 52 | 0% |
| Abdominal hernia obstructive | 3 | 0% |
| Abdominal hernia repair | 5 | 0% |
| Abdominal incarcerated hernia | 1 | 0% |
| Abdominal infection | 45 | 0% |
| Abdominal injury | 6 | 0% |
| Abdominal lymphadenopathy | 62 | 0% |
| Abdominal mass | 67 | 0% |
| Abdominal migraine | 3 | 0% |
| Abdominal neoplasm | 13 | 0% |
| Abdominal operation | 23 | 0% |
| Abdominal pain | 17,975 | 1.09% |
| Abdominal pain lower | 2,114 | 0.13% |
| Abdominal pain upper | 15,711 | 0.96% |
| Abdominal panniculectomy | 1 | 0% |
| Abdominal rebound tenderness | 6 | 0% |
| Abdominal rigidity | 166 | 0.01% |
| Abdominal sepsis | 4 | 0% |
| Abdominal strangulated hernia | 1 | 0% |
| Abdominal symptom | 46 | 0% |
| Abdominal tenderness | 270 | 0.02% |
| Abdominal wall abscess | 9 | 0% |
| Abdominal wall cyst | 2 | 0% |
| Abdominal wall disorder | 1 | 0% |
| Abdominal wall haematoma | 35 | 0% |
| Abdominal wall haemorrhage | 4 | 0% |
| Abdominal wall infection | 1 | 0% |
| Abdominal wall mass | 3 | 0% |
| Abdominal wall oedema | 13 | 0% |
| Abdominal wall operation | 3 | 0% |
| Abdominal wall pain | 4 | 0% |
| Abdominal wall wound | 5 | 0% |
| Abdominal X-ray | 317 | 0.02% |
| Abdominoplasty | 2 | 0% |
| Aberrant aortic arch | 3 | 0% |
| Aberrant motor behaviour | 2 | 0% |
| Abiotrophia defectiva endocarditis | 1 | 0% |
| Ablepharon macrostomia syndrome | 1 | 0% |
| Abnormal behaviour | 644 | 0.04% |
| Abnormal clotting factor | 22 | 0% |
| Abnormal cord insertion | 11 | 0% |
| Abnormal dreams | 877 | 0.05% |
| Abnormal faeces | 487 | 0.03% |
| Abnormal involuntary movement scale | 1 | 0% |
| Abnormal labour | 6 | 0% |
| Abnormal loss of weight | 340 | 0.02% |
| Abnormal menstrual clots | 56 | 0% |
| Abnormal organ growth | 1 | 0% |
| Abnormal palmar/plantar creases | 1 | 0% |
| Abnormal precordial movement | 1 | 0% |
| Abnormal sensation in eye | 271 | 0.02% |
| Abnormal sleep-related event | 33 | 0% |
| Abnormal uterine bleeding | 155 | 0.01% |
| Abnormal weight gain | 68 | 0% |
| Abnormal withdrawal bleeding | 14 | 0% |
| ABO incompatibility | 1 | 0% |
| Aborted pregnancy | 5 | 0% |
| Abortion | 112 | 0.01% |
| Abortion complete | 7 | 0% |
| Abortion complicated | 1 | 0% |
| Abortion early | 23 | 0% |
| Abortion incomplete | 13 | 0% |
| Abortion induced | 81 | 0% |
| Abortion induced complete | 1 | 0% |
| Abortion induced incomplete | 1 | 0% |
| Abortion infected | 2 | 0% |
| Abortion late | 13 | 0% |
| Abortion missed | 185 | 0.01% |
| Abortion of ectopic pregnancy | 5 | 0% |
| Abortion spontaneous | 3,688 | 0.22% |
| Abortion spontaneous complete | 14 | 0% |
| Abortion spontaneous complicated | 1 | 0% |
| Abortion spontaneous incomplete | 5 | 0% |
| Abortion threatened | 31 | 0% |
| Abscess | 332 | 0.02% |
| Abscess bacterial | 4 | 0% |
| Abscess drainage | 94 | 0.01% |
| Abscess fungal | 2 | 0% |
| Abscess intestinal | 18 | 0% |
| Abscess jaw | 17 | 0% |
| Abscess limb | 115 | 0.01% |
| Abscess management | 2 | 0% |
| Abscess neck | 26 | 0% |
| Abscess of external auditory meatus | 3 | 0% |
| Abscess of eyelid | 5 | 0% |
| Abscess of salivary gland | 3 | 0% |
| Abscess oral | 25 | 0% |
| Abscess rupture | 8 | 0% |
| Abscess soft tissue | 2 | 0% |
| Abscess sterile | 1 | 0% |
| Abscess sweat gland | 1 | 0% |
| Absence of immediate treatment response | 8 | 0% |
| Abstains from alcohol | 14 | 0% |
| Abstains from recreational drugs | 3 | 0% |
| Abulia | 22 | 0% |
| Acalculia | 5 | 0% |
| Acanthamoeba keratitis | 2 | 0% |
| Acantholysis | 1 | 0% |
| Acanthoma | 2 | 0% |
| Acanthosis | 1 | 0% |
| Acanthosis nigricans | 1 | 0% |
| Acariasis | 3 | 0% |
| Acarodermatitis | 55 | 0% |
| Accelerated hypertension | 31 | 0% |
| Accelerated idioventricular rhythm | 5 | 0% |
| Acceleromyography | 2 | 0% |
| Accessory auricle | 1 | 0% |
| Accessory breast | 1 | 0% |
| Accessory cardiac pathway | 1 | 0% |
| Accessory muscle | 3 | 0% |
| Accessory nerve disorder | 4 | 0% |
| Accessory spleen | 7 | 0% |
| Accident | 96 | 0.01% |
| Accidental death | 1 | 0% |
| Accidental exposure to product | 117 | 0.01% |
| Accidental exposure to product by child | 1 | 0% |
| Accidental overdose | 668 | 0.04% |
| Accidental poisoning | 1 | 0% |
| Accidental underdose | 919 | 0.06% |
| Accident at home | 7 | 0% |
| Accident at work | 20 | 0% |
| Accommodation disorder | 43 | 0% |
| Acetabulum fracture | 10 | 0% |
| Acetonaemia | 11 | 0% |
| Acetonaemic vomiting | 5 | 0% |
| Acetylcholinesterase deficiency | 1 | 0% |
| Achenbach syndrome | 6 | 0% |
| Achlorhydria | 4 | 0% |
| Achromobacter infection | 2 | 0% |
| Achromotrichia acquired | 2 | 0% |
| Acid-base balance disorder mixed | 1 | 0% |
| Acid base balance | 26 | 0% |
| Acid base balance abnormal | 2 | 0% |
| Acid fast bacilli infection | 5 | 0% |
| Acid haemolysin test | 2 | 0% |
| Acidosis | 158 | 0.01% |
| Acidosis hyperchloraemic | 6 | 0% |
| Acid peptic disease | 5 | 0% |
| Acinetobacter bacteraemia | 3 | 0% |
| Acinetobacter infection | 6 | 0% |
| Acinetobacter sepsis | 1 | 0% |
| Acinetobacter test | 6 | 0% |
| Acinetobacter test positive | 2 | 0% |
| Acinic cell carcinoma of salivary gland | 1 | 0% |
| Acne | 1,053 | 0.06% |
| Acne conglobata | 6 | 0% |
| Acne cystic | 59 | 0% |
| Acne fulminans | 3 | 0% |
| Acne pustular | 17 | 0% |
| Acoustic neuritis | 2 | 0% |
| Acoustic neuroma | 33 | 0% |
| Acoustic shock | 1 | 0% |
| Acoustic stimulation tests | 1,866 | 0.11% |
| Acoustic stimulation tests abnormal | 735 | 0.04% |
| Acoustic stimulation tests normal | 371 | 0.02% |
| Acquired amegakaryocytic thrombocytopenia | 1 | 0% |
| Acquired antithrombin III deficiency | 1 | 0% |
| Acquired ATTR amyloidosis | 1 | 0% |
| Acquired blaschkoid dermatitis | 3 | 0% |
| Acquired C1 inhibitor deficiency | 1 | 0% |
| Acquired cardiac septal defect | 1 | 0% |
| Acquired claw toe | 1 | 0% |
| Acquired diaphragmatic eventration | 78 | 0% |
| Acquired dysfibrinogenaemia | 2 | 0% |
| Acquired epidermolysis bullosa | 7 | 0% |
| Acquired epileptic aphasia | 4 | 0% |
| Acquired factor IX deficiency | 1 | 0% |
| Acquired factor V deficiency | 1 | 0% |
| Acquired factor VIII deficiency | 2 | 0% |
| Acquired factor XI deficiency | 1 | 0% |
| Acquired gene mutation | 4 | 0% |
| Acquired haemophilia | 122 | 0.01% |
| Acquired hepatocerebral degeneration | 1 | 0% |
| Acquired immunodeficiency syndrome | 52 | 0% |
| Acquired macroglossia | 2 | 0% |
| Acquired oesophageal web | 7 | 0% |
| Acquired phimosis | 2 | 0% |
| Acquired porokeratosis | 1 | 0% |
| Acquired syringomyelia | 2 | 0% |
| Acquired Von Willebrand's disease | 5 | 0% |
| Acral lentiginous melanoma | 4 | 0% |
| Acral peeling skin syndrome | 1 | 0% |
| Acrochordon | 17 | 0% |
| Acrochordon excision | 1 | 0% |
| Acrodermatitis chronica atrophicans | 1 | 0% |
| Acrodermatitis enteropathica | 1 | 0% |
| Acrodynia | 1 | 0% |
| Acromegaly | 1 | 0% |
| Acrophobia | 2 | 0% |
| ACTH stimulation test | 27 | 0% |
| ACTH stimulation test abnormal | 4 | 0% |
| ACTH stimulation test normal | 4 | 0% |
| Actinic cheilitis | 1 | 0% |
| Actinic elastosis | 1 | 0% |
| Actinic keratosis | 16 | 0% |
| Actinomyces test positive | 6 | 0% |
| Actinomycosis | 1 | 0% |
| Action tremor | 11 | 0% |
| Activated partial thromboplastin time | 2,612 | 0.16% |
| Activated partial thromboplastin time abnormal | 14 | 0% |
| Activated partial thromboplastin time normal | 183 | 0.01% |
| Activated partial thromboplastin time prolonged | 206 | 0.01% |
| Activated partial thromboplastin time ratio | 362 | 0.02% |
| Activated partial thromboplastin time ratio decreased | 7 | 0% |
| Activated partial thromboplastin time ratio fluctuation | 2 | 0% |
| Activated partial thromboplastin time ratio increased | 4 | 0% |
| Activated partial thromboplastin time ratio normal | 3 | 0% |
| Activated partial thromboplastin time shortened | 221 | 0.01% |
| Activated protein C resistance | 36 | 0% |
| Activated protein C resistance test | 27 | 0% |
| Activated protein C resistance test positive | 3 | 0% |
| Activation syndrome | 2 | 0% |
| Acupuncture | 156 | 0.01% |
| Acute abdomen | 59 | 0% |
| Acute aortic syndrome | 8 | 0% |
| Acute aseptic arthritis | 16 | 0% |
| Acute cardiac event | 80 | 0% |
| Acute chest syndrome | 13 | 0% |
| Acute cholecystitis necrotic | 1 | 0% |
| Acute coronary syndrome | 663 | 0.04% |
| Acute cutaneous lupus erythematosus | 10 | 0% |
| Acute disseminated encephalomyelitis | 307 | 0.02% |
| Acute endocarditis | 4 | 0% |
| Acute fatty liver of pregnancy | 1 | 0% |
| Acute febrile neutrophilic dermatosis | 74 | 0% |
| Acute flaccid myelitis | 4 | 0% |
| Acute generalised exanthematous pustulosis | 85 | 0.01% |
| Acute graft versus host disease | 2 | 0% |
| Acute haemorrhagic conjunctivitis | 1 | 0% |
| Acute haemorrhagic leukoencephalitis | 3 | 0% |
| Acute haemorrhagic oedema of infancy | 1 | 0% |
| Acute haemorrhagic ulcerative colitis | 8 | 0% |
| Acute hepatic failure | 104 | 0.01% |
| Acute hepatitis B | 10 | 0% |
| Acute hepatitis C | 1 | 0% |
| Acute HIV infection | 2 | 0% |
| Acute interstitial pneumonitis | 10 | 0% |
| Acute kidney injury | 4,301 | 0.26% |
| Acute left ventricular failure | 166 | 0.01% |
| Acute leukaemia | 55 | 0% |
| Acute lung injury | 11 | 0% |
| Acute lymphocytic leukaemia | 51 | 0% |
| Acute macular neuroretinopathy | 50 | 0% |
| Acute macular outer retinopathy | 8 | 0% |
| Acute megakaryocytic leukaemia | 2 | 0% |
| Acute monocytic leukaemia | 3 | 0% |
| Acute motor-sensory axonal neuropathy | 31 | 0% |
| Acute motor axonal neuropathy | 30 | 0% |
| Acute myeloid leukaemia | 137 | 0.01% |
| Acute myeloid leukaemia recurrent | 12 | 0% |
| Acute myeloid leukaemia refractory | 1 | 0% |
| Acute myelomonocytic leukaemia | 4 | 0% |
| Acute myocardial infarction | 3,701 | 0.23% |
| Acute on chronic liver failure | 4 | 0% |
| Acute phase reaction | 14 | 0% |
| Acute polyneuropathy | 113 | 0.01% |
| Acute promyelocytic leukaemia | 13 | 0% |
| Acute psychosis | 55 | 0% |
| Acute pulmonary oedema | 262 | 0.02% |
| Acute respiratory distress syndrome | 640 | 0.04% |
| Acute respiratory failure | 6,628 | 0.4% |
| Acute right ventricular failure | 3 | 0% |
| Acute sinusitis | 94 | 0.01% |
| Acute stress disorder | 127 | 0.01% |
| Acute undifferentiated leukaemia | 1 | 0% |
| Acute vestibular syndrome | 85 | 0.01% |
| Acute zonal occult outer retinopathy | 1 | 0% |
| Adactyly | 1 | 0% |
| Adams-Stokes syndrome | 3 | 0% |
| ADAMTS13 activity abnormal | 2 | 0% |
| ADAMTS13 activity assay | 109 | 0.01% |
| ADAMTS13 activity decreased | 13 | 0% |
| ADAMTS13 activity increased | 2 | 0% |
| ADAMTS13 activity normal | 9 | 0% |
| ADAMTS13 inhibitor screen assay | 23 | 0% |
| Addison's disease | 44 | 0% |
| Adenocarcinoma | 49 | 0% |
| Adenocarcinoma gastric | 14 | 0% |
| Adenocarcinoma metastatic | 17 | 0% |
| Adenocarcinoma of appendix | 1 | 0% |
| Adenocarcinoma of colon | 20 | 0% |
| Adenocarcinoma of the cervix | 5 | 0% |
| Adenocarcinoma pancreas | 19 | 0% |
| Adenoidal disorder | 5 | 0% |
| Adenoidal hypertrophy | 7 | 0% |
| Adenoid cystic carcinoma | 1 | 0% |
| Adenoidectomy | 2 | 0% |
| Adenoiditis | 1 | 0% |
| Adenoma benign | 17 | 0% |
| Adenomatous polyposis coli | 3 | 0% |
| Adenomyosis | 176 | 0.01% |
| Adenopathy syphilitic | 4 | 0% |
| Adenosine deaminase | 30 | 0% |
| Adenosine deaminase increased | 2 | 0% |
| Adenotonsillectomy | 1 | 0% |
| Adenoviral conjunctivitis | 3 | 0% |
| Adenoviral meningitis | 1 | 0% |
| Adenovirus infection | 15 | 0% |
| Adenovirus reactivation | 4 | 0% |
| Adenovirus test | 374 | 0.02% |
| Adenovirus test positive | 11 | 0% |
| Adhesiolysis | 8 | 0% |
| Adhesion | 20 | 0% |
| Adhesive tape use | 1 | 0% |
| Adiposis dolorosa | 7 | 0% |
| Adjusted calcium | 85 | 0.01% |
| Adjusted calcium decreased | 1 | 0% |
| Adjusted calcium increased | 3 | 0% |
| Adjustment disorder | 44 | 0% |
| Adjustment disorder with anxiety | 4 | 0% |
| Adjustment disorder with depressed mood | 60 | 0% |
| Adjustment disorder with mixed anxiety and depressed mood | 8 | 0% |
| Adjustment disorder with mixed disturbance of emotion and conduct | 2 | 0% |
| Administration related reaction | 2 | 0% |
| Administration site acne | 1 | 0% |
| Administration site bruise | 26 | 0% |
| Administration site calcification | 2 | 0% |
| Administration site cellulitis | 2 | 0% |
| Administration site coldness | 1 | 0% |
| Administration site cyst | 1 | 0% |
| Administration site discharge | 2 | 0% |
| Administration site discolouration | 2 | 0% |
| Administration site discomfort | 3 | 0% |
| Administration site dryness | 1 | 0% |
| Administration site dysaesthesia | 1 | 0% |
| Administration site erythema | 18 | 0% |
| Administration site extravasation | 4 | 0% |
| Administration site haematoma | 2 | 0% |
| Administration site haemorrhage | 1 | 0% |
| Administration site hyperaesthesia | 1 | 0% |
| Administration site hypersensitivity | 1 | 0% |
| Administration site indentation | 3 | 0% |
| Administration site induration | 5 | 0% |
| Administration site infection | 1 | 0% |
| Administration site inflammation | 4 | 0% |
| Administration site irritation | 2 | 0% |
| Administration site joint erythema | 1 | 0% |
| Administration site joint movement impairment | 4 | 0% |
| Administration site joint pain | 2 | 0% |
| Administration site lymphadenopathy | 2 | 0% |
| Administration site mass | 1 | 0% |
| Administration site movement impairment | 12 | 0% |
| Administration site nerve damage | 2 | 0% |
| Administration site nodule | 8 | 0% |
| Administration site odour | 1 | 0% |
| Administration site oedema | 10 | 0% |
| Administration site pain | 100 | 0.01% |
| Administration site papule | 1 | 0% |
| Administration site pruritus | 6 | 0% |
| Administration site rash | 9 | 0% |
| Administration site reaction | 14 | 0% |
| Administration site recall reaction | 1 | 0% |
| Administration site swelling | 16 | 0% |
| Administration site urticaria | 2 | 0% |
| Administration site warmth | 9 | 0% |
| Administration site wound | 3 | 0% |
| Adnexal torsion | 23 | 0% |
| Adnexa uteri cyst | 4 | 0% |
| Adnexa uteri mass | 14 | 0% |
| Adnexa uteri pain | 531 | 0.03% |
| Adrenal adenoma | 28 | 0% |
| Adrenal atrophy | 1 | 0% |
| Adrenal cortex necrosis | 1 | 0% |
| Adrenal cyst | 1 | 0% |
| Adrenal disorder | 69 | 0% |
| Adrenalectomy | 4 | 0% |
| Adrenal gland cancer | 8 | 0% |
| Adrenal gland operation | 1 | 0% |
| Adrenal haemorrhage | 20 | 0% |
| Adrenal insufficiency | 145 | 0.01% |
| Adrenalitis | 1 | 0% |
| Adrenal mass | 52 | 0% |
| Adrenal neoplasm | 11 | 0% |
| Adrenergic syndrome | 3 | 0% |
| Adrenocortical insufficiency acute | 123 | 0.01% |
| Adrenocortical steroid therapy | 5 | 0% |
| Adrenocorticotropic hormone deficiency | 7 | 0% |
| Adrenogenital syndrome | 2 | 0% |
| Adrenoleukodystrophy | 2 | 0% |
| Adrenomegaly | 5 | 0% |
| Adulterated product | 10 | 0% |
| Adult failure to thrive | 92 | 0.01% |
| Adult T-cell lymphoma/leukaemia | 7 | 0% |
| Advanced sleep phase | 2 | 0% |
| Adverse drug reaction | 1,012 | 0.06% |
| Adverse event | 1,559 | 0.09% |
| Adverse event following immunisation | 168 | 0.01% |
| Adverse food reaction | 53 | 0% |
| Adverse reaction | 1,132 | 0.07% |
| Aerococcus urinae infection | 10 | 0% |
| Aeromonas infection | 1 | 0% |
| Aerophagia | 11 | 0% |
| Aerophobia | 5 | 0% |
| Affective ambivalence | 1 | 0% |
| Affective disorder | 175 | 0.01% |
| Affect lability | 137 | 0.01% |
| African trypanosomiasis | 16 | 0% |
| Afterbirth pain | 1 | 0% |
| Age-related macular degeneration | 29 | 0% |
| Aged parent | 1 | 0% |
| Ageusia | 8,026 | 0.49% |
| Agglutination test | 13 | 0% |
| Aggression | 451 | 0.03% |
| Agitated depression | 12 | 0% |
| Agitation | 1,494 | 0.09% |
| Agitation neonatal | 3 | 0% |
| Agnosia | 16 | 0% |
| Agonal death struggle | 1 | 0% |
| Agonal respiration | 104 | 0.01% |
| Agonal rhythm | 8 | 0% |
| Agoraphobia | 22 | 0% |
| Agranulocytosis | 51 | 0% |
| Agraphia | 8 | 0% |
| Aichmophobia | 1 | 0% |
| Air embolism | 4 | 0% |
| Airway burns | 7 | 0% |
| Airway complication of anaesthesia | 4 | 0% |
| Airway patency device insertion | 3 | 0% |
| Airway peak pressure | 3 | 0% |
| Airway peak pressure increased | 4 | 0% |
| Airway secretion clearance therapy | 15 | 0% |
| Akathisia | 43 | 0% |
| Akinaesthesia | 1 | 0% |
| Akinesia | 65 | 0% |
| Alanine aminotransferase | 4,267 | 0.26% |
| Alanine aminotransferase abnormal | 19 | 0% |
| Alanine aminotransferase decreased | 27 | 0% |
| Alanine aminotransferase increased | 1,550 | 0.09% |
| Alanine aminotransferase normal | 852 | 0.05% |
| Albumin CSF | 57 | 0% |
| Albumin CSF abnormal | 4 | 0% |
| Albumin CSF decreased | 3 | 0% |
| Albumin CSF increased | 13 | 0% |
| Albumin CSF normal | 3 | 0% |
| Albumin globulin ratio | 242 | 0.01% |
| Albumin globulin ratio abnormal | 3 | 0% |
| Albumin globulin ratio decreased | 45 | 0% |
| Albumin globulin ratio increased | 12 | 0% |
| Albumin globulin ratio normal | 88 | 0.01% |
| Albuminuria | 35 | 0% |
| Albumin urine | 111 | 0.01% |
| Albumin urine absent | 11 | 0% |
| Albumin urine present | 19 | 0% |
| Alcohol abuse | 44 | 0% |
| Alcohol detoxification | 1 | 0% |
| Alcoholic | 6 | 0% |
| Alcoholic hangover | 5 | 0% |
| Alcoholic ketoacidosis | 5 | 0% |
| Alcoholic liver disease | 4 | 0% |
| Alcoholic pancreatitis | 7 | 0% |
| Alcoholic psychosis | 1 | 0% |
| Alcoholic seizure | 6 | 0% |
| Alcohol induced persisting dementia | 1 | 0% |
| Alcohol interaction | 6 | 0% |
| Alcohol intolerance | 66 | 0% |
| Alcoholism | 32 | 0% |
| Alcohol poisoning | 47 | 0% |
| Alcohol problem | 5 | 0% |
| Alcohol rehabilitation | 1 | 0% |
| Alcohol test | 37 | 0% |
| Alcohol test false positive | 1 | 0% |
| Alcohol test negative | 20 | 0% |
| Alcohol test positive | 4 | 0% |
| Alcohol use | 94 | 0.01% |
| Alcohol use disorder | 11 | 0% |
| Alcohol withdrawal syndrome | 59 | 0% |
| Aldolase | 81 | 0% |
| Aldolase abnormal | 1 | 0% |
| Aldolase decreased | 2 | 0% |
| Aldolase increased | 18 | 0% |
| Aldolase normal | 15 | 0% |
| Aldosterone urine | 1 | 0% |
| Aldosterone urine increased | 2 | 0% |
| Alexia | 9 | 0% |
| Alexithymia | 1 | 0% |
| Alice in wonderland syndrome | 11 | 0% |
| Alien limb syndrome | 2 | 0% |
| Alkalosis | 8 | 0% |
| Alkalosis hypochloraemic | 3 | 0% |
| Alkalosis hypokalaemic | 1 | 0% |
| ALK gene rearrangement assay | 1 | 0% |
| ALK gene rearrangement positive | 2 | 0% |
| Allen's test | 16 | 0% |
| Allergic bronchitis | 3 | 0% |
| Allergic bronchopulmonary mycosis | 1 | 0% |
| Allergic cough | 34 | 0% |
| Allergic gastroenteritis | 2 | 0% |
| Allergic hepatitis | 4 | 0% |
| Allergic oedema | 39 | 0% |
| Allergic otitis media | 1 | 0% |
| Allergic pharyngitis | 2 | 0% |
| Allergic reaction to excipient | 44 | 0% |
| Allergic respiratory disease | 13 | 0% |
| Allergic respiratory symptom | 45 | 0% |
| Allergic sinusitis | 21 | 0% |
| Allergy alert test | 5 | 0% |
| Allergy alert test negative | 2 | 0% |
| Allergy alert test positive | 1 | 0% |
| Allergy prophylaxis | 2 | 0% |
| Allergy test | 1,000 | 0.06% |
| Allergy test negative | 229 | 0.01% |
| Allergy test positive | 133 | 0.01% |
| Allergy to animal | 61 | 0% |
| Allergy to arthropod bite | 39 | 0% |
| Allergy to arthropod sting | 53 | 0% |
| Allergy to chemicals | 80 | 0% |
| Allergy to metals | 24 | 0% |
| Allergy to plants | 20 | 0% |
| Allergy to surgical sutures | 3 | 0% |
| Allergy to synthetic fabric | 4 | 0% |
| Allergy to vaccine | 851 | 0.05% |
| Allergy to venom | 1 | 0% |
| Allodynia | 194 | 0.01% |
| Allogenic stem cell transplantation | 2 | 0% |
| Alloimmune hepatitis | 4 | 0% |
| Alopecia | 4,064 | 0.25% |
| Alopecia areata | 471 | 0.03% |
| Alopecia scarring | 5 | 0% |
| Alopecia totalis | 41 | 0% |
| Alopecia universalis | 49 | 0% |
| Alpha-1 acid glycoprotein | 2 | 0% |
| Alpha-1 acid glycoprotein abnormal | 2 | 0% |
| Alpha-1 acid glycoprotein increased | 3 | 0% |
| Alpha-1 acid glycoprotein normal | 1 | 0% |
| Alpha-1 anti-trypsin | 42 | 0% |
| Alpha-1 anti-trypsin decreased | 2 | 0% |
| Alpha-1 anti-trypsin increased | 2 | 0% |
| Alpha-1 anti-trypsin normal | 4 | 0% |
| Alpha-1 antitrypsin deficiency | 9 | 0% |
| Alpha-2 macroglobulin | 6 | 0% |
| Alpha-2 macroglobulin increased | 3 | 0% |
| Alpha 1 foetoprotein | 110 | 0.01% |
| Alpha 1 foetoprotein abnormal | 2 | 0% |
| Alpha 1 foetoprotein amniotic fluid | 5 | 0% |
| Alpha 1 foetoprotein increased | 18 | 0% |
| Alpha 1 foetoprotein normal | 14 | 0% |
| Alpha 1 globulin | 117 | 0.01% |
| Alpha 1 globulin abnormal | 2 | 0% |
| Alpha 1 globulin decreased | 4 | 0% |
| Alpha 1 globulin increased | 9 | 0% |
| Alpha 1 globulin normal | 8 | 0% |
| Alpha 1 microglobulin | 6 | 0% |
| Alpha 2 globulin | 123 | 0.01% |
| Alpha 2 globulin abnormal | 2 | 0% |
| Alpha 2 globulin decreased | 4 | 0% |
| Alpha 2 globulin increased | 12 | 0% |
| Alpha 2 globulin normal | 5 | 0% |
| Alpha globulin decreased | 2 | 0% |
| Alpha globulin increased | 2 | 0% |
| Alpha haemolytic streptococcal infection | 6 | 0% |
| Alpha hydroxybutyrate dehydrogenase | 1 | 0% |
| Alpha hydroxybutyrate dehydrogenase increased | 1 | 0% |
| Alpha tumour necrosis factor | 49 | 0% |
| Alpha tumour necrosis factor increased | 8 | 0% |
| Alphavirus test | 1 | 0% |
| Alport's syndrome | 1 | 0% |
| Altered pitch perception | 4 | 0% |
| Altered state of consciousness | 1,588 | 0.1% |
| Altered visual depth perception | 65 | 0% |
| Alternaria infection | 1 | 0% |
| Alveolar-arterial oxygen gradient | 5 | 0% |
| Alveolar lung disease | 16 | 0% |
| Alveolar osteitis | 3 | 0% |
| Alveolar oxygen partial pressure | 5 | 0% |
| Alveolar proteinosis | 3 | 0% |
| Alveolitis | 27 | 0% |
| Amaurosis | 46 | 0% |
| Amaurosis fugax | 160 | 0.01% |
| Amblyopia | 40 | 0% |
| Amblyopia strabismic | 1 | 0% |
| Amegakaryocytic thrombocytopenia | 3 | 0% |
| Amenorrhoea | 3,877 | 0.24% |
| American Society of Anesthesiologists physical status classification | 1 | 0% |
| American trypanosomiasis | 2 | 0% |
| Amimia | 1 | 0% |
| Amino acid level | 45 | 0% |
| Amino acid level abnormal | 1 | 0% |
| Amino acid level decreased | 2 | 0% |
| Amino acid level increased | 9 | 0% |
| Amino acid level normal | 3 | 0% |
| Amino acid metabolism disorder | 1 | 0% |
| Aminopyrine breathing test | 2 | 0% |
| Ammonia | 98 | 0.01% |
| Ammonia abnormal | 1 | 0% |
| Ammonia decreased | 6 | 0% |
| Ammonia increased | 61 | 0% |
| Ammonia normal | 63 | 0% |
| Amnesia | 3,422 | 0.21% |
| Amnestic disorder | 61 | 0% |
| Amniocentesis | 54 | 0% |
| Amniocentesis abnormal | 10 | 0% |
| Amniocentesis normal | 8 | 0% |
| Amniorrhexis | 7 | 0% |
| Amniorrhoea | 35 | 0% |
| Amniotic band syndrome | 1 | 0% |
| Amniotic cavity disorder | 2 | 0% |
| Amniotic cavity infection | 22 | 0% |
| Amniotic fluid index | 7 | 0% |
| Amniotic fluid index decreased | 4 | 0% |
| Amniotic fluid index increased | 1 | 0% |
| Amniotic fluid index normal | 1 | 0% |
| Amniotic fluid volume | 5 | 0% |
| Amniotic fluid volume decreased | 14 | 0% |
| Amniotic fluid volume increased | 8 | 0% |
| Amniotic membrane rupture test | 4 | 0% |
| Amniotic membrane rupture test negative | 1 | 0% |
| Amniotic membrane rupture test positive | 7 | 0% |
| Amoeba test | 1 | 0% |
| Amoebiasis | 2 | 0% |
| Amoebic dysentery | 2 | 0% |
| Amphetamines | 13 | 0% |
| Amphetamines negative | 5 | 0% |
| Amphetamines positive | 6 | 0% |
| Amplified musculoskeletal pain syndrome | 2 | 0% |
| Ampullary renal pelvis | 1 | 0% |
| Amputation | 26 | 0% |
| Amputation stump pain | 3 | 0% |
| Amylase | 532 | 0.03% |
| Amylase abnormal | 1 | 0% |
| Amylase decreased | 17 | 0% |
| Amylase increased | 83 | 0.01% |
| Amylase normal | 36 | 0% |
| Amyloidosis | 56 | 0% |
| Amyloidosis senile | 4 | 0% |
| Amyloid related imaging abnormalities | 1 | 0% |
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | 1 | 0% |
| Amyloid related imaging abnormality-oedema/effusion | 2 | 0% |
| Amyotrophic lateral sclerosis | 287 | 0.02% |
| Amyotrophic lateral sclerosis gene carrier | 2 | 0% |
| Amyotrophy | 56 | 0% |
| Anaemia | 3,071 | 0.19% |
| Anaemia folate deficiency | 12 | 0% |
| Anaemia macrocytic | 73 | 0% |
| Anaemia megaloblastic | 7 | 0% |
| Anaemia neonatal | 2 | 0% |
| Anaemia of chronic disease | 71 | 0% |
| Anaemia of malignant disease | 4 | 0% |
| Anaemia of pregnancy | 6 | 0% |
| Anaemia postoperative | 8 | 0% |
| Anaemia splenic | 1 | 0% |
| Anaemia vitamin B12 deficiency | 21 | 0% |
| Anaemic hypoxia | 2 | 0% |
| Anaesthesia | 108 | 0.01% |
| Anaesthesia dolorosa | 3 | 0% |
| Anaesthesia oral | 52 | 0% |
| Anaesthetic complication | 7 | 0% |
| Anaesthetic complication neurological | 1 | 0% |
| Anal abscess | 50 | 0% |
| Anal atresia | 3 | 0% |
| Anal blister | 1 | 0% |
| Anal cancer | 7 | 0% |
| Anal candidiasis | 3 | 0% |
| Anal cyst | 1 | 0% |
| Anal dilatation | 2 | 0% |
| Anal eczema | 2 | 0% |
| Anal erythema | 6 | 0% |
| Anal examination | 10 | 0% |
| Anal examination abnormal | 1 | 0% |
| Anal fissure | 23 | 0% |
| Anal fissure excision | 1 | 0% |
| Anal fissure haemorrhage | 1 | 0% |
| Anal fistula | 15 | 0% |
| Anal fungal infection | 2 | 0% |
| Analgesic drug level | 40 | 0% |
| Analgesic drug level above therapeutic | 1 | 0% |
| Analgesic drug level decreased | 1 | 0% |
| Analgesic drug level increased | 3 | 0% |
| Analgesic drug level therapeutic | 15 | 0% |
| Analgesic intervention supportive therapy | 1 | 0% |
| Analgesic therapy | 14 | 0% |
| Anal haemorrhage | 117 | 0.01% |
| Anal hypoaesthesia | 9 | 0% |
| Anal incontinence | 627 | 0.04% |
| Anal infection | 2 | 0% |
| Anal inflammation | 9 | 0% |
| Anal injury | 2 | 0% |
| Anal pap smear | 5 | 0% |
| Anal paraesthesia | 2 | 0% |
| Anal polyp | 1 | 0% |
| Anal pruritus | 33 | 0% |
| Anal rash | 15 | 0% |
| Anal skin tags | 2 | 0% |
| Anal sphincter atony | 35 | 0% |
| Anal sphincter hypertonia | 2 | 0% |
| Anal sphincterotomy | 1 | 0% |
| Anal squamous cell carcinoma | 2 | 0% |
| Anal stenosis | 2 | 0% |
| Anal ulcer | 5 | 0% |
| Anamnestic reaction | 12 | 0% |
| Anaphylactic reaction | 9,208 | 0.56% |
| Anaphylactic shock | 1,581 | 0.1% |
| Anaphylactoid reaction | 299 | 0.02% |
| Anaphylactoid shock | 6 | 0% |
| Anaphylactoid syndrome of pregnancy | 2 | 0% |
| Anaphylaxis prophylaxis | 19 | 0% |
| Anaphylaxis treatment | 2 | 0% |
| Anaplastic astrocytoma | 1 | 0% |
| Anaplastic large-cell lymphoma | 4 | 0% |
| Anaplastic large cell lymphoma T- and null-cell types | 2 | 0% |
| Anaplastic lymphoma kinase gene mutation | 1 | 0% |
| Anaplastic lymphoma receptor tyrosine kinase assay | 4 | 0% |
| Anaplastic thyroid cancer | 5 | 0% |
| Anastomotic complication | 1 | 0% |
| Anastomotic leak | 5 | 0% |
| Anastomotic ulcer | 2 | 0% |
| Anastomotic ulcer haemorrhage | 1 | 0% |
| Anastomotic ulcer perforation | 1 | 0% |
| Androgen deficiency | 9 | 0% |
| Androgenetic alopecia | 15 | 0% |
| Androgens | 2 | 0% |
| Androgens abnormal | 2 | 0% |
| Androgens increased | 3 | 0% |
| Anembryonic gestation | 61 | 0% |
| Anencephaly | 11 | 0% |
| Anetoderma | 2 | 0% |
| Aneurysm | 211 | 0.01% |
| Aneurysmal bone cyst | 1 | 0% |
| Aneurysm arteriovenous | 1 | 0% |
| Aneurysmectomy | 1 | 0% |
| Aneurysm repair | 11 | 0% |
| Aneurysm ruptured | 74 | 0% |
| Aneurysm thrombosis | 2 | 0% |
| Angelman's syndrome | 1 | 0% |
| Anger | 428 | 0.03% |
| Angina bullosa haemorrhagica | 9 | 0% |
| Anginal equivalent | 2 | 0% |
| Angina pectoris | 7,884 | 0.48% |
| Angina unstable | 222 | 0.01% |
| Angiocardiogram | 1,648 | 0.1% |
| Angiocentric lymphoma | 4 | 0% |
| Angiodermatitis | 2 | 0% |
| Angiodysplasia | 2 | 0% |
| Angioedema | 4,279 | 0.26% |
| Angiofibroma | 1 | 0% |
| Angiogenesis biomarker | 2 | 0% |
| Angiogram | 6,048 | 0.37% |
| Angiogram abnormal | 332 | 0.02% |
| Angiogram cerebral | 461 | 0.03% |
| Angiogram cerebral abnormal | 350 | 0.02% |
| Angiogram cerebral normal | 337 | 0.02% |
| Angiogram normal | 351 | 0.02% |
| Angiogram peripheral | 12 | 0% |
| Angiogram peripheral abnormal | 16 | 0% |
| Angiogram peripheral normal | 1 | 0% |
| Angiogram pulmonary | 243 | 0.01% |
| Angiogram pulmonary abnormal | 1,571 | 0.1% |
| Angiogram pulmonary normal | 399 | 0.02% |
| Angiogram retina | 120 | 0.01% |
| Angiogram retina abnormal | 8 | 0% |
| Angiogram retina normal | 1 | 0% |
| Angioimmunoblastic T-cell lymphoma | 12 | 0% |
| Angioimmunoblastic T-cell lymphoma recurrent | 2 | 0% |
| Angioimmunoblastic T-cell lymphoma stage III | 1 | 0% |
| Angiokeratoma | 2 | 0% |
| Angiolipoma | 9 | 0% |
| Angiolymphoid hyperplasia with eosinophilia | 1 | 0% |
| Angiomyolipoma | 9 | 0% |
| Angiopathy | 275 | 0.02% |
| Angioplasty | 113 | 0.01% |
| Angiosarcoma | 8 | 0% |
| Angioscopy | 95 | 0.01% |
| Angiotensin converting enzyme | 410 | 0.02% |
| Angiotensin converting enzyme abnormal | 1 | 0% |
| Angiotensin converting enzyme decreased | 10 | 0% |
| Angiotensin converting enzyme increased | 13 | 0% |
| Angiotensin converting enzyme inhibitor foetopathy | 1 | 0% |
| Angiotensin converting enzyme normal | 9 | 0% |
| Angiotensin I | 6 | 0% |
| Angiotensin II | 6 | 0% |
| Angiotensin II abnormal | 1 | 0% |
| Angiotensin II decreased | 1 | 0% |
| Angiotensin II receptor type 1 antibody positive | 3 | 0% |
| Angle closure glaucoma | 39 | 0% |
| Angular cheilitis | 35 | 0% |
| Anhedonia | 32 | 0% |
| Anhidrosis | 20 | 0% |
| Animal-assisted therapy | 1 | 0% |
| Animal attack | 1 | 0% |
| Animal bite | 37 | 0% |
| Animal scratch | 10 | 0% |
| Anion gap | 945 | 0.06% |
| Anion gap abnormal | 4 | 0% |
| Anion gap decreased | 100 | 0.01% |
| Anion gap increased | 81 | 0% |
| Anion gap normal | 116 | 0.01% |
| Anisakiasis | 3 | 0% |
| Anisochromia | 1 | 0% |
| Anisocoria | 49 | 0% |
| Anisocytosis | 35 | 0% |
| Anisomastia | 14 | 0% |
| Anisometropia | 3 | 0% |
| Ankle brachial index | 36 | 0% |
| Ankle brachial index abnormal | 3 | 0% |
| Ankle brachial index normal | 1 | 0% |
| Ankle deformity | 3 | 0% |
| Ankle fracture | 136 | 0.01% |
| Ankle operation | 12 | 0% |
| Ankyloglossia congenital | 14 | 0% |
| Ankylosing spondylitis | 415 | 0.03% |
| Annular elastolytic giant cell granuloma | 1 | 0% |
| Annuloplasty | 2 | 0% |
| Anodontia | 1 | 0% |
| Anogenital lichen planus | 1 | 0% |
| Anogenital warts | 23 | 0% |
| Anomalous atrioventricular excitation | 2 | 0% |
| Anomalous pulmonary venous connection | 2 | 0% |
| Anophthalmos | 2 | 0% |
| Anorectal discomfort | 44 | 0% |
| Anorectal disorder | 49 | 0% |
| Anorectal infection | 1 | 0% |
| Anorectal manometry | 3 | 0% |
| Anorectal operation | 2 | 0% |
| Anorectal swelling | 7 | 0% |
| Anorectal ulcer | 1 | 0% |
| Anorectal varices | 1 | 0% |
| Anorexia nervosa | 9 | 0% |
| Anorgasmia | 18 | 0% |
| Anosmia | 6,616 | 0.4% |
| Anosognosia | 11 | 0% |
| Anotia | 1 | 0% |
| Anovulatory cycle | 135 | 0.01% |
| Anoxia | 11 | 0% |
| Anterior chamber cell | 1 | 0% |
| Anterior chamber disorder | 2 | 0% |
| Anterior chamber flare | 3 | 0% |
| Anterior chamber inflammation | 5 | 0% |
| Anterior chamber opacity | 1 | 0% |
| Anterior chamber reformation | 1 | 0% |
| Anterior cord syndrome | 3 | 0% |
| Anterior interosseous syndrome | 1 | 0% |
| Anterior segment ischaemia | 4 | 0% |
| Anterior spinal artery syndrome | 1 | 0% |
| Anterograde amnesia | 23 | 0% |
| Anti-actin antibody | 12 | 0% |
| Anti-actin antibody positive | 1 | 0% |
| Anti-aquaporin-4 antibody | 203 | 0.01% |
| Anti-aquaporin-4 antibody negative | 12 | 0% |
| Anti-aquaporin-4 antibody positive | 7 | 0% |
| Anti-complement antibody | 9 | 0% |
| Anti-cyclic citrullinated peptide antibody | 803 | 0.05% |
| Anti-cyclic citrullinated peptide antibody negative | 89 | 0.01% |
| Anti-cyclic citrullinated peptide antibody positive | 57 | 0% |
| Anti-epithelial antibody | 2 | 0% |
| Anti-erythrocyte antibody | 11 | 0% |
| Anti-erythrocyte antibody positive | 1 | 0% |
| Anti-erythropoietin antibody | 1 | 0% |
| Anti-erythropoietin antibody positive | 1 | 0% |
| Anti-GAD antibody | 142 | 0.01% |
| Anti-GAD antibody negative | 7 | 0% |
| Anti-GAD antibody positive | 26 | 0% |
| Anti-ganglioside antibody | 221 | 0.01% |
| Anti-ganglioside antibody negative | 11 | 0% |
| Anti-ganglioside antibody positive | 24 | 0% |
| Anti-glomerular basement membrane antibody | 117 | 0.01% |
| Anti-glomerular basement membrane antibody negative | 3 | 0% |
| Anti-glomerular basement membrane antibody positive | 5 | 0% |
| Anti-glomerular basement membrane disease | 21 | 0% |
| Anti-glycyl-tRNA synthetase antibody | 5 | 0% |
| Anti-HLA antibody test | 15 | 0% |
| Anti-HLA antibody test positive | 2 | 0% |
| Anti-IA2 antibody | 38 | 0% |
| Anti-IA2 antibody negative | 2 | 0% |
| Anti-IA2 antibody positive | 4 | 0% |
| Anti-insulin antibody | 20 | 0% |
| Anti-insulin antibody increased | 1 | 0% |
| Anti-interferon antibody | 5 | 0% |
| Anti-islet cell antibody | 21 | 0% |
| Anti-islet cell antibody negative | 2 | 0% |
| Anti-islet cell antibody positive | 3 | 0% |
| Anti-JC virus antibody index | 3 | 0% |
| Anti-Jo-1 antibody | 4 | 0% |
| Anti-melanoma differentiation-associated protein 5 antibody positive | 17 | 0% |
| Anti-Muellerian hormone level | 47 | 0% |
| Anti-Muellerian hormone level decreased | 16 | 0% |
| Anti-Muellerian hormone level increased | 1 | 0% |
| Anti-Muellerian hormone level normal | 1 | 0% |
| Anti-muscle specific kinase antibody | 54 | 0% |
| Anti-muscle specific kinase antibody negative | 4 | 0% |
| Anti-muscle specific kinase antibody positive | 1 | 0% |
| Anti-myelin-associated glycoprotein antibodies positive | 14 | 0% |
| Anti-myelin-associated glycoprotein associated polyneuropathy | 7 | 0% |
| Anti-neuronal antibody | 82 | 0% |
| Anti-neuronal antibody negative | 1 | 0% |
| Anti-neuronal antibody positive | 1 | 0% |
| Anti-neutrophil cytoplasmic antibody positive vasculitis | 162 | 0.01% |
| Anti-NMDA antibody | 32 | 0% |
| Anti-NMDA antibody negative | 5 | 0% |
| Anti-NMDA antibody positive | 3 | 0% |
| Anti-nucleosome antibody | 2 | 0% |
| Anti-platelet antibody | 177 | 0.01% |
| Anti-platelet antibody negative | 2 | 0% |
| Anti-platelet antibody positive | 16 | 0% |
| Anti-platelet factor 4 antibody negative | 8 | 0% |
| Anti-platelet factor 4 antibody positive | 5 | 0% |
| Anti-platelet factor 4 antibody test | 232 | 0.01% |
| Anti-PM/Scl antibody | 2 | 0% |
| Anti-polyethylene glycol antibody | 2 | 0% |
| Anti-polyethylene glycol antibody absent | 1 | 0% |
| Anti-polyethylene glycol antibody present | 3 | 0% |
| Anti-prothrombin antibody positive | 4 | 0% |
| Anti-RNA polymerase III antibody | 29 | 0% |
| Anti-RNA polymerase III antibody negative | 7 | 0% |
| Anti-RNA polymerase III antibody positive | 1 | 0% |
| Anti-saccharomyces cerevisiae antibody | 18 | 0% |
| Anti-saccharomyces cerevisiae antibody test positive | 1 | 0% |
| Anti-soluble liver antigen/liver pancreas antibody | 5 | 0% |
| Anti-SRP antibody positive | 5 | 0% |
| Anti-sulfatide autoantibody | 2 | 0% |
| Anti-thrombin antibody | 20 | 0% |
| Anti-thyroid antibody | 843 | 0.05% |
| Anti-thyroid antibody decreased | 3 | 0% |
| Anti-thyroid antibody increased | 92 | 0.01% |
| Anti-thyroid antibody negative | 26 | 0% |
| Anti-thyroid antibody positive | 108 | 0.01% |
| Anti-titin antibody | 12 | 0% |
| Anti-transglutaminase antibody | 98 | 0.01% |
| Anti-transglutaminase antibody increased | 2 | 0% |
| Anti-transglutaminase antibody negative | 15 | 0% |
| Anti-VGCC antibody | 6 | 0% |
| Anti-VGCC antibody negative | 2 | 0% |
| Anti-VGCC antibody positive | 1 | 0% |
| Anti-VGKC antibody | 4 | 0% |
| Anti-VGKC antibody negative | 1 | 0% |
| Anti-zinc transporter 8 antibody | 21 | 0% |
| Anti-zinc transporter 8 antibody negative | 1 | 0% |
| Anti-zinc transporter 8 antibody positive | 2 | 0% |
| Anti A antibody | 1 | 0% |
| Antiacetylcholine receptor antibody | 161 | 0.01% |
| Antiacetylcholine receptor antibody positive | 38 | 0% |
| Antiallergic therapy | 6 | 0% |
| Antiangiogenic therapy | 2 | 0% |
| Anti B antibody | 4 | 0% |
| Anti B antibody positive | 1 | 0% |
| Antibiotic level | 8 | 0% |
| Antibiotic therapy | 13 | 0% |
| Antibody-dependent enhancement | 7 | 0% |
| Antibody test | 3,356 | 0.2% |
| Antibody test abnormal | 118 | 0.01% |
| Antibody test negative | 192 | 0.01% |
| Antibody test normal | 25 | 0% |
| Antibody test positive | 154 | 0.01% |
| Anticholinergic syndrome | 2 | 0% |
| Anticipatory anxiety | 10 | 0% |
| Anticoagulant therapy | 4,551 | 0.28% |
| Anticoagulation drug level | 16 | 0% |
| Anticoagulation drug level above therapeutic | 56 | 0% |
| Anticoagulation drug level below therapeutic | 22 | 0% |
| Anticoagulation drug level increased | 3 | 0% |
| Anticoagulation drug level normal | 1 | 0% |
| Anticoagulation drug level therapeutic | 7 | 0% |
| Anticonvulsant drug level | 18 | 0% |
| Anticonvulsant drug level below therapeutic | 5 | 0% |
| Anticonvulsant drug level decreased | 7 | 0% |
| Anticonvulsant drug level increased | 2 | 0% |
| Anticonvulsant drug level therapeutic | 7 | 0% |
| Antidepressant drug level | 19 | 0% |
| Antiemetic supportive care | 2 | 0% |
| Antiendomysial antibody positive | 1 | 0% |
| Antiendomysial antibody test | 10 | 0% |
| Anti factor IX antibody | 2 | 0% |
| Anti factor IX antibody increased | 3 | 0% |
| Anti factor V antibody | 9 | 0% |
| Anti factor V antibody positive | 1 | 0% |
| Anti factor VIII antibody increased | 8 | 0% |
| Anti factor VIII antibody positive | 7 | 0% |
| Anti factor VIII antibody test | 57 | 0% |
| Anti factor Xa activity decreased | 4 | 0% |
| Anti factor Xa assay | 4 | 0% |
| Anti factor Xa assay normal | 7 | 0% |
| Anti factor X activity | 12 | 0% |
| Anti factor X activity increased | 1 | 0% |
| Anti factor X antibody | 3 | 0% |
| Anti factor XI antibody positive | 1 | 0% |
| Antifungal treatment | 2 | 0% |
| Antigliadin antibody | 15 | 0% |
| Antigliadin antibody positive | 2 | 0% |
| Antiinflammatory therapy | 1 | 0% |
| Antimicrobial susceptibility test | 42 | 0% |
| Antimicrobial susceptibility test resistant | 5 | 0% |
| Antimicrobial susceptibility test sensitive | 7 | 0% |
| Antimitochondrial antibody | 159 | 0.01% |
| Antimitochondrial antibody normal | 13 | 0% |
| Antimitochondrial antibody positive | 15 | 0% |
| Antimyocardial antibody | 1 | 0% |
| Antimyocardial antibody positive | 1 | 0% |
| Antineutrophil cytoplasmic antibody | 1,330 | 0.08% |
| Antineutrophil cytoplasmic antibody decreased | 2 | 0% |
| Antineutrophil cytoplasmic antibody increased | 33 | 0% |
| Antineutrophil cytoplasmic antibody negative | 122 | 0.01% |
| Antineutrophil cytoplasmic antibody positive | 87 | 0.01% |
| Antinuclear antibody | 3,588 | 0.22% |
| Antinuclear antibody increased | 202 | 0.01% |
| Antinuclear antibody negative | 543 | 0.03% |
| Antinuclear antibody positive | 736 | 0.04% |
| Antioestrogen therapy | 1 | 0% |
| Antioxidant capacity test | 5 | 0% |
| Antiphospholipid antibodies | 707 | 0.04% |
| Antiphospholipid antibodies negative | 85 | 0.01% |
| Antiphospholipid antibodies positive | 75 | 0% |
| Antiphospholipid syndrome | 223 | 0.01% |
| Antiplatelet therapy | 71 | 0% |
| Antipsychotic drug level | 24 | 0% |
| Antipsychotic drug level below therapeutic | 3 | 0% |
| Antipsychotic drug level decreased | 1 | 0% |
| Antipsychotic drug level increased | 11 | 0% |
| Antipsychotic therapy | 1 | 0% |
| Antiretroviral therapy | 1 | 0% |
| Antiribosomal P antibody | 18 | 0% |
| Antiribosomal P antibody positive | 1 | 0% |
| Antisocial behaviour | 9 | 0% |
| Antisocial personality disorder | 2 | 0% |
| Antisynthetase syndrome | 37 | 0% |
| Antithrombin III | 316 | 0.02% |
| Antithrombin III abnormal | 1 | 0% |
| Antithrombin III decreased | 13 | 0% |
| Antithrombin III deficiency | 14 | 0% |
| Antithrombin III increased | 4 | 0% |
| Antiviral treatment | 8 | 0% |
| Antral follicle count | 11 | 0% |
| Antral follicle count low | 8 | 0% |
| Anuria | 147 | 0.01% |
| Anxiety | 14,793 | 0.9% |
| Anxiety disorder | 225 | 0.01% |
| Anxiety disorder due to a general medical condition | 2 | 0% |
| Aorta hypoplasia | 3 | 0% |
| Aortic aneurysm | 271 | 0.02% |
| Aortic aneurysm repair | 15 | 0% |
| Aortic aneurysm rupture | 55 | 0% |
| Aortic arteriosclerosis | 317 | 0.02% |
| Aortic bruit | 8 | 0% |
| Aortic bypass | 3 | 0% |
| Aortic dilatation | 118 | 0.01% |
| Aortic disorder | 46 | 0% |
| Aortic dissection | 284 | 0.02% |
| Aortic dissection rupture | 9 | 0% |
| Aortic elongation | 5 | 0% |
| Aortic embolus | 9 | 0% |
| Aortic injury | 4 | 0% |
| Aortic intramural haematoma | 8 | 0% |
| Aortic occlusion | 25 | 0% |
| Aorticopulmonary septal defect | 1 | 0% |
| Aortic perforation | 5 | 0% |
| Aortic root compression | 1 | 0% |
| Aortic root enlargement procedure | 1 | 0% |
| Aortic rupture | 15 | 0% |
| Aortic stenosis | 156 | 0.01% |
| Aortic stent insertion | 5 | 0% |
| Aortic surgery | 3 | 0% |
| Aortic thrombosis | 102 | 0.01% |
| Aortic valve calcification | 28 | 0% |
| Aortic valve disease | 19 | 0% |
| Aortic valve disease mixed | 5 | 0% |
| Aortic valve incompetence | 245 | 0.01% |
| Aortic valve repair | 6 | 0% |
| Aortic valve replacement | 61 | 0% |
| Aortic valve sclerosis | 31 | 0% |
| Aortic valve stenosis | 86 | 0.01% |
| Aortic valve thickening | 19 | 0% |
| Aortic wall hypertrophy | 2 | 0% |
| Aortitis | 48 | 0% |
| Aortogram | 9 | 0% |
| Aortogram normal | 1 | 0% |
| APACHE II score | 1 | 0% |
| Apallic syndrome | 26 | 0% |
| Apathy | 831 | 0.05% |
| Apgar score | 44 | 0% |
| Apgar score abnormal | 1 | 0% |
| Apgar score low | 3 | 0% |
| Apgar score normal | 1 | 0% |
| Aphakia | 2 | 0% |
| Aphasia | 4,451 | 0.27% |
| Apheresis | 5 | 0% |
| Aphonia | 1,258 | 0.08% |
| Aphthous ulcer | 719 | 0.04% |
| Aphthovirus test positive | 1 | 0% |
| Apical granuloma | 2 | 0% |
| Aplasia | 8 | 0% |
| Aplasia cutis congenita | 3 | 0% |
| Aplasia pure red cell | 13 | 0% |
| Aplastic anaemia | 146 | 0.01% |
| Apnoea | 334 | 0.02% |
| Apnoea test | 41 | 0% |
| Apnoea test abnormal | 3 | 0% |
| Apnoeic attack | 30 | 0% |
| Apolipoprotein | 8 | 0% |
| Apolipoprotein A-I | 8 | 0% |
| Apolipoprotein A-II | 1 | 0% |
| Apolipoprotein B | 10 | 0% |
| Apolipoprotein B increased | 1 | 0% |
| Apolipoprotein E gene status assay | 1 | 0% |
| Apoptosis | 3 | 0% |
| Apparent death | 1 | 0% |
| Apparent life threatening event | 10 | 0% |
| Appendiceal abscess | 12 | 0% |
| Appendicectomy | 602 | 0.04% |
| Appendicitis | 1,574 | 0.1% |
| Appendicitis noninfective | 2 | 0% |
| Appendicitis perforated | 208 | 0.01% |
| Appendicolith | 10 | 0% |
| Appendix cancer | 4 | 0% |
| Appendix cancer metastatic | 1 | 0% |
| Appendix disorder | 38 | 0% |
| Appetite disorder | 249 | 0.02% |
| Application site acne | 2 | 0% |
| Application site bruise | 7 | 0% |
| Application site burn | 3 | 0% |
| Application site coldness | 6 | 0% |
| Application site discolouration | 5 | 0% |
| Application site discomfort | 4 | 0% |
| Application site dysaesthesia | 1 | 0% |
| Application site erythema | 47 | 0% |
| Application site haematoma | 5 | 0% |
| Application site haemorrhage | 4 | 0% |
| Application site hypersensitivity | 1 | 0% |
| Application site hypoaesthesia | 12 | 0% |
| Application site induration | 2 | 0% |
| Application site infection | 2 | 0% |
| Application site inflammation | 4 | 0% |
| Application site joint erythema | 1 | 0% |
| Application site joint movement impairment | 2 | 0% |
| Application site joint pain | 1 | 0% |
| Application site joint swelling | 1 | 0% |
| Application site laceration | 1 | 0% |
| Application site lymphadenopathy | 1 | 0% |
| Application site movement impairment | 11 | 0% |
| Application site necrosis | 2 | 0% |
| Application site nerve damage | 2 | 0% |
| Application site nodule | 1 | 0% |
| Application site oedema | 2 | 0% |
| Application site pain | 139 | 0.01% |
| Application site paraesthesia | 4 | 0% |
| Application site plaque | 1 | 0% |
| Application site pruritus | 7 | 0% |
| Application site pustules | 1 | 0% |
| Application site rash | 5 | 0% |
| Application site reaction | 20 | 0% |
| Application site swelling | 42 | 0% |
| Application site thrombosis | 1 | 0% |
| Application site vasculitis | 2 | 0% |
| Application site vesicles | 5 | 0% |
| Application site warmth | 5 | 0% |
| Apraxia | 123 | 0.01% |
| Aptyalism | 76 | 0% |
| Aqueductal stenosis | 4 | 0% |
| Aqueous humour leakage | 1 | 0% |
| Arachnodactyly | 1 | 0% |
| Arachnoid cyst | 37 | 0% |
| Arachnoiditis | 10 | 0% |
| Arachnoid web | 3 | 0% |
| Arboviral infection | 1 | 0% |
| Areflexia | 266 | 0.02% |
| Argininosuccinate lyase decreased | 1 | 0% |
| Argininosuccinate synthetase deficiency | 3 | 0% |
| Argon plasma coagulation | 2 | 0% |
| Arm amputation | 5 | 0% |
| Arnold-Chiari malformation | 24 | 0% |
| Arrested labour | 6 | 0% |
| Arrhythmia | 17,052 | 1.04% |
| Arrhythmia neonatal | 8 | 0% |
| Arrhythmia supraventricular | 99 | 0.01% |
| Arrhythmic storm | 5 | 0% |
| Arrhythmogenic right ventricular dysplasia | 10 | 0% |
| Arterial angioplasty | 3 | 0% |
| Arterial bruit | 1 | 0% |
| Arterial bypass operation | 3 | 0% |
| Arterial catheterisation | 66 | 0% |
| Arterial catheterisation abnormal | 7 | 0% |
| Arterial catheterisation normal | 3 | 0% |
| Arterial compression therapy | 2 | 0% |
| Arterial disorder | 71 | 0% |
| Arterial dolichoectasia | 1 | 0% |
| Arterial fibrosis | 3 | 0% |
| Arterial flow velocity decreased | 1 | 0% |
| Arterial graft | 2 | 0% |
| Arterial haemorrhage | 21 | 0% |
| Arterial injury | 22 | 0% |
| Arterial insufficiency | 7 | 0% |
| Arterial intramural haematoma | 2 | 0% |
| Arterial occlusive disease | 258 | 0.02% |
| Arterial perforation | 1 | 0% |
| Arterial puncture | 5 | 0% |
| Arterial recanalisation procedure | 2 | 0% |
| Arterial repair | 3 | 0% |
| Arterial revascularisation | 3 | 0% |
| Arterial rupture | 29 | 0% |
| Arterial segmental pressure test | 2 | 0% |
| Arterial spasm | 9 | 0% |
| Arterial stenosis | 45 | 0% |
| Arterial stent insertion | 33 | 0% |
| Arterial stiffness | 1 | 0% |
| Arterial therapeutic procedure | 7 | 0% |
| Arterial thrombosis | 165 | 0.01% |
| Arterial tortuosity syndrome | 2 | 0% |
| Arterial wall hypertrophy | 2 | 0% |
| Arteriogram | 80 | 0% |
| Arteriogram abnormal | 6 | 0% |
| Arteriogram carotid | 239 | 0.01% |
| Arteriogram carotid abnormal | 147 | 0.01% |
| Arteriogram carotid normal | 214 | 0.01% |
| Arteriogram coronary abnormal | 152 | 0.01% |
| Arteriogram coronary normal | 133 | 0.01% |
| Arteriogram normal | 6 | 0% |
| Arteriogram renal | 4 | 0% |
| Arteriosclerosis | 438 | 0.03% |
| Arteriosclerosis coronary artery | 276 | 0.02% |
| Arteriosclerotic gangrene | 1 | 0% |
| Arteriosclerotic retinopathy | 7 | 0% |
| Arteriospasm coronary | 71 | 0% |
| Arteriotomy | 1 | 0% |
| Arteriovenous fistula | 37 | 0% |
| Arteriovenous fistula aneurysm | 2 | 0% |
| Arteriovenous fistula occlusion | 1 | 0% |
| Arteriovenous fistula operation | 7 | 0% |
| Arteriovenous fistula site complication | 4 | 0% |
| Arteriovenous fistula site haemorrhage | 6 | 0% |
| Arteriovenous fistula site pseudoaneurysm | 1 | 0% |
| Arteriovenous fistula thrombosis | 11 | 0% |
| Arteriovenous graft | 1 | 0% |
| Arteriovenous graft site infection | 1 | 0% |
| Arteriovenous graft thrombosis | 2 | 0% |
| Arteriovenous malformation | 29 | 0% |
| Arteritis | 42 | 0% |
| Arteritis coronary | 8 | 0% |
| Artery dissection | 64 | 0% |
| Arthralgia | 90,029 | 5.48% |
| Arthritis | 4,360 | 0.27% |
| Arthritis allergic | 4 | 0% |
| Arthritis bacterial | 77 | 0% |
| Arthritis enteropathic | 7 | 0% |
| Arthritis gonococcal | 1 | 0% |
| Arthritis infective | 45 | 0% |
| Arthritis reactive | 573 | 0.03% |
| Arthritis viral | 5 | 0% |
| Arthrodesis | 8 | 0% |
| Arthrofibrosis | 3 | 0% |
| Arthrogram | 38 | 0% |
| Arthropathy | 894 | 0.05% |
| Arthropod-borne disease | 2 | 0% |
| Arthropod bite | 259 | 0.02% |
| Arthropod sting | 73 | 0% |
| Arthroscopic surgery | 3 | 0% |
| Arthroscopy | 34 | 0% |
| Arthrotomy | 4 | 0% |
| Articular calcification | 8 | 0% |
| Articular disc disorder | 2 | 0% |
| Artificial blood vessel occlusion | 1 | 0% |
| Artificial crown procedure | 8 | 0% |
| Artificial heart device user | 3 | 0% |
| Artificial insemination | 3 | 0% |
| Artificial rupture of membranes | 3 | 0% |
| Artificial skin graft | 1 | 0% |
| ASAH1 related disorder | 1 | 0% |
| Asbestosis | 2 | 0% |
| Ascariasis | 3 | 0% |
| Ascending flaccid paralysis | 6 | 0% |
| Ascites | 392 | 0.02% |
| ASIA syndrome | 13 | 0% |
| Asocial behaviour | 4 | 0% |
| Aspartate-glutamate-transporter deficiency | 1 | 0% |
| Aspartate aminotransferase | 3,599 | 0.22% |
| Aspartate aminotransferase abnormal | 28 | 0% |
| Aspartate aminotransferase decreased | 50 | 0% |
| Aspartate aminotransferase increased | 1,553 | 0.09% |
| Aspartate aminotransferase normal | 730 | 0.04% |
| Aspergilloma | 1 | 0% |
| Aspergillus infection | 22 | 0% |
| Aspergillus test | 62 | 0% |
| Aspergillus test negative | 14 | 0% |
| Aspergillus test positive | 11 | 0% |
| Aspermia | 1 | 0% |
| Asphyxia | 223 | 0.01% |
| Aspiration | 364 | 0.02% |
| Aspiration bone marrow | 118 | 0.01% |
| Aspiration bone marrow abnormal | 5 | 0% |
| Aspiration bursa | 4 | 0% |
| Aspiration bursa normal | 1 | 0% |
| Aspiration joint | 117 | 0.01% |
| Aspiration joint abnormal | 11 | 0% |
| Aspiration joint normal | 5 | 0% |
| Aspiration pleural cavity | 239 | 0.01% |
| Aspiration pleural cavity abnormal | 1 | 0% |
| Aspiration pleural cavity normal | 1 | 0% |
| Aspiration tracheal abnormal | 1 | 0% |
| Aspiration tracheal normal | 1 | 0% |
| Aspirin-exacerbated respiratory disease | 2 | 0% |
| Asplenia | 2 | 0% |
| Assisted reproductive technology | 1 | 0% |
| Assisted suicide | 3 | 0% |
| AST/ALT ratio | 73 | 0% |
| AST/ALT ratio abnormal | 16 | 0% |
| Asteatosis | 1 | 0% |
| Asterixis | 19 | 0% |
| Asthenia | 64,229 | 3.91% |
| Asthenopia | 774 | 0.05% |
| Asthenospermia | 2 | 0% |
| Asthma | 4,992 | 0.3% |
| Asthma-chronic obstructive pulmonary disease overlap syndrome | 20 | 0% |
| Asthma exercise induced | 38 | 0% |
| Asthma late onset | 5 | 0% |
| Asthma prophylaxis | 10 | 0% |
| Asthmatic crisis | 334 | 0.02% |
| Astigmatism | 56 | 0% |
| Astrocytoma | 1 | 0% |
| Astrocytoma malignant | 3 | 0% |
| Astrovirus test | 4 | 0% |
| AST to platelet ratio index | 1 | 0% |
| AST to platelet ratio index increased | 3 | 0% |
| ASXL1 gene mutation | 1 | 0% |
| Asymmetric di-methylarginine increased | 1 | 0% |
| Asymmetric thigh fold | 1 | 0% |
| Asymptomatic bacteriuria | 23 | 0% |
| Asymptomatic COVID-19 | 3,247 | 0.2% |
| Asymptomatic HIV infection | 1 | 0% |
| Ataxia | 750 | 0.05% |
| Ataxia assessment scale | 2 | 0% |
| Ataxia telangiectasia | 2 | 0% |
| Atelectasis | 1,123 | 0.07% |
| Atherectomy | 2 | 0% |
| Atheroembolism | 4 | 0% |
| Atherosclerotic plaque rupture | 8 | 0% |
| Athetosis | 1 | 0% |
| Athletic heart syndrome | 3 | 0% |
| Atonic seizures | 51 | 0% |
| Atonic urinary bladder | 4 | 0% |
| Atopic keratoconjunctivitis | 1 | 0% |
| Atopy | 23 | 0% |
| Atrial appendage closure | 3 | 0% |
| Atrial appendage resection | 2 | 0% |
| Atrial enlargement | 55 | 0% |
| Atrial escape rhythm | 1 | 0% |
| Atrial fibrillation | 9,903 | 0.6% |
| Atrial flutter | 873 | 0.05% |
| Atrial hypertrophy | 1 | 0% |
| Atrial natriuretic peptide | 15 | 0% |
| Atrial natriuretic peptide normal | 1 | 0% |
| Atrial pressure | 28 | 0% |
| Atrial pressure increased | 8 | 0% |
| Atrial septal defect | 150 | 0.01% |
| Atrial septal defect repair | 4 | 0% |
| Atrial tachycardia | 167 | 0.01% |
| Atrial thrombosis | 47 | 0% |
| Atrioventricular block | 377 | 0.02% |
| Atrioventricular block complete | 313 | 0.02% |
| Atrioventricular block first degree | 172 | 0.01% |
| Atrioventricular block second degree | 196 | 0.01% |
| Atrioventricular conduction time shortened | 1 | 0% |
| Atrioventricular dissociation | 3 | 0% |
| Atrioventricular node dysfunction | 2 | 0% |
| Atrioventricular septal defect | 7 | 0% |
| Atrophic glossitis | 3 | 0% |
| Atrophic thyroiditis | 1 | 0% |
| Atrophic vulvovaginitis | 7 | 0% |
| Atrophie blanche | 1 | 0% |
| Atrophy | 100 | 0.01% |
| Atrophy of globe | 2 | 0% |
| Atropine stress test | 1 | 0% |
| Attention-seeking behaviour | 1 | 0% |
| Attention deficit hyperactivity disorder | 121 | 0.01% |
| Atypical femur fracture | 2 | 0% |
| Atypical haemolytic uraemic syndrome | 20 | 0% |
| Atypical migraine | 3 | 0% |
| Atypical mycobacterial infection | 8 | 0% |
| Atypical mycobacterial lower respiratory tract infection | 1 | 0% |
| Atypical pneumonia | 286 | 0.02% |
| Audiogram | 1,088 | 0.07% |
| Audiogram abnormal | 260 | 0.02% |
| Audiogram normal | 72 | 0% |
| Auditory disorder | 225 | 0.01% |
| Auditory nerve disorder | 21 | 0% |
| Auditory neuropathy spectrum disorder | 1 | 0% |
| Aura | 271 | 0.02% |
| Aural polyp | 1 | 0% |
| Auricular chondritis | 1 | 0% |
| Auricular haematoma | 1 | 0% |
| Auricular swelling | 26 | 0% |
| Auscultation | 2,002 | 0.12% |
| Autism spectrum disorder | 42 | 0% |
| Autoantibody negative | 34 | 0% |
| Autoantibody positive | 181 | 0.01% |
| Autoantibody test | 621 | 0.04% |
| Autoimmune anaemia | 15 | 0% |
| Autoimmune aplastic anaemia | 1 | 0% |
| Autoimmune arthritis | 43 | 0% |
| Autoimmune blistering disease | 7 | 0% |
| Autoimmune cholangitis | 2 | 0% |
| Autoimmune colitis | 8 | 0% |
| Autoimmune demyelinating disease | 12 | 0% |
| Autoimmune dermatitis | 10 | 0% |
| Autoimmune disorder | 1,876 | 0.11% |
| Autoimmune encephalopathy | 24 | 0% |
| Autoimmune endocrine disorder | 1 | 0% |
| Autoimmune eye disorder | 8 | 0% |
| Autoimmune haemolytic anaemia | 269 | 0.02% |
| Autoimmune heparin-induced thrombocytopenia | 1 | 0% |
| Autoimmune hepatitis | 490 | 0.03% |
| Autoimmune hypothyroidism | 20 | 0% |
| Autoimmune inner ear disease | 8 | 0% |
| Autoimmune lung disease | 8 | 0% |
| Autoimmune lymphoproliferative syndrome | 3 | 0% |
| Autoimmune myocarditis | 6 | 0% |
| Autoimmune myositis | 64 | 0% |
| Autoimmune nephritis | 1 | 0% |
| Autoimmune neuropathy | 39 | 0% |
| Autoimmune neutropenia | 12 | 0% |
| Autoimmune pancreatitis | 42 | 0% |
| Autoimmune pancytopenia | 1 | 0% |
| Autoimmune pericarditis | 2 | 0% |
| Autoimmune retinopathy | 1 | 0% |
| Autoimmune thyroid disorder | 33 | 0% |
| Autoimmune thyroiditis | 812 | 0.05% |
| Autoimmune uveitis | 8 | 0% |
| Autoinflammatory disease | 31 | 0% |
| Automatic bladder | 1 | 0% |
| Automatic positive airway pressure | 7 | 0% |
| Automatism | 5 | 0% |
| Automatism epileptic | 1 | 0% |
| Autonomic dysreflexia | 12 | 0% |
| Autonomic failure syndrome | 2 | 0% |
| Autonomic nervous system imbalance | 529 | 0.03% |
| Autonomic neuropathy | 62 | 0% |
| Autonomic seizure | 5 | 0% |
| Autophobia | 1 | 0% |
| Autophony | 8 | 0% |
| Autopsy | 568 | 0.03% |
| Autoresuscitation | 1 | 0% |
| Autoscopy | 127 | 0.01% |
| Aversion | 12 | 0% |
| Avoidant personality disorder | 2 | 0% |
| Avulsion fracture | 6 | 0% |
| Axial spondyloarthritis | 20 | 0% |
| Axillary lymphadenectomy | 21 | 0% |
| Axillary mass | 1,597 | 0.1% |
| Axillary nerve injury | 19 | 0% |
| Axillary pain | 11,229 | 0.68% |
| Axillary vein thrombosis | 77 | 0% |
| Axillary web syndrome | 11 | 0% |
| Axonal and demyelinating polyneuropathy | 32 | 0% |
| Axonal neuropathy | 43 | 0% |
| Azoospermia | 3 | 0% |
| Azotaemia | 102 | 0.01% |
| B-cell depletion therapy | 1 | 0% |
| B-cell lymphoma | 100 | 0.01% |
| B-cell lymphoma recurrent | 1 | 0% |
| B-cell lymphoma stage II | 2 | 0% |
| B-cell lymphoma stage III | 1 | 0% |
| B-cell lymphoma stage IV | 2 | 0% |
| B-cell small lymphocytic lymphoma | 11 | 0% |
| B-cell type acute leukaemia | 8 | 0% |
| B-lymphocyte abnormalities | 1 | 0% |
| B-lymphocyte count | 83 | 0.01% |
| B-lymphocyte count abnormal | 4 | 0% |
| B-lymphocyte count decreased | 25 | 0% |
| B-lymphocyte count increased | 13 | 0% |
| Babesiosis | 10 | 0% |
| Babinski reflex test | 107 | 0.01% |
| Bacille Calmette-Guerin scar reactivation | 49 | 0% |
| Bacillus bacteraemia | 1 | 0% |
| Bacillus infection | 4 | 0% |
| Bacillus test positive | 9 | 0% |
| Back disorder | 188 | 0.01% |
| Back injury | 141 | 0.01% |
| Back pain | 26,087 | 1.59% |
| Bacteraemia | 258 | 0.02% |
| Bacterial abdominal infection | 1 | 0% |
| Bacterial blepharitis | 1 | 0% |
| Bacterial colitis | 3 | 0% |
| Bacterial diarrhoea | 5 | 0% |
| Bacterial disease carrier | 31 | 0% |
| Bacterial gingivitis | 1 | 0% |
| Bacterial infection | 459 | 0.03% |
| Bacterial pericarditis | 2 | 0% |
| Bacterial prostatitis | 7 | 0% |
| Bacterial pyelonephritis | 2 | 0% |
| Bacterial rhinitis | 1 | 0% |
| Bacterial sepsis | 31 | 0% |
| Bacterial test | 916 | 0.06% |
| Bacterial test negative | 217 | 0.01% |
| Bacterial test positive | 271 | 0.02% |
| Bacterial toxaemia | 1 | 0% |
| Bacterial translocation | 2 | 0% |
| Bacterial vaginosis | 66 | 0% |
| Bacterial vulvovaginitis | 2 | 0% |
| Bacteriuria | 41 | 0% |
| Bacteroides bacteraemia | 8 | 0% |
| Bacteroides test positive | 3 | 0% |
| Balance disorder | 9,018 | 0.55% |
| Balance test | 130 | 0.01% |
| Balanitis candida | 3 | 0% |
| Balanoposthitis | 23 | 0% |
| Ballismus | 14 | 0% |
| Bandaemia | 20 | 0% |
| Band neutrophil count | 53 | 0% |
| Band neutrophil count decreased | 2 | 0% |
| Band neutrophil count increased | 7 | 0% |
| Band neutrophil percentage | 34 | 0% |
| Band neutrophil percentage decreased | 2 | 0% |
| Band neutrophil percentage increased | 12 | 0% |
| Band sensation | 42 | 0% |
| Barbiturates | 6 | 0% |
| Barbiturates negative | 9 | 0% |
| Barbiturates positive | 3 | 0% |
| Barbotage | 1 | 0% |
| Barium double contrast | 2 | 0% |
| Barium enema | 2 | 0% |
| Barium enema abnormal | 1 | 0% |
| Barium enema normal | 1 | 0% |
| Barium meal | 4 | 0% |
| Barium swallow | 52 | 0% |
| Barium swallow abnormal | 22 | 0% |
| Barium swallow normal | 14 | 0% |
| Barotitis media | 1 | 0% |
| Barotrauma | 5 | 0% |
| Barre test | 52 | 0% |
| Barrett's oesophagus | 28 | 0% |
| Bartholin's abscess | 10 | 0% |
| Bartholin's cyst | 17 | 0% |
| Bartholin's cyst removal | 1 | 0% |
| Bartholinitis | 9 | 0% |
| Bartonella test | 84 | 0.01% |
| Bartonella test negative | 24 | 0% |
| Bartonella test positive | 6 | 0% |
| Bartonellosis | 11 | 0% |
| Basal cell carcinoma | 93 | 0.01% |
| Basal ganglia haematoma | 4 | 0% |
| Basal ganglia haemorrhage | 67 | 0% |
| Basal ganglia infarction | 78 | 0% |
| Basal ganglia stroke | 50 | 0% |
| Basal ganglion degeneration | 1 | 0% |
| Basedow's disease | 819 | 0.05% |
| Base excess | 324 | 0.02% |
| Base excess abnormal | 2 | 0% |
| Base excess decreased | 15 | 0% |
| Base excess increased | 21 | 0% |
| Base excess negative | 4 | 0% |
| Basilar artery aneurysm | 5 | 0% |
| Basilar artery occlusion | 26 | 0% |
| Basilar artery stenosis | 13 | 0% |
| Basilar artery thrombosis | 61 | 0% |
| Basilar migraine | 8 | 0% |
| Basophil count | 1,062 | 0.06% |
| Basophil count abnormal | 6 | 0% |
| Basophil count decreased | 382 | 0.02% |
| Basophil count increased | 51 | 0% |
| Basophil count normal | 248 | 0.02% |
| Basophil degranulation test | 13 | 0% |
| Basophilia | 4 | 0% |
| Basophil morphology | 1 | 0% |
| Basophilopenia | 2 | 0% |
| Basophil percentage | 495 | 0.03% |
| Basophil percentage decreased | 389 | 0.02% |
| Basophil percentage increased | 49 | 0% |
| Basosquamous carcinoma | 3 | 0% |
| BCL-2 gene status assay | 2 | 0% |
| Beckwith-Wiedemann syndrome | 1 | 0% |
| Bed bug infestation | 5 | 0% |
| Bed rest | 341 | 0.02% |
| Bedridden | 1,928 | 0.12% |
| Bed sharing | 31 | 0% |
| Behavioural therapy | 4 | 0% |
| Behaviour disorder | 148 | 0.01% |
| Behaviour disorder due to a general medical condition | 1 | 0% |
| Behcet's syndrome | 93 | 0.01% |
| Bell's palsy | 7,341 | 0.45% |
| Bell's phenomenon | 5 | 0% |
| Belligerence | 4 | 0% |
| Bence Jones proteinuria | 7 | 0% |
| Bence Jones protein urine | 19 | 0% |
| Bence Jones protein urine absent | 1 | 0% |
| Bence Jones protein urine present | 2 | 0% |
| Bendopnoea | 2 | 0% |
| Benign biliary neoplasm | 1 | 0% |
| Benign bone neoplasm | 1 | 0% |
| Benign breast neoplasm | 28 | 0% |
| Benign cardiac neoplasm | 1 | 0% |
| Benign enlargement of the subarachnoid spaces | 3 | 0% |
| Benign familial haematuria | 2 | 0% |
| Benign familial pemphigus | 2 | 0% |
| Benign fasciculation syndrome | 7 | 0% |
| Benign gastrointestinal neoplasm | 2 | 0% |
| Benign hepatic neoplasm | 3 | 0% |
| Benign hydatidiform mole | 23 | 0% |
| Benign lung neoplasm | 3 | 0% |
| Benign lymph node neoplasm | 14 | 0% |
| Benign neoplasm | 12 | 0% |
| Benign neoplasm of bladder | 1 | 0% |
| Benign neoplasm of cervix uteri | 2 | 0% |
| Benign neoplasm of choroid | 1 | 0% |
| Benign neoplasm of eye | 1 | 0% |
| Benign neoplasm of skin | 1 | 0% |
| Benign neoplasm of testis | 1 | 0% |
| Benign neoplasm of thyroid gland | 14 | 0% |
| Benign oesophageal neoplasm | 1 | 0% |
| Benign ovarian tumour | 5 | 0% |
| Benign prostatic hyperplasia | 176 | 0.01% |
| Benign salivary gland neoplasm | 2 | 0% |
| Benign soft tissue neoplasm | 1 | 0% |
| Benign tumour excision | 5 | 0% |
| Benign uterine neoplasm | 3 | 0% |
| Benzodiazepine drug level | 28 | 0% |
| Benzodiazepine drug level abnormal | 1 | 0% |
| Benzodiazepine drug level increased | 1 | 0% |
| Bereavement | 3 | 0% |
| Beta-2 glycoprotein antibody | 361 | 0.02% |
| Beta-2 glycoprotein antibody negative | 48 | 0% |
| Beta-2 glycoprotein antibody positive | 19 | 0% |
| Beta-N-acetyl-D-glucosaminidase | 11 | 0% |
| Beta 2 globulin | 68 | 0% |
| Beta 2 microglobulin | 119 | 0.01% |
| Beta 2 microglobulin abnormal | 2 | 0% |
| Beta 2 microglobulin increased | 11 | 0% |
| Beta 2 microglobulin normal | 1 | 0% |
| Beta 2 microglobulin urine | 17 | 0% |
| Beta 2 microglobulin urine increased | 1 | 0% |
| Beta globulin | 93 | 0.01% |
| Beta globulin decreased | 5 | 0% |
| Beta globulin increased | 6 | 0% |
| Beta globulin normal | 3 | 0% |
| Beta haemolytic streptococcal infection | 35 | 0% |
| Beta ketothiolase deficiency | 1 | 0% |
| Bickerstaff's encephalitis | 23 | 0% |
| Bicuspid aortic valve | 14 | 0% |
| Bicytopenia | 44 | 0% |
| Biernacki's sign | 7 | 0% |
| Bifascicular block | 21 | 0% |
| Bifidobacterium infection | 1 | 0% |
| Bilateral breast buds | 1 | 0% |
| Bile acid malabsorption | 15 | 0% |
| Bile acids | 6 | 0% |
| Bile acids abnormal | 1 | 0% |
| Bile culture | 2 | 0% |
| Bile culture negative | 2 | 0% |
| Bile culture positive | 1 | 0% |
| Bile duct cancer | 8 | 0% |
| Bile duct cancer stage IV | 1 | 0% |
| Bile duct stenosis | 11 | 0% |
| Bile duct stent insertion | 20 | 0% |
| Bile duct stent removal | 3 | 0% |
| Bile duct stone | 60 | 0% |
| Bile output | 9 | 0% |
| Bile output abnormal | 6 | 0% |
| Bile output decreased | 1 | 0% |
| Bile output increased | 3 | 0% |
| Bilevel positive airway pressure | 187 | 0.01% |
| Biliary adenoma | 2 | 0% |
| Biliary ascites | 1 | 0% |
| Biliary catheter insertion | 8 | 0% |
| Biliary cirrhosis | 1 | 0% |
| Biliary colic | 152 | 0.01% |
| Biliary cyst | 18 | 0% |
| Biliary dilatation | 53 | 0% |
| Biliary dyskinesia | 8 | 0% |
| Biliary fistula | 1 | 0% |
| Biliary obstruction | 23 | 0% |
| Biliary sepsis | 6 | 0% |
| Biliary sphincterotomy | 3 | 0% |
| Biliary tract dilation procedure | 3 | 0% |
| Biliary tract disorder | 26 | 0% |
| Biliary tract infection | 6 | 0% |
| Bilirubin conjugated | 526 | 0.03% |
| Bilirubin conjugated abnormal | 8 | 0% |
| Bilirubin conjugated decreased | 9 | 0% |
| Bilirubin conjugated increased | 88 | 0.01% |
| Bilirubin conjugated normal | 36 | 0% |
| Bilirubin excretion disorder | 1 | 0% |
| Bilirubinuria | 8 | 0% |
| Bilirubin urine | 310 | 0.02% |
| Bilirubin urine present | 36 | 0% |
| Biloma | 1 | 0% |
| Binge drinking | 6 | 0% |
| Binge eating | 8 | 0% |
| Binocular eye movement disorder | 24 | 0% |
| Binocular visual dysfunction | 1 | 0% |
| Biochemical pregnancy | 10 | 0% |
| Biofeedback therapy | 1 | 0% |
| Biomedical photography | 3 | 0% |
| Biopsy | 3,049 | 0.19% |
| Biopsy abdominal wall | 8 | 0% |
| Biopsy abdominal wall normal | 4 | 0% |
| Biopsy adrenal gland | 2 | 0% |
| Biopsy adrenal gland abnormal | 2 | 0% |
| Biopsy artery | 99 | 0.01% |
| Biopsy artery abnormal | 21 | 0% |
| Biopsy artery normal | 20 | 0% |
| Biopsy bile duct | 1 | 0% |
| Biopsy bile duct abnormal | 2 | 0% |
| Biopsy bladder | 10 | 0% |
| Biopsy bladder abnormal | 7 | 0% |
| Biopsy bladder normal | 1 | 0% |
| Biopsy blood vessel | 2 | 0% |
| Biopsy blood vessel abnormal | 3 | 0% |
| Biopsy bone | 40 | 0% |
| Biopsy bone abnormal | 15 | 0% |
| Biopsy bone marrow | 605 | 0.04% |
| Biopsy bone marrow abnormal | 101 | 0.01% |
| Biopsy bone marrow normal | 35 | 0% |
| Biopsy bone normal | 5 | 0% |
| Biopsy brain | 48 | 0% |
| Biopsy brain abnormal | 11 | 0% |
| Biopsy brain normal | 3 | 0% |
| Biopsy breast | 152 | 0.01% |
| Biopsy breast abnormal | 135 | 0.01% |
| Biopsy breast normal | 16 | 0% |
| Biopsy bronchus | 18 | 0% |
| Biopsy bronchus abnormal | 2 | 0% |
| Biopsy bronchus normal | 1 | 0% |
| Biopsy cartilage | 2 | 0% |
| Biopsy cervix | 34 | 0% |
| Biopsy cervix abnormal | 4 | 0% |
| Biopsy cervix normal | 3 | 0% |
| Biopsy chest wall | 2 | 0% |
| Biopsy chest wall abnormal | 1 | 0% |
| Biopsy chest wall normal | 1 | 0% |
| Biopsy chorionic villous | 7 | 0% |
| Biopsy chorionic villous abnormal | 1 | 0% |
| Biopsy colon | 59 | 0% |
| Biopsy colon abnormal | 32 | 0% |
| Biopsy colon normal | 9 | 0% |
| Biopsy ear | 2 | 0% |
| Biopsy ear abnormal | 2 | 0% |
| Biopsy endometrium | 98 | 0.01% |
| Biopsy endometrium abnormal | 16 | 0% |
| Biopsy endometrium normal | 37 | 0% |
| Biopsy eyelid normal | 1 | 0% |
| Biopsy fallopian tube | 2 | 0% |
| Biopsy fallopian tube normal | 1 | 0% |
| Biopsy foetal | 5 | 0% |
| Biopsy gallbladder abnormal | 1 | 0% |
| Biopsy gingival | 6 | 0% |
| Biopsy heart | 175 | 0.01% |
| Biopsy heart abnormal | 11 | 0% |
| Biopsy heart normal | 3 | 0% |
| Biopsy intestine | 12 | 0% |
| Biopsy intestine abnormal | 7 | 0% |
| Biopsy intestine normal | 3 | 0% |
| Biopsy kidney | 763 | 0.05% |
| Biopsy kidney abnormal | 81 | 0% |
| Biopsy kidney normal | 7 | 0% |
| Biopsy larynx | 1 | 0% |
| Biopsy larynx abnormal | 1 | 0% |
| Biopsy lip | 11 | 0% |
| Biopsy lip abnormal | 2 | 0% |
| Biopsy lip normal | 1 | 0% |
| Biopsy liver | 376 | 0.02% |
| Biopsy liver abnormal | 79 | 0% |
| Biopsy liver normal | 8 | 0% |
| Biopsy lung | 110 | 0.01% |
| Biopsy lung abnormal | 35 | 0% |
| Biopsy lung normal | 9 | 0% |
| Biopsy lymph gland | 246 | 0.01% |
| Biopsy lymph gland abnormal | 62 | 0% |
| Biopsy lymph gland normal | 32 | 0% |
| Biopsy mucosa abnormal | 2 | 0% |
| Biopsy mucosa normal | 1 | 0% |
| Biopsy muscle | 177 | 0.01% |
| Biopsy muscle abnormal | 21 | 0% |
| Biopsy muscle normal | 4 | 0% |
| Biopsy nasopharynx | 1 | 0% |
| Biopsy nasopharynx abnormal | 1 | 0% |
| Biopsy oesophagus | 11 | 0% |
| Biopsy oesophagus abnormal | 8 | 0% |
| Biopsy oesophagus normal | 2 | 0% |
| Biopsy ovary | 3 | 0% |
| Biopsy ovary abnormal | 2 | 0% |
| Biopsy palate | 3 | 0% |
| Biopsy pancreas | 8 | 0% |
| Biopsy pancreas abnormal | 10 | 0% |
| Biopsy pancreas normal | 1 | 0% |
| Biopsy penis | 1 | 0% |
| Biopsy pericardium | 18 | 0% |
| Biopsy pericardium abnormal | 3 | 0% |
| Biopsy peripheral nerve | 14 | 0% |
| Biopsy peripheral nerve abnormal | 6 | 0% |
| Biopsy peripheral nerve normal | 3 | 0% |
| Biopsy peritoneum | 3 | 0% |
| Biopsy pharynx | 5 | 0% |
| Biopsy pharynx abnormal | 1 | 0% |
| Biopsy pharynx normal | 1 | 0% |
| Biopsy placenta | 16 | 0% |
| Biopsy pleura | 12 | 0% |
| Biopsy pleura abnormal | 1 | 0% |
| Biopsy prostate | 21 | 0% |
| Biopsy prostate abnormal | 14 | 0% |
| Biopsy prostate normal | 1 | 0% |
| Biopsy rectum | 11 | 0% |
| Biopsy rectum abnormal | 3 | 0% |
| Biopsy rectum normal | 1 | 0% |
| Biopsy retina abnormal | 1 | 0% |
| Biopsy salivary gland | 77 | 0% |
| Biopsy salivary gland abnormal | 1 | 0% |
| Biopsy sclera abnormal | 3 | 0% |
| Biopsy site unspecified abnormal | 14 | 0% |
| Biopsy site unspecified normal | 5 | 0% |
| Biopsy skin | 1,575 | 0.1% |
| Biopsy skin abnormal | 486 | 0.03% |
| Biopsy skin normal | 58 | 0% |
| Biopsy small intestine | 14 | 0% |
| Biopsy small intestine abnormal | 4 | 0% |
| Biopsy small intestine normal | 4 | 0% |
| Biopsy soft tissue | 13 | 0% |
| Biopsy spinal cord | 15 | 0% |
| Biopsy spinal cord abnormal | 2 | 0% |
| Biopsy spleen | 1 | 0% |
| Biopsy spleen abnormal | 1 | 0% |
| Biopsy stomach | 40 | 0% |
| Biopsy stomach abnormal | 7 | 0% |
| Biopsy stomach normal | 10 | 0% |
| Biopsy tendon | 1 | 0% |
| Biopsy testes | 7 | 0% |
| Biopsy testes abnormal | 1 | 0% |
| Biopsy thyroid gland | 50 | 0% |
| Biopsy thyroid gland abnormal | 7 | 0% |
| Biopsy thyroid gland normal | 9 | 0% |
| Biopsy tongue | 6 | 0% |
| Biopsy tongue abnormal | 5 | 0% |
| Biopsy tonsil | 7 | 0% |
| Biopsy trachea | 2 | 0% |
| Biopsy trachea abnormal | 1 | 0% |
| Biopsy urethra abnormal | 1 | 0% |
| Biopsy uterus | 57 | 0% |
| Biopsy uterus abnormal | 13 | 0% |
| Biopsy uterus normal | 36 | 0% |
| Biopsy vagina | 13 | 0% |
| Biopsy vagina abnormal | 1 | 0% |
| Biopsy vagina normal | 2 | 0% |
| Biopsy vocal cord abnormal | 1 | 0% |
| Biopsy vulva | 3 | 0% |
| Biopsy vulva abnormal | 7 | 0% |
| Biopsy vulva normal | 1 | 0% |
| Bipolar disorder | 94 | 0.01% |
| Bipolar I disorder | 31 | 0% |
| Bipolar II disorder | 3 | 0% |
| Birdshot chorioretinopathy | 5 | 0% |
| Birth mark | 5 | 0% |
| Birth trauma | 3 | 0% |
| Birth weight normal | 1 | 0% |
| Bisalbuminaemia | 1 | 0% |
| Bite | 48 | 0% |
| BK polyomavirus test | 10 | 0% |
| BK polyomavirus test negative | 2 | 0% |
| BK polyomavirus test positive | 1 | 0% |
| BK virus infection | 3 | 0% |
| Bladder adenocarcinoma stage unspecified | 1 | 0% |
| Bladder calculus removal | 1 | 0% |
| Bladder cancer | 105 | 0.01% |
| Bladder cancer recurrent | 10 | 0% |
| Bladder cancer stage III | 1 | 0% |
| Bladder cancer stage IV | 3 | 0% |
| Bladder catheterisation | 395 | 0.02% |
| Bladder catheter permanent | 3 | 0% |
| Bladder catheter removal | 13 | 0% |
| Bladder catheter replacement | 15 | 0% |
| Bladder catheter temporary | 2 | 0% |
| Bladder cyst | 2 | 0% |
| Bladder dilatation | 42 | 0% |
| Bladder discomfort | 85 | 0.01% |
| Bladder disorder | 226 | 0.01% |
| Bladder diverticulum | 6 | 0% |
| Bladder dysfunction | 70 | 0% |
| Bladder fibrosis | 1 | 0% |
| Bladder hydrodistension | 4 | 0% |
| Bladder hypertrophy | 37 | 0% |
| Bladder injury | 8 | 0% |
| Bladder instillation procedure | 1 | 0% |
| Bladder irrigation | 18 | 0% |
| Bladder irritation | 44 | 0% |
| Bladder mass | 15 | 0% |
| Bladder neck obstruction | 1 | 0% |
| Bladder neck operation | 5 | 0% |
| Bladder neoplasm | 21 | 0% |
| Bladder neoplasm surgery | 4 | 0% |
| Bladder obstruction | 7 | 0% |
| Bladder operation | 4 | 0% |
| Bladder outlet obstruction | 8 | 0% |
| Bladder pain | 231 | 0.01% |
| Bladder perforation | 1 | 0% |
| Bladder polypectomy | 1 | 0% |
| Bladder prolapse | 4 | 0% |
| Bladder scan | 67 | 0% |
| Bladder spasm | 51 | 0% |
| Bladder sphincter atony | 19 | 0% |
| Bladder sphincterectomy | 1 | 0% |
| Bladder squamous cell carcinoma stage unspecified | 1 | 0% |
| Bladder stenosis | 2 | 0% |
| Bladder tamponade | 3 | 0% |
| Bladder trabeculation | 3 | 0% |
| Bladder transitional cell carcinoma | 9 | 0% |
| Bladder transitional cell carcinoma stage IV | 1 | 0% |
| Bladder tumour antigen | 1 | 0% |
| Bladder ulcer | 1 | 0% |
| Bladder wall calcification | 3 | 0% |
| Blast cell crisis | 2 | 0% |
| Blast cell proliferation | 1 | 0% |
| Blast cells | 46 | 0% |
| Blast cells present | 16 | 0% |
| Blast crisis in myelogenous leukaemia | 1 | 0% |
| Blastic plasmacytoid dendritic cell neoplasia | 1 | 0% |
| Blastocystis infection | 4 | 0% |
| Blastocystis test | 1 | 0% |
| Blastomycosis | 5 | 0% |
| Bleeding anovulatory | 7 | 0% |
| Bleeding risk assessment | 1 | 0% |
| Bleeding time | 33 | 0% |
| Bleeding time abnormal | 5 | 0% |
| Bleeding time prolonged | 48 | 0% |
| Bleeding time shortened | 3 | 0% |
| Bleeding varicose vein | 6 | 0% |
| Blepharal papilloma | 1 | 0% |
| Blepharal pigmentation | 1 | 0% |
| Blepharitis | 166 | 0.01% |
| Blepharitis allergic | 1 | 0% |
| Blepharochalasis | 5 | 0% |
| Blepharorrhaphy | 1 | 0% |
| Blepharospasm | 1,011 | 0.06% |
| Blindness | 2,563 | 0.16% |
| Blindness congenital | 1 | 0% |
| Blindness cortical | 8 | 0% |
| Blindness transient | 595 | 0.04% |
| Blindness traumatic | 1 | 0% |
| Blindness unilateral | 1,006 | 0.06% |
| Blister | 4,122 | 0.25% |
| Blister infected | 26 | 0% |
| Blister rupture | 81 | 0% |
| Bloch-Sulzberger syndrome | 1 | 0% |
| Block vertebra | 6 | 0% |
| Blood 1,25-dihydroxycholecalciferol | 8 | 0% |
| Blood 1,25-dihydroxycholecalciferol decreased | 2 | 0% |
| Blood 1,25-dihydroxycholecalciferol increased | 3 | 0% |
| Blood 25-hydroxycholecalciferol | 128 | 0.01% |
| Blood 25-hydroxycholecalciferol decreased | 8 | 0% |
| Blood 25-hydroxycholecalciferol increased | 1 | 0% |
| Blood acid phosphatase | 10 | 0% |
| Blood acid phosphatase increased | 1 | 0% |
| Blood albumin | 1,746 | 0.11% |
| Blood albumin abnormal | 7 | 0% |
| Blood albumin decreased | 580 | 0.04% |
| Blood albumin increased | 45 | 0% |
| Blood albumin normal | 527 | 0.03% |
| Blood alcohol | 42 | 0% |
| Blood alcohol abnormal | 1 | 0% |
| Blood alcohol decreased | 1 | 0% |
| Blood alcohol increased | 19 | 0% |
| Blood alcohol normal | 18 | 0% |
| Blood aldosterone | 43 | 0% |
| Blood aldosterone abnormal | 1 | 0% |
| Blood aldosterone increased | 7 | 0% |
| Blood aldosterone normal | 3 | 0% |
| Blood alkaline phosphatase | 2,081 | 0.13% |
| Blood alkaline phosphatase abnormal | 2 | 0% |
| Blood alkaline phosphatase decreased | 26 | 0% |
| Blood alkaline phosphatase increased | 657 | 0.04% |
| Blood alkaline phosphatase normal | 829 | 0.05% |
| Blood aluminium | 4 | 0% |
| Blood androstenedione | 16 | 0% |
| Blood androstenedione increased | 3 | 0% |
| Blood antidiuretic hormone | 13 | 0% |
| Blood antidiuretic hormone abnormal | 1 | 0% |
| Blood antidiuretic hormone increased | 1 | 0% |
| Blood antidiuretic hormone normal | 1 | 0% |
| Blood arsenic increased | 3 | 0% |
| Blood arsenic normal | 3 | 0% |
| Blood bactericidal activity | 3 | 0% |
| Blood beryllium | 2 | 0% |
| Blood beta-D-glucan | 48 | 0% |
| Blood beta-D-glucan abnormal | 1 | 0% |
| Blood beta-D-glucan increased | 3 | 0% |
| Blood beta-D-glucan negative | 9 | 0% |
| Blood beta-D-glucan normal | 3 | 0% |
| Blood beta-D-glucan positive | 5 | 0% |
| Blood bicarbonate | 973 | 0.06% |
| Blood bicarbonate abnormal | 4 | 0% |
| Blood bicarbonate decreased | 238 | 0.01% |
| Blood bicarbonate increased | 127 | 0.01% |
| Blood bicarbonate normal | 227 | 0.01% |
| Blood bilirubin | 2,345 | 0.14% |
| Blood bilirubin abnormal | 19 | 0% |
| Blood bilirubin decreased | 103 | 0.01% |
| Blood bilirubin increased | 606 | 0.04% |
| Blood bilirubin normal | 767 | 0.05% |
| Blood bilirubin unconjugated | 136 | 0.01% |
| Blood bilirubin unconjugated decreased | 2 | 0% |
| Blood bilirubin unconjugated increased | 22 | 0% |
| Blood bilirubin unconjugated normal | 6 | 0% |
| Blood blister | 216 | 0.01% |
| Blood brain barrier defect | 8 | 0% |
| Blood bromide | 5 | 0% |
| Blood cadmium | 8 | 0% |
| Blood caffeine decreased | 3 | 0% |
| Blood caffeine increased | 1 | 0% |
| Blood calcitonin | 22 | 0% |
| Blood calcitonin increased | 3 | 0% |
| Blood calcitonin normal | 6 | 0% |
| Blood calcium | 1,576 | 0.1% |
| Blood calcium abnormal | 13 | 0% |
| Blood calcium decreased | 623 | 0.04% |
| Blood calcium increased | 147 | 0.01% |
| Blood calcium normal | 632 | 0.04% |
| Blood cannabinoids | 17 | 0% |
| Blood cannabinoids decreased | 1 | 0% |
| Blood cannabinoids normal | 2 | 0% |
| Blood carbon monoxide | 7 | 0% |
| Blood carbon monoxide increased | 1 | 0% |
| Blood catecholamines | 29 | 0% |
| Blood catecholamines increased | 2 | 0% |
| Blood catecholamines normal | 8 | 0% |
| Blood chloride | 1,170 | 0.07% |
| Blood chloride abnormal | 4 | 0% |
| Blood chloride decreased | 344 | 0.02% |
| Blood chloride increased | 316 | 0.02% |
| Blood chloride normal | 880 | 0.05% |
| Blood cholesterol | 2,132 | 0.13% |
| Blood cholesterol abnormal | 21 | 0% |
| Blood cholesterol decreased | 27 | 0% |
| Blood cholesterol increased | 627 | 0.04% |
| Blood cholesterol normal | 150 | 0.01% |
| Blood cholinesterase | 89 | 0.01% |
| Blood cholinesterase decreased | 2 | 0% |
| Blood cholinesterase increased | 6 | 0% |
| Blood chromium | 20 | 0% |
| Blood chromium increased | 2 | 0% |
| Blood chromium normal | 1 | 0% |
| Blood chromogranin A | 13 | 0% |
| Blood chromogranin A increased | 1 | 0% |
| Blood citric acid decreased | 1 | 0% |
| Blood cobalt increased | 1 | 0% |
| Blood copper | 101 | 0.01% |
| Blood copper abnormal | 1 | 0% |
| Blood copper decreased | 4 | 0% |
| Blood copper increased | 6 | 0% |
| Blood copper normal | 18 | 0% |
| Blood corticosterone | 1 | 0% |
| Blood corticotrophin | 89 | 0.01% |
| Blood corticotrophin abnormal | 4 | 0% |
| Blood corticotrophin decreased | 4 | 0% |
| Blood corticotrophin increased | 5 | 0% |
| Blood corticotrophin normal | 9 | 0% |
| Blood cortisol | 278 | 0.02% |
| Blood count | 508 | 0.03% |
| Blood count abnormal | 47 | 0% |
| Blood count normal | 30 | 0% |
| Blood creatine | 612 | 0.04% |
| Blood creatine abnormal | 9 | 0% |
| Blood creatine decreased | 9 | 0% |
| Blood creatine increased | 136 | 0.01% |
| Blood creatine normal | 46 | 0% |
| Blood creatine phosphokinase | 4,291 | 0.26% |
| Blood creatine phosphokinase abnormal | 19 | 0% |
| Blood creatine phosphokinase BB | 2 | 0% |
| Blood creatine phosphokinase decreased | 54 | 0% |
| Blood creatine phosphokinase increased | 1,145 | 0.07% |
| Blood creatine phosphokinase MB | 1,249 | 0.08% |
| Blood creatine phosphokinase MB abnormal | 2 | 0% |
| Blood creatine phosphokinase MB decreased | 6 | 0% |
| Blood creatine phosphokinase MB increased | 165 | 0.01% |
| Blood creatine phosphokinase MB normal | 16 | 0% |
| Blood creatine phosphokinase MM | 6 | 0% |
| Blood creatine phosphokinase MM increased | 1 | 0% |
| Blood creatine phosphokinase MM normal | 1 | 0% |
| Blood creatine phosphokinase normal | 396 | 0.02% |
| Blood creatinine | 6,311 | 0.38% |
| Blood creatinine abnormal | 47 | 0% |
| Blood creatinine decreased | 135 | 0.01% |
| Blood creatinine increased | 2,438 | 0.15% |
| Blood creatinine normal | 1,241 | 0.08% |
| Blood culture | 1,855 | 0.11% |
| Blood culture negative | 839 | 0.05% |
| Blood culture positive | 352 | 0.02% |
| Blood cyanide | 1 | 0% |
| Blood disorder | 249 | 0.02% |
| Blood donation | 14 | 0% |
| Blood donor | 8 | 0% |
| Blood elastase | 6 | 0% |
| Blood elastase decreased | 1 | 0% |
| Blood electrolytes | 1,432 | 0.09% |
| Blood electrolytes abnormal | 41 | 0% |
| Blood electrolytes decreased | 32 | 0% |
| Blood electrolytes increased | 2 | 0% |
| Blood electrolytes normal | 306 | 0.02% |
| Blood erythropoietin | 10 | 0% |
| Blood erythropoietin decreased | 1 | 0% |
| Blood erythropoietin increased | 4 | 0% |
| Blood erythropoietin normal | 2 | 0% |
| Blood ethanal increased | 1 | 0% |
| Blood ethanol | 55 | 0% |
| Blood ethanol decreased | 1 | 0% |
| Blood ethanol increased | 9 | 0% |
| Blood ethanol normal | 18 | 0% |
| Blood fibrinogen | 2,165 | 0.13% |
| Blood fibrinogen abnormal | 9 | 0% |
| Blood fibrinogen decreased | 51 | 0% |
| Blood fibrinogen increased | 264 | 0.02% |
| Blood fibrinogen normal | 77 | 0% |
| Blood folate | 810 | 0.05% |
| Blood folate abnormal | 5 | 0% |
| Blood folate decreased | 56 | 0% |
| Blood folate increased | 27 | 0% |
| Blood folate normal | 153 | 0.01% |
| Blood follicle stimulating hormone | 255 | 0.02% |
| Blood follicle stimulating hormone abnormal | 5 | 0% |
| Blood follicle stimulating hormone decreased | 5 | 0% |
| Blood follicle stimulating hormone increased | 44 | 0% |
| Blood follicle stimulating hormone normal | 34 | 0% |
| Blood galactose | 2 | 0% |
| Blood gases | 1,187 | 0.07% |
| Blood gases abnormal | 247 | 0.02% |
| Blood gases normal | 74 | 0% |
| Blood gastrin | 4 | 0% |
| Blood gastrin decreased | 1 | 0% |
| Blood glucagon | 29 | 0% |
| Blood glucagon decreased | 1 | 0% |
| Blood glucagon increased | 1 | 0% |
| Blood glucose | 6,805 | 0.41% |
| Blood glucose abnormal | 431 | 0.03% |
| Blood glucose decreased | 920 | 0.06% |
| Blood glucose fluctuation | 243 | 0.01% |
| Blood glucose increased | 3,389 | 0.21% |
| Blood glucose normal | 2,902 | 0.18% |
| Blood gonadotrophin | 8 | 0% |
| Blood gonadotrophin decreased | 2 | 0% |
| Blood gonadotrophin increased | 1 | 0% |
| Blood gonadotrophin normal | 2 | 0% |
| Blood gonadotrophin releasing hormone | 1 | 0% |
| Blood group A | 8 | 0% |
| Blood group AB | 1 | 0% |
| Blood group B | 6 | 0% |
| Blood grouping | 130 | 0.01% |
| Blood group O | 5 | 0% |
| Blood growth hormone | 14 | 0% |
| Blood growth hormone abnormal | 1 | 0% |
| Blood growth hormone decreased | 2 | 0% |
| Blood heavy metal abnormal | 2 | 0% |
| Blood heavy metal normal | 7 | 0% |
| Blood heavy metal test | 6 | 0% |
| Blood HIV RNA | 20 | 0% |
| Blood HIV RNA below assay limit | 8 | 0% |
| Blood HIV RNA increased | 4 | 0% |
| Blood homocysteine | 319 | 0.02% |
| Blood homocysteine abnormal | 1 | 0% |
| Blood homocysteine decreased | 1 | 0% |
| Blood homocysteine increased | 30 | 0% |
| Blood homocysteine normal | 21 | 0% |
| Blood hyposmosis | 1 | 0% |
| Blood immunoglobulin A | 679 | 0.04% |
| Blood immunoglobulin A abnormal | 1 | 0% |
| Blood immunoglobulin A decreased | 22 | 0% |
| Blood immunoglobulin A increased | 34 | 0% |
| Blood immunoglobulin A normal | 34 | 0% |
| Blood immunoglobulin D | 2 | 0% |
| Blood immunoglobulin E | 589 | 0.04% |
| Blood immunoglobulin E decreased | 2 | 0% |
| Blood immunoglobulin E increased | 112 | 0.01% |
| Blood immunoglobulin E normal | 20 | 0% |
| Blood immunoglobulin G | 1,984 | 0.12% |
| Blood immunoglobulin G abnormal | 3 | 0% |
| Blood immunoglobulin G decreased | 77 | 0% |
| Blood immunoglobulin G increased | 91 | 0.01% |
| Blood immunoglobulin G normal | 101 | 0.01% |
| Blood immunoglobulin M | 1,124 | 0.07% |
| Blood immunoglobulin M abnormal | 2 | 0% |
| Blood immunoglobulin M decreased | 36 | 0% |
| Blood immunoglobulin M increased | 44 | 0% |
| Blood immunoglobulin M normal | 32 | 0% |
| Blood incompatibility haemolytic anaemia of newborn | 1 | 0% |
| Blood insulin | 48 | 0% |
| Blood insulin abnormal | 8 | 0% |
| Blood insulin decreased | 7 | 0% |
| Blood insulin increased | 15 | 0% |
| Blood insulin normal | 2 | 0% |
| Blood iron | 1,102 | 0.07% |
| Blood iron abnormal | 20 | 0% |
| Blood iron decreased | 480 | 0.03% |
| Blood iron increased | 48 | 0% |
| Blood iron normal | 119 | 0.01% |
| Blood isotope clearance | 1 | 0% |
| Blood ketone body | 223 | 0.01% |
| Blood ketone body absent | 7 | 0% |
| Blood ketone body decreased | 2 | 0% |
| Blood ketone body increased | 26 | 0% |
| Blood ketone body present | 3 | 0% |
| Blood lactate dehydrogenase | 2,354 | 0.14% |
| Blood lactate dehydrogenase abnormal | 11 | 0% |
| Blood lactate dehydrogenase decreased | 13 | 0% |
| Blood lactate dehydrogenase increased | 491 | 0.03% |
| Blood lactate dehydrogenase normal | 80 | 0% |
| Blood lactic acid | 2,055 | 0.12% |
| Blood lactic acid abnormal | 17 | 0% |
| Blood lactic acid decreased | 123 | 0.01% |
| Blood lactic acid increased | 427 | 0.03% |
| Blood lactic acid normal | 318 | 0.02% |
| Blood lead | 14 | 0% |
| Blood lead increased | 2 | 0% |
| Blood lead normal | 4 | 0% |
| Blood loss anaemia | 203 | 0.01% |
| Blood loss assessment | 11 | 0% |
| Blood luteinising hormone | 174 | 0.01% |
| Blood luteinising hormone abnormal | 3 | 0% |
| Blood luteinising hormone decreased | 13 | 0% |
| Blood luteinising hormone increased | 16 | 0% |
| Blood luteinising hormone normal | 17 | 0% |
| Blood magnesium | 1,087 | 0.07% |
| Blood magnesium abnormal | 10 | 0% |
| Blood magnesium decreased | 186 | 0.01% |
| Blood magnesium increased | 117 | 0.01% |
| Blood magnesium normal | 608 | 0.04% |
| Blood mercury | 10 | 0% |
| Blood mercury abnormal | 4 | 0% |
| Blood mercury normal | 3 | 0% |
| Blood methaemoglobin | 66 | 0% |
| Blood methaemoglobin present | 1 | 0% |
| Blood methanol | 1 | 0% |
| Blood oestrogen | 76 | 0% |
| Blood oestrogen abnormal | 7 | 0% |
| Blood oestrogen decreased | 37 | 0% |
| Blood oestrogen increased | 32 | 0% |
| Blood oestrogen normal | 7 | 0% |
| Blood osmolarity | 185 | 0.01% |
| Blood osmolarity abnormal | 2 | 0% |
| Blood osmolarity decreased | 119 | 0.01% |
| Blood osmolarity increased | 34 | 0% |
| Blood osmolarity normal | 34 | 0% |
| Blood parathyroid hormone | 129 | 0.01% |
| Blood parathyroid hormone abnormal | 4 | 0% |
| Blood parathyroid hormone decreased | 6 | 0% |
| Blood parathyroid hormone increased | 30 | 0% |
| Blood parathyroid hormone normal | 18 | 0% |
| Blood pH | 324 | 0.02% |
| Blood pH abnormal | 11 | 0% |
| Blood pH decreased | 202 | 0.01% |
| Blood pH increased | 126 | 0.01% |
| Blood pH normal | 201 | 0.01% |
| Blood phosphorus | 686 | 0.04% |
| Blood phosphorus abnormal | 4 | 0% |
| Blood phosphorus decreased | 116 | 0.01% |
| Blood phosphorus increased | 43 | 0% |
| Blood phosphorus normal | 116 | 0.01% |
| Blood potassium | 3,745 | 0.23% |
| Blood potassium abnormal | 25 | 0% |
| Blood potassium decreased | 1,133 | 0.07% |
| Blood potassium increased | 446 | 0.03% |
| Blood potassium normal | 1,267 | 0.08% |
| Blood pressure abnormal | 1,296 | 0.08% |
| Blood pressure ambulatory | 59 | 0% |
| Blood pressure ambulatory abnormal | 3 | 0% |
| Blood pressure ambulatory decreased | 2 | 0% |
| Blood pressure ambulatory increased | 9 | 0% |
| Blood pressure ambulatory normal | 2 | 0% |
| Blood pressure decreased | 4,473 | 0.27% |
| Blood pressure diastolic | 821 | 0.05% |
| Blood pressure diastolic abnormal | 17 | 0% |
| Blood pressure diastolic decreased | 138 | 0.01% |
| Blood pressure diastolic increased | 163 | 0.01% |
| Blood pressure difference of extremities | 6 | 0% |
| Blood pressure fluctuation | 1,553 | 0.09% |
| Blood pressure immeasurable | 85 | 0.01% |
| Blood pressure inadequately controlled | 62 | 0% |
| Blood pressure increased | 15,363 | 0.93% |
| Blood pressure management | 31 | 0% |
| Blood pressure measurement | 34,739 | 2.11% |
| Blood pressure normal | 152 | 0.01% |
| Blood pressure orthostatic | 49 | 0% |
| Blood pressure orthostatic abnormal | 11 | 0% |
| Blood pressure orthostatic decreased | 9 | 0% |
| Blood pressure orthostatic increased | 5 | 0% |
| Blood pressure orthostatic normal | 5 | 0% |
| Blood pressure systolic | 1,619 | 0.1% |
| Blood pressure systolic abnormal | 18 | 0% |
| Blood pressure systolic decreased | 129 | 0.01% |
| Blood pressure systolic increased | 516 | 0.03% |
| Blood pressure systolic inspiratory decreased | 4 | 0% |
| Blood pressure systolic normal | 5 | 0% |
| Blood product refusal | 1 | 0% |
| Blood product transfusion dependent | 5 | 0% |
| Blood prolactin | 194 | 0.01% |
| Blood prolactin abnormal | 5 | 0% |
| Blood prolactin decreased | 3 | 0% |
| Blood prolactin increased | 51 | 0% |
| Blood prolactin normal | 30 | 0% |
| Blood pyruvic acid | 13 | 0% |
| Blood pyruvic acid increased | 1 | 0% |
| Blood selenium | 25 | 0% |
| Blood selenium decreased | 2 | 0% |
| Blood smear test | 215 | 0.01% |
| Blood smear test abnormal | 37 | 0% |
| Blood smear test normal | 17 | 0% |
| Blood sodium | 3,399 | 0.21% |
| Blood sodium abnormal | 22 | 0% |
| Blood sodium decreased | 1,282 | 0.08% |
| Blood sodium increased | 164 | 0.01% |
| Blood sodium normal | 1,070 | 0.07% |
| Blood test | 43,868 | 2.67% |
| Blood test abnormal | 2,707 | 0.16% |
| Blood test normal | 5,872 | 0.36% |
| Blood testosterone | 168 | 0.01% |
| Blood testosterone abnormal | 3 | 0% |
| Blood testosterone decreased | 63 | 0% |
| Blood testosterone free | 7 | 0% |
| Blood testosterone free increased | 5 | 0% |
| Blood testosterone free normal | 1 | 0% |
| Blood testosterone increased | 23 | 0% |
| Blood testosterone normal | 36 | 0% |
| Blood thrombin | 14 | 0% |
| Blood thrombin increased | 2 | 0% |
| Blood thromboplastin | 69 | 0% |
| Blood thromboplastin decreased | 2 | 0% |
| Blood thromboplastin increased | 1 | 0% |
| Blood thromboplastin normal | 4 | 0% |
| Blood thyroid stimulating hormone | 4,749 | 0.29% |
| Blood thyroid stimulating hormone abnormal | 41 | 0% |
| Blood thyroid stimulating hormone decreased | 512 | 0.03% |
| Blood thyroid stimulating hormone increased | 437 | 0.03% |
| Blood thyroid stimulating hormone normal | 860 | 0.05% |
| Blood triglycerides | 1,429 | 0.09% |
| Blood triglycerides abnormal | 9 | 0% |
| Blood triglycerides decreased | 8 | 0% |
| Blood triglycerides increased | 203 | 0.01% |
| Blood triglycerides normal | 110 | 0.01% |
| Blood trypsin | 2 | 0% |
| Blood urea | 2,829 | 0.17% |
| Blood urea abnormal | 21 | 0% |
| Blood urea decreased | 168 | 0.01% |
| Blood urea increased | 1,199 | 0.07% |
| Blood urea nitrogen/creatinine ratio | 257 | 0.02% |
| Blood urea nitrogen/creatinine ratio decreased | 7 | 0% |
| Blood urea nitrogen/creatinine ratio increased | 56 | 0% |
| Blood urea normal | 814 | 0.05% |
| Blood uric acid | 888 | 0.05% |
| Blood uric acid abnormal | 12 | 0% |
| Blood uric acid decreased | 7 | 0% |
| Blood uric acid increased | 118 | 0.01% |
| Blood uric acid normal | 100 | 0.01% |
| Blood urine | 281 | 0.02% |
| Blood urine absent | 95 | 0.01% |
| Blood urine present | 1,344 | 0.08% |
| Blood viscosity abnormal | 3 | 0% |
| Blood viscosity decreased | 3 | 0% |
| Blood viscosity increased | 17 | 0% |
| Blood volume expansion | 3 | 0% |
| Bloody discharge | 103 | 0.01% |
| Blood zinc | 84 | 0.01% |
| Blood zinc abnormal | 2 | 0% |
| Blood zinc decreased | 8 | 0% |
| Blood zinc normal | 9 | 0% |
| Blue toe syndrome | 77 | 0% |
| Blunted affect | 7 | 0% |
| Body dysmorphic disorder | 6 | 0% |
| Body fat disorder | 2 | 0% |
| Body fluid analysis | 33 | 0% |
| Body height | 547 | 0.03% |
| Body height abnormal | 2 | 0% |
| Body height decreased | 79 | 0% |
| Body height increased | 2 | 0% |
| Body mass index | 1,886 | 0.11% |
| Body mass index abnormal | 1 | 0% |
| Body mass index increased | 9 | 0% |
| Body surface area | 285 | 0.02% |
| Body temperature | 49,771 | 3.03% |
| Body temperature abnormal | 583 | 0.04% |
| Body temperature decreased | 882 | 0.05% |
| Body temperature fluctuation | 485 | 0.03% |
| Body temperature increased | 10,396 | 0.63% |
| Body temperature normal | 47 | 0% |
| Body tinea | 23 | 0% |
| Bone abscess | 5 | 0% |
| Bone anchored hearing aid implantation | 1 | 0% |
| Bone atrophy | 5 | 0% |
| Bone cancer | 28 | 0% |
| Bone cancer metastatic | 13 | 0% |
| Bone contusion | 55 | 0% |
| Bone cyst | 14 | 0% |
| Bone debridement | 2 | 0% |
| Bone decalcification | 1 | 0% |
| Bone deformity | 7 | 0% |
| Bone demineralisation | 6 | 0% |
| Bone densitometry | 162 | 0.01% |
| Bone density abnormal | 23 | 0% |
| Bone density decreased | 13 | 0% |
| Bone density increased | 2 | 0% |
| Bone development abnormal | 1 | 0% |
| Bone disorder | 138 | 0.01% |
| Bone erosion | 18 | 0% |
| Bone fissure | 6 | 0% |
| Bone formation increased | 1 | 0% |
| Bone formation test | 2 | 0% |
| Bone fragmentation | 7 | 0% |
| Bone giant cell tumour | 1 | 0% |
| Bone graft | 5 | 0% |
| Bone graft removal | 1 | 0% |
| Bone hypertrophy | 5 | 0% |
| Bone infarction | 7 | 0% |
| Bone lesion | 32 | 0% |
| Bone loss | 14 | 0% |
| Bone marrow disorder | 40 | 0% |
| Bone marrow failure | 41 | 0% |
| Bone marrow granuloma | 1 | 0% |
| Bone marrow infiltration | 5 | 0% |
| Bone marrow ischaemia | 1 | 0% |
| Bone marrow myelogram | 11 | 0% |
| Bone marrow myelogram abnormal | 5 | 0% |
| Bone marrow myelogram normal | 1 | 0% |
| Bone marrow necrosis | 1 | 0% |
| Bone marrow oedema | 65 | 0% |
| Bone marrow oedema syndrome | 2 | 0% |
| Bone marrow reticulin fibrosis | 2 | 0% |
| Bone marrow transplant | 20 | 0% |
| Bone metabolism disorder | 3 | 0% |
| Bone neoplasm | 17 | 0% |
| Bone operation | 4 | 0% |
| Bone pain | 4,906 | 0.3% |
| Bone resorption test | 1 | 0% |
| Bone sarcoma | 1 | 0% |
| Bone scan | 198 | 0.01% |
| Bone scan abnormal | 14 | 0% |
| Bone scan normal | 18 | 0% |
| Bone swelling | 127 | 0.01% |
| Bone tuberculosis | 9 | 0% |
| Booster dose missed | 2 | 0% |
| Borderline mucinous tumour of ovary | 1 | 0% |
| Borderline ovarian tumour | 5 | 0% |
| Borderline personality disorder | 4 | 0% |
| Bordetella test | 23 | 0% |
| Bordetella test negative | 168 | 0.01% |
| Bordetella test positive | 5 | 0% |
| Boredom | 8 | 0% |
| Borrelia infection | 59 | 0% |
| Borrelia test | 979 | 0.06% |
| Borrelia test negative | 360 | 0.02% |
| Borrelia test positive | 64 | 0% |
| Botulinum toxin injection | 24 | 0% |
| Botulism | 1 | 0% |
| Boutonneuse fever | 2 | 0% |
| Bowel movement irregularity | 331 | 0.02% |
| Bowel obstruction surgery | 3 | 0% |
| Bowel preparation | 3 | 0% |
| Bowen's disease | 3 | 0% |
| B precursor type acute leukaemia | 3 | 0% |
| Brachial artery entrapment syndrome | 2 | 0% |
| Brachial plexopathy | 77 | 0% |
| Brachial plexus injury | 28 | 0% |
| Brachial pulse | 5 | 0% |
| Brachial pulse decreased | 8 | 0% |
| Brachial pulse increased | 3 | 0% |
| Brachiocephalic artery occlusion | 2 | 0% |
| Brachiocephalic artery stenosis | 2 | 0% |
| Brachiocephalic vein occlusion | 1 | 0% |
| Brachiocephalic vein thrombosis | 28 | 0% |
| Brachioradial pruritus | 2 | 0% |
| Brachydactyly | 3 | 0% |
| Brachyolmia | 1 | 0% |
| Brachytherapy | 1 | 0% |
| Bradyarrhythmia | 20 | 0% |
| Bradycardia | 2,982 | 0.18% |
| Bradycardia foetal | 20 | 0% |
| Bradycardia neonatal | 5 | 0% |
| Bradykinesia | 359 | 0.02% |
| Bradyphrenia | 376 | 0.02% |
| Bradypnoea | 14 | 0% |
| BRAF gene mutation | 6 | 0% |
| Brain abscess | 27 | 0% |
| Brain cancer metastatic | 13 | 0% |
| Brain compression | 28 | 0% |
| Brain contusion | 40 | 0% |
| Brain death | 108 | 0.01% |
| Brain empyema | 2 | 0% |
| Brain fog | 1,011 | 0.06% |
| Brain herniation | 88 | 0.01% |
| Brain hypoxia | 34 | 0% |
| Brain injury | 347 | 0.02% |
| Brain lobectomy | 1 | 0% |
| Brain malformation | 2 | 0% |
| Brain midline shift | 2 | 0% |
| Brain natriuretic peptide | 1,865 | 0.11% |
| Brain natriuretic peptide abnormal | 15 | 0% |
| Brain natriuretic peptide decreased | 15 | 0% |
| Brain natriuretic peptide increased | 1,140 | 0.07% |
| Brain natriuretic peptide normal | 476 | 0.03% |
| Brain neoplasm | 140 | 0.01% |
| Brain neoplasm benign | 6 | 0% |
| Brain neoplasm malignant | 15 | 0% |
| Brain oedema | 412 | 0.03% |
| Brain operation | 64 | 0% |
| Brain radiation necrosis | 1 | 0% |
| Brain scan abnormal | 66 | 0% |
| Brain scan normal | 127 | 0.01% |
| Brain stem auditory evoked response | 57 | 0% |
| Brain stem auditory evoked response abnormal | 3 | 0% |
| Brain stem auditory evoked response normal | 2 | 0% |
| Brain stem embolism | 2 | 0% |
| Brain stem glioma | 2 | 0% |
| Brain stem haematoma | 1 | 0% |
| Brain stem haemorrhage | 85 | 0.01% |
| Brain stem infarction | 188 | 0.01% |
| Brain stem ischaemia | 23 | 0% |
| Brain stem microhaemorrhage | 2 | 0% |
| Brain stem stroke | 84 | 0.01% |
| Brain stem syndrome | 55 | 0% |
| Brain stem thrombosis | 23 | 0% |
| Brain stent insertion | 2 | 0% |
| Brain tumour operation | 2 | 0% |
| Branchial cyst | 5 | 0% |
| BRCA1 gene mutation | 5 | 0% |
| BRCA1 gene mutation assay | 5 | 0% |
| BRCA2 gene mutation | 3 | 0% |
| BRCA2 gene mutation assay | 5 | 0% |
| Breakthrough COVID-19 | 779 | 0.05% |
| Breakthrough haemolysis | 7 | 0% |
| Breakthrough pain | 10 | 0% |
| Breast abscess | 57 | 0% |
| Breast adenoma | 1 | 0% |
| Breast angiosarcoma | 1 | 0% |
| Breast atrophy | 11 | 0% |
| Breast calcifications | 23 | 0% |
| Breast cancer | 437 | 0.03% |
| Breast cancer female | 290 | 0.02% |
| Breast cancer in situ | 5 | 0% |
| Breast cancer male | 6 | 0% |
| Breast cancer metastatic | 56 | 0% |
| Breast cancer recurrent | 47 | 0% |
| Breast cancer stage I | 11 | 0% |
| Breast cancer stage II | 7 | 0% |
| Breast cancer stage III | 11 | 0% |
| Breast cancer stage IV | 15 | 0% |
| Breast cellulitis | 18 | 0% |
| Breast conserving surgery | 70 | 0% |
| Breast cyst | 180 | 0.01% |
| Breast cyst drainage | 3 | 0% |
| Breast cyst rupture | 1 | 0% |
| Breast discharge | 113 | 0.01% |
| Breast discharge infected | 4 | 0% |
| Breast discolouration | 21 | 0% |
| Breast discomfort | 314 | 0.02% |
| Breast disorder | 49 | 0% |
| Breast disorder female | 41 | 0% |
| Breast disorder male | 1 | 0% |
| Breast dysplasia | 1 | 0% |
| Breast engorgement | 63 | 0% |
| Breast enlargement | 245 | 0.01% |
| Breast feeding | 157 | 0.01% |
| Breast fibrosis | 6 | 0% |
| Breast haematoma | 15 | 0% |
| Breast haemorrhage | 28 | 0% |
| Breast hyperplasia | 14 | 0% |
| Breast implant palpable | 1 | 0% |
| Breast induration | 50 | 0% |
| Breast inflammation | 160 | 0.01% |
| Breast injury | 8 | 0% |
| Breast malformation | 2 | 0% |
| Breast mass | 908 | 0.06% |
| Breast milk discolouration | 16 | 0% |
| Breast milk substitute intolerance | 1 | 0% |
| Breast necrosis | 6 | 0% |
| Breast neoplasm | 28 | 0% |
| Breast oedema | 66 | 0% |
| Breast operation | 23 | 0% |
| Breast pain | 4,471 | 0.27% |
| Breast paraesthesia | 1 | 0% |
| Breast proliferative changes | 2 | 0% |
| Breast prosthesis removal | 5 | 0% |
| Breast prosthesis user | 5 | 0% |
| Breast reconstruction | 8 | 0% |
| Breast sarcoma | 1 | 0% |
| Breast scan | 35 | 0% |
| Breast scan abnormal | 3 | 0% |
| Breast swelling | 1,361 | 0.08% |
| Breast tenderness | 892 | 0.05% |
| Breast tumour excision | 3 | 0% |
| Breast ulceration | 2 | 0% |
| Breath alcohol test | 5 | 0% |
| Breath alcohol test positive | 1 | 0% |
| Breath holding | 21 | 0% |
| Breathing-related sleep disorder | 25 | 0% |
| Breath odour | 89 | 0.01% |
| Breath sounds | 179 | 0.01% |
| Breath sounds abnormal | 480 | 0.03% |
| Breath sounds absent | 36 | 0% |
| Breath sounds normal | 15 | 0% |
| Breech delivery | 2 | 0% |
| Breech presentation | 31 | 0% |
| Brenner tumour | 1 | 0% |
| Brief psychotic disorder, with postpartum onset | 2 | 0% |
| Brief psychotic disorder with marked stressors | 3 | 0% |
| Brief psychotic disorder without marked stressors | 1 | 0% |
| Brief resolved unexplained event | 23 | 0% |
| Bromhidrosis | 1 | 0% |
| Bromoderma | 1 | 0% |
| Bromosulphthalein test | 1 | 0% |
| Bromosulphthalein test abnormal | 1 | 0% |
| Bronchial aspiration procedure | 11 | 0% |
| Bronchial atresia | 2 | 0% |
| Bronchial carcinoma | 21 | 0% |
| Bronchial disorder | 87 | 0.01% |
| Bronchial dysplasia | 2 | 0% |
| Bronchial haemorrhage | 8 | 0% |
| Bronchial hyperreactivity | 109 | 0.01% |
| Bronchial injury | 1 | 0% |
| Bronchial irritation | 23 | 0% |
| Bronchial neoplasm | 2 | 0% |
| Bronchial obstruction | 42 | 0% |
| Bronchial oedema | 7 | 0% |
| Bronchial secretion retention | 110 | 0.01% |
| Bronchial stent insertion | 1 | 0% |
| Bronchial wall thickening | 114 | 0.01% |
| Bronchiectasis | 161 | 0.01% |
| Bronchiolitis | 80 | 0% |
| Bronchiolitis obliterans syndrome | 2 | 0% |
| Bronchioloalveolar carcinoma | 2 | 0% |
| Bronchitis | 1,702 | 0.1% |
| Bronchitis bacterial | 30 | 0% |
| Bronchitis chronic | 69 | 0% |
| Bronchitis viral | 30 | 0% |
| Bronchoalveolar lavage | 171 | 0.01% |
| Bronchoalveolar lavage abnormal | 26 | 0% |
| Bronchoalveolar lavage normal | 9 | 0% |
| Bronchogenic cyst | 5 | 0% |
| Bronchogram | 5 | 0% |
| Bronchogram abnormal | 5 | 0% |
| Bronchomalacia | 1 | 0% |
| Bronchopleural fistula | 4 | 0% |
| Bronchopneumopathy | 26 | 0% |
| Bronchopulmonary aspergillosis | 20 | 0% |
| Bronchopulmonary aspergillosis allergic | 2 | 0% |
| Bronchopulmonary disease | 6 | 0% |
| Bronchopulmonary dysplasia | 1 | 0% |
| Bronchoscopic lung volume reduction | 1 | 0% |
| Bronchoscopy | 361 | 0.02% |
| Bronchoscopy abnormal | 79 | 0% |
| Bronchoscopy normal | 22 | 0% |
| Bronchospasm | 766 | 0.05% |
| Bronchostenosis | 35 | 0% |
| Brown-Sequard syndrome | 10 | 0% |
| Brow ptosis | 4 | 0% |
| Brucella test | 72 | 0% |
| Brucella test negative | 8 | 0% |
| Brucella test positive | 1 | 0% |
| Brucellosis | 15 | 0% |
| Brudzinski's sign | 5 | 0% |
| Brugada syndrome | 26 | 0% |
| Bruxism | 174 | 0.01% |
| Budd-Chiari syndrome | 12 | 0% |
| Bulbar palsy | 22 | 0% |
| Bulimia nervosa | 2 | 0% |
| Bullous erysipelas | 4 | 0% |
| Bullous haemorrhagic dermatosis | 24 | 0% |
| Bullous impetigo | 4 | 0% |
| Bundle branch block | 60 | 0% |
| Bundle branch block bilateral | 6 | 0% |
| Bundle branch block left | 371 | 0.02% |
| Bundle branch block right | 464 | 0.03% |
| Bunion operation | 6 | 0% |
| Buried penis syndrome | 1 | 0% |
| Burkitt's leukaemia | 1 | 0% |
| Burkitt's lymphoma | 10 | 0% |
| Burkitt's lymphoma stage I | 2 | 0% |
| Burkitt's lymphoma stage IV | 1 | 0% |
| Burn dressing | 1 | 0% |
| Burning feet syndrome | 46 | 0% |
| Burning mouth syndrome | 64 | 0% |
| Burning sensation | 11,666 | 0.71% |
| Burning sensation mucosal | 26 | 0% |
| Burn oesophageal | 21 | 0% |
| Burn of internal organs | 10 | 0% |
| Burn oral cavity | 33 | 0% |
| Burnout syndrome | 63 | 0% |
| Burns first degree | 3 | 0% |
| Burns second degree | 39 | 0% |
| Burns third degree | 24 | 0% |
| Bursa calcification | 1 | 0% |
| Bursa disorder | 25 | 0% |
| Bursa injury | 12 | 0% |
| Bursal fluid accumulation | 26 | 0% |
| Bursal haematoma | 4 | 0% |
| Bursa removal | 3 | 0% |
| Bursitis | 1,032 | 0.06% |
| Bursitis infective | 8 | 0% |
| Butterfly rash | 67 | 0% |
| Buttock injury | 16 | 0% |
| C-kit gene mutation | 2 | 0% |
| C-kit gene status assay | 1 | 0% |
| C-reactive protein | 15,913 | 0.97% |
| C-reactive protein abnormal | 126 | 0.01% |
| C-reactive protein decreased | 92 | 0.01% |
| C-reactive protein increased | 5,332 | 0.32% |
| C-reactive protein normal | 940 | 0.06% |
| C-telopeptide | 2 | 0% |
| C1 esterase inhibitor decreased | 1 | 0% |
| C1 esterase inhibitor test | 44 | 0% |
| C1 esterase inhibitor test normal | 6 | 0% |
| C1q nephropathy | 1 | 0% |
| C3 glomerulopathy | 20 | 0% |
| Cachexia | 145 | 0.01% |
| CADASIL | 1 | 0% |
| Caecectomy | 2 | 0% |
| Caecopexy | 1 | 0% |
| Caesarean section | 267 | 0.02% |
| Cafe au lait spots | 1 | 0% |
| Caffeine allergy | 10 | 0% |
| Caffeine consumption | 15 | 0% |
| Calcification of muscle | 6 | 0% |
| Calcific deposits removal | 2 | 0% |
| Calcinosis | 28 | 0% |
| Calciphylaxis | 3 | 0% |
| Calcitonin stimulation test | 1 | 0% |
| Calcium deficiency | 4 | 0% |
| Calcium embolism | 2 | 0% |
| Calcium ionised | 120 | 0.01% |
| Calcium ionised abnormal | 1 | 0% |
| Calcium ionised decreased | 22 | 0% |
| Calcium ionised increased | 6 | 0% |
| Calcium ionised normal | 15 | 0% |
| Calcium metabolism disorder | 3 | 0% |
| Calcium phosphate product | 7 | 0% |
| Calculus bladder | 24 | 0% |
| Calculus urethral | 1 | 0% |
| Calculus urinary | 37 | 0% |
| CALR gene mutation | 8 | 0% |
| Calyceal diverticulum | 1 | 0% |
| Camptocormia | 2 | 0% |
| Campylobacter colitis | 4 | 0% |
| Campylobacter gastroenteritis | 19 | 0% |
| Campylobacter infection | 29 | 0% |
| Campylobacter test | 57 | 0% |
| Campylobacter test positive | 20 | 0% |
| Canalith repositioning procedure | 44 | 0% |
| Cancer cells present | 2 | 0% |
| Cancer fatigue | 5 | 0% |
| Cancer gene carrier | 2 | 0% |
| Cancer in remission | 15 | 0% |
| Cancer pain | 21 | 0% |
| Cancer screening | 36 | 0% |
| Cancer screening abnormal | 1 | 0% |
| Cancer screening normal | 1 | 0% |
| Cancer staging | 4 | 0% |
| Cancer surgery | 32 | 0% |
| Candida infection | 265 | 0.02% |
| Candida sepsis | 2 | 0% |
| Candida test | 25 | 0% |
| Candida test negative | 11 | 0% |
| Candida test positive | 27 | 0% |
| Cannabinoid hyperemesis syndrome | 4 | 0% |
| Capillaritis | 17 | 0% |
| Capillary disorder | 40 | 0% |
| Capillary fragility | 110 | 0.01% |
| Capillary fragility increased | 3 | 0% |
| Capillary fragility test | 10 | 0% |
| Capillary leak syndrome | 109 | 0.01% |
| Capillary nail refill test | 93 | 0.01% |
| Capillary nail refill test abnormal | 22 | 0% |
| Capillary permeability | 2 | 0% |
| Capillary permeability increased | 11 | 0% |
| Capnocytophaga infection | 1 | 0% |
| Capnocytophaga sepsis | 1 | 0% |
| Capnogram | 3 | 0% |
| Capsular contracture associated with breast implant | 14 | 0% |
| Capsular contracture associated with implant | 1 | 0% |
| Capsule endoscopy | 29 | 0% |
| Carbohydrate antigen 15-3 | 72 | 0% |
| Carbohydrate antigen 15-3 increased | 12 | 0% |
| Carbohydrate antigen 19-9 | 136 | 0.01% |
| Carbohydrate antigen 19-9 increased | 10 | 0% |
| Carbohydrate antigen 27.29 | 4 | 0% |
| Carbohydrate antigen 27.29 increased | 1 | 0% |
| Carbohydrate antigen 72-4 | 2 | 0% |
| Carbohydrate antigen 125 | 122 | 0.01% |
| Carbohydrate antigen 125 increased | 20 | 0% |
| Carbohydrate antigen 125 normal | 2 | 0% |
| Carbohydrate deficient transferrin test | 4 | 0% |
| Carbohydrate intolerance | 6 | 0% |
| Carbohydrate metabolism disorder | 2 | 0% |
| Carbon dioxide | 382 | 0.02% |
| Carbon dioxide abnormal | 24 | 0% |
| Carbon dioxide decreased | 378 | 0.02% |
| Carbon dioxide increased | 178 | 0.01% |
| Carbon dioxide normal | 701 | 0.04% |
| Carbonic anhydrase gene mutation | 1 | 0% |
| Carbonic anhydrase gene mutation assay | 3 | 0% |
| Carbon monoxide poisoning | 4 | 0% |
| Carboxyhaemoglobin | 67 | 0% |
| Carboxyhaemoglobin decreased | 2 | 0% |
| Carboxyhaemoglobin increased | 2 | 0% |
| Carboxyhaemoglobin normal | 11 | 0% |
| Carbuncle | 14 | 0% |
| Carcinoembryonic antigen | 153 | 0.01% |
| Carcinoembryonic antigen increased | 36 | 0% |
| Carcinoembryonic antigen normal | 12 | 0% |
| Carcinogenicity | 1 | 0% |
| Carcinoid crisis | 1 | 0% |
| Carcinoid syndrome | 4 | 0% |
| Carcinoid tumour | 7 | 0% |
| Carcinoid tumour of the gastrointestinal tract | 2 | 0% |
| Carcinoid tumour pulmonary | 2 | 0% |
| Carcinoma in situ | 2 | 0% |
| Cardiac ablation | 275 | 0.02% |
| Cardiac amyloidosis | 23 | 0% |
| Cardiac aneurysm | 58 | 0% |
| Cardiac arrest | 3,667 | 0.22% |
| Cardiac arrest neonatal | 1 | 0% |
| Cardiac assistance device user | 121 | 0.01% |
| Cardiac asthma | 12 | 0% |
| Cardiac autonomic neuropathy | 6 | 0% |
| Cardiac cirrhosis | 5 | 0% |
| Cardiac clearance | 5 | 0% |
| Cardiac complication associated with device | 2 | 0% |
| Cardiac contractility decreased | 8 | 0% |
| Cardiac contusion | 4 | 0% |
| Cardiac death | 103 | 0.01% |
| Cardiac device implantation | 3 | 0% |
| Cardiac device replacement | 2 | 0% |
| Cardiac device reprogramming | 5 | 0% |
| Cardiac discomfort | 1,604 | 0.1% |
| Cardiac disorder | 3,065 | 0.19% |
| Cardiac dysfunction | 246 | 0.01% |
| Cardiac electrophysiologic study | 155 | 0.01% |
| Cardiac electrophysiologic study abnormal | 9 | 0% |
| Cardiac electrophysiologic study normal | 2 | 0% |
| Cardiac failure | 3,727 | 0.23% |
| Cardiac failure acute | 716 | 0.04% |
| Cardiac failure chronic | 218 | 0.01% |
| Cardiac failure congestive | 1,713 | 0.1% |
| Cardiac failure high output | 4 | 0% |
| Cardiac fibrillation | 333 | 0.02% |
| Cardiac flutter | 2,915 | 0.18% |
| Cardiac function test | 759 | 0.05% |
| Cardiac function test abnormal | 32 | 0% |
| Cardiac function test normal | 119 | 0.01% |
| Cardiac granuloma | 2 | 0% |
| Cardiac herniation | 1 | 0% |
| Cardiac hypertrophy | 80 | 0% |
| Cardiac imaging procedure | 166 | 0.01% |
| Cardiac imaging procedure abnormal | 322 | 0.02% |
| Cardiac imaging procedure normal | 70 | 0% |
| Cardiac index | 40 | 0% |
| Cardiac index decreased | 6 | 0% |
| Cardiac index increased | 3 | 0% |
| Cardiac infection | 98 | 0.01% |
| Cardiac malposition | 2 | 0% |
| Cardiac massage | 1 | 0% |
| Cardiac monitoring | 1,967 | 0.12% |
| Cardiac monitoring abnormal | 401 | 0.02% |
| Cardiac monitoring normal | 236 | 0.01% |
| Cardiac murmur | 389 | 0.02% |
| Cardiac murmur functional | 10 | 0% |
| Cardiac myxoma | 2 | 0% |
| Cardiac neoplasm malignant | 1 | 0% |
| Cardiac neoplasm unspecified | 5 | 0% |
| Cardiac operation | 116 | 0.01% |
| Cardiac output | 87 | 0.01% |
| Cardiac output decreased | 33 | 0% |
| Cardiac output increased | 1 | 0% |
| Cardiac pacemaker adjustment | 5 | 0% |
| Cardiac pacemaker evaluation | 25 | 0% |
| Cardiac pacemaker insertion | 385 | 0.02% |
| Cardiac pacemaker removal | 2 | 0% |
| Cardiac pacemaker replacement | 10 | 0% |
| Cardiac perforation | 3 | 0% |
| Cardiac perfusion defect | 14 | 0% |
| Cardiac pharmacologic stress test | 21 | 0% |
| Cardiac pharmacologic stress test abnormal | 1 | 0% |
| Cardiac procedure complication | 10 | 0% |
| Cardiac rehabilitation therapy | 3 | 0% |
| Cardiac resynchronisation therapy | 30 | 0% |
| Cardiac sarcoidosis | 29 | 0% |
| Cardiac septal defect | 11 | 0% |
| Cardiac septal defect repair | 1 | 0% |
| Cardiac septal defect residual shunt | 2 | 0% |
| Cardiac septal hypertrophy | 22 | 0% |
| Cardiac steatosis | 7 | 0% |
| Cardiac stress test | 2,262 | 0.14% |
| Cardiac stress test abnormal | 249 | 0.02% |
| Cardiac stress test normal | 482 | 0.03% |
| Cardiac tamponade | 208 | 0.01% |
| Cardiac telemetry | 595 | 0.04% |
| Cardiac telemetry abnormal | 93 | 0.01% |
| Cardiac telemetry normal | 62 | 0% |
| Cardiac therapeutic procedure | 6 | 0% |
| Cardiac valve abscess | 1 | 0% |
| Cardiac valve discolouration | 2 | 0% |
| Cardiac valve disease | 144 | 0.01% |
| Cardiac valve fatty infiltration | 1 | 0% |
| Cardiac valve fibroelastoma | 5 | 0% |
| Cardiac valve prosthesis user | 3 | 0% |
| Cardiac valve rupture | 5 | 0% |
| Cardiac valve sclerosis | 3 | 0% |
| Cardiac valve thickening | 4 | 0% |
| Cardiac valve vegetation | 21 | 0% |
| Cardiac vein dissection | 5 | 0% |
| Cardiac vein perforation | 1 | 0% |
| Cardiac ventricular disorder | 27 | 0% |
| Cardiac ventricular scarring | 5 | 0% |
| Cardiac ventricular thrombosis | 99 | 0.01% |
| Cardiac ventriculogram | 29 | 0% |
| Cardiac ventriculogram abnormal | 1 | 0% |
| Cardiac ventriculogram left | 26 | 0% |
| Cardiac ventriculogram left abnormal | 5 | 0% |
| Cardiac ventriculogram left normal | 5 | 0% |
| Cardiac ventriculogram right | 1 | 0% |
| Cardio-ankle vascular index | 1 | 0% |
| Cardio-respiratory arrest | 1,493 | 0.09% |
| Cardio-respiratory distress | 20 | 0% |
| Cardioactive drug level | 24 | 0% |
| Cardioactive drug level decreased | 1 | 0% |
| Cardioactive drug level increased | 3 | 0% |
| Cardiogenic shock | 576 | 0.04% |
| Cardiolipin antibody | 610 | 0.04% |
| Cardiolipin antibody negative | 59 | 0% |
| Cardiolipin antibody positive | 40 | 0% |
| Cardiomegaly | 1,319 | 0.08% |
| Cardiomyopathy | 778 | 0.05% |
| Cardiomyopathy acute | 12 | 0% |
| Cardiomyopathy alcoholic | 1 | 0% |
| Cardiomyopathy neonatal | 2 | 0% |
| Cardioplegia | 1 | 0% |
| Cardiopulmonary bypass | 10 | 0% |
| Cardiopulmonary exercise test | 79 | 0% |
| Cardiopulmonary exercise test abnormal | 7 | 0% |
| Cardiopulmonary exercise test normal | 3 | 0% |
| Cardiopulmonary failure | 87 | 0.01% |
| Cardiorenal syndrome | 25 | 0% |
| Cardiospasm | 40 | 0% |
| Cardiothoracic ratio | 35 | 0% |
| Cardiothoracic ratio increased | 7 | 0% |
| Cardiotoxicity | 3 | 0% |
| Cardiovascular autonomic function test | 18 | 0% |
| Cardiovascular autonomic function test abnormal | 3 | 0% |
| Cardiovascular deconditioning | 23 | 0% |
| Cardiovascular disorder | 2,066 | 0.13% |
| Cardiovascular evaluation | 279 | 0.02% |
| Cardiovascular event prophylaxis | 1 | 0% |
| Cardiovascular examination | 1,139 | 0.07% |
| Cardiovascular examination abnormal | 3 | 0% |
| Cardiovascular function test | 143 | 0.01% |
| Cardiovascular function test abnormal | 3 | 0% |
| Cardiovascular function test normal | 5 | 0% |
| Cardiovascular insufficiency | 166 | 0.01% |
| Cardiovascular somatic symptom disorder | 4 | 0% |
| Cardiovascular symptom | 106 | 0.01% |
| Cardioversion | 770 | 0.05% |
| Carditis | 345 | 0.02% |
| Caregiver | 16 | 0% |
| Carney complex | 1 | 0% |
| Carnitine | 6 | 0% |
| Carnitine normal | 1 | 0% |
| Carotid aneurysm rupture | 2 | 0% |
| Carotid angioplasty | 4 | 0% |
| Carotid arterial embolus | 2 | 0% |
| Carotid arteriosclerosis | 105 | 0.01% |
| Carotid artery aneurysm | 31 | 0% |
| Carotid artery bypass | 2 | 0% |
| Carotid artery disease | 41 | 0% |
| Carotid artery dissection | 116 | 0.01% |
| Carotid artery dolichoectasia | 1 | 0% |
| Carotid artery occlusion | 158 | 0.01% |
| Carotid artery perforation | 1 | 0% |
| Carotid artery stenosis | 205 | 0.01% |
| Carotid artery stent insertion | 14 | 0% |
| Carotid artery thrombosis | 110 | 0.01% |
| Carotid bruit | 8 | 0% |
| Carotid endarterectomy | 22 | 0% |
| Carotid intima-media thickness increased | 3 | 0% |
| Carotid pulse | 7 | 0% |
| Carotid pulse abnormal | 9 | 0% |
| Carotid pulse decreased | 1 | 0% |
| Carotid pulse increased | 2 | 0% |
| Carotid revascularisation | 2 | 0% |
| Carotid sinus massage | 3 | 0% |
| Carotidynia | 9 | 0% |
| Carpal collapse | 1 | 0% |
| Carpal tunnel decompression | 18 | 0% |
| Carpal tunnel syndrome | 427 | 0.03% |
| Cartilage atrophy | 3 | 0% |
| Cartilage graft | 1 | 0% |
| Cartilage hypertrophy | 1 | 0% |
| Cartilage injury | 48 | 0% |
| Cartilage neoplasm | 1 | 0% |
| Cartilage operation | 1 | 0% |
| Cast application | 16 | 0% |
| Castleman's disease | 28 | 0% |
| Catabolic state | 1 | 0% |
| Catamenial pneumothorax | 1 | 0% |
| Cataplexy | 41 | 0% |
| Cataract | 424 | 0.03% |
| Cataract congenital | 3 | 0% |
| Cataract cortical | 4 | 0% |
| Cataract diabetic | 4 | 0% |
| Cataract nuclear | 7 | 0% |
| Cataract operation | 48 | 0% |
| Cataract operation complication | 2 | 0% |
| Cataract subcapsular | 2 | 0% |
| Catarrh | 116 | 0.01% |
| Catastrophic reaction | 3 | 0% |
| Catatonia | 65 | 0% |
| Catecholamine crisis | 1 | 0% |
| Catecholamines urine | 11 | 0% |
| Catecholamines urine increased | 1 | 0% |
| Catecholamines urine normal | 4 | 0% |
| Catheter culture | 7 | 0% |
| Catheter culture positive | 1 | 0% |
| Catheter directed thrombolysis | 48 | 0% |
| Catheterisation cardiac | 1,263 | 0.08% |
| Catheterisation cardiac abnormal | 503 | 0.03% |
| Catheterisation cardiac normal | 378 | 0.02% |
| Catheterisation venous | 7 | 0% |
| Catheter management | 10 | 0% |
| Catheter placement | 146 | 0.01% |
| Catheter removal | 20 | 0% |
| Catheter site discharge | 2 | 0% |
| Catheter site erythema | 3 | 0% |
| Catheter site haematoma | 2 | 0% |
| Catheter site haemorrhage | 11 | 0% |
| Catheter site infection | 5 | 0% |
| Catheter site injury | 1 | 0% |
| Catheter site irritation | 1 | 0% |
| Catheter site pain | 4 | 0% |
| Catheter site related reaction | 1 | 0% |
| Catheter site swelling | 3 | 0% |
| Catheter site thrombosis | 4 | 0% |
| Catheter site warmth | 1 | 0% |
| Cat scratch disease | 6 | 0% |
| Cauda equina syndrome | 34 | 0% |
| Cautery to nose | 20 | 0% |
| Cavernous sinus syndrome | 4 | 0% |
| Cavernous sinus thrombosis | 24 | 0% |
| CCR5 receptor positive | 1 | 0% |
| CD4 lymphocyte percentage | 3 | 0% |
| CD4 lymphocyte percentage decreased | 1 | 0% |
| CD4 lymphocyte percentage increased | 1 | 0% |
| CD4 lymphocytes | 191 | 0.01% |
| CD4 lymphocytes abnormal | 1 | 0% |
| CD4 lymphocytes decreased | 20 | 0% |
| CD4 lymphocytes increased | 11 | 0% |
| CD4 lymphocytes normal | 3 | 0% |
| CD4/CD8 ratio | 82 | 0% |
| CD4/CD8 ratio decreased | 4 | 0% |
| CD4/CD8 ratio increased | 7 | 0% |
| CD8 lymphocyte percentage decreased | 5 | 0% |
| CD8 lymphocyte percentage increased | 2 | 0% |
| CD8 lymphocytes | 130 | 0.01% |
| CD8 lymphocytes decreased | 8 | 0% |
| CD8 lymphocytes increased | 4 | 0% |
| CD19 antigen | 4 | 0% |
| CD19 antigen loss | 1 | 0% |
| CD19 lymphocyte count abnormal | 3 | 0% |
| CD19 lymphocytes decreased | 5 | 0% |
| CD19 lymphocytes increased | 3 | 0% |
| CD20 antigen positive | 1 | 0% |
| CD25 antigen positive | 5 | 0% |
| CD30 expression | 15 | 0% |
| CD34 cell count decreased | 2 | 0% |
| CD45 expression decreased | 2 | 0% |
| CD45 expression increased | 2 | 0% |
| Cell-mediated cytotoxicity | 2 | 0% |
| Cell-mediated immune deficiency | 6 | 0% |
| Cell death | 71 | 0% |
| Cell marker | 79 | 0% |
| Cell marker decreased | 1 | 0% |
| Cell marker increased | 3 | 0% |
| Cells in urine | 11 | 0% |
| Cellulite | 5 | 0% |
| Cellulitis | 3,102 | 0.19% |
| Cellulitis orbital | 16 | 0% |
| Cellulitis pasteurella | 1 | 0% |
| Cellulitis pharyngeal | 1 | 0% |
| Cellulitis staphylococcal | 6 | 0% |
| Cellulitis streptococcal | 1 | 0% |
| Central auditory processing disorder | 2 | 0% |
| Central cord syndrome | 4 | 0% |
| Central hypothyroidism | 3 | 0% |
| Central nervous system abscess | 1 | 0% |
| Central nervous system function test | 17 | 0% |
| Central nervous system function test abnormal | 1 | 0% |
| Central nervous system function test normal | 4 | 0% |
| Central nervous system fungal infection | 1 | 0% |
| Central nervous system haemorrhage | 2 | 0% |
| Central nervous system immune reconstitution inflammatory response | 1 | 0% |
| Central nervous system infection | 16 | 0% |
| Central nervous system inflammation | 115 | 0.01% |
| Central nervous system injury | 3 | 0% |
| Central nervous system lesion | 309 | 0.02% |
| Central nervous system leukaemia | 1 | 0% |
| Central nervous system lupus | 4 | 0% |
| Central nervous system lymphoma | 12 | 0% |
| Central nervous system necrosis | 1 | 0% |
| Central nervous system stimulation | 5 | 0% |
| Central nervous system vasculitis | 48 | 0% |
| Central nervous system viral infection | 4 | 0% |
| Central obesity | 2 | 0% |
| Central pain syndrome | 32 | 0% |
| Central serous chorioretinopathy | 35 | 0% |
| Central sleep apnoea syndrome | 6 | 0% |
| Central venous catheterisation | 290 | 0.02% |
| Central venous catheter removal | 12 | 0% |
| Central venous pressure | 9 | 0% |
| Central venous pressure abnormal | 1 | 0% |
| Central venous pressure increased | 4 | 0% |
| Central venous pressure normal | 1 | 0% |
| Central vision loss | 33 | 0% |
| Cephalhaematoma | 2 | 0% |
| Cephalin flocculation | 14 | 0% |
| Cephalin flocculation abnormal | 2 | 0% |
| Cerebellar artery occlusion | 15 | 0% |
| Cerebellar artery thrombosis | 16 | 0% |
| Cerebellar ataxia | 45 | 0% |
| Cerebellar atrophy | 20 | 0% |
| Cerebellar cognitive affective syndrome | 1 | 0% |
| Cerebellar embolism | 5 | 0% |
| Cerebellar haematoma | 10 | 0% |
| Cerebellar haemorrhage | 85 | 0.01% |
| Cerebellar hypoplasia | 5 | 0% |
| Cerebellar infarction | 270 | 0.02% |
| Cerebellar ischaemia | 32 | 0% |
| Cerebellar microhaemorrhage | 1 | 0% |
| Cerebellar stroke | 190 | 0.01% |
| Cerebellar syndrome | 58 | 0% |
| Cerebellar tonsillar ectopia | 3 | 0% |
| Cerebellar tumour | 3 | 0% |
| Cerebral amyloid angiopathy | 31 | 0% |
| Cerebral aneurysm perforation | 1 | 0% |
| Cerebral arteriosclerosis | 50 | 0% |
| Cerebral arteriovenous malformation haemorrhagic | 5 | 0% |
| Cerebral artery embolism | 127 | 0.01% |
| Cerebral artery occlusion | 259 | 0.02% |
| Cerebral artery perforation | 2 | 0% |
| Cerebral artery stenosis | 68 | 0% |
| Cerebral artery stent insertion | 7 | 0% |
| Cerebral artery thrombosis | 107 | 0.01% |
| Cerebral ataxia | 1 | 0% |
| Cerebral atrophy | 231 | 0.01% |
| Cerebral calcification | 30 | 0% |
| Cerebral capillary telangiectasia | 2 | 0% |
| Cerebral cavernous malformation | 14 | 0% |
| Cerebral circulatory failure | 5 | 0% |
| Cerebral congestion | 42 | 0% |
| Cerebral cyst | 15 | 0% |
| Cerebral disorder | 334 | 0.02% |
| Cerebral dysrhythmia | 1 | 0% |
| Cerebral endovascular aneurysm repair | 16 | 0% |
| Cerebral fungal infection | 1 | 0% |
| Cerebral haemangioma | 4 | 0% |
| Cerebral haematoma | 145 | 0.01% |
| Cerebral haemorrhage | 2,149 | 0.13% |
| Cerebral haemorrhage foetal | 8 | 0% |
| Cerebral haemorrhage neonatal | 4 | 0% |
| Cerebral hyperperfusion syndrome | 1 | 0% |
| Cerebral hypoperfusion | 17 | 0% |
| Cerebral infarction | 2,897 | 0.18% |
| Cerebral infarction foetal | 1 | 0% |
| Cerebral ischaemia | 484 | 0.03% |
| Cerebral mass effect | 97 | 0.01% |
| Cerebral microangiopathy | 38 | 0% |
| Cerebral microembolism | 6 | 0% |
| Cerebral microhaemorrhage | 28 | 0% |
| Cerebral microinfarction | 11 | 0% |
| Cerebral palsy | 55 | 0% |
| Cerebral reperfusion injury | 1 | 0% |
| Cerebral revascularisation | 2 | 0% |
| Cerebral salt-wasting syndrome | 3 | 0% |
| Cerebral septic infarct | 1 | 0% |
| Cerebral small vessel ischaemic disease | 224 | 0.01% |
| Cerebral thrombosis | 720 | 0.04% |
| Cerebral toxoplasmosis | 1 | 0% |
| Cerebral vascular occlusion | 10 | 0% |
| Cerebral vasoconstriction | 16 | 0% |
| Cerebral vasodilatation | 1 | 0% |
| Cerebral venous sinus thrombosis | 1,044 | 0.06% |
| Cerebral venous thrombosis | 398 | 0.02% |
| Cerebral ventricle collapse | 11 | 0% |
| Cerebral ventricle dilatation | 44 | 0% |
| Cerebral ventricular rupture | 17 | 0% |
| Cerebrosclerosis | 3 | 0% |
| Cerebrospinal fistula | 1 | 0% |
| Cerebrospinal fluid circulation disorder | 6 | 0% |
| Cerebrospinal fluid drainage | 16 | 0% |
| Cerebrospinal fluid leakage | 51 | 0% |
| Cerebrospinal fluid retention | 4 | 0% |
| Cerebrovascular accident | 10,479 | 0.64% |
| Cerebrovascular arteriovenous malformation | 11 | 0% |
| Cerebrovascular disorder | 175 | 0.01% |
| Cerebrovascular insufficiency | 6 | 0% |
| Cerebrovascular operation | 3 | 0% |
| Cerebrovascular stenosis | 8 | 0% |
| Ceruloplasmin | 79 | 0% |
| Ceruloplasmin decreased | 3 | 0% |
| Ceruloplasmin increased | 1 | 0% |
| Ceruloplasmin normal | 8 | 0% |
| Cerumen impaction | 23 | 0% |
| Cerumen removal | 59 | 0% |
| Cervical conisation | 4 | 0% |
| Cervical cord compression | 13 | 0% |
| Cervical cyst | 7 | 0% |
| Cervical diathermy | 1 | 0% |
| Cervical dilatation | 14 | 0% |
| Cervical discharge | 10 | 0% |
| Cervical dysplasia | 27 | 0% |
| Cervical incompetence | 10 | 0% |
| Cervical neuritis | 2 | 0% |
| Cervical plexus lesion | 2 | 0% |
| Cervical polyp | 14 | 0% |
| Cervical polypectomy | 1 | 0% |
| Cervical radiculopathy | 146 | 0.01% |
| Cervical spinal cord paralysis | 2 | 0% |
| Cervical spinal stenosis | 77 | 0% |
| Cervical vertebral fracture | 34 | 0% |
| Cervicectomy | 2 | 0% |
| Cervicitis | 5 | 0% |
| Cervicitis trichomonal | 2 | 0% |
| Cervicobrachial syndrome | 146 | 0.01% |
| Cervicogenic headache | 14 | 0% |
| Cervicogenic vertigo | 1 | 0% |
| Cervix cancer metastatic | 2 | 0% |
| Cervix carcinoma | 32 | 0% |
| Cervix carcinoma recurrent | 2 | 0% |
| Cervix carcinoma stage 0 | 4 | 0% |
| Cervix carcinoma stage IV | 2 | 0% |
| Cervix cerclage procedure | 3 | 0% |
| Cervix disorder | 21 | 0% |
| Cervix dystocia | 1 | 0% |
| Cervix enlargement | 1 | 0% |
| Cervix erythema | 1 | 0% |
| Cervix haematoma uterine | 2 | 0% |
| Cervix haemorrhage uterine | 18 | 0% |
| Cervix inflammation | 6 | 0% |
| Cervix injury | 1 | 0% |
| Cervix neoplasm | 4 | 0% |
| Cervix oedema | 1 | 0% |
| Cervix operation | 1 | 0% |
| Cervix tumour excision | 1 | 0% |
| Cestode infection | 1 | 0% |
| CFTR gene mutation | 3 | 0% |
| CHA2DS2-VASc-score | 84 | 0.01% |
| CHA2DS2-VASc annual stroke risk high | 5 | 0% |
| Chalazion | 45 | 0% |
| Change in seizure presentation | 6 | 0% |
| Change in sustained attention | 23 | 0% |
| Change of bowel habit | 90 | 0.01% |
| Chapped lips | 293 | 0.02% |
| Charles Bonnet syndrome | 3 | 0% |
| Checkpoint kinase 2 gene mutation | 1 | 0% |
| Cheilitis | 405 | 0.02% |
| Cheilitis granulomatosa | 1 | 0% |
| Chemical burn | 14 | 0% |
| Chemical burn of oral cavity | 1 | 0% |
| Chemical burn of skin | 11 | 0% |
| Chemical peel of skin | 1 | 0% |
| Chemical poisoning | 3 | 0% |
| Chemocauterisation | 1 | 0% |
| Chemokine decreased | 1 | 0% |
| Chemokine increased | 8 | 0% |
| Chemokine test | 29 | 0% |
| Chemotherapy | 449 | 0.03% |
| Chemotherapy multiple agents systemic | 1 | 0% |
| Chemotherapy side effect prophylaxis | 1 | 0% |
| Chest crushing | 40 | 0% |
| Chest discomfort | 31,234 | 1.9% |
| Chest expansion decreased | 2 | 0% |
| Chest injury | 87 | 0.01% |
| Chest pain | 55,769 | 3.39% |
| Chest scan | 504 | 0.03% |
| Chest scan abnormal | 4 | 0% |
| Chest tube insertion | 214 | 0.01% |
| Chest tube removal | 23 | 0% |
| Chest wall abscess | 3 | 0% |
| Chest wall cyst | 3 | 0% |
| Chest wall haematoma | 14 | 0% |
| Chest wall mass | 25 | 0% |
| Chest wall tumour | 2 | 0% |
| Chest X-ray | 15,186 | 0.92% |
| Chest X-ray abnormal | 5,977 | 0.36% |
| Chest X-ray normal | 5,389 | 0.33% |
| Cheyne-Stokes respiration | 14 | 0% |
| Chiari network | 1 | 0% |
| Chikungunya virus infection | 9 | 0% |
| Child-Pugh-Turcotte score | 7 | 0% |
| Child-Pugh-Turcotte score increased | 2 | 0% |
| Childhood asthma | 18 | 0% |
| Child maltreatment syndrome | 39 | 0% |
| CHILD syndrome | 1 | 0% |
| Chillblains | 192 | 0.01% |
| Chills | 141,274 | 8.59% |
| Chimerism | 1 | 0% |
| Chiropractic | 68 | 0% |
| Chitotriosidase | 1 | 0% |
| Chlamydial infection | 34 | 0% |
| Chlamydia test | 216 | 0.01% |
| Chlamydia test negative | 199 | 0.01% |
| Chlamydia test positive | 17 | 0% |
| Chloasma | 11 | 0% |
| Chloroma | 1 | 0% |
| Chloropsia | 4 | 0% |
| Choking | 530 | 0.03% |
| Choking sensation | 317 | 0.02% |
| Cholangiocarcinoma | 24 | 0% |
| Cholangiogram | 26 | 0% |
| Cholangiogram abnormal | 3 | 0% |
| Cholangiogram normal | 1 | 0% |
| Cholangiosarcoma | 1 | 0% |
| Cholangiostomy | 2 | 0% |
| Cholangitis | 92 | 0.01% |
| Cholangitis acute | 16 | 0% |
| Cholangitis chronic | 1 | 0% |
| Cholangitis infective | 1 | 0% |
| Cholangitis sclerosing | 21 | 0% |
| Cholecystectomy | 227 | 0.01% |
| Cholecystitis | 275 | 0.02% |
| Cholecystitis acute | 136 | 0.01% |
| Cholecystitis chronic | 12 | 0% |
| Cholecystitis infective | 51 | 0% |
| Cholecystocholangitis | 1 | 0% |
| Cholecystogram intravenous abnormal | 1 | 0% |
| Cholecystostomy | 13 | 0% |
| Choledochoenterostomy | 1 | 0% |
| Choledocholithotomy | 2 | 0% |
| Cholelithiasis | 506 | 0.03% |
| Cholelithotomy | 9 | 0% |
| Cholelithotripsy | 1 | 0% |
| Cholera | 2 | 0% |
| Cholestasis | 182 | 0.01% |
| Cholestasis of pregnancy | 17 | 0% |
| Cholestatic liver injury | 17 | 0% |
| Cholesteatoma | 4 | 0% |
| Cholesterosis | 2 | 0% |
| Cholinergic syndrome | 26 | 0% |
| Cholinesterase inhibition | 1 | 0% |
| Choluria | 18 | 0% |
| Chondritis | 11 | 0% |
| Chondrocalcinosis | 44 | 0% |
| Chondrocalcinosis pyrophosphate | 40 | 0% |
| Chondrodermatitis nodularis chronica helicis | 2 | 0% |
| Chondrodystrophy | 1 | 0% |
| Chondroma | 2 | 0% |
| Chondromalacia | 7 | 0% |
| Chondromatosis | 3 | 0% |
| Chondropathy | 42 | 0% |
| Chondrosarcoma | 4 | 0% |
| Chondrosis | 2 | 0% |
| Chordae tendinae rupture | 11 | 0% |
| Chordee | 2 | 0% |
| Chorea | 47 | 0% |
| Choreoathetosis | 7 | 0% |
| Chorioamniotic separation | 1 | 0% |
| Choriocarcinoma | 1 | 0% |
| Chorioretinal atrophy | 1 | 0% |
| Chorioretinal disorder | 8 | 0% |
| Chorioretinal folds | 1 | 0% |
| Chorioretinitis | 47 | 0% |
| Chorioretinopathy | 76 | 0% |
| Choroidal detachment | 3 | 0% |
| Choroidal effusion | 4 | 0% |
| Choroidal haemangioma | 1 | 0% |
| Choroidal haemorrhage | 1 | 0% |
| Choroidal infarction | 1 | 0% |
| Choroidal neovascularisation | 20 | 0% |
| Choroidal rupture | 2 | 0% |
| Choroiditis | 17 | 0% |
| Choroid melanoma | 2 | 0% |
| Chromatopsia | 41 | 0% |
| Chromaturia | 1,114 | 0.07% |
| Chromopertubation | 3 | 0% |
| Chromosomal analysis | 25 | 0% |
| Chromosome analysis abnormal | 3 | 0% |
| Chromosome analysis normal | 15 | 0% |
| Chromosome banding | 1 | 0% |
| Chronic actinic dermatitis | 1 | 0% |
| Chronic active Epstein-Barr virus infection | 10 | 0% |
| Chronic allograft nephropathy | 3 | 0% |
| Chronic cheek biting | 1 | 0% |
| Chronic coronary syndrome | 8 | 0% |
| Chronic cutaneous lupus erythematosus | 31 | 0% |
| Chronic disease | 18 | 0% |
| Chronic eosinophilic leukaemia | 1 | 0% |
| Chronic fatigue syndrome | 1,366 | 0.08% |
| Chronic gastritis | 84 | 0.01% |
| Chronic graft versus host disease | 15 | 0% |
| Chronic graft versus host disease in skin | 1 | 0% |
| Chronic graft versus host disease oral | 5 | 0% |
| Chronic granulomatous disease | 5 | 0% |
| Chronic hepatic failure | 4 | 0% |
| Chronic hepatitis | 11 | 0% |
| Chronic hepatitis B | 7 | 0% |
| Chronic hepatitis C | 11 | 0% |
| Chronic hyperplastic eosinophilic sinusitis | 1 | 0% |
| Chronic idiopathic pain syndrome | 19 | 0% |
| Chronic inflammatory demyelinating polyradiculoneuropathy | 291 | 0.02% |
| Chronic inflammatory response syndrome | 12 | 0% |
| Chronic kidney disease | 968 | 0.06% |
| Chronic kidney disease-mineral and bone disorder | 7 | 0% |
| Chronic left ventricular failure | 144 | 0.01% |
| Chronic leukaemia | 9 | 0% |
| Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids | 5 | 0% |
| Chronic lymphocytic leukaemia | 165 | 0.01% |
| Chronic lymphocytic leukaemia recurrent | 8 | 0% |
| Chronic lymphocytic leukaemia refractory | 1 | 0% |
| Chronic lymphocytic leukaemia stage 0 | 2 | 0% |
| Chronic lymphocytic leukaemia stage 2 | 1 | 0% |
| Chronic lymphocytic leukaemia transformation | 1 | 0% |
| Chronic myeloid leukaemia | 41 | 0% |
| Chronic myeloid leukaemia (in remission) | 1 | 0% |
| Chronic myeloid leukaemia recurrent | 2 | 0% |
| Chronic myelomonocytic leukaemia | 16 | 0% |
| Chronic myocarditis | 8 | 0% |
| Chronic obstructive pulmonary disease | 1,839 | 0.11% |
| Chronic papillomatous dermatitis | 1 | 0% |
| Chronic paroxysmal hemicrania | 3 | 0% |
| Chronic pigmented purpura | 23 | 0% |
| Chronic respiratory disease | 25 | 0% |
| Chronic respiratory failure | 552 | 0.03% |
| Chronic rhinosinusitis with nasal polyps | 1 | 0% |
| Chronic rhinosinusitis without nasal polyps | 2 | 0% |
| Chronic right ventricular failure | 1 | 0% |
| Chronic sinusitis | 103 | 0.01% |
| Chronic spontaneous urticaria | 310 | 0.02% |
| Chronic tonsillitis | 12 | 0% |
| Chronic traumatic encephalopathy | 1 | 0% |
| Chronic villitis of unknown etiology | 3 | 0% |
| Chronotropic incompetence | 2 | 0% |
| Chvostek's sign | 3 | 0% |
| Chylomicrons | 1 | 0% |
| Ciliary body disorder | 1 | 0% |
| Ciliary ganglionitis | 1 | 0% |
| Circadian rhythm sleep disorder | 44 | 0% |
| Circulating anticoagulant | 67 | 0% |
| Circulating anticoagulant positive | 5 | 0% |
| Circulatory collapse | 2,211 | 0.13% |
| Circulatory failure neonatal | 1 | 0% |
| Circumcision | 1 | 0% |
| Circumoral oedema | 25 | 0% |
| Circumoral swelling | 79 | 0% |
| Circumstance or information capable of leading to device use error | 6 | 0% |
| Circumstance or information capable of leading to medication error | 626 | 0.04% |
| Circumstantiality | 1 | 0% |
| Cirrhosis alcoholic | 20 | 0% |
| Cisternogram | 2 | 0% |
| Citrobacter bacteraemia | 1 | 0% |
| Citrobacter infection | 7 | 0% |
| Citrobacter sepsis | 2 | 0% |
| Citrobacter test positive | 7 | 0% |
| Clamping of blood vessel | 2 | 0% |
| Clang associations | 1 | 0% |
| Claude's syndrome | 5 | 0% |
| Claudication of jaw muscles | 17 | 0% |
| Claustrophobia | 46 | 0% |
| Clavicle fracture | 55 | 0% |
| Clear cell endometrial carcinoma | 1 | 0% |
| Clear cell renal cell carcinoma | 4 | 0% |
| Clear cell sarcoma of soft tissue | 1 | 0% |
| Cleft lip | 10 | 0% |
| Cleft lip and palate | 5 | 0% |
| Cleft palate | 9 | 0% |
| Cleft uvula | 1 | 0% |
| Clinical death | 1 | 0% |
| Clinical dementia rating scale | 5 | 0% |
| Clinically isolated syndrome | 32 | 0% |
| Clinical trial participant | 3 | 0% |
| Clinodactyly | 1 | 0% |
| Clinomania | 7 | 0% |
| Clitoral engorgement | 1 | 0% |
| Cloacal exstrophy | 3 | 0% |
| Clonal evolution | 1 | 0% |
| Clonal haematopoiesis | 1 | 0% |
| Clonic convulsion | 75 | 0% |
| Clonus | 99 | 0.01% |
| Closed fracture manipulation | 1 | 0% |
| Clostridial infection | 9 | 0% |
| Clostridial sepsis | 1 | 0% |
| Clostridium bacteraemia | 1 | 0% |
| Clostridium colitis | 3 | 0% |
| Clostridium difficile colitis | 112 | 0.01% |
| Clostridium difficile infection | 156 | 0.01% |
| Clostridium test | 186 | 0.01% |
| Clostridium test negative | 71 | 0% |
| Clostridium test positive | 81 | 0% |
| Clot retraction | 7 | 0% |
| Clot retraction normal | 1 | 0% |
| Clot retraction time shortened | 1 | 0% |
| Clotting factor transfusion | 1 | 0% |
| Clubbing | 5 | 0% |
| Clumsiness | 198 | 0.01% |
| Cluster headache | 580 | 0.04% |
| Clusterin | 1 | 0% |
| CNS ventriculitis | 5 | 0% |
| Coagulation disorder neonatal | 1 | 0% |
| Coagulation factor | 189 | 0.01% |
| Coagulation factor decreased | 1 | 0% |
| Coagulation factor deficiency | 5 | 0% |
| Coagulation factor increased | 10 | 0% |
| Coagulation factor inhibitor assay | 8 | 0% |
| Coagulation factor IX level | 28 | 0% |
| Coagulation factor IX level normal | 3 | 0% |
| Coagulation factor level normal | 4 | 0% |
| Coagulation factor mutation | 3 | 0% |
| Coagulation factor VIII level | 88 | 0.01% |
| Coagulation factor VIII level abnormal | 1 | 0% |
| Coagulation factor VIII level decreased | 5 | 0% |
| Coagulation factor VIII level increased | 17 | 0% |
| Coagulation factor VIII level normal | 2 | 0% |
| Coagulation factor VII level | 31 | 0% |
| Coagulation factor VII level decreased | 4 | 0% |
| Coagulation factor VII level increased | 1 | 0% |
| Coagulation factor V level | 89 | 0.01% |
| Coagulation factor V level abnormal | 5 | 0% |
| Coagulation factor V level decreased | 3 | 0% |
| Coagulation factor V level normal | 19 | 0% |
| Coagulation factor XIII level | 12 | 0% |
| Coagulation factor XIII level decreased | 3 | 0% |
| Coagulation factor XII level | 11 | 0% |
| Coagulation factor XII level decreased | 1 | 0% |
| Coagulation factor XII level increased | 1 | 0% |
| Coagulation factor XII level normal | 1 | 0% |
| Coagulation factor XI level | 17 | 0% |
| Coagulation factor XI level normal | 2 | 0% |
| Coagulation factor X level | 21 | 0% |
| Coagulation factor X level normal | 5 | 0% |
| Coagulation test | 1,096 | 0.07% |
| Coagulation test abnormal | 64 | 0% |
| Coagulation test normal | 119 | 0.01% |
| Coagulation time | 168 | 0.01% |
| Coagulation time abnormal | 4 | 0% |
| Coagulation time normal | 4 | 0% |
| Coagulation time prolonged | 23 | 0% |
| Coagulation time shortened | 11 | 0% |
| Coagulopathy | 953 | 0.06% |
| Coarctation of the aorta | 3 | 0% |
| Coating in mouth | 29 | 0% |
| Coccidioidomycosis | 12 | 0% |
| Coccydynia | 108 | 0.01% |
| Cochlea implant | 8 | 0% |
| Cochlear injury | 3 | 0% |
| Cockroach allergy | 1 | 0% |
| Coeliac artery aneurysm | 2 | 0% |
| Coeliac artery compression syndrome | 5 | 0% |
| Coeliac artery occlusion | 1 | 0% |
| Coeliac artery stenosis | 8 | 0% |
| Coeliac disease | 158 | 0.01% |
| Coeliac plexus block | 1 | 0% |
| Cogan's syndrome | 6 | 0% |
| Cognitive disorder | 2,420 | 0.15% |
| Cognitive linguistic deficit | 9 | 0% |
| Cognitive test | 74 | 0% |
| Cogwheel rigidity | 7 | 0% |
| Coinfection | 7 | 0% |
| Coital bleeding | 35 | 0% |
| Cold-stimulus headache | 82 | 0% |
| Cold agglutinins | 35 | 0% |
| Cold agglutinins negative | 2 | 0% |
| Cold agglutinins positive | 7 | 0% |
| Cold burn | 4 | 0% |
| Cold dysaesthesia | 3 | 0% |
| Cold exposure injury | 3 | 0% |
| Cold shock response | 2 | 0% |
| Cold sweat | 7,599 | 0.46% |
| Cold type haemolytic anaemia | 35 | 0% |
| Cold urticaria | 60 | 0% |
| Colectomy | 94 | 0.01% |
| Colectomy total | 3 | 0% |
| Colitis | 789 | 0.05% |
| Colitis ischaemic | 211 | 0.01% |
| Colitis microscopic | 184 | 0.01% |
| Colitis ulcerative | 1,188 | 0.07% |
| Collagen-vascular disease | 3 | 0% |
| Collagen antigen type IV | 1 | 0% |
| Collagen disorder | 79 | 0% |
| Collateral circulation | 2 | 0% |
| Colloid brain cyst | 6 | 0% |
| Colon adenoma | 5 | 0% |
| Colon cancer | 124 | 0.01% |
| Colon cancer metastatic | 28 | 0% |
| Colon cancer stage II | 1 | 0% |
| Colon cancer stage III | 1 | 0% |
| Colon cancer stage IV | 10 | 0% |
| Colon gangrene | 3 | 0% |
| Colonic abscess | 16 | 0% |
| Colonic fistula | 4 | 0% |
| Colonic lavage | 3 | 0% |
| Colon injury | 9 | 0% |
| Colon neoplasm | 14 | 0% |
| Colon operation | 11 | 0% |
| Colonoscopy | 1,825 | 0.11% |
| Colonoscopy abnormal | 259 | 0.02% |
| Colonoscopy normal | 143 | 0.01% |
| Colopathy | 1 | 0% |
| Colorectal adenocarcinoma | 2 | 0% |
| Colorectal adenoma | 17 | 0% |
| Colorectal cancer | 17 | 0% |
| Colorectal cancer stage III | 2 | 0% |
| Colorectal cancer stage IV | 1 | 0% |
| Colorectostomy | 2 | 0% |
| Colostomy | 49 | 0% |
| Colostomy closure | 5 | 0% |
| Colostomy infection | 2 | 0% |
| Colour blindness | 28 | 0% |
| Colour blindness acquired | 3 | 0% |
| Colour vision tests | 37 | 0% |
| Colour vision tests abnormal | 1 | 0% |
| Colour vision tests abnormal red-green | 1 | 0% |
| Colposcopy | 35 | 0% |
| Colposcopy abnormal | 1 | 0% |
| Colposcopy normal | 1 | 0% |
| Columbia suicide severity rating scale | 1 | 0% |
| Coma | 588 | 0.04% |
| Coma acidotic | 1 | 0% |
| Coma hepatic | 2 | 0% |
| Coma scale | 2,295 | 0.14% |
| Coma scale abnormal | 88 | 0.01% |
| Coma scale normal | 14 | 0% |
| Combined immunodeficiency | 5 | 0% |
| Combined pulmonary fibrosis and emphysema | 1 | 0% |
| Combined tibia-fibula fracture | 1 | 0% |
| Comminuted fracture | 12 | 0% |
| Communication disorder | 295 | 0.02% |
| Community acquired infection | 3 | 0% |
| Compartment pressure test | 2 | 0% |
| Compartment syndrome | 40 | 0% |
| Compensatory sweating | 1 | 0% |
| Complement analysis | 52 | 0% |
| Complement factor | 178 | 0.01% |
| Complement factor abnormal | 1 | 0% |
| Complement factor C1 | 16 | 0% |
| Complement factor C2 | 4 | 0% |
| Complement factor C3 | 685 | 0.04% |
| Complement factor C3 decreased | 18 | 0% |
| Complement factor C3 increased | 17 | 0% |
| Complement factor C4 | 663 | 0.04% |
| Complement factor C4 decreased | 27 | 0% |
| Complement factor C4 increased | 13 | 0% |
| Complement factor decreased | 9 | 0% |
| Complement factor increased | 13 | 0% |
| Complement factor normal | 27 | 0% |
| Complement fixation test positive | 2 | 0% |
| Complete decongestive therapy | 1 | 0% |
| Completed suicide | 78 | 0% |
| Complex regional pain syndrome | 187 | 0.01% |
| Complex tic | 1 | 0% |
| Complicated appendicitis | 38 | 0% |
| Complicated fracture | 1 | 0% |
| Complication associated with device | 76 | 0% |
| Complication of delivery | 6 | 0% |
| Complication of device insertion | 9 | 0% |
| Complication of device removal | 4 | 0% |
| Complication of pregnancy | 57 | 0% |
| Complications of transplanted heart | 2 | 0% |
| Complications of transplanted kidney | 3 | 0% |
| Complications of transplanted lung | 3 | 0% |
| Complications of transplant surgery | 2 | 0% |
| Compression fracture | 32 | 0% |
| Compression garment application | 58 | 0% |
| Compulsions | 7 | 0% |
| Compulsive cheek biting | 1 | 0% |
| Compulsive handwashing | 1 | 0% |
| Compulsive hoarding | 3 | 0% |
| Compulsive lip biting | 3 | 0% |
| Computed tomographic abscessogram | 59 | 0% |
| Computed tomographic gastrography | 5 | 0% |
| Computerised tomogram | 23,001 | 1.4% |
| Computerised tomogram abdomen | 2,405 | 0.15% |
| Computerised tomogram abdomen abnormal | 1,414 | 0.09% |
| Computerised tomogram abdomen normal | 376 | 0.02% |
| Computerised tomogram abnormal | 1,802 | 0.11% |
| Computerised tomogram aorta | 70 | 0% |
| Computerised tomogram breast abnormal | 2 | 0% |
| Computerised tomogram coronary artery | 166 | 0.01% |
| Computerised tomogram coronary artery abnormal | 27 | 0% |
| Computerised tomogram coronary artery normal | 33 | 0% |
| Computerised tomogram ear | 1 | 0% |
| Computerised tomogram head | 7,595 | 0.46% |
| Computerised tomogram head abnormal | 1,431 | 0.09% |
| Computerised tomogram head normal | 2,009 | 0.12% |
| Computerised tomogram heart | 45 | 0% |
| Computerised tomogram heart abnormal | 14 | 0% |
| Computerised tomogram heart normal | 4 | 0% |
| Computerised tomogram intestine | 37 | 0% |
| Computerised tomogram kidney | 30 | 0% |
| Computerised tomogram kidney abnormal | 32 | 0% |
| Computerised tomogram kidney normal | 9 | 0% |
| Computerised tomogram limb | 10 | 0% |
| Computerised tomogram liver | 27 | 0% |
| Computerised tomogram liver abnormal | 15 | 0% |
| Computerised tomogram neck | 712 | 0.04% |
| Computerised tomogram normal | 2,702 | 0.16% |
| Computerised tomogram oesophagus abnormal | 1 | 0% |
| Computerised tomogram of gallbladder | 5 | 0% |
| Computerised tomogram pancreas | 16 | 0% |
| Computerised tomogram pancreas abnormal | 9 | 0% |
| Computerised tomogram pancreas normal | 6 | 0% |
| Computerised tomogram pelvis | 430 | 0.03% |
| Computerised tomogram pelvis abnormal | 137 | 0.01% |
| Computerised tomogram spine | 393 | 0.02% |
| Computerised tomogram spine abnormal | 12 | 0% |
| Computerised tomogram spine normal | 10 | 0% |
| Computerised tomogram thorax | 5,235 | 0.32% |
| Computerised tomogram thorax abnormal | 2,738 | 0.17% |
| Computerised tomogram thorax normal | 625 | 0.04% |
| Computerised tomogram venography head | 13 | 0% |
| Computer vision syndrome | 1 | 0% |
| Concentric sclerosis | 1 | 0% |
| Concomitant disease aggravated | 382 | 0.02% |
| Concomitant disease progression | 26 | 0% |
| Concussion | 419 | 0.03% |
| Condition aggravated | 27,783 | 1.69% |
| Condom | 1 | 0% |
| Condom catheter placement | 2 | 0% |
| Conduction disorder | 51 | 0% |
| Conductive deafness | 25 | 0% |
| Condyloma latum | 1 | 0% |
| Cone dystrophy | 2 | 0% |
| Confabulation | 6 | 0% |
| Confirmed e-cigarette or vaping product use associated lung injury | 1 | 0% |
| Confluent and reticulate papillomatosis | 1 | 0% |
| Confusional arousal | 5 | 0% |
| Confusional state | 11,638 | 0.71% |
| Confusion postoperative | 1 | 0% |
| Congenital abdominal hernia | 1 | 0% |
| Congenital absence of bile ducts | 1 | 0% |
| Congenital absence of cranial vault | 2 | 0% |
| Congenital amputation | 1 | 0% |
| Congenital anomaly | 53 | 0% |
| Congenital aortic anomaly | 1 | 0% |
| Congenital aortic stenosis | 2 | 0% |
| Congenital aortic valve incompetence | 1 | 0% |
| Congenital aplastic anaemia | 1 | 0% |
| Congenital arterial malformation | 3 | 0% |
| Congenital brain damage | 1 | 0% |
| Congenital cardiovascular anomaly | 5 | 0% |
| Congenital central nervous system anomaly | 12 | 0% |
| Congenital cerebrovascular anomaly | 4 | 0% |
| Congenital coagulopathy | 3 | 0% |
| Congenital coronary artery malformation | 2 | 0% |
| Congenital cyst | 1 | 0% |
| Congenital cystic kidney disease | 12 | 0% |
| Congenital cystic lung | 4 | 0% |
| Congenital cytomegalovirus infection | 1 | 0% |
| Congenital diaphragmatic hernia | 4 | 0% |
| Congenital eye disorder | 1 | 0% |
| Congenital foot malformation | 3 | 0% |
| Congenital genital malformation | 1 | 0% |
| Congenital genitourinary abnormality | 1 | 0% |
| Congenital great vessel anomaly | 2 | 0% |
| Congenital haematological disorder | 1 | 0% |
| Congenital hand malformation | 2 | 0% |
| Congenital hearing disorder | 2 | 0% |
| Congenital heart valve disorder | 3 | 0% |
| Congenital hydrocephalus | 9 | 0% |
| Congenital hydronephrosis | 8 | 0% |
| Congenital hypercoagulation | 5 | 0% |
| Congenital hyperthyroidism | 2 | 0% |
| Congenital hypothyroidism | 2 | 0% |
| Congenital inguinal hernia | 2 | 0% |
| Congenital jaw malformation | 2 | 0% |
| Congenital LUMBAR syndrome | 2 | 0% |
| Congenital megacolon | 1 | 0% |
| Congenital megaureter | 3 | 0% |
| Congenital melanocytic naevus | 1 | 0% |
| Congenital methaemoglobinaemia | 2 | 0% |
| Congenital midline defect | 2 | 0% |
| Congenital mitral valve incompetence | 1 | 0% |
| Congenital musculoskeletal anomaly | 2 | 0% |
| Congenital musculoskeletal disorder of limbs | 2 | 0% |
| Congenital musculoskeletal disorder of spine | 4 | 0% |
| Congenital myasthenic syndrome | 1 | 0% |
| Congenital myopathy | 2 | 0% |
| Congenital naevus | 1 | 0% |
| Congenital neurological degeneration | 1 | 0% |
| Congenital neurological disorder | 1 | 0% |
| Congenital neuropathy | 3 | 0% |
| Congenital nose malformation | 2 | 0% |
| Congenital optic nerve anomaly | 1 | 0% |
| Congenital oral malformation | 1 | 0% |
| Congenital renal disorder | 1 | 0% |
| Congenital scoliosis | 1 | 0% |
| Congenital skin dimples | 4 | 0% |
| Congenital skin disorder | 2 | 0% |
| Congenital spinal fusion | 1 | 0% |
| Congenital thrombocyte disorder | 1 | 0% |
| Congenital thyroid disorder | 1 | 0% |
| Congenital tongue anomaly | 1 | 0% |
| Congenital tracheomalacia | 1 | 0% |
| Congenital tricuspid valve atresia | 2 | 0% |
| Congenital tricuspid valve incompetence | 1 | 0% |
| Congenital umbilical hernia | 1 | 0% |
| Congenital ureterocele | 2 | 0% |
| Congenital ureteropelvic junction obstruction | 3 | 0% |
| Congenital uterine anomaly | 4 | 0% |
| Congenital vesicoureteric reflux | 2 | 0% |
| Congestive cardiomyopathy | 260 | 0.02% |
| Congestive hepatopathy | 22 | 0% |
| Conjoined twins | 1 | 0% |
| Conjunctival adhesion | 3 | 0% |
| Conjunctival bleb | 1 | 0% |
| Conjunctival cyst | 2 | 0% |
| Conjunctival discolouration | 2 | 0% |
| Conjunctival disorder | 8 | 0% |
| Conjunctival haemorrhage | 736 | 0.04% |
| Conjunctival hyperaemia | 182 | 0.01% |
| Conjunctival irritation | 9 | 0% |
| Conjunctival oedema | 41 | 0% |
| Conjunctival pallor | 7 | 0% |
| Conjunctival scar | 2 | 0% |
| Conjunctival staining | 1 | 0% |
| Conjunctival suffusion | 1 | 0% |
| Conjunctival telangiectasia | 1 | 0% |
| Conjunctival ulcer | 2 | 0% |
| Conjunctival vascular disorder | 1 | 0% |
| Conjunctivitis | 844 | 0.05% |
| Conjunctivitis allergic | 42 | 0% |
| Conjunctivitis bacterial | 26 | 0% |
| Conjunctivitis viral | 20 | 0% |
| Conjunctivochalasis | 2 | 0% |
| Connective tissue disorder | 108 | 0.01% |
| Connective tissue inflammation | 14 | 0% |
| Consciousness fluctuating | 154 | 0.01% |
| Constipation | 2,762 | 0.17% |
| Constricted affect | 13 | 0% |
| Contact lens intolerance | 7 | 0% |
| Contact lens therapy | 1 | 0% |
| Continuous glucose monitoring | 25 | 0% |
| Continuous haemodiafiltration | 4 | 0% |
| Continuous positive airway pressure | 64 | 0% |
| Contraception | 67 | 0% |
| Contraceptive cap | 1 | 0% |
| Contraceptive diaphragm | 3 | 0% |
| Contraceptive implant | 7 | 0% |
| Contracted bladder | 1 | 0% |
| Contraindicated product administered | 21 | 0% |
| Contraindicated product prescribed | 6 | 0% |
| Contraindication to medical treatment | 2 | 0% |
| Contraindication to vaccination | 37 | 0% |
| Contrast-enhanced magnetic resonance venography | 9 | 0% |
| Contrast echocardiogram | 14 | 0% |
| Contrast media allergy | 20 | 0% |
| Contrast media deposition | 2 | 0% |
| Contrast media reaction | 13 | 0% |
| Contusion | 7,545 | 0.46% |
| Conus medullaris syndrome | 3 | 0% |
| Convalescent | 6 | 0% |
| Convalescent plasma transfusion | 64 | 0% |
| Conversion disorder | 226 | 0.01% |
| Convulsion in childhood | 5 | 0% |
| Convulsions local | 32 | 0% |
| Convulsive threshold lowered | 3 | 0% |
| Cooling therapy | 54 | 0% |
| Coombs direct test | 142 | 0.01% |
| Coombs direct test negative | 8 | 0% |
| Coombs direct test positive | 15 | 0% |
| Coombs indirect test | 36 | 0% |
| Coombs indirect test negative | 3 | 0% |
| Coombs indirect test positive | 3 | 0% |
| Coombs negative haemolytic anaemia | 7 | 0% |
| Coombs positive haemolytic anaemia | 13 | 0% |
| Coombs test | 112 | 0.01% |
| Coombs test negative | 7 | 0% |
| Coombs test positive | 16 | 0% |
| Coordination abnormal | 1,030 | 0.06% |
| COPD assessment test | 2 | 0% |
| Copeptin | 1 | 0% |
| Copper deficiency | 3 | 0% |
| Coprolalia | 3 | 0% |
| Coproporphyrinogen increased | 1 | 0% |
| Corneal abrasion | 27 | 0% |
| Corneal abscess | 1 | 0% |
| Corneal bleeding | 15 | 0% |
| Corneal cross linking | 1 | 0% |
| Corneal decompensation | 1 | 0% |
| Corneal defect | 1 | 0% |
| Corneal degeneration | 4 | 0% |
| Corneal disorder | 31 | 0% |
| Corneal dystrophy | 8 | 0% |
| Corneal endothelial cell loss | 1 | 0% |
| Corneal endothelial microscopy | 7 | 0% |
| Corneal endotheliitis | 11 | 0% |
| Corneal epithelium defect | 5 | 0% |
| Corneal erosion | 11 | 0% |
| Corneal exfoliation | 2 | 0% |
| Corneal graft failure | 1 | 0% |
| Corneal graft rejection | 62 | 0% |
| Corneal infection | 3 | 0% |
| Corneal infiltrates | 3 | 0% |
| Corneal irritation | 5 | 0% |
| Corneal laceration | 2 | 0% |
| Corneal lesion | 8 | 0% |
| Corneal light reflex test | 1 | 0% |
| Corneal light reflex test abnormal | 3 | 0% |
| Corneal neovascularisation | 3 | 0% |
| Corneal oedema | 24 | 0% |
| Corneal opacity | 31 | 0% |
| Corneal operation | 1 | 0% |
| Corneal pachymetry | 17 | 0% |
| Corneal pigmentation | 1 | 0% |
| Corneal reflex decreased | 92 | 0.01% |
| Corneal reflex test | 9 | 0% |
| Corneal scar | 9 | 0% |
| Corneal striae | 1 | 0% |
| Corneal thinning | 2 | 0% |
| Corneal transplant | 8 | 0% |
| Cornea verticillata | 1 | 0% |
| Coronary angioplasty | 74 | 0% |
| Coronary arterial stent insertion | 400 | 0.02% |
| Coronary artery aneurysm | 17 | 0% |
| Coronary artery bypass | 145 | 0.01% |
| Coronary artery dilatation | 29 | 0% |
| Coronary artery disease | 934 | 0.06% |
| Coronary artery dissection | 107 | 0.01% |
| Coronary artery embolism | 13 | 0% |
| Coronary artery insufficiency | 4 | 0% |
| Coronary artery occlusion | 399 | 0.02% |
| Coronary artery perforation | 1 | 0% |
| Coronary artery reocclusion | 3 | 0% |
| Coronary artery restenosis | 1 | 0% |
| Coronary artery stenosis | 207 | 0.01% |
| Coronary artery stent removal | 1 | 0% |
| Coronary artery surgery | 2 | 0% |
| Coronary artery thrombosis | 236 | 0.01% |
| Coronary bypass thrombosis | 1 | 0% |
| Coronary ostial stenosis | 10 | 0% |
| Coronary sinus dilatation | 1 | 0% |
| Coronary vascular graft occlusion | 1 | 0% |
| Coronavirus infection | 156 | 0.01% |
| Coronavirus pneumonia | 20 | 0% |
| Coronavirus test | 314 | 0.02% |
| Coronavirus test negative | 136 | 0.01% |
| Coronavirus test positive | 123 | 0.01% |
| Cor pulmonale | 51 | 0% |
| Cor pulmonale acute | 72 | 0% |
| Cor pulmonale chronic | 3 | 0% |
| Corrective lens user | 52 | 0% |
| Corrosive gastritis | 1 | 0% |
| Cortical dysplasia | 2 | 0% |
| Cortical laminar necrosis | 3 | 0% |
| Cortical visual impairment | 2 | 0% |
| Corticosteroid binding globulin test | 6 | 0% |
| Corticotropin-releasing hormone stimulation test | 6 | 0% |
| Cortisol abnormal | 8 | 0% |
| Cortisol decreased | 41 | 0% |
| Cortisol free urine | 10 | 0% |
| Cortisol free urine increased | 2 | 0% |
| Cortisol free urine normal | 2 | 0% |
| Cortisol increased | 35 | 0% |
| Cortisol normal | 39 | 0% |
| Corynebacterium bacteraemia | 1 | 0% |
| Corynebacterium infection | 3 | 0% |
| Corynebacterium test | 2 | 0% |
| Corynebacterium test positive | 9 | 0% |
| Costochondritis | 609 | 0.04% |
| Costovertebral angle tenderness | 19 | 0% |
| Cough | 50,030 | 3.04% |
| Cough challenge test | 1 | 0% |
| Cough decreased | 13 | 0% |
| Cough variant asthma | 33 | 0% |
| Counterfeit product administered | 4 | 0% |
| COVID-19 | 221,268 | 13.46% |
| COVID-19 immunisation | 3,067 | 0.19% |
| COVID-19 pneumonia | 8,304 | 0.51% |
| COVID-19 screening | 165 | 0.01% |
| COVID-19 treatment | 15 | 0% |
| Cowden's disease | 2 | 0% |
| Cow pox | 4 | 0% |
| Cows milk free diet | 6 | 0% |
| Cox-Maze procedure | 3 | 0% |
| Coxiella test | 68 | 0% |
| Coxiella test positive | 1 | 0% |
| Coxsackie myocarditis | 2 | 0% |
| Coxsackie viral infection | 16 | 0% |
| Coxsackie virus test | 88 | 0.01% |
| Coxsackie virus test negative | 16 | 0% |
| Coxsackie virus test positive | 11 | 0% |
| Cramp-fasciculation syndrome | 16 | 0% |
| Cranial nerve decompression | 2 | 0% |
| Cranial nerve disorder | 124 | 0.01% |
| Cranial nerve infection | 5 | 0% |
| Cranial nerve injury | 10 | 0% |
| Cranial nerve neoplasm benign | 1 | 0% |
| Cranial nerve palsies multiple | 18 | 0% |
| Cranial nerve paralysis | 52 | 0% |
| Craniectomy | 25 | 0% |
| Craniocerebral injury | 142 | 0.01% |
| Craniofacial deformity | 1 | 0% |
| Craniofacial fracture | 8 | 0% |
| Craniofacial injury | 6 | 0% |
| Craniopharyngioma | 2 | 0% |
| Cranioplasty | 2 | 0% |
| Craniosynostosis | 4 | 0% |
| Craniotomy | 82 | 0% |
| Creatine urine | 12 | 0% |
| Creatine urine decreased | 1 | 0% |
| Creatine urine increased | 6 | 0% |
| Creatinine renal clearance | 402 | 0.02% |
| Creatinine renal clearance abnormal | 7 | 0% |
| Creatinine renal clearance decreased | 164 | 0.01% |
| Creatinine renal clearance increased | 15 | 0% |
| Creatinine renal clearance normal | 15 | 0% |
| Creatinine urine | 136 | 0.01% |
| Creatinine urine abnormal | 1 | 0% |
| Creatinine urine decreased | 5 | 0% |
| Creatinine urine increased | 5 | 0% |
| Creatinine urine normal | 4 | 0% |
| Crepitations | 178 | 0.01% |
| CREST syndrome | 6 | 0% |
| Creutzfeldt-Jakob disease | 94 | 0.01% |
| Cricopharyngeal myotomy | 1 | 0% |
| Crime | 1 | 0% |
| Critical illness | 75 | 0% |
| Crohn's disease | 831 | 0.05% |
| Cronkhite-Canada syndrome | 2 | 0% |
| Crossmatch | 3 | 0% |
| Cross sensitivity reaction | 9 | 0% |
| Croup infectious | 50 | 0% |
| Crown lengthening | 1 | 0% |
| Crush injury | 3 | 0% |
| Crush syndrome | 4 | 0% |
| Crying | 1,640 | 0.1% |
| Cryofibrinogenaemia | 2 | 0% |
| Cryoglobulinaemia | 60 | 0% |
| Cryoglobulins | 160 | 0.01% |
| Cryoglobulins absent | 10 | 0% |
| Cryoglobulins present | 6 | 0% |
| Cryoglobulinuria | 1 | 0% |
| Cryopyrin associated periodic syndrome | 3 | 0% |
| Cryotherapy | 19 | 0% |
| Cryptitis | 1 | 0% |
| Cryptococcal cutaneous infection | 2 | 0% |
| Cryptococcal meningoencephalitis | 1 | 0% |
| Cryptococcosis | 3 | 0% |
| Cryptococcus test | 87 | 0.01% |
| Cryptococcus test positive | 1 | 0% |
| Cryptorchism | 3 | 0% |
| Cryptosporidiosis infection | 2 | 0% |
| Crystal arthropathy | 15 | 0% |
| Crystalluria | 1 | 0% |
| Crystal nephropathy | 1 | 0% |
| Crystal urine | 10 | 0% |
| Crystal urine absent | 6 | 0% |
| Crystal urine present | 24 | 0% |
| CSF cell count | 498 | 0.03% |
| CSF cell count abnormal | 9 | 0% |
| CSF cell count decreased | 2 | 0% |
| CSF cell count increased | 35 | 0% |
| CSF cell count normal | 45 | 0% |
| CSF chloride | 2 | 0% |
| CSF chloride decreased | 1 | 0% |
| CSF culture | 214 | 0.01% |
| CSF culture negative | 82 | 0% |
| CSF culture positive | 9 | 0% |
| CSF electrophoresis | 24 | 0% |
| CSF electrophoresis abnormal | 1 | 0% |
| CSF electrophoresis normal | 1 | 0% |
| CSF eosinophil count | 6 | 0% |
| CSF glucose | 358 | 0.02% |
| CSF glucose abnormal | 2 | 0% |
| CSF glucose decreased | 21 | 0% |
| CSF glucose increased | 57 | 0% |
| CSF glucose normal | 100 | 0.01% |
| CSF granulocyte count | 3 | 0% |
| CSF immunoglobulin | 49 | 0% |
| CSF immunoglobulin decreased | 1 | 0% |
| CSF immunoglobulin G index | 58 | 0% |
| CSF immunoglobulin increased | 31 | 0% |
| CSF lactate | 59 | 0% |
| CSF lactate dehydrogenase | 6 | 0% |
| CSF lactate dehydrogenase normal | 1 | 0% |
| CSF lactate increased | 2 | 0% |
| CSF leukocyte/erythrocyte ratio | 5 | 0% |
| CSF lymphocyte count | 65 | 0% |
| CSF lymphocyte count abnormal | 9 | 0% |
| CSF lymphocyte count increased | 39 | 0% |
| CSF lymphocyte count normal | 14 | 0% |
| CSF monocyte count | 29 | 0% |
| CSF monocyte count decreased | 14 | 0% |
| CSF monocyte count increased | 4 | 0% |
| CSF monocyte count negative | 3 | 0% |
| CSF mononuclear cell count increased | 6 | 0% |
| CSF myelin basic protein | 30 | 0% |
| CSF myelin basic protein increased | 4 | 0% |
| CSF myelin basic protein normal | 4 | 0% |
| CSF neutrophil count | 17 | 0% |
| CSF neutrophil count increased | 15 | 0% |
| CSF neutrophil count negative | 2 | 0% |
| CSF neutrophil count positive | 3 | 0% |
| CSF oligoclonal band | 199 | 0.01% |
| CSF oligoclonal band absent | 32 | 0% |
| CSF oligoclonal band present | 52 | 0% |
| CSF pH | 4 | 0% |
| CSF pH normal | 1 | 0% |
| CSF polymorphonuclear cell count increased | 2 | 0% |
| CSF pressure | 71 | 0% |
| CSF pressure abnormal | 2 | 0% |
| CSF pressure decreased | 3 | 0% |
| CSF pressure increased | 30 | 0% |
| CSF pressure normal | 4 | 0% |
| CSF protein | 691 | 0.04% |
| CSF protein abnormal | 12 | 0% |
| CSF protein decreased | 5 | 0% |
| CSF protein increased | 365 | 0.02% |
| CSF protein normal | 59 | 0% |
| CSF red blood cell count | 124 | 0.01% |
| CSF red blood cell count positive | 106 | 0.01% |
| CSF shunt operation | 3 | 0% |
| CSF shunt removal | 2 | 0% |
| CSF specific gravity | 1 | 0% |
| CSF test | 1,264 | 0.08% |
| CSF test abnormal | 153 | 0.01% |
| CSF test normal | 56 | 0% |
| CSF valve removal | 1 | 0% |
| CSF virus identified | 4 | 0% |
| CSF virus no organisms observed | 14 | 0% |
| CSF volume | 34 | 0% |
| CSF volume decreased | 3 | 0% |
| CSF volume increased | 11 | 0% |
| CSF white blood cell count | 209 | 0.01% |
| CSF white blood cell count decreased | 4 | 0% |
| CSF white blood cell count increased | 81 | 0% |
| CSF white blood cell count negative | 41 | 0% |
| CSF white blood cell count positive | 7 | 0% |
| CSF white blood cell differential | 12 | 0% |
| CT hypotension complex | 3 | 0% |
| CTLA4 deficiency | 1 | 0% |
| Cubital tunnel syndrome | 32 | 0% |
| Cuboid syndrome | 1 | 0% |
| Cullen's sign | 1 | 0% |
| Culture | 663 | 0.04% |
| Culture cervix | 7 | 0% |
| Culture cervix negative | 2 | 0% |
| Culture negative | 222 | 0.01% |
| Culture positive | 139 | 0.01% |
| Culture stool | 379 | 0.02% |
| Culture stool negative | 89 | 0.01% |
| Culture stool positive | 17 | 0% |
| Culture throat | 178 | 0.01% |
| Culture throat negative | 47 | 0% |
| Culture throat positive | 9 | 0% |
| Culture tissue specimen | 13 | 0% |
| Culture tissue specimen negative | 5 | 0% |
| Culture tissue specimen positive | 3 | 0% |
| Culture urine | 1,204 | 0.07% |
| Culture urine negative | 372 | 0.02% |
| Culture urine positive | 396 | 0.02% |
| Culture wound | 37 | 0% |
| Culture wound negative | 14 | 0% |
| Culture wound positive | 36 | 0% |
| Cupping therapy | 3 | 0% |
| Cushing's syndrome | 12 | 0% |
| Cushingoid | 8 | 0% |
| Cutaneous lupus erythematosus | 54 | 0% |
| Cutaneous lymphoma | 14 | 0% |
| Cutaneous mucormycosis | 4 | 0% |
| Cutaneous sarcoidosis | 34 | 0% |
| Cutaneous symptom | 44 | 0% |
| Cutaneous T-cell lymphoma | 31 | 0% |
| Cutaneous T-cell lymphoma recurrent | 2 | 0% |
| Cutaneous T-cell lymphoma stage I | 1 | 0% |
| Cutaneous tuberculosis | 1 | 0% |
| Cutaneous vasculitis | 484 | 0.03% |
| Cutibacterium test positive | 1 | 0% |
| Cutis laxa | 1 | 0% |
| Cutis verticis gyrata | 2 | 0% |
| Cyanopsia | 18 | 0% |
| Cyanosis | 1,573 | 0.1% |
| Cyanosis central | 4 | 0% |
| Cyanosis neonatal | 1 | 0% |
| Cyclic AMP normal | 1 | 0% |
| Cyclic vomiting syndrome | 19 | 0% |
| Cyclitis | 3 | 0% |
| Cyclothymic disorder | 5 | 0% |
| CYP2C9 gene status assay | 1 | 0% |
| CYP2C19 gene status assay | 3 | 0% |
| CYP2C19 polymorphism | 2 | 0% |
| Cyst | 492 | 0.03% |
| Cystadenocarcinoma pancreas | 1 | 0% |
| Cyst aspiration | 7 | 0% |
| Cyst aspiration abnormal | 4 | 0% |
| Cystatin C | 27 | 0% |
| Cystatin C increased | 2 | 0% |
| Cyst drainage | 13 | 0% |
| Cysteine urine | 1 | 0% |
| Cystic fibrosis | 10 | 0% |
| Cystic fibrosis carrier | 1 | 0% |
| Cystic fibrosis lung | 1 | 0% |
| Cystic lung disease | 13 | 0% |
| Cystic lymphangioma | 7 | 0% |
| Cystine deposit in tissue | 1 | 0% |
| Cystinosis | 1 | 0% |
| Cystitis | 831 | 0.05% |
| Cystitis-like symptom | 6 | 0% |
| Cystitis bacterial | 14 | 0% |
| Cystitis erosive | 1 | 0% |
| Cystitis escherichia | 16 | 0% |
| Cystitis glandularis | 2 | 0% |
| Cystitis haemorrhagic | 68 | 0% |
| Cystitis interstitial | 78 | 0% |
| Cystitis klebsiella | 2 | 0% |
| Cystitis noninfective | 183 | 0.01% |
| Cystitis radiation | 1 | 0% |
| Cystitis viral | 2 | 0% |
| Cystocele | 6 | 0% |
| Cystogram | 11 | 0% |
| Cystogram abnormal | 1 | 0% |
| Cystogram normal | 2 | 0% |
| Cystoid macular oedema | 44 | 0% |
| Cystometrogram | 1 | 0% |
| Cystoprostatectomy | 1 | 0% |
| Cystoscopy | 179 | 0.01% |
| Cystoscopy abnormal | 42 | 0% |
| Cystoscopy normal | 30 | 0% |
| Cyst removal | 24 | 0% |
| Cyst rupture | 24 | 0% |
| Cytogenetic abnormality | 19 | 0% |
| Cytogenetic analysis | 106 | 0.01% |
| Cytogenetic analysis abnormal | 6 | 0% |
| Cytogenetic analysis normal | 22 | 0% |
| Cytokeratin 19 | 4 | 0% |
| Cytokeratin 19 increased | 1 | 0% |
| Cytokine abnormal | 7 | 0% |
| Cytokine increased | 25 | 0% |
| Cytokine release syndrome | 22 | 0% |
| Cytokine storm | 78 | 0% |
| Cytokine test | 92 | 0.01% |
| Cytology | 271 | 0.02% |
| Cytology abnormal | 20 | 0% |
| Cytology normal | 35 | 0% |
| Cytomegalovirus chorioretinitis | 4 | 0% |
| Cytomegalovirus colitis | 5 | 0% |
| Cytomegalovirus enterocolitis | 3 | 0% |
| Cytomegalovirus hepatitis | 14 | 0% |
| Cytomegalovirus immunisation | 2 | 0% |
| Cytomegalovirus infection | 131 | 0.01% |
| Cytomegalovirus infection reactivation | 39 | 0% |
| Cytomegalovirus mononucleosis | 1 | 0% |
| Cytomegalovirus oesophagitis | 1 | 0% |
| Cytomegalovirus pericarditis | 1 | 0% |
| Cytomegalovirus syndrome | 2 | 0% |
| Cytomegalovirus test | 1,399 | 0.09% |
| Cytomegalovirus test negative | 191 | 0.01% |
| Cytomegalovirus test positive | 79 | 0% |
| Cytomegalovirus viraemia | 30 | 0% |
| Cytopenia | 42 | 0% |
| Cytoreductive surgery | 4 | 0% |
| Cytotoxic lesions of corpus callosum | 11 | 0% |
| Cytotoxic oedema | 9 | 0% |
| Dacryoadenitis acquired | 13 | 0% |
| Dacryocanaliculitis | 3 | 0% |
| Dacryocystitis | 9 | 0% |
| Dacryostenosis acquired | 14 | 0% |
| Dacryostenosis congenital | 1 | 0% |
| Dactylitis | 22 | 0% |
| Dairy intolerance | 27 | 0% |
| Dandruff | 34 | 0% |
| Dark circles under eyes | 95 | 0.01% |
| Daydreaming | 78 | 0% |
| Deaf mutism | 1 | 0% |
| Deafness | 3,795 | 0.23% |
| Deafness bilateral | 352 | 0.02% |
| Deafness congenital | 3 | 0% |
| Deafness neurosensory | 689 | 0.04% |
| Deafness permanent | 24 | 0% |
| Deafness transitory | 114 | 0.01% |
| Deafness traumatic | 7 | 0% |
| Deafness unilateral | 2,462 | 0.15% |
| Death | 19,413 | 1.18% |
| Death neonatal | 11 | 0% |
| Death of companion | 2 | 0% |
| Death of pet | 1 | 0% |
| Death of relative | 32 | 0% |
| Debridement | 70 | 0% |
| Decapitation | 1 | 0% |
| Decerebrate posture | 9 | 0% |
| Decidual cast | 11 | 0% |
| Decompensated hypothyroidism | 1 | 0% |
| Decompressive craniectomy | 19 | 0% |
| Decorticate posture | 4 | 0% |
| Decreased activity | 425 | 0.03% |
| Decreased appetite | 22,483 | 1.37% |
| Decreased bronchial secretion | 2 | 0% |
| Decreased embryo viability | 7 | 0% |
| Decreased eye contact | 17 | 0% |
| Decreased gait velocity | 8 | 0% |
| Decreased immune responsiveness | 189 | 0.01% |
| Decreased insulin requirement | 7 | 0% |
| Decreased interest | 92 | 0.01% |
| Decreased nasolabial fold | 17 | 0% |
| Decreased ventricular afterload | 1 | 0% |
| Decreased vibratory sense | 55 | 0% |
| Decubitus ulcer | 190 | 0.01% |
| Dedifferentiated liposarcoma | 3 | 0% |
| Deep brain stimulation | 2 | 0% |
| Deep tissue injury | 2 | 0% |
| Deep vein thrombosis | 9,768 | 0.59% |
| Deep vein thrombosis postoperative | 3 | 0% |
| Defaecation disorder | 54 | 0% |
| Defaecation urgency | 224 | 0.01% |
| Defecography | 3 | 0% |
| Defect conduction intraventricular | 29 | 0% |
| Defiant behaviour | 1 | 0% |
| Deficiency anaemia | 2 | 0% |
| Deficiency of bile secretion | 5 | 0% |
| Deformity | 43 | 0% |
| Deformity thorax | 4 | 0% |
| Degenerative aortic valve disease | 3 | 0% |
| Degenerative bone disease | 18 | 0% |
| Degenerative mitral valve disease | 3 | 0% |
| Dehiscence | 3 | 0% |
| Dehydration | 4,766 | 0.29% |
| Dehydroepiandrosterone decreased | 4 | 0% |
| Dehydroepiandrosterone increased | 3 | 0% |
| Dehydroepiandrosterone test | 50 | 0% |
| Deja vu | 14 | 0% |
| Delayed delivery | 2 | 0% |
| Delayed graft function | 1 | 0% |
| Delayed ischaemic neurological deficit | 1 | 0% |
| Delayed menarche | 3 | 0% |
| Delayed recovery from anaesthesia | 5 | 0% |
| Delayed sleep phase | 3 | 0% |
| Delayed umbilical cord clamping | 1 | 0% |
| Delirium | 1,544 | 0.09% |
| Delirium febrile | 50 | 0% |
| Delirium tremens | 4 | 0% |
| Delivery | 390 | 0.02% |
| Delivery outside health facility | 1 | 0% |
| Deltaretrovirus test positive | 1 | 0% |
| Delusion | 294 | 0.02% |
| Delusional disorder, erotomanic type | 2 | 0% |
| Delusional disorder, persecutory type | 2 | 0% |
| Delusional disorder, unspecified type | 10 | 0% |
| Delusional perception | 20 | 0% |
| Delusion of grandeur | 6 | 0% |
| Delusion of parasitosis | 6 | 0% |
| Delusion of reference | 1 | 0% |
| Delusion of replacement | 1 | 0% |
| Dementia | 876 | 0.05% |
| Dementia Alzheimer's type | 178 | 0.01% |
| Dementia of the Alzheimer's type, with delirium | 3 | 0% |
| Dementia of the Alzheimer's type, with depressed mood | 1 | 0% |
| Dementia with Lewy bodies | 24 | 0% |
| Demodicidosis | 2 | 0% |
| Demyelinating polyneuropathy | 160 | 0.01% |
| Demyelination | 371 | 0.02% |
| Dengue fever | 38 | 0% |
| Dengue haemorrhagic fever | 1 | 0% |
| Dengue virus test | 25 | 0% |
| Dengue virus test negative | 6 | 0% |
| Dengue virus test positive | 17 | 0% |
| Dental alveolar anomaly | 1 | 0% |
| Dental care | 20 | 0% |
| Dental caries | 60 | 0% |
| Dental cleaning | 7 | 0% |
| Dental cyst | 4 | 0% |
| Dental discomfort | 97 | 0.01% |
| Dental dysaesthesia | 2 | 0% |
| Dental examination | 70 | 0% |
| Dental examination abnormal | 6 | 0% |
| Dental examination normal | 11 | 0% |
| Dental fistula | 2 | 0% |
| Dental implantation | 10 | 0% |
| Dental implant removal | 1 | 0% |
| Dental impression procedure | 3 | 0% |
| Dental leakage | 2 | 0% |
| Dental necrosis | 7 | 0% |
| Dental operation | 18 | 0% |
| Dental paraesthesia | 47 | 0% |
| Dental plaque | 3 | 0% |
| Dental prosthesis placement | 1 | 0% |
| Dental prosthesis user | 1 | 0% |
| Dental pulp disorder | 1 | 0% |
| Dental restoration failure | 8 | 0% |
| Dental root perforation | 1 | 0% |
| Dental sepsis | 1 | 0% |
| Dentofacial functional disorder | 1 | 0% |
| Denture stomatitis | 1 | 0% |
| Denture wearer | 2 | 0% |
| Dependence | 4 | 0% |
| Dependence on oxygen therapy | 25 | 0% |
| Dependence on respirator | 49 | 0% |
| Dependent personality disorder | 2 | 0% |
| Dependent rubor | 2 | 0% |
| Depersonalisation/derealisation disorder | 173 | 0.01% |
| Depilation | 1 | 0% |
| Deposit eye | 1 | 0% |
| Depressed level of consciousness | 3,127 | 0.19% |
| Depressed mood | 1,785 | 0.11% |
| Depression | 3,925 | 0.24% |
| Depression rating scale score | 8 | 0% |
| Depression suicidal | 60 | 0% |
| Depressive delusion | 1 | 0% |
| Depressive symptom | 58 | 0% |
| Derailment | 4 | 0% |
| Derealisation | 110 | 0.01% |
| Dermabrasion | 9 | 0% |
| Dermal cyst | 83 | 0.01% |
| Dermal filler injection | 33 | 0% |
| Dermal filler overcorrection | 1 | 0% |
| Dermal filler reaction | 8 | 0% |
| Dermatillomania | 4 | 0% |
| Dermatitis | 1,064 | 0.06% |
| Dermatitis acneiform | 204 | 0.01% |
| Dermatitis allergic | 858 | 0.05% |
| Dermatitis artefacta | 2 | 0% |
| Dermatitis atopic | 325 | 0.02% |
| Dermatitis bullous | 522 | 0.03% |
| Dermatitis contact | 373 | 0.02% |
| Dermatitis diaper | 19 | 0% |
| Dermatitis exfoliative | 24 | 0% |
| Dermatitis exfoliative generalised | 144 | 0.01% |
| Dermatitis herpetiformis | 17 | 0% |
| Dermatitis infected | 25 | 0% |
| Dermatitis psoriasiform | 76 | 0% |
| Dermatochalasis | 23 | 0% |
| Dermatofibrosarcoma protuberans | 1 | 0% |
| Dermatologic examination | 375 | 0.02% |
| Dermatologic examination abnormal | 13 | 0% |
| Dermatologic examination normal | 5 | 0% |
| Dermatomyositis | 264 | 0.02% |
| Dermatopathic lymphadenopathy | 1 | 0% |
| Dermatophagia | 3 | 0% |
| Dermatophytosis | 1 | 0% |
| Dermatosis | 28 | 0% |
| Dermo-hypodermitis | 40 | 0% |
| Dermoid cyst | 16 | 0% |
| Dermoscopy | 19 | 0% |
| Desmoid tumour | 13 | 0% |
| Desmoplastic small round cell tumour | 1 | 0% |
| Detached Descemet's membrane | 1 | 0% |
| Detachment of macular retinal pigment epithelium | 2 | 0% |
| Detachment of retinal pigment epithelium | 3 | 0% |
| Detoxification | 36 | 0% |
| Developmental coordination disorder | 2 | 0% |
| Developmental delay | 12 | 0% |
| Developmental hip dysplasia | 4 | 0% |
| Developmental regression | 4 | 0% |
| Device adhesion issue | 1 | 0% |
| Device alarm issue | 2 | 0% |
| Device breakage | 24 | 0% |
| Device connection issue | 522 | 0.03% |
| Device defective | 2 | 0% |
| Device dependence | 11 | 0% |
| Device deposit issue | 1 | 0% |
| Device difficult to use | 9 | 0% |
| Device dislocation | 28 | 0% |
| Device dispensing error | 1 | 0% |
| Device electrical finding | 1 | 0% |
| Device electrical impedance issue | 1 | 0% |
| Device embolisation | 2 | 0% |
| Device expulsion | 13 | 0% |
| Device extrusion | 1 | 0% |
| Device failure | 13 | 0% |
| Device function test | 13 | 0% |
| Device inappropriate shock delivery | 1 | 0% |
| Device ineffective shock delivery | 1 | 0% |
| Device information output issue | 2 | 0% |
| Device infusion issue | 6 | 0% |
| Device intolerance | 18 | 0% |
| Device issue | 53 | 0% |
| Device kink | 2 | 0% |
| Device leakage | 31 | 0% |
| Device loosening | 5 | 0% |
| Device malfunction | 57 | 0% |
| Device material issue | 5 | 0% |
| Device occlusion | 32 | 0% |
| Device operational issue | 2 | 0% |
| Device pacing issue | 1 | 0% |
| Device physical property issue | 9 | 0% |
| Device placement issue | 3 | 0% |
| Device power source issue | 2 | 0% |
| Device related bacteraemia | 2 | 0% |
| Device related infection | 77 | 0% |
| Device related sepsis | 4 | 0% |
| Device related thrombosis | 5 | 0% |
| Device temperature issue | 2 | 0% |
| Device therapy | 3 | 0% |
| Device use confusion | 2 | 0% |
| Device use error | 3 | 0% |
| Device use issue | 10 | 0% |
| Dexamethasone suppression test | 3 | 0% |
| Dextrocardia | 4 | 0% |
| Diabetes insipidus | 67 | 0% |
| Diabetes mellitus | 1,217 | 0.07% |
| Diabetes mellitus inadequate control | 428 | 0.03% |
| Diabetes mellitus management | 133 | 0.01% |
| Diabetic autonomic neuropathy | 2 | 0% |
| Diabetic cardiomyopathy | 1 | 0% |
| Diabetic cheiroarthropathy | 1 | 0% |
| Diabetic coma | 19 | 0% |
| Diabetic complication | 15 | 0% |
| Diabetic complication cardiovascular | 1 | 0% |
| Diabetic complication neurological | 1 | 0% |
| Diabetic diet | 22 | 0% |
| Diabetic dyslipidaemia | 3 | 0% |
| Diabetic end stage renal disease | 1 | 0% |
| Diabetic eye disease | 9 | 0% |
| Diabetic foot | 44 | 0% |
| Diabetic foot infection | 16 | 0% |
| Diabetic gangrene | 3 | 0% |
| Diabetic gastroparesis | 6 | 0% |
| Diabetic gastropathy | 1 | 0% |
| Diabetic glaucoma | 1 | 0% |
| Diabetic hyperglycaemic coma | 1 | 0% |
| Diabetic hyperosmolar coma | 7 | 0% |
| Diabetic ketoacidosis | 477 | 0.03% |
| Diabetic ketoacidotic hyperglycaemic coma | 2 | 0% |
| Diabetic ketosis | 9 | 0% |
| Diabetic metabolic decompensation | 46 | 0% |
| Diabetic mononeuropathy | 1 | 0% |
| Diabetic nephropathy | 67 | 0% |
| Diabetic neuropathy | 63 | 0% |
| Diabetic retinal oedema | 3 | 0% |
| Diabetic retinopathy | 17 | 0% |
| Diabetic vascular disorder | 8 | 0% |
| Diabetic wound | 6 | 0% |
| Diagnostic aspiration | 153 | 0.01% |
| Diagnostic procedure | 551 | 0.03% |
| Dialysis | 368 | 0.02% |
| Dialysis device insertion | 6 | 0% |
| Dialysis disequilibrium syndrome | 1 | 0% |
| Dialysis hypotension | 2 | 0% |
| Dialysis related complication | 7 | 0% |
| Diamine oxidase deficiency | 2 | 0% |
| Diaphragmalgia | 91 | 0.01% |
| Diaphragmatic disorder | 56 | 0% |
| Diaphragmatic hernia | 19 | 0% |
| Diaphragmatic injury | 1 | 0% |
| Diaphragmatic operation | 1 | 0% |
| Diaphragmatic paralysis | 44 | 0% |
| Diaphragmatic rupture | 1 | 0% |
| Diaphragmatic spasm | 26 | 0% |
| Diaphragm muscle weakness | 8 | 0% |
| Diarrhoea | 45,968 | 2.8% |
| Diarrhoea haemorrhagic | 566 | 0.03% |
| Diarrhoea infectious | 14 | 0% |
| Diarrhoea neonatal | 8 | 0% |
| Diastema | 2 | 0% |
| Diastematomyelia | 1 | 0% |
| Diastolic dysfunction | 223 | 0.01% |
| Diastolic hypertension | 23 | 0% |
| Diastolic hypotension | 1 | 0% |
| Dientamoeba infection | 1 | 0% |
| Diet failure | 2 | 0% |
| Diet noncompliance | 6 | 0% |
| Diet refusal | 69 | 0% |
| Dieulafoy's vascular malformation | 1 | 0% |
| Differential white blood cell count | 1,596 | 0.1% |
| Differential white blood cell count abnormal | 200 | 0.01% |
| Differential white blood cell count normal | 469 | 0.03% |
| Diffuse alopecia | 90 | 0.01% |
| Diffuse alveolar damage | 11 | 0% |
| Diffuse axonal injury | 1 | 0% |
| Diffuse cutaneous mastocytosis | 2 | 0% |
| Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia | 1 | 0% |
| Diffuse idiopathic skeletal hyperostosis | 4 | 0% |
| Diffuse large B-cell lymphoma | 65 | 0% |
| Diffuse large B-cell lymphoma recurrent | 4 | 0% |
| Diffuse large B-cell lymphoma stage I | 1 | 0% |
| Diffuse large B-cell lymphoma stage II | 2 | 0% |
| Diffuse large B-cell lymphoma stage IV | 3 | 0% |
| Diffuse mesangial sclerosis | 1 | 0% |
| Diffuse panbronchiolitis | 3 | 0% |
| Diffuse vasculitis | 12 | 0% |
| Diffusion-weighted brain MRI | 29 | 0% |
| Diffusion-weighted brain MRI abnormal | 12 | 0% |
| Diffusion-weighted brain MRI normal | 4 | 0% |
| DiGeorge's syndrome | 1 | 0% |
| Digestive enzyme abnormal | 6 | 0% |
| Digestive enzyme decreased | 3 | 0% |
| Digestive enzyme normal | 1 | 0% |
| Digestive enzyme test | 8 | 0% |
| Digital pulpitis | 2 | 0% |
| Digital radiogram | 2 | 0% |
| Dihydrotestosterone level | 2 | 0% |
| Dilatation atrial | 30 | 0% |
| Dilatation intrahepatic duct acquired | 4 | 0% |
| Dilatation ventricular | 17 | 0% |
| Dilated cardiomyopathy | 65 | 0% |
| Dilated pores | 2 | 0% |
| Diminished ovarian reserve | 1 | 0% |
| Diphtheria | 4 | 0% |
| Diplacusis | 13 | 0% |
| Diplegia | 464 | 0.03% |
| Diplopia | 2,913 | 0.18% |
| Direct calorimetry | 2 | 0% |
| Directional Doppler flow tests | 7 | 0% |
| Directional Doppler flow tests abnormal | 2 | 0% |
| Directional Doppler flow tests normal | 3 | 0% |
| Disability | 314 | 0.02% |
| Disability assessment scale | 38 | 0% |
| Disability assessment scale score increased | 4 | 0% |
| Discharge | 218 | 0.01% |
| Discogram abnormal | 2 | 0% |
| Discoloured vomit | 108 | 0.01% |
| Discomfort | 8,804 | 0.54% |
| Discontinued product administered | 457 | 0.03% |
| Discouragement | 27 | 0% |
| Disease complication | 36 | 0% |
| Disease prodromal stage | 6 | 0% |
| Disease progression | 186 | 0.01% |
| Disease propensity | 4 | 0% |
| Disease recurrence | 3,875 | 0.24% |
| Disease risk factor | 19 | 0% |
| Disease susceptibility | 25 | 0% |
| Disinhibition | 12 | 0% |
| Dislocation of vertebra | 8 | 0% |
| Disorder of globe | 1 | 0% |
| Disorder of orbit | 6 | 0% |
| Disorganised speech | 168 | 0.01% |
| Disorientation | 4,358 | 0.27% |
| Disruption of the photoreceptor inner segment-outer segment | 1 | 0% |
| Disruptive mood dysregulation disorder | 1 | 0% |
| Disseminated Bacillus Calmette-Guerin infection | 37 | 0% |
| Disseminated cryptococcosis | 1 | 0% |
| Disseminated intravascular coagulation | 245 | 0.01% |
| Disseminated intravascular coagulation in newborn | 1 | 0% |
| Disseminated superficial actinic porokeratosis | 1 | 0% |
| Disseminated tuberculosis | 5 | 0% |
| Disseminated varicella | 2 | 0% |
| Disseminated varicella zoster vaccine virus infection | 1 | 0% |
| Disseminated varicella zoster virus infection | 30 | 0% |
| Dissociation | 279 | 0.02% |
| Dissociative amnesia | 11 | 0% |
| Dissociative disorder | 43 | 0% |
| Dissociative identity disorder | 2 | 0% |
| Distal intestinal obstruction syndrome | 2 | 0% |
| Distractibility | 58 | 0% |
| Distraction osteogenesis | 1 | 0% |
| Distributive shock | 22 | 0% |
| Disturbance in attention | 8,439 | 0.51% |
| Disturbance in sexual arousal | 20 | 0% |
| Disturbance in social behaviour | 14 | 0% |
| Diuretic therapy | 199 | 0.01% |
| Diverticular fistula | 1 | 0% |
| Diverticular hernia | 1 | 0% |
| Diverticular perforation | 21 | 0% |
| Diverticulectomy | 1 | 0% |
| Diverticulitis | 792 | 0.05% |
| Diverticulitis intestinal haemorrhagic | 9 | 0% |
| Diverticulitis intestinal perforated | 21 | 0% |
| Diverticulitis Meckel's | 1 | 0% |
| Diverticulum | 134 | 0.01% |
| Diverticulum gastric | 3 | 0% |
| Diverticulum intestinal | 128 | 0.01% |
| Diverticulum intestinal haemorrhagic | 19 | 0% |
| Diverticulum oesophageal | 2 | 0% |
| Divorced | 1 | 0% |
| Dizziness | 127,505 | 7.75% |
| Dizziness exertional | 190 | 0.01% |
| Dizziness postural | 2,179 | 0.13% |
| DNA antibody | 419 | 0.03% |
| DNA antibody negative | 20 | 0% |
| DNA antibody positive | 9 | 0% |
| DNA test for fragile X | 7 | 0% |
| Documented hypersensitivity to administered product | 2 | 0% |
| Dolichocolon | 3 | 0% |
| Dolichocolon acquired | 1 | 0% |
| Donor specific antibody present | 2 | 0% |
| Dopamine dysregulation syndrome | 1 | 0% |
| Dopamine transporter scintigraphy | 8 | 0% |
| Dopamine transporter scintigraphy abnormal | 2 | 0% |
| Dorsal ramus syndrome | 1 | 0% |
| Dose calculation error | 7 | 0% |
| Double hit lymphoma | 1 | 0% |
| Double outlet right ventricle | 3 | 0% |
| Double stranded DNA antibody | 390 | 0.02% |
| Double stranded DNA antibody positive | 33 | 0% |
| Douglas' abscess | 1 | 0% |
| Dowling-Degos disease | 1 | 0% |
| Drainage | 270 | 0.02% |
| Drain of cerebral subdural space | 5 | 0% |
| Drain placement | 78 | 0% |
| Drain removal | 17 | 0% |
| Drain site complication | 6 | 0% |
| Dreamy state | 46 | 0% |
| Dressler's syndrome | 16 | 0% |
| Drooling | 396 | 0.02% |
| Drooping shoulder syndrome | 7 | 0% |
| Drop attacks | 49 | 0% |
| Dropped head syndrome | 14 | 0% |
| Drowning | 42 | 0% |
| Drug-device interaction | 2 | 0% |
| Drug-disease interaction | 1 | 0% |
| Drug-genetic interaction | 1 | 0% |
| Drug-induced liver injury | 102 | 0.01% |
| Drug abuse | 36 | 0% |
| Drug abuser | 4 | 0% |
| Drug administered in wrong device | 3 | 0% |
| Drug chemical incompatibility | 1 | 0% |
| Drug clearance | 3 | 0% |
| Drug clearance increased | 1 | 0% |
| Drug delivery system malfunction | 4 | 0% |
| Drug dependence | 17 | 0% |
| Drug detoxification | 2 | 0% |
| Drug dispensed to wrong patient | 7 | 0% |
| Drug dose omission by device | 5 | 0% |
| Drug effective for unapproved indication | 2 | 0% |
| Drug effect less than expected | 3 | 0% |
| Drug eruption | 277 | 0.02% |
| Drug exposure before pregnancy | 17 | 0% |
| Drug hypersensitivity | 620 | 0.04% |
| Drug ineffective | 78,690 | 4.79% |
| Drug ineffective for unapproved indication | 4 | 0% |
| Drug interaction | 174 | 0.01% |
| Drug intolerance | 83 | 0.01% |
| Drug level | 114 | 0.01% |
| Drug level abnormal | 1 | 0% |
| Drug level above therapeutic | 1 | 0% |
| Drug level decreased | 16 | 0% |
| Drug level fluctuating | 1 | 0% |
| Drug level increased | 7 | 0% |
| Drug level therapeutic | 5 | 0% |
| Drug monitoring procedure incorrectly performed | 2 | 0% |
| Drug monitoring procedure not performed | 2 | 0% |
| Drug provocation test | 10 | 0% |
| Drug reaction with eosinophilia and systemic symptoms | 96 | 0.01% |
| Drug resistance | 17 | 0% |
| Drug screen | 187 | 0.01% |
| Drug screen false positive | 1 | 0% |
| Drug screen negative | 170 | 0.01% |
| Drug screen positive | 73 | 0% |
| Drug specific antibody | 32 | 0% |
| Drug specific antibody absent | 11 | 0% |
| Drug specific antibody present | 6 | 0% |
| Drug therapy | 3 | 0% |
| Drug titration | 1 | 0% |
| Drug titration error | 2 | 0% |
| Drug tolerance | 3 | 0% |
| Drug tolerance decreased | 8 | 0% |
| Drug tolerance increased | 1 | 0% |
| Drug trough level | 13 | 0% |
| Drug use disorder | 12 | 0% |
| Drug withdrawal convulsions | 3 | 0% |
| Drug withdrawal headache | 3 | 0% |
| Drug withdrawal maintenance therapy | 2 | 0% |
| Drug withdrawal syndrome | 11 | 0% |
| Drug withdrawal syndrome neonatal | 2 | 0% |
| Dry age-related macular degeneration | 12 | 0% |
| Dry eye | 1,326 | 0.08% |
| Dry gangrene | 13 | 0% |
| Dry lung syndrome | 3 | 0% |
| Dry mouth | 3,717 | 0.23% |
| Dry skin | 1,706 | 0.1% |
| Dry skin prophylaxis | 2 | 0% |
| Dry throat | 1,364 | 0.08% |
| Dry weight evaluation | 2 | 0% |
| Duchenne muscular dystrophy | 2 | 0% |
| Ductus arteriosus premature closure | 3 | 0% |
| Ductus venosus agenesis | 1 | 0% |
| Dumping syndrome | 5 | 0% |
| Duodenal obstruction | 2 | 0% |
| Duodenal operation | 1 | 0% |
| Duodenal perforation | 7 | 0% |
| Duodenal polyp | 1 | 0% |
| Duodenal rupture | 1 | 0% |
| Duodenal stenosis | 2 | 0% |
| Duodenal ulcer | 62 | 0% |
| Duodenal ulcer haemorrhage | 17 | 0% |
| Duodenal ulcer perforation | 8 | 0% |
| Duodenal ulcer repair | 2 | 0% |
| Duodenitis | 54 | 0% |
| Duodenogastric reflux | 37 | 0% |
| Duodenostomy | 1 | 0% |
| Duplicate therapy error | 2 | 0% |
| Dupuytren's contracture | 54 | 0% |
| Dupuytren's contracture operation | 1 | 0% |
| Dural arteriovenous fistula | 20 | 0% |
| Dural tear | 1 | 0% |
| Durotomy procedure | 1 | 0% |
| Dust allergy | 15 | 0% |
| Dysacusis | 25 | 0% |
| Dysaesthesia | 871 | 0.05% |
| Dysaesthesia pharynx | 2 | 0% |
| Dysania | 1 | 0% |
| Dysarthria | 3,820 | 0.23% |
| Dysbiosis | 46 | 0% |
| Dyscalculia | 10 | 0% |
| Dyschezia | 129 | 0.01% |
| Dyschromatopsia | 119 | 0.01% |
| Dysdiadochokinesis | 11 | 0% |
| Dysentery | 454 | 0.03% |
| Dysgeusia | 6,965 | 0.42% |
| Dysglobulinaemia | 2 | 0% |
| Dysgraphia | 245 | 0.01% |
| Dyshidrotic eczema | 107 | 0.01% |
| Dyskinesia | 2,253 | 0.14% |
| Dyskinesia oesophageal | 4 | 0% |
| Dyslalia | 113 | 0.01% |
| Dyslexia | 35 | 0% |
| Dyslipidaemia | 124 | 0.01% |
| Dysmenorrhoea | 8,954 | 0.54% |
| Dysmetria | 40 | 0% |
| Dysmetropsia | 1 | 0% |
| Dysmorphism | 13 | 0% |
| Dyspareunia | 51 | 0% |
| Dyspepsia | 3,598 | 0.22% |
| Dysphagia | 8,491 | 0.52% |
| Dysphemia | 329 | 0.02% |
| Dysphonia | 3,737 | 0.23% |
| Dysphonia psychogenic | 2 | 0% |
| Dysphoria | 336 | 0.02% |
| Dysphotopsia | 1 | 0% |
| Dysplasia | 18 | 0% |
| Dysplastic naevus | 6 | 0% |
| Dyspnoea | 95,581 | 5.81% |
| Dyspnoea at rest | 489 | 0.03% |
| Dyspnoea exertional | 5,436 | 0.33% |
| Dyspnoea paroxysmal nocturnal | 68 | 0% |
| Dysponesis | 1 | 0% |
| Dyspraxia | 47 | 0% |
| Dysprosody | 1 | 0% |
| Dyssomnia | 5 | 0% |
| Dysstasia | 4,804 | 0.29% |
| Dystonia | 202 | 0.01% |
| Dystonic tremor | 4 | 0% |
| Dystrophic calcification | 2 | 0% |
| Dysuria | 1,485 | 0.09% |
| Eagle's syndrome | 2 | 0% |
| Ear, nose and throat disorder | 6 | 0% |
| Ear, nose and throat examination | 1,251 | 0.08% |
| Ear, nose and throat examination abnormal | 46 | 0% |
| Ear, nose and throat examination normal | 40 | 0% |
| Ear, nose and throat infection | 11 | 0% |
| Ear and hearing disorder prophylaxis | 1 | 0% |
| Ear canal erythema | 16 | 0% |
| Ear canal injury | 4 | 0% |
| Ear canal stenosis | 3 | 0% |
| Ear congestion | 458 | 0.03% |
| Ear deformity acquired | 2 | 0% |
| Ear discomfort | 4,323 | 0.26% |
| Ear disorder | 389 | 0.02% |
| Ear dryness | 3 | 0% |
| Ear haemorrhage | 133 | 0.01% |
| Ear infection | 1,085 | 0.07% |
| Ear infection bacterial | 12 | 0% |
| Ear infection fungal | 8 | 0% |
| Ear infection viral | 13 | 0% |
| Ear inflammation | 101 | 0.01% |
| Ear injury | 26 | 0% |
| Ear irrigation | 20 | 0% |
| Ear lobe infection | 1 | 0% |
| Early repolarisation syndrome | 8 | 0% |
| Early retirement | 6 | 0% |
| Early satiety | 19 | 0% |
| Ear malformation | 1 | 0% |
| Ear neoplasm | 4 | 0% |
| Ear neoplasm malignant | 1 | 0% |
| Ear odour | 1 | 0% |
| Ear operation | 3 | 0% |
| Ear pain | 7,414 | 0.45% |
| Ear pruritus | 358 | 0.02% |
| Ear swelling | 782 | 0.05% |
| Ear tube insertion | 20 | 0% |
| Eastern Cooperative Oncology Group performance status | 21 | 0% |
| Eastern Cooperative Oncology Group performance status worsened | 3 | 0% |
| Eating disorder | 859 | 0.05% |
| Eating disorder symptom | 36 | 0% |
| Ebola disease | 1 | 0% |
| Ecchymosis | 447 | 0.03% |
| ECG electrically inactive area | 1 | 0% |
| ECG P wave inverted | 6 | 0% |
| ECG signs of myocardial infarction | 3 | 0% |
| ECG signs of myocardial ischaemia | 4 | 0% |
| ECG signs of ventricular hypertrophy | 1 | 0% |
| Echinococciasis | 4 | 0% |
| Echocardiogram | 18,330 | 1.11% |
| Echocardiogram abnormal | 2,312 | 0.14% |
| Echocardiogram normal | 2,452 | 0.15% |
| Echoencephalogram | 16 | 0% |
| Echoencephalogram normal | 1 | 0% |
| Echolalia | 4 | 0% |
| Echopraxia | 1 | 0% |
| Echo virus infection | 1 | 0% |
| Echovirus test | 35 | 0% |
| Echovirus test negative | 2 | 0% |
| Eclampsia | 10 | 0% |
| Economic problem | 45 | 0% |
| Ecouvillonage | 1 | 0% |
| Ecthyma | 2 | 0% |
| Ectopic gastric mucosa | 1 | 0% |
| Ectopic pregnancy | 134 | 0.01% |
| Ectopic pregnancy termination | 6 | 0% |
| Ectopic pregnancy with contraceptive device | 3 | 0% |
| Ectopic thyroid | 1 | 0% |
| Ectrodactyly | 1 | 0% |
| Ectropion | 7 | 0% |
| Ectropion of cervix | 7 | 0% |
| Eczema | 2,160 | 0.13% |
| Eczema asteatotic | 14 | 0% |
| Eczema eyelids | 25 | 0% |
| Eczema herpeticum | 33 | 0% |
| Eczema impetiginous | 7 | 0% |
| Eczema infantile | 3 | 0% |
| Eczema infected | 20 | 0% |
| Eczema nummular | 63 | 0% |
| Eczema vesicular | 5 | 0% |
| Eczema weeping | 15 | 0% |
| Edentulous | 2 | 0% |
| Educational problem | 25 | 0% |
| Effusion | 112 | 0.01% |
| EGFR gene mutation | 9 | 0% |
| EGFR status assay | 124 | 0.01% |
| Egobronchophony | 2 | 0% |
| Ehlers-Danlos syndrome | 42 | 0% |
| Ehrlichia test | 38 | 0% |
| Ehrlichia test positive | 2 | 0% |
| Ejaculation delayed | 6 | 0% |
| Ejaculation disorder | 24 | 0% |
| Ejaculation failure | 19 | 0% |
| Ejection fraction | 2,018 | 0.12% |
| Ejection fraction abnormal | 35 | 0% |
| Ejection fraction decreased | 1,061 | 0.06% |
| Ejection fraction normal | 539 | 0.03% |
| Elastofibroma | 3 | 0% |
| Elbow deformity | 5 | 0% |
| Elbow operation | 8 | 0% |
| Elderly | 3 | 0% |
| Elective procedure | 4 | 0% |
| Elective surgery | 2 | 0% |
| Electric injury | 1 | 0% |
| Electric shock | 62 | 0% |
| Electric shock sensation | 1,549 | 0.09% |
| Electrocardiogram | 37,598 | 2.29% |
| Electrocardiogram abnormal | 4,546 | 0.28% |
| Electrocardiogram ambulatory | 3,133 | 0.19% |
| Electrocardiogram ambulatory abnormal | 345 | 0.02% |
| Electrocardiogram ambulatory normal | 184 | 0.01% |
| Electrocardiogram change | 60 | 0% |
| Electrocardiogram delta waves abnormal | 3 | 0% |
| Electrocardiogram J wave | 1 | 0% |
| Electrocardiogram J wave abnormal | 4 | 0% |
| Electrocardiogram J wave increased | 1 | 0% |
| Electrocardiogram low voltage | 7 | 0% |
| Electrocardiogram normal | 6,717 | 0.41% |
| Electrocardiogram pacemaker spike | 2 | 0% |
| Electrocardiogram PR interval | 72 | 0% |
| Electrocardiogram PR prolongation | 30 | 0% |
| Electrocardiogram PR segment depression | 64 | 0% |
| Electrocardiogram PR segment elevation | 9 | 0% |
| Electrocardiogram PR shortened | 28 | 0% |
| Electrocardiogram P wave | 6 | 0% |
| Electrocardiogram P wave abnormal | 7 | 0% |
| Electrocardiogram P wave biphasic | 1 | 0% |
| Electrocardiogram P wave normal | 3 | 0% |
| Electrocardiogram QRS complex | 78 | 0% |
| Electrocardiogram QRS complex abnormal | 26 | 0% |
| Electrocardiogram QRS complex normal | 14 | 0% |
| Electrocardiogram QRS complex prolonged | 36 | 0% |
| Electrocardiogram QRS complex shortened | 29 | 0% |
| Electrocardiogram QT interval | 176 | 0.01% |
| Electrocardiogram QT interval abnormal | 3 | 0% |
| Electrocardiogram QT interval normal | 10 | 0% |
| Electrocardiogram QT prolonged | 202 | 0.01% |
| Electrocardiogram QT shortened | 2 | 0% |
| Electrocardiogram Q wave abnormal | 17 | 0% |
| Electrocardiogram Q waves | 17 | 0% |
| Electrocardiogram repolarisation abnormality | 94 | 0.01% |
| Electrocardiogram R on T phenomenon | 1 | 0% |
| Electrocardiogram RR interval | 8 | 0% |
| Electrocardiogram S1-S2-S3 pattern | 3 | 0% |
| Electrocardiogram ST-T change | 75 | 0% |
| Electrocardiogram ST-T segment abnormal | 85 | 0.01% |
| Electrocardiogram ST-T segment depression | 4 | 0% |
| Electrocardiogram ST-T segment elevation | 7 | 0% |
| Electrocardiogram ST segment | 189 | 0.01% |
| Electrocardiogram ST segment abnormal | 165 | 0.01% |
| Electrocardiogram ST segment depression | 215 | 0.01% |
| Electrocardiogram ST segment elevation | 1,142 | 0.07% |
| Electrocardiogram ST segment normal | 14 | 0% |
| Electrocardiogram T wave abnormal | 188 | 0.01% |
| Electrocardiogram T wave alternans | 1 | 0% |
| Electrocardiogram T wave amplitude decreased | 21 | 0% |
| Electrocardiogram T wave amplitude increased | 9 | 0% |
| Electrocardiogram T wave biphasic | 4 | 0% |
| Electrocardiogram T wave inversion | 289 | 0.02% |
| Electrocardiogram T wave normal | 13 | 0% |
| Electrocardiogram T wave peaked | 17 | 0% |
| Electrocardiogram U-wave abnormality | 1 | 0% |
| Electrocardiogram U wave inversion | 1 | 0% |
| Electrocardiogram U wave present | 1 | 0% |
| Electrocauterisation | 14 | 0% |
| Electrocochleogram | 12 | 0% |
| Electrocochleogram abnormal | 3 | 0% |
| Electroconvulsive therapy | 15 | 0% |
| Electrocorticogram | 4 | 0% |
| Electrocution | 3 | 0% |
| Electrodesiccation | 1 | 0% |
| Electroencephalogram | 2,829 | 0.17% |
| Electroencephalogram abnormal | 261 | 0.02% |
| Electroencephalogram normal | 428 | 0.03% |
| Electrogastrogram | 4 | 0% |
| Electrolyte depletion | 27 | 0% |
| Electrolyte imbalance | 285 | 0.02% |
| Electrolyte substitution therapy | 81 | 0% |
| Electromagnetic interference | 4 | 0% |
| Electromyogram | 2,594 | 0.16% |
| Electromyogram abnormal | 289 | 0.02% |
| Electromyogram normal | 238 | 0.01% |
| Electroneurography | 289 | 0.02% |
| Electroneuromyography | 333 | 0.02% |
| Electronic cigarette user | 2 | 0% |
| Electronystagmogram | 154 | 0.01% |
| Electronystagmogram abnormal | 14 | 0% |
| Electronystagmogram normal | 9 | 0% |
| Electrooculogram | 3 | 0% |
| Electrophoresis | 240 | 0.01% |
| Electrophoresis abnormal | 6 | 0% |
| Electrophoresis normal | 6 | 0% |
| Electrophoresis protein | 906 | 0.06% |
| Electrophoresis protein abnormal | 8 | 0% |
| Electrophoresis protein normal | 45 | 0% |
| Elephantiasis | 4 | 0% |
| Elliptocytosis | 8 | 0% |
| Elliptocytosis hereditary | 1 | 0% |
| Elsberg syndrome | 3 | 0% |
| Embedded device | 1 | 0% |
| Embolia cutis medicamentosa | 3 | 0% |
| Embolic cerebellar infarction | 8 | 0% |
| Embolic cerebral infarction | 59 | 0% |
| Embolic pneumonia | 2 | 0% |
| Embolic stroke | 351 | 0.02% |
| Embolism | 586 | 0.04% |
| Embolism arterial | 98 | 0.01% |
| Embolism venous | 167 | 0.01% |
| Emergency care | 54 | 0% |
| Emergency care examination | 536 | 0.03% |
| Emergency care examination normal | 2 | 0% |
| Emetophobia | 1 | 0% |
| Emotional disorder | 530 | 0.03% |
| Emotional disorder of childhood | 1 | 0% |
| Emotional distress | 890 | 0.05% |
| Emotional poverty | 23 | 0% |
| Emphysema | 407 | 0.02% |
| Emphysematous cystitis | 7 | 0% |
| Emphysematous pyelonephritis | 2 | 0% |
| Empty sella syndrome | 11 | 0% |
| Empyema | 47 | 0% |
| Empyema drainage | 1 | 0% |
| Enamel anomaly | 2 | 0% |
| Enanthema | 23 | 0% |
| Encapsulation reaction | 4 | 0% |
| Encephalitis | 770 | 0.05% |
| Encephalitis allergic | 3 | 0% |
| Encephalitis autoimmune | 169 | 0.01% |
| Encephalitis brain stem | 23 | 0% |
| Encephalitis enteroviral | 1 | 0% |
| Encephalitis haemorrhagic | 1 | 0% |
| Encephalitis Japanese B | 2 | 0% |
| Encephalitis lethargica | 1 | 0% |
| Encephalitis meningococcal | 4 | 0% |
| Encephalitis post immunisation | 13 | 0% |
| Encephalitis rickettsial | 1 | 0% |
| Encephalitis viral | 45 | 0% |
| Encephalocele | 3 | 0% |
| Encephalomalacia | 38 | 0% |
| Encephalomyelitis | 93 | 0.01% |
| Encephalomyelitis viral | 2 | 0% |
| Encephalopathy | 1,050 | 0.06% |
| Encephalopathy neonatal | 1 | 0% |
| Enchondromatosis | 4 | 0% |
| Encopresis | 3 | 0% |
| End-tidal CO2 | 7 | 0% |
| End-tidal CO2 decreased | 2 | 0% |
| Endarterectomy | 10 | 0% |
| Endobronchial ultrasound | 12 | 0% |
| Endobronchial ultrasound transbronchial needle aspiration | 10 | 0% |
| Endobronchial valve implantation | 1 | 0% |
| Endocardial disease | 2 | 0% |
| Endocardial fibrosis | 1 | 0% |
| Endocarditis | 256 | 0.02% |
| Endocarditis bacterial | 14 | 0% |
| Endocarditis enterococcal | 1 | 0% |
| Endocarditis fibroplastica | 2 | 0% |
| Endocarditis haemophilus | 1 | 0% |
| Endocarditis histoplasma | 1 | 0% |
| Endocarditis noninfective | 3 | 0% |
| Endocarditis Q fever | 2 | 0% |
| Endocarditis rheumatic | 1 | 0% |
| Endocarditis staphylococcal | 1 | 0% |
| Endocarditis viral | 1 | 0% |
| Endocervical curettage | 1 | 0% |
| Endocervical mucosal thickening | 2 | 0% |
| Endocrine disorder | 55 | 0% |
| Endocrine hypertension | 1 | 0% |
| Endocrine neoplasm | 1 | 0% |
| Endocrine neoplasm malignant | 1 | 0% |
| Endocrine ophthalmopathy | 139 | 0.01% |
| Endocrine system examination | 19 | 0% |
| Endocrine test | 175 | 0.01% |
| Endocrine test abnormal | 2 | 0% |
| Endocrine test normal | 7 | 0% |
| Endodontic procedure | 47 | 0% |
| Endolymphatic hydrops | 48 | 0% |
| Endometrial ablation | 37 | 0% |
| Endometrial adenocarcinoma | 14 | 0% |
| Endometrial atrophy | 9 | 0% |
| Endometrial cancer | 35 | 0% |
| Endometrial cancer stage I | 3 | 0% |
| Endometrial cancer stage II | 1 | 0% |
| Endometrial cancer stage III | 1 | 0% |
| Endometrial disorder | 41 | 0% |
| Endometrial dysplasia | 2 | 0% |
| Endometrial hyperplasia | 47 | 0% |
| Endometrial hypertrophy | 4 | 0% |
| Endometrial hypoplasia | 2 | 0% |
| Endometrial neoplasm | 1 | 0% |
| Endometrial scratching | 1 | 0% |
| Endometrial thickening | 92 | 0.01% |
| Endometriosis | 559 | 0.03% |
| Endometriosis ablation | 2 | 0% |
| Endometritis | 22 | 0% |
| Endometritis decidual | 1 | 0% |
| Endophthalmitis | 6 | 0% |
| Endoscopic retrograde cholangiopancreatography | 75 | 0% |
| Endoscopic retrograde cholangiopancreatography abnormal | 6 | 0% |
| Endoscopic retrograde cholangiopancreatography normal | 1 | 0% |
| Endoscopic swallowing evaluation | 6 | 0% |
| Endoscopic swallowing evaluation abnormal | 1 | 0% |
| Endoscopic ultrasound | 58 | 0% |
| Endoscopic ultrasound abnormal | 6 | 0% |
| Endoscopic ultrasound normal | 2 | 0% |
| Endoscopy | 901 | 0.05% |
| Endoscopy abnormal | 142 | 0.01% |
| Endoscopy biliary tract | 5 | 0% |
| Endoscopy gastrointestinal | 104 | 0.01% |
| Endoscopy gastrointestinal abnormal | 6 | 0% |
| Endoscopy gastrointestinal normal | 5 | 0% |
| Endoscopy large bowel | 8 | 0% |
| Endoscopy normal | 108 | 0.01% |
| Endoscopy small intestine | 31 | 0% |
| Endoscopy small intestine abnormal | 5 | 0% |
| Endoscopy upper gastrointestinal tract | 798 | 0.05% |
| Endoscopy upper gastrointestinal tract abnormal | 40 | 0% |
| Endoscopy upper gastrointestinal tract normal | 32 | 0% |
| Endothelial dysfunction | 50 | 0% |
| Endothelin | 3 | 0% |
| Endothelin abnormal | 3 | 0% |
| Endotracheal intubation | 2,561 | 0.16% |
| Endotracheal intubation complication | 24 | 0% |
| Endovenous ablation | 4 | 0% |
| End stage renal disease | 228 | 0.01% |
| Enema administration | 25 | 0% |
| Energy increased | 265 | 0.02% |
| Enhanced respiratory disease | 1 | 0% |
| Enlarged cerebral perivascular spaces | 2 | 0% |
| Enlarged clitoris | 2 | 0% |
| Enlarged foetal cisterna magna | 1 | 0% |
| Enlarged uvula | 190 | 0.01% |
| Enophthalmos | 5 | 0% |
| Enostosis | 1 | 0% |
| Enteral nutrition | 48 | 0% |
| Enteric neuropathy | 1 | 0% |
| Enteritis | 169 | 0.01% |
| Enteritis infectious | 28 | 0% |
| Enterobacter bacteraemia | 5 | 0% |
| Enterobacter infection | 23 | 0% |
| Enterobacter pneumonia | 2 | 0% |
| Enterobacter sepsis | 2 | 0% |
| Enterobacter test positive | 17 | 0% |
| Enterobiasis | 1 | 0% |
| Enteroclysis | 1 | 0% |
| Enterococcal bacteraemia | 16 | 0% |
| Enterococcal infection | 56 | 0% |
| Enterococcal sepsis | 2 | 0% |
| Enterococcus test | 20 | 0% |
| Enterococcus test negative | 2 | 0% |
| Enterococcus test positive | 62 | 0% |
| Enterocolitis | 88 | 0.01% |
| Enterocolitis bacterial | 1 | 0% |
| Enterocolitis haemorrhagic | 30 | 0% |
| Enterocolitis infectious | 4 | 0% |
| Enterocolitis viral | 2 | 0% |
| Enterocutaneous fistula | 5 | 0% |
| Enteropathic spondylitis | 1 | 0% |
| Enteropathy-associated T-cell lymphoma | 1 | 0% |
| Enterorrhaphy | 3 | 0% |
| Enterostomy | 1 | 0% |
| Enterovesical fistula | 4 | 0% |
| Enterovirus infection | 25 | 0% |
| Enterovirus myocarditis | 1 | 0% |
| Enterovirus test | 206 | 0.01% |
| Enterovirus test negative | 223 | 0.01% |
| Enterovirus test positive | 30 | 0% |
| Enthesopathy | 78 | 0% |
| Enthesophyte | 1 | 0% |
| Enuresis | 118 | 0.01% |
| Environmental exposure | 4 | 0% |
| Enzyme abnormality | 16 | 0% |
| Enzyme activity assay | 7 | 0% |
| Enzyme activity increased | 1 | 0% |
| Enzyme activity normal | 12 | 0% |
| Enzyme level abnormal | 7 | 0% |
| Enzyme level decreased | 2 | 0% |
| Enzyme level increased | 23 | 0% |
| Enzyme level test | 108 | 0.01% |
| Eosinopenia | 4 | 0% |
| Eosinophil cationic protein | 14 | 0% |
| Eosinophil count | 1,770 | 0.11% |
| Eosinophil count abnormal | 13 | 0% |
| Eosinophil count decreased | 365 | 0.02% |
| Eosinophil count increased | 248 | 0.02% |
| Eosinophil count normal | 349 | 0.02% |
| Eosinophilia | 248 | 0.02% |
| Eosinophilia myalgia syndrome | 1 | 0% |
| Eosinophilic bronchitis | 4 | 0% |
| Eosinophilic cellulitis | 22 | 0% |
| Eosinophilic colitis | 6 | 0% |
| Eosinophilic cystitis | 1 | 0% |
| Eosinophilic fasciitis | 27 | 0% |
| Eosinophilic gastritis | 1 | 0% |
| Eosinophilic granulomatosis with polyangiitis | 74 | 0% |
| Eosinophilic myocarditis | 29 | 0% |
| Eosinophilic oesophagitis | 38 | 0% |
| Eosinophilic pleural effusion | 6 | 0% |
| Eosinophilic pneumonia | 49 | 0% |
| Eosinophilic pneumonia acute | 9 | 0% |
| Eosinophilic pneumonia chronic | 6 | 0% |
| Eosinophilic pustular folliculitis | 3 | 0% |
| Eosinophil morphology | 4 | 0% |
| Eosinophil percentage | 605 | 0.04% |
| Eosinophil percentage abnormal | 2 | 0% |
| Eosinophil percentage decreased | 381 | 0.02% |
| Eosinophil percentage increased | 103 | 0.01% |
| Eosinophils urine | 5 | 0% |
| Eosinophils urine absent | 1 | 0% |
| Eosinophils urine present | 1 | 0% |
| Ependymoma | 3 | 0% |
| Ephelides | 21 | 0% |
| Epicondylitis | 167 | 0.01% |
| Epidemic pleurodynia | 1 | 0% |
| Epidemic polyarthritis | 1 | 0% |
| Epidermal naevus | 1 | 0% |
| Epidermal naevus syndrome | 1 | 0% |
| Epidermal necrosis | 10 | 0% |
| Epidermolysis | 5 | 0% |
| Epidermolysis bullosa | 10 | 0% |
| Epididymal calculus | 1 | 0% |
| Epididymal cyst | 5 | 0% |
| Epididymal disorder | 2 | 0% |
| Epididymal enlargement | 3 | 0% |
| Epididymal tenderness | 4 | 0% |
| Epididymitis | 163 | 0.01% |
| Epidural anaesthesia | 2 | 0% |
| Epidural analgesia | 2 | 0% |
| Epidural blood patch | 12 | 0% |
| Epidural catheter placement | 2 | 0% |
| Epidural haemorrhage | 8 | 0% |
| Epidural injection | 35 | 0% |
| Epidural lipomatosis | 5 | 0% |
| Epidural test dose | 1 | 0% |
| Epigastric discomfort | 159 | 0.01% |
| Epiglottic cancer | 2 | 0% |
| Epiglottic cyst | 1 | 0% |
| Epiglottic mass | 1 | 0% |
| Epiglottic oedema | 24 | 0% |
| Epiglottis ulcer | 1 | 0% |
| Epiglottitis | 31 | 0% |
| Epiglottitis obstructive | 1 | 0% |
| Epilepsia partialis continua | 1 | 0% |
| Epilepsy | 2,798 | 0.17% |
| Epilepsy with myoclonic-atonic seizures | 1 | 0% |
| Epileptic aura | 24 | 0% |
| Epileptic encephalopathy | 7 | 0% |
| Epileptic psychosis | 1 | 0% |
| Epinephrine | 54 | 0% |
| Epinephrine abnormal | 3 | 0% |
| Epinephrine decreased | 1 | 0% |
| Epinephrine increased | 24 | 0% |
| Epiphyseal disorder | 1 | 0% |
| Epiphyseal injury | 1 | 0% |
| Epiphyses premature fusion | 1 | 0% |
| Epiphysiolysis | 1 | 0% |
| Epiploic appendagitis | 23 | 0% |
| Epiretinal membrane | 16 | 0% |
| Episcleritis | 87 | 0.01% |
| Episiotomy | 2 | 0% |
| Epistaxis | 4,957 | 0.3% |
| Epithelioid mesothelioma | 1 | 0% |
| Epithelioid sarcoma | 2 | 0% |
| Epstein-Barr viraemia | 25 | 0% |
| Epstein-Barr virus antibody | 364 | 0.02% |
| Epstein-Barr virus antibody negative | 71 | 0% |
| Epstein-Barr virus antibody positive | 165 | 0.01% |
| Epstein-Barr virus antigen positive | 28 | 0% |
| Epstein-Barr virus associated lymphoma | 3 | 0% |
| Epstein-Barr virus associated lymphoproliferative disorder | 3 | 0% |
| Epstein-Barr virus infection | 292 | 0.02% |
| Epstein-Barr virus infection reactivation | 282 | 0.02% |
| Epstein-Barr virus test | 1,111 | 0.07% |
| Epstein-Barr virus test negative | 113 | 0.01% |
| Epstein-Barr virus test positive | 96 | 0.01% |
| Epstein Barr virus positive mucocutaneous ulcer | 4 | 0% |
| Epulis | 1 | 0% |
| Erectile dysfunction | 1,021 | 0.06% |
| Erection increased | 27 | 0% |
| Ergotherapy | 3 | 0% |
| Ergot poisoning | 1 | 0% |
| Erosive duodenitis | 6 | 0% |
| Erosive oesophagitis | 11 | 0% |
| Eructation | 632 | 0.04% |
| Erysipelas | 762 | 0.05% |
| Erysipeloid | 3 | 0% |
| Erythema | 33,714 | 2.05% |
| Erythema ab igne | 1 | 0% |
| Erythema annulare | 19 | 0% |
| Erythema dyschromicum perstans | 1 | 0% |
| Erythema elevatum diutinum | 1 | 0% |
| Erythema induratum | 28 | 0% |
| Erythema infectiosum | 2 | 0% |
| Erythema marginatum | 4 | 0% |
| Erythema migrans | 12 | 0% |
| Erythema multiforme | 1,276 | 0.08% |
| Erythema nodosum | 335 | 0.02% |
| Erythema of eyelid | 260 | 0.02% |
| Erythematotelangiectatic rosacea | 2 | 0% |
| Erythrasma | 3 | 0% |
| Erythroblast count | 124 | 0.01% |
| Erythroblast count abnormal | 1 | 0% |
| Erythroblast count normal | 1 | 0% |
| Erythroblastosis | 1 | 0% |
| Erythroblastosis foetalis | 1 | 0% |
| Erythrocyanosis | 1 | 0% |
| Erythrocyte electrophoretic index increased | 1 | 0% |
| Erythrocyte osmotic fragility test | 5 | 0% |
| Erythrodermic atopic dermatitis | 1 | 0% |
| Erythrodermic psoriasis | 20 | 0% |
| Erythroid series abnormal | 1 | 0% |
| Erythromelalgia | 45 | 0% |
| Erythropenia | 11 | 0% |
| Erythroplasia | 1 | 0% |
| Erythropoiesis abnormal | 5 | 0% |
| Erythropoietin deficiency anaemia | 2 | 0% |
| Erythropsia | 14 | 0% |
| Erythrosis | 9 | 0% |
| Eschar | 12 | 0% |
| Escherichia bacteraemia | 60 | 0% |
| Escherichia infection | 158 | 0.01% |
| Escherichia pyelonephritis | 7 | 0% |
| Escherichia sepsis | 25 | 0% |
| Escherichia test | 52 | 0% |
| Escherichia test negative | 16 | 0% |
| Escherichia test positive | 178 | 0.01% |
| Escherichia urinary tract infection | 62 | 0% |
| Essential hypertension | 297 | 0.02% |
| Essential thrombocythaemia | 41 | 0% |
| Essential tremor | 94 | 0.01% |
| Eubacterium infection | 1 | 0% |
| Euglycaemic diabetic ketoacidosis | 3 | 0% |
| Euphoric mood | 399 | 0.02% |
| Eustachian tube disorder | 51 | 0% |
| Eustachian tube dysfunction | 86 | 0.01% |
| Eustachian tube obstruction | 32 | 0% |
| Eustachian tube patulous | 1 | 0% |
| Euthyroid sick syndrome | 5 | 0% |
| Evacuation of retained products of conception | 2 | 0% |
| Evans syndrome | 36 | 0% |
| Evidence based treatment | 2 | 0% |
| Ewing's sarcoma | 3 | 0% |
| Ewing's sarcoma metastatic | 1 | 0% |
| Ex-alcohol user | 2 | 0% |
| Ex-drug abuser | 1 | 0% |
| Ex-tobacco user | 22 | 0% |
| Exaggerated startle response | 14 | 0% |
| Excessive cerumen production | 75 | 0% |
| Excessive dietary supplement intake | 1 | 0% |
| Excessive exercise | 2 | 0% |
| Excessive eye blinking | 65 | 0% |
| Excessive granulation tissue | 16 | 0% |
| Excessive masturbation | 2 | 0% |
| Excessive maternal gestational weight gain | 1 | 0% |
| Excessive ocular convergence | 1 | 0% |
| Excessive skin | 3 | 0% |
| Executive dysfunction | 26 | 0% |
| Exercise adequate | 2 | 0% |
| Exercise electrocardiogram | 413 | 0.03% |
| Exercise electrocardiogram abnormal | 22 | 0% |
| Exercise electrocardiogram normal | 10 | 0% |
| Exercise lack of | 33 | 0% |
| Exercise test | 150 | 0.01% |
| Exercise test abnormal | 1 | 0% |
| Exercise test normal | 5 | 0% |
| Exercise tolerance decreased | 2,552 | 0.16% |
| Exercise tolerance increased | 8 | 0% |
| Exeresis | 2 | 0% |
| Exertional headache | 31 | 0% |
| Exfoliation glaucoma | 1 | 0% |
| Exfoliation syndrome | 2 | 0% |
| Exfoliative rash | 167 | 0.01% |
| Exhibitionism | 2 | 0% |
| Exocrine pancreatic function test | 3 | 0% |
| Exocrine pancreatic function test normal | 1 | 0% |
| Exomphalos | 6 | 0% |
| Exophthalmos | 141 | 0.01% |
| Exostosis | 96 | 0.01% |
| Exostosis of jaw | 1 | 0% |
| Expanded disability status scale | 108 | 0.01% |
| Expanded disability status scale score increased | 2 | 0% |
| Expiratory reserve volume | 6 | 0% |
| Expiratory reserve volume decreased | 1 | 0% |
| Expired device used | 4 | 0% |
| Expired product administered | 41,200 | 2.51% |
| Exploding head syndrome | 22 | 0% |
| Explorative laparotomy | 53 | 0% |
| Exploratory operation | 13 | 0% |
| Exposed bone in jaw | 1 | 0% |
| Exposure during pregnancy | 4,401 | 0.27% |
| Exposure keratitis | 6 | 0% |
| Exposure to allergen | 5 | 0% |
| Exposure to chemical pollution | 1 | 0% |
| Exposure to communicable disease | 85 | 0.01% |
| Exposure to contaminated air | 3 | 0% |
| Exposure to contaminated device | 2 | 0% |
| Exposure to contaminated water | 2 | 0% |
| Exposure to extreme temperature | 17 | 0% |
| Exposure to fungus | 10 | 0% |
| Exposure to noise | 5 | 0% |
| Exposure to radiation | 1 | 0% |
| Exposure to SARS-CoV-2 | 3,680 | 0.22% |
| Exposure to tobacco | 1 | 0% |
| Exposure to toxic agent | 15 | 0% |
| Exposure to unspecified agent | 1 | 0% |
| Exposure to vaccinated person | 13 | 0% |
| Exposure via body fluid | 3 | 0% |
| Exposure via breast milk | 682 | 0.04% |
| Exposure via contaminated device | 1 | 0% |
| Exposure via direct contact | 21 | 0% |
| Exposure via eye contact | 7 | 0% |
| Exposure via father | 1 | 0% |
| Exposure via ingestion | 1 | 0% |
| Exposure via inhalation | 1 | 0% |
| Exposure via partner | 2 | 0% |
| Exposure via skin contact | 216 | 0.01% |
| Exposure via transplant | 1 | 0% |
| Exposure via unknown route | 2 | 0% |
| Expulsion of medication | 1 | 0% |
| Exsanguination | 4 | 0% |
| Extensive swelling of vaccinated limb | 1,382 | 0.08% |
| Extensor plantar response | 38 | 0% |
| External auditory canal atresia | 1 | 0% |
| External cephalic version | 2 | 0% |
| External compression headache | 7 | 0% |
| External ear cellulitis | 6 | 0% |
| External ear disorder | 8 | 0% |
| External ear inflammation | 26 | 0% |
| External ear pain | 67 | 0% |
| External fixation of fracture | 5 | 0% |
| External vagal nerve stimulation | 6 | 0% |
| Extra dose administered | 9,742 | 0.59% |
| Extradural abscess | 19 | 0% |
| Extradural haematoma | 24 | 0% |
| Extradural neoplasm | 1 | 0% |
| Extramedullary haemopoiesis | 1 | 0% |
| Extranodal marginal zone B-cell lymphoma (MALT type) | 10 | 0% |
| Extraocular muscle disorder | 32 | 0% |
| Extraocular muscle paresis | 77 | 0% |
| Extrapulmonary tuberculosis | 2 | 0% |
| Extrapyramidal disorder | 48 | 0% |
| Extraskeletal ossification | 3 | 0% |
| Extrasystoles | 2,426 | 0.15% |
| Extravasation | 17 | 0% |
| Extravasation blood | 12 | 0% |
| Extremity contracture | 80 | 0% |
| Extremity necrosis | 38 | 0% |
| Extubation | 105 | 0.01% |
| Exudative retinopathy | 2 | 0% |
| Eye abrasion | 3 | 0% |
| Eye abscess | 11 | 0% |
| Eye allergy | 55 | 0% |
| Eye colour change | 50 | 0% |
| Eye complication associated with device | 4 | 0% |
| Eye contusion | 235 | 0.01% |
| Eye degenerative disorder | 2 | 0% |
| Eye discharge | 409 | 0.02% |
| Eye disorder | 1,288 | 0.08% |
| Eye drop instillation | 1 | 0% |
| Eye excision | 4 | 0% |
| Eye exercises | 1 | 0% |
| Eyeglasses therapy | 12 | 0% |
| Eye haemangioma | 1 | 0% |
| Eye haematoma | 95 | 0.01% |
| Eye haemorrhage | 1,163 | 0.07% |
| Eye infarction | 118 | 0.01% |
| Eye infection | 259 | 0.02% |
| Eye infection bacterial | 14 | 0% |
| Eye infection chlamydial | 1 | 0% |
| Eye infection fungal | 3 | 0% |
| Eye infection intraocular | 2 | 0% |
| Eye infection staphylococcal | 3 | 0% |
| Eye infection syphilitic | 1 | 0% |
| Eye infection toxoplasmal | 7 | 0% |
| Eye infection viral | 13 | 0% |
| Eye inflammation | 545 | 0.03% |
| Eye injury | 164 | 0.01% |
| Eye irrigation | 8 | 0% |
| Eye irritation | 1,962 | 0.12% |
| Eye laser surgery | 39 | 0% |
| Eyelash changes | 2 | 0% |
| Eyelash discolouration | 4 | 0% |
| Eyelid abrasion | 2 | 0% |
| Eyelid bleeding | 12 | 0% |
| Eyelid boil | 5 | 0% |
| Eyelid contusion | 14 | 0% |
| Eyelid cyst | 19 | 0% |
| Eyelid cyst removal | 3 | 0% |
| Eyelid disorder | 274 | 0.02% |
| Eyelid exfoliation | 13 | 0% |
| Eyelid function disorder | 337 | 0.02% |
| Eyelid haematoma | 20 | 0% |
| Eyelid infection | 25 | 0% |
| Eyelid injury | 16 | 0% |
| Eyelid irritation | 127 | 0.01% |
| Eyelid margin crusting | 94 | 0.01% |
| Eyelid myoclonus | 30 | 0% |
| Eyelid myokymia | 13 | 0% |
| Eyelid oedema | 513 | 0.03% |
| Eyelid operation | 3 | 0% |
| Eyelid pain | 193 | 0.01% |
| Eyelid ptosis | 788 | 0.05% |
| Eyelid ptosis congenital | 1 | 0% |
| Eyelid rash | 179 | 0.01% |
| Eyelid retraction | 8 | 0% |
| Eyelid scar | 4 | 0% |
| Eyelid sensory disorder | 40 | 0% |
| Eyelid skin dryness | 23 | 0% |
| Eyelids pruritus | 178 | 0.01% |
| Eyelid thickening | 13 | 0% |
| Eyelid tumour | 3 | 0% |
| Eyelid vascular disorder | 2 | 0% |
| Eye luxation | 2 | 0% |
| Eye movement disorder | 1,504 | 0.09% |
| Eye muscle entrapment | 1 | 0% |
| Eye muscle operation | 1 | 0% |
| Eye muscle recession | 1 | 0% |
| Eye naevus | 6 | 0% |
| Eye oedema | 179 | 0.01% |
| Eye opacity | 3 | 0% |
| Eye operation | 50 | 0% |
| Eye pain | 7,126 | 0.43% |
| Eye paraesthesia | 34 | 0% |
| Eye patch application | 9 | 0% |
| Eye pH test | 4 | 0% |
| Eye pruritus | 2,153 | 0.13% |
| Eye swelling | 4,680 | 0.28% |
| Eye symptom | 30 | 0% |
| Eye ulcer | 24 | 0% |
| Fabry's disease | 5 | 0% |
| Face and mouth X-ray | 54 | 0% |
| Face and mouth X-ray abnormal | 7 | 0% |
| Face and mouth X-ray normal | 12 | 0% |
| Face crushing | 7 | 0% |
| Face injury | 500 | 0.03% |
| Face lift | 1 | 0% |
| Face oedema | 1,127 | 0.07% |
| Face presentation | 1 | 0% |
| Facetectomy | 5 | 0% |
| Facet joint block | 2 | 0% |
| Facet joint syndrome | 49 | 0% |
| Facial asymmetry | 234 | 0.01% |
| Facial bones fracture | 154 | 0.01% |
| Facial discomfort | 470 | 0.03% |
| Facial myokymia | 17 | 0% |
| Facial nerve disorder | 125 | 0.01% |
| Facial nerve exploration | 1 | 0% |
| Facial neuralgia | 52 | 0% |
| Facial operation | 3 | 0% |
| Facial pain | 2,585 | 0.16% |
| Facial paralysis | 9,689 | 0.59% |
| Facial paresis | 2,147 | 0.13% |
| Facial spasm | 213 | 0.01% |
| Facial wasting | 6 | 0% |
| Faciobrachial dystonic seizure | 3 | 0% |
| Facioscapulohumeral muscular dystrophy | 3 | 0% |
| Factitious disorder | 7 | 0% |
| Factor II deficiency | 3 | 0% |
| Factor II inhibition | 1 | 0% |
| Factor II mutation | 105 | 0.01% |
| Factor IX deficiency | 5 | 0% |
| Factor IX inhibition | 3 | 0% |
| Factor V deficiency | 12 | 0% |
| Factor VII deficiency | 5 | 0% |
| Factor VIII activity abnormal | 1 | 0% |
| Factor VIII activity decreased | 1 | 0% |
| Factor VIII activity increased | 1 | 0% |
| Factor VIII activity normal | 1 | 0% |
| Factor VIII activity test | 58 | 0% |
| Factor VIII deficiency | 25 | 0% |
| Factor VIII inhibition | 21 | 0% |
| Factor V inhibition | 3 | 0% |
| Factor V Leiden carrier | 20 | 0% |
| Factor V Leiden mutation | 170 | 0.01% |
| Factor Xa activity increased | 1 | 0% |
| Factor Xa activity test | 18 | 0% |
| Factor X deficiency | 3 | 0% |
| Factor XI deficiency | 4 | 0% |
| Factor XII deficiency | 1 | 0% |
| Factor XIII deficiency | 3 | 0% |
| Factor XIII inhibition | 2 | 0% |
| Faecal calprotectin | 198 | 0.01% |
| Faecal calprotectin abnormal | 5 | 0% |
| Faecal calprotectin increased | 44 | 0% |
| Faecal calprotectin normal | 4 | 0% |
| Faecal disimpaction | 11 | 0% |
| Faecal elastase concentration abnormal | 1 | 0% |
| Faecal elastase concentration decreased | 3 | 0% |
| Faecal elastase test | 21 | 0% |
| Faecal fat increased | 2 | 0% |
| Faecal fat test | 3 | 0% |
| Faecalith | 7 | 0% |
| Faecal lactoferrin | 2 | 0% |
| Faecal lactoferrin increased | 1 | 0% |
| Faecaloma | 94 | 0.01% |
| Faecal volume | 4 | 0% |
| Faecal volume decreased | 8 | 0% |
| Faecal volume increased | 12 | 0% |
| Faecal vomiting | 17 | 0% |
| Faeces discoloured | 709 | 0.04% |
| Faeces hard | 54 | 0% |
| Faeces pale | 60 | 0% |
| Faeces soft | 235 | 0.01% |
| Failed back surgery syndrome | 1 | 0% |
| Failed induction of labour | 3 | 0% |
| Failed in vitro fertilisation | 8 | 0% |
| Failure to thrive | 161 | 0.01% |
| Fall | 14,766 | 0.9% |
| Fallopian tube abscess | 1 | 0% |
| Fallopian tube cancer | 4 | 0% |
| Fallopian tube cancer stage III | 1 | 0% |
| Fallopian tube cyst | 4 | 0% |
| Fallopian tube disorder | 9 | 0% |
| Fallopian tube neoplasm | 1 | 0% |
| Fallopian tube obstruction | 3 | 0% |
| Fallopian tube operation | 11 | 0% |
| Fallopian tube perforation | 3 | 0% |
| Fallopian tube spasm | 1 | 0% |
| Fallot's pentalogy | 1 | 0% |
| Fallot's tetralogy | 9 | 0% |
| False labour | 8 | 0% |
| False lumen dilatation of aortic dissection | 1 | 0% |
| False negative investigation result | 3 | 0% |
| False negative pregnancy test | 2 | 0% |
| False positive investigation result | 19 | 0% |
| False positive radioisotope investigation result | 1 | 0% |
| False positive tuberculosis test | 1 | 0% |
| Familial amyotrophic lateral sclerosis | 2 | 0% |
| Familial hemiplegic migraine | 2 | 0% |
| Familial mediterranean fever | 11 | 0% |
| Familial periodic paralysis | 5 | 0% |
| Familial risk factor | 5 | 0% |
| Familial tremor | 4 | 0% |
| Family stress | 13 | 0% |
| Fanconi syndrome | 1 | 0% |
| Fascial infection | 1 | 0% |
| Fascial operation | 1 | 0% |
| Fascial rupture | 3 | 0% |
| Fascia release | 1 | 0% |
| Fascicular block | 1 | 0% |
| Fasciectomy | 3 | 0% |
| Fasciitis | 40 | 0% |
| Fascioliasis | 2 | 0% |
| Fasciolopsiasis | 1 | 0% |
| Fasciotomy | 13 | 0% |
| Fasting | 39 | 0% |
| Fat embolism | 3 | 0% |
| Fatigue | 208,576 | 12.69% |
| Fat intolerance | 1 | 0% |
| Fat necrosis | 16 | 0% |
| Fat tissue decreased | 5 | 0% |
| Fat tissue increased | 23 | 0% |
| Fatty acid deficiency | 1 | 0% |
| Fatty liver alcoholic | 1 | 0% |
| Fazekas scale | 1 | 0% |
| Fear | 1,434 | 0.09% |
| Fear-related avoidance of activities | 9 | 0% |
| Fear of closed spaces | 1 | 0% |
| Fear of death | 223 | 0.01% |
| Fear of disease | 37 | 0% |
| Fear of eating | 13 | 0% |
| Fear of falling | 35 | 0% |
| Fear of injection | 365 | 0.02% |
| Fear of open spaces | 1 | 0% |
| Fear of pregnancy | 4 | 0% |
| Fear of weight gain | 1 | 0% |
| Febrile bone marrow aplasia | 3 | 0% |
| Febrile convulsion | 343 | 0.02% |
| Febrile infection | 26 | 0% |
| Febrile infection-related epilepsy syndrome | 2 | 0% |
| Febrile neutropenia | 114 | 0.01% |
| Febrile status epilepticus | 1 | 0% |
| Feeding disorder | 2,426 | 0.15% |
| Feeding intolerance | 25 | 0% |
| Feeding tube user | 63 | 0% |
| Feeling abnormal | 36,869 | 2.24% |
| Feeling cold | 12,063 | 0.73% |
| Feeling drunk | 664 | 0.04% |
| Feeling guilty | 13 | 0% |
| Feeling hot | 18,850 | 1.15% |
| Feeling jittery | 840 | 0.05% |
| Feeling of body temperature change | 3,087 | 0.19% |
| Feeling of despair | 169 | 0.01% |
| Feeling of relaxation | 47 | 0% |
| Feelings of worthlessness | 19 | 0% |
| Female genital organs X-ray | 1 | 0% |
| Female genital tract fistula | 4 | 0% |
| Female orgasmic disorder | 9 | 0% |
| Female reproductive tract disorder | 33 | 0% |
| Female sex hormone level | 32 | 0% |
| Female sex hormone level abnormal | 6 | 0% |
| Female sexual arousal disorder | 1 | 0% |
| Female sexual dysfunction | 5 | 0% |
| Female sterilisation | 4 | 0% |
| Feminisation acquired | 3 | 0% |
| Femoral anteversion | 1 | 0% |
| Femoral artery aneurysm | 3 | 0% |
| Femoral artery embolism | 10 | 0% |
| Femoral hernia | 1 | 0% |
| Femoral neck fracture | 94 | 0.01% |
| Femoral nerve injury | 4 | 0% |
| Femoral nerve palsy | 2 | 0% |
| Femoral pulse | 4 | 0% |
| Femoral pulse decreased | 1 | 0% |
| Femoroacetabular impingement | 6 | 0% |
| Femur fracture | 194 | 0.01% |
| Femur resection | 1 | 0% |
| Fertility increased | 2 | 0% |
| FEV1/FVC ratio | 53 | 0% |
| FEV1/FVC ratio abnormal | 1 | 0% |
| FEV1/FVC ratio decreased | 1 | 0% |
| Fever neonatal | 12 | 0% |
| Fibrillary glomerulonephritis | 4 | 0% |
| Fibrin | 47 | 0% |
| Fibrin abnormal | 4 | 0% |
| Fibrin D dimer | 11,116 | 0.68% |
| Fibrin D dimer decreased | 26 | 0% |
| Fibrin D dimer increased | 4,085 | 0.25% |
| Fibrin D dimer normal | 766 | 0.05% |
| Fibrin degradation products | 172 | 0.01% |
| Fibrin degradation products increased | 13 | 0% |
| Fibrin degradation products normal | 2 | 0% |
| Fibrin increased | 3 | 0% |
| Fibrinogen degradation products increased | 4 | 0% |
| Fibrinolysis | 12 | 0% |
| Fibrinolysis abnormal | 1 | 0% |
| Fibrinolysis increased | 3 | 0% |
| Fibrinolysis normal | 1 | 0% |
| Fibrinous bronchitis | 1 | 0% |
| Fibroadenoma of breast | 34 | 0% |
| Fibroblast growth factor 23 | 5 | 0% |
| Fibroblast growth factor 23 increased | 1 | 0% |
| Fibrocystic breast disease | 22 | 0% |
| Fibrodysplasia ossificans progressiva | 1 | 0% |
| Fibroma | 13 | 0% |
| Fibromatosis | 2 | 0% |
| Fibromuscular dysplasia | 17 | 0% |
| Fibromyalgia | 1,335 | 0.08% |
| Fibronectin | 6 | 0% |
| Fibronectin abnormal | 1 | 0% |
| Fibronectin decreased | 2 | 0% |
| Fibronectin increased | 2 | 0% |
| Fibronectin normal | 3 | 0% |
| Fibrosarcoma | 2 | 0% |
| Fibrosis | 80 | 0% |
| Fibrosis-4 index | 1 | 0% |
| Fibrosis tendinous | 1 | 0% |
| Fibrous cortical defect | 1 | 0% |
| Fibrous histiocytoma | 5 | 0% |
| Fibula fracture | 34 | 0% |
| Fiducial marker placement | 1 | 0% |
| Fine motor delay | 5 | 0% |
| Fine motor skill dysfunction | 421 | 0.03% |
| Finger amputation | 5 | 0% |
| Finger deformity | 73 | 0% |
| Finger licking | 1 | 0% |
| Fingerprint loss | 2 | 0% |
| Finger repair operation | 1 | 0% |
| Finger tapping test | 4 | 0% |
| Finkelstein test | 2 | 0% |
| FIP1L1/PDGFR alpha fusion kinase positive | 1 | 0% |
| First bite syndrome | 2 | 0% |
| First trimester pregnancy | 23 | 0% |
| Fistula | 36 | 0% |
| Fistula discharge | 5 | 0% |
| Fistula of small intestine | 4 | 0% |
| Fistulogram | 5 | 0% |
| Fixed bowel loop | 1 | 0% |
| Fixed eruption | 20 | 0% |
| Flagellate dermatitis | 3 | 0% |
| Flail chest | 4 | 0% |
| Flank pain | 1,257 | 0.08% |
| Flashback | 15 | 0% |
| Flat affect | 58 | 0% |
| Flatback syndrome | 2 | 0% |
| Flat chest | 1 | 0% |
| Flatulence | 1,619 | 0.1% |
| Flavivirus test | 20 | 0% |
| Flavivirus test negative | 3 | 0% |
| Flavivirus test positive | 1 | 0% |
| Flea infestation | 1 | 0% |
| Flight of ideas | 8 | 0% |
| Flooding | 1 | 0% |
| Floppy eyelid syndrome | 3 | 0% |
| Flow cytometry | 192 | 0.01% |
| FLT3 gene mutation | 2 | 0% |
| Fluctuance | 2 | 0% |
| Fluid balance assessment | 55 | 0% |
| Fluid balance negative | 6 | 0% |
| Fluid balance positive | 6 | 0% |
| Fluid imbalance | 14 | 0% |
| Fluid intake reduced | 381 | 0.02% |
| Fluid intake restriction | 62 | 0% |
| Fluid overload | 65 | 0% |
| Fluid replacement | 45 | 0% |
| Fluid retention | 887 | 0.05% |
| Fluid wave test | 3 | 0% |
| Fluorescence angiogram | 147 | 0.01% |
| Fluorescence angiogram abnormal | 23 | 0% |
| Fluorescence angiogram normal | 8 | 0% |
| Fluorescent in situ hybridisation | 50 | 0% |
| Fluorescent in situ hybridisation negative | 1 | 0% |
| Fluorescent in situ hybridisation positive | 1 | 0% |
| Flushing | 11,079 | 0.67% |
| Foaming at mouth | 194 | 0.01% |
| Focal dyscognitive seizures | 56 | 0% |
| Focal myositis | 4 | 0% |
| Focal nodular hyperplasia | 6 | 0% |
| Focal peritonitis | 11 | 0% |
| Focal segmental glomerulosclerosis | 56 | 0% |
| Foetal-maternal haemorrhage | 6 | 0% |
| Foetal anaemia | 3 | 0% |
| Foetal arrhythmia | 10 | 0% |
| Foetal biophysical profile score | 2 | 0% |
| Foetal biophysical profile score abnormal | 4 | 0% |
| Foetal cardiac arrest | 22 | 0% |
| Foetal cardiac disorder | 28 | 0% |
| Foetal cerebrovascular disorder | 2 | 0% |
| Foetal chromosome abnormality | 18 | 0% |
| Foetal cystic hygroma | 12 | 0% |
| Foetal damage | 1 | 0% |
| Foetal death | 395 | 0.02% |
| Foetal disorder | 44 | 0% |
| Foetal distress syndrome | 20 | 0% |
| Foetal exposure during pregnancy | 261 | 0.02% |
| Foetal exposure timing unspecified | 2 | 0% |
| Foetal gastrointestinal tract imaging abnormal | 1 | 0% |
| Foetal growth abnormality | 23 | 0% |
| Foetal growth restriction | 238 | 0.01% |
| Foetal haemoglobin | 3 | 0% |
| Foetal heart rate | 36 | 0% |
| Foetal heart rate abnormal | 190 | 0.01% |
| Foetal heart rate acceleration abnormality | 2 | 0% |
| Foetal heart rate deceleration abnormality | 12 | 0% |
| Foetal heart rate decreased | 25 | 0% |
| Foetal heart rate disorder | 3 | 0% |
| Foetal heart rate increased | 7 | 0% |
| Foetal heart rate indeterminate | 2 | 0% |
| Foetal heart rate normal | 4 | 0% |
| Foetal hypokinesia | 172 | 0.01% |
| Foetal macrosomia | 3 | 0% |
| Foetal malformation | 34 | 0% |
| Foetal malnutrition | 1 | 0% |
| Foetal malposition | 1 | 0% |
| Foetal megacystis | 1 | 0% |
| Foetal monitoring | 81 | 0% |
| Foetal monitoring abnormal | 4 | 0% |
| Foetal monitoring normal | 8 | 0% |
| Foetal movement disorder | 16 | 0% |
| Foetal non-stress test | 20 | 0% |
| Foetal non-stress test abnormal | 11 | 0% |
| Foetal non-stress test normal | 5 | 0% |
| Foetal placental thrombosis | 6 | 0% |
| Foetal renal imaging abnormal | 1 | 0% |
| Foetal renal impairment | 5 | 0% |
| Foetal vascular malperfusion | 22 | 0% |
| Foetal weight | 1 | 0% |
| Folate deficiency | 111 | 0.01% |
| Follicle centre lymphoma, follicular grade I, II, III | 1 | 0% |
| Follicle centre lymphoma, follicular grade I, II, III recurrent | 1 | 0% |
| Follicular cystitis | 3 | 0% |
| Follicular disorder | 3 | 0% |
| Follicular eczema | 4 | 0% |
| Follicular lymphoma | 47 | 0% |
| Follicular lymphoma stage I | 2 | 0% |
| Follicular lymphoma stage II | 4 | 0% |
| Follicular lymphoma stage III | 4 | 0% |
| Follicular lymphoma stage IV | 4 | 0% |
| Follicular mucinosis | 1 | 0% |
| Folliculitis | 124 | 0.01% |
| Fontanelle bulging | 3 | 0% |
| Food allergy | 543 | 0.03% |
| Food aversion | 105 | 0.01% |
| Food craving | 72 | 0% |
| Food intolerance | 333 | 0.02% |
| Food poisoning | 97 | 0.01% |
| Food protein-induced enterocolitis syndrome | 2 | 0% |
| Food refusal | 93 | 0.01% |
| Foot amputation | 13 | 0% |
| Foot and mouth disease | 1 | 0% |
| Foot deformity | 105 | 0.01% |
| Foot fracture | 129 | 0.01% |
| Foot operation | 19 | 0% |
| Foot prosthesis user | 1 | 0% |
| Foraminotomy | 4 | 0% |
| Forced expiratory flow | 8 | 0% |
| Forced expiratory flow decreased | 1 | 0% |
| Forced expiratory volume | 115 | 0.01% |
| Forced expiratory volume abnormal | 2 | 0% |
| Forced expiratory volume decreased | 7 | 0% |
| Forced expiratory volume increased | 7 | 0% |
| Forced vital capacity | 70 | 0% |
| Forced vital capacity decreased | 5 | 0% |
| Forced vital capacity increased | 1 | 0% |
| Forceps delivery | 5 | 0% |
| Fordyce spots | 1 | 0% |
| Forearm fracture | 7 | 0% |
| Foreign body | 11 | 0% |
| Foreign body aspiration | 2 | 0% |
| Foreign body in ear | 3 | 0% |
| Foreign body in eye | 10 | 0% |
| Foreign body in gastrointestinal tract | 10 | 0% |
| Foreign body ingestion | 5 | 0% |
| Foreign body in mouth | 1 | 0% |
| Foreign body in reproductive tract | 1 | 0% |
| Foreign body in respiratory tract | 5 | 0% |
| Foreign body in skin or subcutaneous tissue | 2 | 0% |
| Foreign body in throat | 65 | 0% |
| Foreign body in urogenital tract | 1 | 0% |
| Foreign body reaction | 6 | 0% |
| Foreign body sensation in eyes | 139 | 0.01% |
| Foreign travel | 103 | 0.01% |
| Foreskin oedema | 1 | 0% |
| Formication | 865 | 0.05% |
| Foster-Kennedy Syndrome | 1 | 0% |
| Fournier's gangrene | 8 | 0% |
| Foveal reflex abnormal | 1 | 0% |
| Fowler's position | 3 | 0% |
| Fowler's syndrome | 1 | 0% |
| Fractional excretion of sodium | 8 | 0% |
| Fractional exhaled nitric oxide | 24 | 0% |
| Fractional exhaled nitric oxide abnormal | 2 | 0% |
| Fractional flow reserve | 8 | 0% |
| Fraction of inspired oxygen | 180 | 0.01% |
| Fracture | 198 | 0.01% |
| Fracture blisters | 1 | 0% |
| Fractured coccyx | 13 | 0% |
| Fracture debridement | 2 | 0% |
| Fracture displacement | 25 | 0% |
| Fractured sacrum | 22 | 0% |
| Fractured skull depressed | 1 | 0% |
| Fracture nonunion | 2 | 0% |
| Fracture pain | 7 | 0% |
| Fracture reduction | 6 | 0% |
| Fracture treatment | 15 | 0% |
| Fragile X carrier | 1 | 0% |
| Fragile X syndrome | 2 | 0% |
| Framingham risk score | 1 | 0% |
| Francisella test | 8 | 0% |
| Free androgen index | 2 | 0% |
| Free fatty acids | 3 | 0% |
| Free haemoglobin | 7 | 0% |
| Free prostate-specific antigen | 26 | 0% |
| Free prostate-specific antigen increased | 1 | 0% |
| Free prostate-specific antigen negative | 1 | 0% |
| Free thyroxine index | 96 | 0.01% |
| Free thyroxine index decreased | 1 | 0% |
| Freezing phenomenon | 95 | 0.01% |
| Frequent bowel movements | 487 | 0.03% |
| Friedreich's ataxia | 2 | 0% |
| Frigophobia | 2 | 0% |
| Frontal lobe epilepsy | 2 | 0% |
| Frontal sinus operation | 5 | 0% |
| Frontotemporal dementia | 12 | 0% |
| Frostbite | 38 | 0% |
| Fructosamine | 2 | 0% |
| Fructose | 2 | 0% |
| Fructose intolerance | 8 | 0% |
| Frustration tolerance decreased | 240 | 0.01% |
| Fuchs' syndrome | 8 | 0% |
| Fulguration | 4 | 0% |
| Full blood count | 11,588 | 0.7% |
| Full blood count abnormal | 947 | 0.06% |
| Full blood count decreased | 30 | 0% |
| Full blood count increased | 11 | 0% |
| Full blood count normal | 3,595 | 0.22% |
| Fulminant type 1 diabetes mellitus | 21 | 0% |
| Fumbling | 9 | 0% |
| Functional endoscopic sinus surgery | 1 | 0% |
| Functional gastrointestinal disorder | 209 | 0.01% |
| Functional residual capacity | 8 | 0% |
| Functional residual capacity abnormal | 1 | 0% |
| Functional residual capacity decreased | 6 | 0% |
| Fundoscopy | 247 | 0.02% |
| Fundoscopy abnormal | 2 | 0% |
| Fundoscopy normal | 14 | 0% |
| Fundus autofluorescence | 82 | 0% |
| Fungaemia | 17 | 0% |
| Fungal balanitis | 1 | 0% |
| Fungal disease carrier | 5 | 0% |
| Fungal foot infection | 5 | 0% |
| Fungal infection | 409 | 0.02% |
| Fungal myositis | 1 | 0% |
| Fungal oesophagitis | 2 | 0% |
| Fungal peritonitis | 1 | 0% |
| Fungal pharyngitis | 1 | 0% |
| Fungal rhinitis | 1 | 0% |
| Fungal skin infection | 84 | 0.01% |
| Fungal test | 142 | 0.01% |
| Fungal test negative | 70 | 0% |
| Fungal test positive | 37 | 0% |
| Fungating wound | 4 | 0% |
| Funisitis | 5 | 0% |
| Furuncle | 282 | 0.02% |
| Fusobacterium test positive | 1 | 0% |
| Gait deviation | 17 | 0% |
| Gait disturbance | 16,503 | 1% |
| Gait inability | 4,684 | 0.28% |
| Gait spastic | 13 | 0% |
| Galactography | 1 | 0% |
| Galactorrhoea | 38 | 0% |
| Galactose intolerance | 1 | 0% |
| Galactosialidosis | 5 | 0% |
| Galactostasis | 35 | 0% |
| Galectin-3 test | 2 | 0% |
| Gallbladder adenocarcinoma | 4 | 0% |
| Gallbladder adenoma | 1 | 0% |
| Gallbladder cancer | 6 | 0% |
| Gallbladder cancer metastatic | 3 | 0% |
| Gallbladder cholesterolosis | 2 | 0% |
| Gallbladder disorder | 185 | 0.01% |
| Gallbladder enlargement | 67 | 0% |
| Gallbladder hypofunction | 7 | 0% |
| Gallbladder injury | 4 | 0% |
| Gallbladder mass | 2 | 0% |
| Gallbladder necrosis | 5 | 0% |
| Gallbladder neoplasm | 2 | 0% |
| Gallbladder obstruction | 1 | 0% |
| Gallbladder oedema | 17 | 0% |
| Gallbladder operation | 15 | 0% |
| Gallbladder polyp | 21 | 0% |
| Gallbladder rupture | 11 | 0% |
| Gallstone ileus | 1 | 0% |
| Gambling disorder | 1 | 0% |
| Gamma-glutamyltransferase | 2,515 | 0.15% |
| Gamma-glutamyltransferase abnormal | 11 | 0% |
| Gamma-glutamyltransferase decreased | 4 | 0% |
| Gamma-glutamyltransferase increased | 315 | 0.02% |
| Gamma-glutamyltransferase normal | 12 | 0% |
| Gamma interferon therapy | 4 | 0% |
| Gamma radiation therapy | 2 | 0% |
| Gamma radiation therapy to brain | 1 | 0% |
| Gamma radiation therapy to lung | 1 | 0% |
| Gammopathy | 4 | 0% |
| Ganglioneuroma | 4 | 0% |
| Gangrene | 90 | 0.01% |
| Gardnerella test | 2 | 0% |
| Gardnerella test negative | 4 | 0% |
| Gardnerella test positive | 2 | 0% |
| Gas gangrene | 5 | 0% |
| Gasping syndrome | 3 | 0% |
| Gastrectomy | 17 | 0% |
| Gastric adenoma | 1 | 0% |
| Gastric antral vascular ectasia | 15 | 0% |
| Gastric aspiration procedure | 2 | 0% |
| Gastric atony | 1 | 0% |
| Gastric banding | 4 | 0% |
| Gastric bypass | 6 | 0% |
| Gastric cancer | 31 | 0% |
| Gastric cancer stage I | 1 | 0% |
| Gastric cancer stage IV | 4 | 0% |
| Gastric dilatation | 72 | 0% |
| Gastric disorder | 445 | 0.03% |
| Gastric dysplasia | 1 | 0% |
| Gastric electrical stimulation | 1 | 0% |
| Gastric emptying study | 48 | 0% |
| Gastric fibrosis | 1 | 0% |
| Gastric fluid analysis | 1 | 0% |
| Gastric haemangioma | 1 | 0% |
| Gastric haemorrhage | 94 | 0.01% |
| Gastric hypertonia | 1 | 0% |
| Gastric hypomotility | 3 | 0% |
| Gastric infection | 25 | 0% |
| Gastric ischaemia | 3 | 0% |
| Gastric lavage | 9 | 0% |
| Gastric mucosa erythema | 7 | 0% |
| Gastric mucosal hypertrophy | 1 | 0% |
| Gastric mucosal lesion | 4 | 0% |
| Gastric neoplasm | 4 | 0% |
| Gastric occult blood positive | 3 | 0% |
| Gastric perforation | 9 | 0% |
| Gastric pH | 5 | 0% |
| Gastric pH decreased | 22 | 0% |
| Gastric pH increased | 1 | 0% |
| Gastric polyps | 18 | 0% |
| Gastric residual assessment | 2 | 0% |
| Gastric residual increased | 1 | 0% |
| Gastric stenosis | 2 | 0% |
| Gastric ulcer | 164 | 0.01% |
| Gastric ulcer haemorrhage | 32 | 0% |
| Gastric ulcer helicobacter | 4 | 0% |
| Gastric ulcer perforation | 8 | 0% |
| Gastric ulcer surgery | 2 | 0% |
| Gastric varices | 9 | 0% |
| Gastric varices haemorrhage | 4 | 0% |
| Gastric volvulus | 4 | 0% |
| Gastrin-releasing peptide precursor | 2 | 0% |
| Gastritis | 804 | 0.05% |
| Gastritis alcoholic | 3 | 0% |
| Gastritis bacterial | 3 | 0% |
| Gastritis erosive | 45 | 0% |
| Gastritis haemorrhagic | 8 | 0% |
| Gastritis herpes | 1 | 0% |
| Gastritis hypertrophic | 1 | 0% |
| Gastritis viral | 1 | 0% |
| Gastrocardiac syndrome | 2 | 0% |
| Gastroenteritis | 384 | 0.02% |
| Gastroenteritis adenovirus | 1 | 0% |
| Gastroenteritis bacterial | 4 | 0% |
| Gastroenteritis clostridial | 1 | 0% |
| Gastroenteritis cryptosporidial | 1 | 0% |
| Gastroenteritis eosinophilic | 8 | 0% |
| Gastroenteritis Escherichia coli | 14 | 0% |
| Gastroenteritis norovirus | 6 | 0% |
| Gastroenteritis proteus | 1 | 0% |
| Gastroenteritis rotavirus | 1 | 0% |
| Gastroenteritis salmonella | 3 | 0% |
| Gastroenteritis shigella | 1 | 0% |
| Gastroenteritis viral | 235 | 0.01% |
| Gastroenteritis yersinia | 2 | 0% |
| Gastroenterostomy | 8 | 0% |
| Gastrointestinal adenocarcinoma | 1 | 0% |
| Gastrointestinal anastomotic leak | 2 | 0% |
| Gastrointestinal anastomotic stenosis | 1 | 0% |
| Gastrointestinal angiectasia | 1 | 0% |
| Gastrointestinal angiodysplasia | 4 | 0% |
| Gastrointestinal arteriovenous malformation | 5 | 0% |
| Gastrointestinal bacterial infection | 8 | 0% |
| Gastrointestinal bacterial overgrowth | 37 | 0% |
| Gastrointestinal cancer metastatic | 1 | 0% |
| Gastrointestinal candidiasis | 5 | 0% |
| Gastrointestinal carcinoma | 31 | 0% |
| Gastrointestinal decompression | 11 | 0% |
| Gastrointestinal dilation procedure | 4 | 0% |
| Gastrointestinal disorder | 2,025 | 0.12% |
| Gastrointestinal disorder prophylaxis | 1 | 0% |
| Gastrointestinal endoscopic therapy | 3 | 0% |
| Gastrointestinal erosion | 5 | 0% |
| Gastrointestinal examination | 219 | 0.01% |
| Gastrointestinal examination abnormal | 2 | 0% |
| Gastrointestinal examination normal | 9 | 0% |
| Gastrointestinal fistula | 5 | 0% |
| Gastrointestinal fungal infection | 5 | 0% |
| Gastrointestinal haemorrhage | 791 | 0.05% |
| Gastrointestinal hypermotility | 24 | 0% |
| Gastrointestinal hypomotility | 29 | 0% |
| Gastrointestinal infection | 78 | 0% |
| Gastrointestinal inflammation | 255 | 0.02% |
| Gastrointestinal injury | 12 | 0% |
| Gastrointestinal ischaemia | 2 | 0% |
| Gastrointestinal lymphoma | 2 | 0% |
| Gastrointestinal malformation | 2 | 0% |
| Gastrointestinal motility disorder | 107 | 0.01% |
| Gastrointestinal mucosa hyperaemia | 4 | 0% |
| Gastrointestinal mucosal disorder | 5 | 0% |
| Gastrointestinal mucosal exfoliation | 1 | 0% |
| Gastrointestinal necrosis | 56 | 0% |
| Gastrointestinal neoplasm | 6 | 0% |
| Gastrointestinal neuroendocrine carcinoma | 1 | 0% |
| Gastrointestinal obstruction | 8 | 0% |
| Gastrointestinal oedema | 51 | 0% |
| Gastrointestinal pain | 1,157 | 0.07% |
| Gastrointestinal pathogen panel | 42 | 0% |
| Gastrointestinal perforation | 8 | 0% |
| Gastrointestinal polyp | 3 | 0% |
| Gastrointestinal polyp haemorrhage | 6 | 0% |
| Gastrointestinal scan | 17 | 0% |
| Gastrointestinal scarring | 6 | 0% |
| Gastrointestinal somatic symptom disorder | 3 | 0% |
| Gastrointestinal sounds abnormal | 175 | 0.01% |
| Gastrointestinal stoma complication | 15 | 0% |
| Gastrointestinal stoma output increased | 4 | 0% |
| Gastrointestinal stromal tumour | 7 | 0% |
| Gastrointestinal surgery | 6 | 0% |
| Gastrointestinal toxicity | 2 | 0% |
| Gastrointestinal tract biopsy | 8 | 0% |
| Gastrointestinal tract irritation | 43 | 0% |
| Gastrointestinal tube insertion | 231 | 0.01% |
| Gastrointestinal tube removal | 18 | 0% |
| Gastrointestinal ulcer | 18 | 0% |
| Gastrointestinal ulcer haemorrhage | 2 | 0% |
| Gastrointestinal vascular malformation | 1 | 0% |
| Gastrointestinal vascular malformation haemorrhagic | 1 | 0% |
| Gastrointestinal viral infection | 15 | 0% |
| Gastrointestinal wall abnormal | 1 | 0% |
| Gastrointestinal wall thickening | 92 | 0.01% |
| Gastrointestinal wall thinning | 1 | 0% |
| Gastrolithiasis | 1 | 0% |
| Gastrooesophageal cancer | 2 | 0% |
| Gastrooesophageal reflux disease | 1,858 | 0.11% |
| Gastrooesophageal sphincter insufficiency | 4 | 0% |
| Gastroparesis postoperative | 1 | 0% |
| Gastrorrhaphy | 2 | 0% |
| Gastroschisis | 6 | 0% |
| Gastrostomy | 175 | 0.01% |
| Gastrostomy tube removal | 3 | 0% |
| Gastrostomy tube site complication | 5 | 0% |
| Gated single photon emission computerised tomogram | 1 | 0% |
| Gaze palsy | 498 | 0.03% |
| Gelastic seizure | 1 | 0% |
| Gelatinous transformation of the bone marrow | 1 | 0% |
| Gender dysphoria | 2 | 0% |
| Gene mutation | 62 | 0% |
| Gene mutation identification test | 165 | 0.01% |
| Gene mutation identification test negative | 47 | 0% |
| Gene mutation identification test positive | 28 | 0% |
| General anaesthesia | 2 | 0% |
| Generalised anxiety disorder | 70 | 0% |
| Generalised bullous fixed drug eruption | 11 | 0% |
| Generalised oedema | 384 | 0.02% |
| Generalised onset non-motor seizure | 6 | 0% |
| Generalised pustular psoriasis | 1 | 0% |
| Generalised tonic-clonic seizure | 1,345 | 0.08% |
| General physical condition | 70 | 0% |
| General physical condition abnormal | 322 | 0.02% |
| General physical condition normal | 4 | 0% |
| General physical health deterioration | 4,689 | 0.29% |
| General symptom | 271 | 0.02% |
| Gene sequencing | 297 | 0.02% |
| Genetic counselling | 19 | 0% |
| Genetic polymorphism | 3 | 0% |
| Geniculate ganglionitis | 1 | 0% |
| Genital abscess | 22 | 0% |
| Genital anaesthesia | 6 | 0% |
| Genital atrophy | 2 | 0% |
| Genital blister | 29 | 0% |
| Genital burning sensation | 32 | 0% |
| Genital candidiasis | 6 | 0% |
| Genital contusion | 2 | 0% |
| Genital cyst | 3 | 0% |
| Genital discharge | 5 | 0% |
| Genital discolouration | 6 | 0% |
| Genital discomfort | 37 | 0% |
| Genital disorder | 6 | 0% |
| Genital dysaesthesia | 2 | 0% |
| Genital erosion | 1 | 0% |
| Genital erythema | 23 | 0% |
| Genital exfoliation | 1 | 0% |
| Genital haemorrhage | 242 | 0.01% |
| Genital herpes | 361 | 0.02% |
| Genital herpes simplex | 19 | 0% |
| Genital herpes zoster | 23 | 0% |
| Genital hyperaesthesia | 3 | 0% |
| Genital hypoaesthesia | 19 | 0% |
| Genital infection | 8 | 0% |
| Genital infection bacterial | 3 | 0% |
| Genital infection female | 2 | 0% |
| Genital infection fungal | 13 | 0% |
| Genital infection viral | 3 | 0% |
| Genital injury | 5 | 0% |
| Genital lesion | 23 | 0% |
| Genital macule | 1 | 0% |
| Genital neoplasm malignant female | 1 | 0% |
| Genital odour | 4 | 0% |
| Genital pain | 134 | 0.01% |
| Genital paraesthesia | 21 | 0% |
| Genital prolapse | 2 | 0% |
| Genital rash | 102 | 0.01% |
| Genital scarring | 1 | 0% |
| Genitals enlarged | 2 | 0% |
| Genital swelling | 58 | 0% |
| Genital tract inflammation | 18 | 0% |
| Genital ulceration | 96 | 0.01% |
| Genital ulcer syndrome | 5 | 0% |
| Genito-pelvic pain/penetration disorder | 6 | 0% |
| Genitourinary chlamydia infection | 1 | 0% |
| Genitourinary operation | 2 | 0% |
| Genitourinary symptom | 21 | 0% |
| Genitourinary tract infection | 5 | 0% |
| Genotoxicity | 3 | 0% |
| Genotype drug resistance test | 2 | 0% |
| Genotype drug resistance test positive | 1 | 0% |
| Geriatric assessment | 12 | 0% |
| Germ cell cancer | 1 | 0% |
| Germ cell neoplasm | 2 | 0% |
| Gerstmann's syndrome | 1 | 0% |
| Gestational age test | 1 | 0% |
| Gestational age test abnormal | 1 | 0% |
| Gestational diabetes | 88 | 0.01% |
| Gestational hypertension | 57 | 0% |
| Gestational trophoblastic detachment | 3 | 0% |
| Gestational trophoblastic tumour | 1 | 0% |
| Gianotti-Crosti syndrome | 8 | 0% |
| Giant cell arteritis | 525 | 0.03% |
| Giant cell myocarditis | 19 | 0% |
| Giant cell tumour of tendon sheath | 2 | 0% |
| Giant papillary conjunctivitis | 5 | 0% |
| Giardiasis | 5 | 0% |
| Giardia test | 13 | 0% |
| Giardia test negative | 20 | 0% |
| Giardia test positive | 1 | 0% |
| Gilbert's syndrome | 19 | 0% |
| Gingival abscess | 21 | 0% |
| Gingival atrophy | 2 | 0% |
| Gingival bleeding | 640 | 0.04% |
| Gingival blister | 61 | 0% |
| Gingival cancer | 1 | 0% |
| Gingival cyst | 1 | 0% |
| Gingival discolouration | 29 | 0% |
| Gingival discomfort | 87 | 0.01% |
| Gingival disorder | 60 | 0% |
| Gingival erosion | 4 | 0% |
| Gingival erythema | 59 | 0% |
| Gingival hypertrophy | 3 | 0% |
| Gingival injury | 8 | 0% |
| Gingival oedema | 10 | 0% |
| Gingival operation | 1 | 0% |
| Gingival pain | 619 | 0.04% |
| Gingival pruritus | 20 | 0% |
| Gingival recession | 28 | 0% |
| Gingival swelling | 394 | 0.02% |
| Gingival ulceration | 23 | 0% |
| Gingivitis | 174 | 0.01% |
| Gingivitis ulcerative | 9 | 0% |
| Glabellar reflex abnormal | 1 | 0% |
| Glare | 30 | 0% |
| Glassy eyes | 149 | 0.01% |
| Glaucoma | 250 | 0.02% |
| Glaucoma drainage device placement | 3 | 0% |
| Glaucomatocyclitic crises | 6 | 0% |
| Gleason grading score | 9 | 0% |
| Glial scar | 1 | 0% |
| Glioblastoma | 68 | 0% |
| Glioblastoma multiforme | 22 | 0% |
| Glioma | 14 | 0% |
| Gliosis | 32 | 0% |
| Globulin | 226 | 0.01% |
| Globulin abnormal | 3 | 0% |
| Globulins decreased | 15 | 0% |
| Globulins increased | 77 | 0% |
| Globulinuria | 1 | 0% |
| Glomerular filtration rate | 3,120 | 0.19% |
| Glomerular filtration rate abnormal | 17 | 0% |
| Glomerular filtration rate decreased | 827 | 0.05% |
| Glomerular filtration rate increased | 55 | 0% |
| Glomerular filtration rate normal | 501 | 0.03% |
| Glomerulonephritis | 169 | 0.01% |
| Glomerulonephritis acute | 20 | 0% |
| Glomerulonephritis chronic | 13 | 0% |
| Glomerulonephritis membranoproliferative | 12 | 0% |
| Glomerulonephritis membranous | 87 | 0.01% |
| Glomerulonephritis minimal lesion | 139 | 0.01% |
| Glomerulonephritis proliferative | 6 | 0% |
| Glomerulonephritis rapidly progressive | 90 | 0.01% |
| Glomerulonephropathy | 5 | 0% |
| Glomerulosclerosis | 9 | 0% |
| Glomus tumour | 1 | 0% |
| Glossectomy | 4 | 0% |
| Glossitis | 246 | 0.01% |
| Glossodynia | 941 | 0.06% |
| Glossopharyngeal nerve disorder | 4 | 0% |
| Glossopharyngeal nerve paralysis | 2 | 0% |
| Glossopharyngeal neuralgia | 16 | 0% |
| Glossoptosis | 7 | 0% |
| Glottal incompetence | 1 | 0% |
| Glucagon tolerance test | 1 | 0% |
| Glucocorticoid deficiency | 10 | 0% |
| Glucocorticoids abnormal | 1 | 0% |
| Glucocorticoids normal | 2 | 0% |
| Glucose-6-phosphate dehydrogenase | 17 | 0% |
| Glucose-6-phosphate dehydrogenase abnormal | 1 | 0% |
| Glucose-6-phosphate dehydrogenase deficiency | 10 | 0% |
| Glucose-6-phosphate dehydrogenase normal | 5 | 0% |
| Glucose tolerance impaired | 125 | 0.01% |
| Glucose tolerance impaired in pregnancy | 1 | 0% |
| Glucose tolerance test | 152 | 0.01% |
| Glucose tolerance test abnormal | 5 | 0% |
| Glucose tolerance test normal | 11 | 0% |
| Glucose urine | 199 | 0.01% |
| Glucose urine absent | 223 | 0.01% |
| Glucose urine present | 67 | 0% |
| Glutamate dehydrogenase | 11 | 0% |
| Glutamate dehydrogenase increased | 1 | 0% |
| Glutamate dehydrogenase level abnormal | 1 | 0% |
| Glutathione decreased | 2 | 0% |
| Glutathione test | 3 | 0% |
| Gluten free diet | 7 | 0% |
| Gluten sensitivity | 80 | 0% |
| Glycated albumin | 12 | 0% |
| Glycated albumin increased | 1 | 0% |
| Glycine test | 3 | 0% |
| Glycogen storage disease type I | 1 | 0% |
| Glycogen storage disease type II | 1 | 0% |
| Glycogen storage disease type V | 4 | 0% |
| Glycogen storage disorder | 1 | 0% |
| Glycolysis increased | 2 | 0% |
| Glycopenia | 1 | 0% |
| Glycosuria | 10 | 0% |
| Glycosylated haemoglobin | 2,248 | 0.14% |
| Glycosylated haemoglobin abnormal | 9 | 0% |
| Glycosylated haemoglobin decreased | 19 | 0% |
| Glycosylated haemoglobin increased | 681 | 0.04% |
| Glycosylated haemoglobin normal | 326 | 0.02% |
| GM2 gangliosidosis | 3 | 0% |
| Gnathoschisis | 2 | 0% |
| Goitre | 387 | 0.02% |
| Gomori methenamine silver stain | 5 | 0% |
| Gonadotrophin deficiency | 1 | 0% |
| Gonadotrophin releasing hormone stimulation test | 1 | 0% |
| Gonioscopy | 8 | 0% |
| Gonococcal infection | 2 | 0% |
| Gonorrhoea | 16 | 0% |
| Goodpasture's syndrome | 12 | 0% |
| Good syndrome | 2 | 0% |
| Gout | 901 | 0.05% |
| Gouty arthritis | 22 | 0% |
| Gouty tophus | 8 | 0% |
| Graft complication | 1 | 0% |
| Graft haemorrhage | 1 | 0% |
| Graft thrombosis | 3 | 0% |
| Graft versus host disease | 17 | 0% |
| Graft versus host disease in eye | 1 | 0% |
| Graft versus host disease in liver | 1 | 0% |
| Graft versus host disease in lung | 1 | 0% |
| Graft versus host disease in skin | 1 | 0% |
| Gram stain | 116 | 0.01% |
| Gram stain negative | 46 | 0% |
| Gram stain positive | 83 | 0.01% |
| Grandiosity | 2 | 0% |
| Granulocyte-colony stimulating factor level normal | 1 | 0% |
| Granulocyte-colony stimulating factor test | 1 | 0% |
| Granulocyte count | 219 | 0.01% |
| Granulocyte count decreased | 12 | 0% |
| Granulocyte count increased | 21 | 0% |
| Granulocyte percentage | 193 | 0.01% |
| Granulocyte percentage increased | 2 | 0% |
| Granulocytes abnormal | 17 | 0% |
| Granulocytes maturation arrest | 2 | 0% |
| Granulocytopenia | 8 | 0% |
| Granulocytosis | 4 | 0% |
| Granuloma | 97 | 0.01% |
| Granuloma annulare | 149 | 0.01% |
| Granuloma skin | 10 | 0% |
| Granulomatosis with polyangiitis | 115 | 0.01% |
| Granulomatous dermatitis | 5 | 0% |
| Granulomatous liver disease | 9 | 0% |
| Granulomatous lymphadenitis | 7 | 0% |
| Granulomatous rosacea | 1 | 0% |
| Graves' disease | 137 | 0.01% |
| Gravitational oedema | 25 | 0% |
| Greater trochanteric pain syndrome | 11 | 0% |
| Great saphenous vein closure | 1 | 0% |
| Greenstick fracture | 1 | 0% |
| Grey matter heterotopia | 3 | 0% |
| Grief reaction | 16 | 0% |
| Grimacing | 24 | 0% |
| Grip strength | 114 | 0.01% |
| Grip strength decreased | 986 | 0.06% |
| Groin abscess | 34 | 0% |
| Groin infection | 9 | 0% |
| Groin pain | 1,103 | 0.07% |
| Gross motor delay | 18 | 0% |
| Group B streptococcus neonatal sepsis | 3 | 0% |
| Growing pains | 24 | 0% |
| Growth accelerated | 2 | 0% |
| Growth disorder | 6 | 0% |
| Growth failure | 3 | 0% |
| Growth hormone deficiency | 5 | 0% |
| Growth of eyelashes | 3 | 0% |
| Growth retardation | 8 | 0% |
| Grunting | 58 | 0% |
| Guillain-Barre syndrome | 3,643 | 0.22% |
| Gulf war syndrome | 1 | 0% |
| Gun shot wound | 12 | 0% |
| Gustometry | 1 | 0% |
| Gut fermentation syndrome | 2 | 0% |
| Guthrie test | 1 | 0% |
| Guttate psoriasis | 92 | 0.01% |
| Gynaecological examination | 926 | 0.06% |
| Gynaecological examination abnormal | 13 | 0% |
| Gynaecological examination normal | 26 | 0% |
| Gynaecomastia | 56 | 0% |
| H1N1 influenza | 7 | 0% |
| Habit cough | 18 | 0% |
| Habitual abortion | 8 | 0% |
| Haemangioblastoma | 3 | 0% |
| Haemangioma | 105 | 0.01% |
| Haemangioma-thrombocytopenia syndrome | 1 | 0% |
| Haemangioma congenital | 2 | 0% |
| Haemangioma of bone | 9 | 0% |
| Haemangioma of breast | 2 | 0% |
| Haemangioma of liver | 43 | 0% |
| Haemangioma of skin | 30 | 0% |
| Haemangioma of spleen | 3 | 0% |
| Haemangioma rupture | 2 | 0% |
| Haemangiopericytoma | 1 | 0% |
| Haemarthrosis | 65 | 0% |
| Haematemesis | 774 | 0.05% |
| Haematidrosis | 3 | 0% |
| Haematinuria | 4 | 0% |
| Haematochezia | 1,756 | 0.11% |
| Haematocrit | 2,444 | 0.15% |
| Haematocrit abnormal | 21 | 0% |
| Haematocrit decreased | 1,097 | 0.07% |
| Haematocrit increased | 175 | 0.01% |
| Haematocrit normal | 857 | 0.05% |
| Haematological infection | 7 | 0% |
| Haematological malignancy | 16 | 0% |
| Haematological neoplasm | 1 | 0% |
| Haematology test | 508 | 0.03% |
| Haematology test abnormal | 38 | 0% |
| Haematology test normal | 37 | 0% |
| Haematoma | 1,674 | 0.1% |
| Haematoma evacuation | 20 | 0% |
| Haematoma infection | 8 | 0% |
| Haematoma muscle | 57 | 0% |
| Haematopoietic neoplasm | 3 | 0% |
| Haematosalpinx | 5 | 0% |
| Haematospermia | 41 | 0% |
| Haematotympanum | 5 | 0% |
| Haematuria | 1,441 | 0.09% |
| Haematuria traumatic | 1 | 0% |
| Haemobilia | 2 | 0% |
| Haemochromatosis | 26 | 0% |
| Haemoconcentration | 12 | 0% |
| Haemodialysis | 263 | 0.02% |
| Haemodialysis complication | 2 | 0% |
| Haemodilution | 3 | 0% |
| Haemodynamic instability | 98 | 0.01% |
| Haemodynamic rebound | 1 | 0% |
| Haemodynamic test | 215 | 0.01% |
| Haemodynamic test abnormal | 2 | 0% |
| Haemodynamic test normal | 16 | 0% |
| Haemofiltration | 95 | 0.01% |
| Haemoglobin | 7,509 | 0.46% |
| Haemoglobin A2 | 2 | 0% |
| Haemoglobin A absent | 2 | 0% |
| Haemoglobin abnormal | 52 | 0% |
| Haemoglobinaemia | 17 | 0% |
| Haemoglobin A present | 2 | 0% |
| Haemoglobin C | 3 | 0% |
| Haemoglobin decreased | 2,932 | 0.18% |
| Haemoglobin distribution width | 41 | 0% |
| Haemoglobin distribution width increased | 1 | 0% |
| Haemoglobin E | 6 | 0% |
| Haemoglobin electrophoresis | 15 | 0% |
| Haemoglobin increased | 198 | 0.01% |
| Haemoglobin normal | 1,178 | 0.07% |
| Haemoglobinopathy | 1 | 0% |
| Haemoglobin S | 4 | 0% |
| Haemoglobinuria | 14 | 0% |
| Haemoglobin urine | 62 | 0% |
| Haemoglobin urine absent | 35 | 0% |
| Haemoglobin urine present | 47 | 0% |
| Haemolysis | 191 | 0.01% |
| Haemolytic anaemia | 199 | 0.01% |
| Haemolytic transfusion reaction | 1 | 0% |
| Haemolytic uraemic syndrome | 15 | 0% |
| Haemoperitoneum | 40 | 0% |
| Haemophagocytic lymphohistiocytosis | 179 | 0.01% |
| Haemophilia | 16 | 0% |
| Haemophilia A with anti factor VIII | 1 | 0% |
| Haemophilia carrier | 1 | 0% |
| Haemophilic arthropathy | 2 | 0% |
| Haemophilus infection | 22 | 0% |
| Haemophilus test | 39 | 0% |
| Haemophilus test positive | 21 | 0% |
| Haemophobia | 5 | 0% |
| Haemoptysis | 1,188 | 0.07% |
| Haemorrhage | 4,479 | 0.27% |
| Haemorrhage coronary artery | 2 | 0% |
| Haemorrhage foetal | 4 | 0% |
| Haemorrhage in pregnancy | 175 | 0.01% |
| Haemorrhage intracranial | 240 | 0.01% |
| Haemorrhage neonatal | 4 | 0% |
| Haemorrhage subcutaneous | 357 | 0.02% |
| Haemorrhage subepidermal | 5 | 0% |
| Haemorrhage urinary tract | 251 | 0.02% |
| Haemorrhagic arteriovenous malformation | 3 | 0% |
| Haemorrhagic ascites | 2 | 0% |
| Haemorrhagic breast cyst | 3 | 0% |
| Haemorrhagic cerebellar infarction | 1 | 0% |
| Haemorrhagic cerebral infarction | 31 | 0% |
| Haemorrhagic cyst | 20 | 0% |
| Haemorrhagic diathesis | 133 | 0.01% |
| Haemorrhagic disorder | 73 | 0% |
| Haemorrhagic erosive gastritis | 2 | 0% |
| Haemorrhagic fever with renal syndrome | 2 | 0% |
| Haemorrhagic infarction | 24 | 0% |
| Haemorrhagic necrotic pancreatitis | 1 | 0% |
| Haemorrhagic ovarian cyst | 46 | 0% |
| Haemorrhagic pneumonia | 5 | 0% |
| Haemorrhagic stroke | 400 | 0.02% |
| Haemorrhagic thyroid cyst | 2 | 0% |
| Haemorrhagic transformation stroke | 45 | 0% |
| Haemorrhagic urticaria | 5 | 0% |
| Haemorrhagic varicella syndrome | 1 | 0% |
| Haemorrhagic vasculitis | 7 | 0% |
| Haemorrhoidal haemorrhage | 48 | 0% |
| Haemorrhoid infection | 2 | 0% |
| Haemorrhoid operation | 13 | 0% |
| Haemorrhoids | 362 | 0.02% |
| Haemorrhoids thrombosed | 117 | 0.01% |
| Haemosiderin stain | 5 | 0% |
| Haemosiderosis | 5 | 0% |
| Haemostasis | 167 | 0.01% |
| Haemothorax | 42 | 0% |
| Hair colour changes | 33 | 0% |
| Hair disorder | 49 | 0% |
| Hair dye user | 1 | 0% |
| Hair follicle tumour benign | 7 | 0% |
| Hair growth abnormal | 48 | 0% |
| Hair growth rate abnormal | 6 | 0% |
| Hair injury | 9 | 0% |
| Hair pull test | 2 | 0% |
| Hair texture abnormal | 58 | 0% |
| Hairy cell leukaemia | 4 | 0% |
| Hallucination | 2,549 | 0.16% |
| Hallucination, auditory | 281 | 0.02% |
| Hallucination, gustatory | 5 | 0% |
| Hallucination, olfactory | 89 | 0.01% |
| Hallucination, tactile | 14 | 0% |
| Hallucination, visual | 435 | 0.03% |
| Hallucinations, mixed | 79 | 0% |
| Halo vision | 50 | 0% |
| Hamartoma | 4 | 0% |
| Hand-arm vibration syndrome | 8 | 0% |
| Hand-eye coordination impaired | 25 | 0% |
| Hand-foot-and-mouth disease | 33 | 0% |
| Hand amputation | 1 | 0% |
| Hand deformity | 73 | 0% |
| Hand dermatitis | 87 | 0.01% |
| Hand fracture | 46 | 0% |
| Hand repair operation | 1 | 0% |
| Hanging | 3 | 0% |
| Hangnail | 3 | 0% |
| Hangover | 296 | 0.02% |
| Hantaviral infection | 2 | 0% |
| Hantavirus pulmonary infection | 2 | 0% |
| Hantavirus test positive | 1 | 0% |
| Haphephobia | 1 | 0% |
| Haptoglobin | 306 | 0.02% |
| Haptoglobin abnormal | 1 | 0% |
| Haptoglobin decreased | 35 | 0% |
| Haptoglobin increased | 9 | 0% |
| Haptoglobin normal | 22 | 0% |
| Harlequin syndrome | 1 | 0% |
| Hashimoto's encephalopathy | 14 | 0% |
| Hashitoxicosis | 1 | 0% |
| HCoV-OC43 infection | 2 | 0% |
| Headache | 238,662 | 14.51% |
| Head and neck cancer | 1 | 0% |
| Head and neck cancer metastatic | 1 | 0% |
| Head banging | 65 | 0% |
| Head circumference | 42 | 0% |
| Head circumference abnormal | 2 | 0% |
| Head circumference normal | 1 | 0% |
| Head deformity | 8 | 0% |
| Head discomfort | 5,949 | 0.36% |
| Head impulse test | 58 | 0% |
| Head injury | 3,215 | 0.2% |
| Head lag | 18 | 0% |
| Head lag abnormal | 1 | 0% |
| Head titubation | 158 | 0.01% |
| Hearing aid therapy | 14 | 0% |
| Hearing aid user | 92 | 0.01% |
| Hearing disability | 40 | 0% |
| Heart alternation | 17 | 0% |
| Heart disease congenital | 62 | 0% |
| Heart failure with preserved ejection fraction | 3 | 0% |
| Heart failure with reduced ejection fraction | 3 | 0% |
| Heart injury | 66 | 0% |
| Heart rate | 26,270 | 1.6% |
| Heart rate abnormal | 1,154 | 0.07% |
| Heart rate decreased | 2,419 | 0.15% |
| Heart rate increased | 23,260 | 1.41% |
| Heart rate irregular | 3,979 | 0.24% |
| Heart rate normal | 136 | 0.01% |
| Heart rate variability decreased | 20 | 0% |
| Heart rate variability increased | 25 | 0% |
| Heart rate variability test | 33 | 0% |
| Heart sounds | 408 | 0.02% |
| Heart sounds abnormal | 96 | 0.01% |
| Heart sounds normal | 12 | 0% |
| Heart transplant | 9 | 0% |
| Heart transplant rejection | 5 | 0% |
| Heart valve calcification | 11 | 0% |
| Heart valve incompetence | 146 | 0.01% |
| Heart valve operation | 11 | 0% |
| Heart valve replacement | 15 | 0% |
| Heart valve stenosis | 5 | 0% |
| Heat cramps | 7 | 0% |
| Heat exhaustion | 30 | 0% |
| Heat illness | 46 | 0% |
| Heat oedema | 14 | 0% |
| Heat stroke | 55 | 0% |
| Heat therapy | 19 | 0% |
| Heavy exposure to ultraviolet light | 6 | 0% |
| Heavy menstrual bleeding | 16,333 | 0.99% |
| Heavy metal increased | 2 | 0% |
| Heavy metal normal | 10 | 0% |
| Heavy metal test | 18 | 0% |
| Heel-knee-shin test abnormal | 3 | 0% |
| Heerfordt's syndrome | 3 | 0% |
| Heinz bodies | 1 | 0% |
| Helicobacter gastritis | 17 | 0% |
| Helicobacter infection | 74 | 0% |
| Helicobacter test | 166 | 0.01% |
| Helicobacter test negative | 59 | 0% |
| Helicobacter test positive | 26 | 0% |
| Heliotrope rash | 3 | 0% |
| HELLP syndrome | 27 | 0% |
| Helminthic infection | 9 | 0% |
| Helplessness | 38 | 0% |
| Hemianaesthesia | 357 | 0.02% |
| Hemianopia | 124 | 0.01% |
| Hemianopia heteronymous | 3 | 0% |
| Hemianopia homonymous | 76 | 0% |
| Hemiapraxia | 5 | 0% |
| Hemiasomatognosia | 4 | 0% |
| Hemiataxia | 25 | 0% |
| Hemidysaesthesia | 55 | 0% |
| Hemihyperaesthesia | 26 | 0% |
| Hemihypoaesthesia | 242 | 0.01% |
| Hemiparaesthesia | 602 | 0.04% |
| Hemiparesis | 3,266 | 0.2% |
| Hemiplegia | 1,335 | 0.08% |
| Hemiplegic migraine | 134 | 0.01% |
| Henoch-Schonlein purpura | 274 | 0.02% |
| Henoch-Schonlein purpura nephritis | 8 | 0% |
| Heparin-induced thrombocytopenia | 50 | 0% |
| Heparin-induced thrombocytopenia test | 233 | 0.01% |
| Heparin-induced thrombocytopenia test positive | 33 | 0% |
| Hepatectomy | 11 | 0% |
| Hepatic adenoma | 5 | 0% |
| Hepatic amoebiasis | 1 | 0% |
| Hepatic angiogram | 1 | 0% |
| Hepatic angiosarcoma | 1 | 0% |
| Hepatic artery aneurysm | 1 | 0% |
| Hepatic artery embolism | 2 | 0% |
| Hepatic artery stenosis | 1 | 0% |
| Hepatic artery thrombosis | 11 | 0% |
| Hepatic atrophy | 5 | 0% |
| Hepatic calcification | 6 | 0% |
| Hepatic cancer | 60 | 0% |
| Hepatic cancer metastatic | 15 | 0% |
| Hepatic cancer recurrent | 2 | 0% |
| Hepatic cancer stage IV | 3 | 0% |
| Hepatic cirrhosis | 238 | 0.01% |
| Hepatic cyst | 130 | 0.01% |
| Hepatic cyst infection | 1 | 0% |
| Hepatic cytolysis | 300 | 0.02% |
| Hepatic embolisation | 3 | 0% |
| Hepatic encephalopathy | 71 | 0% |
| Hepatic enzyme | 462 | 0.03% |
| Hepatic enzyme abnormal | 166 | 0.01% |
| Hepatic enzyme decreased | 4 | 0% |
| Hepatic enzyme increased | 894 | 0.05% |
| Hepatic failure | 224 | 0.01% |
| Hepatic fibrosis | 19 | 0% |
| Hepatic fibrosis marker test | 9 | 0% |
| Hepatic function abnormal | 439 | 0.03% |
| Hepatic haematoma | 4 | 0% |
| Hepatic haemorrhage | 12 | 0% |
| Hepatic hydrothorax | 2 | 0% |
| Hepatic hypertrophy | 4 | 0% |
| Hepatic hypoperfusion | 1 | 0% |
| Hepatic infarction | 21 | 0% |
| Hepatic infection | 9 | 0% |
| Hepatic ischaemia | 3 | 0% |
| Hepatic lesion | 106 | 0.01% |
| Hepatic lymphocytic infiltration | 2 | 0% |
| Hepatic mass | 90 | 0.01% |
| Hepatic necrosis | 14 | 0% |
| Hepatic neoplasm | 27 | 0% |
| Hepatic pain | 295 | 0.02% |
| Hepatic perfusion disorder | 4 | 0% |
| Hepatic rupture | 5 | 0% |
| Hepatic steatosis | 398 | 0.02% |
| Hepatic vascular disorder | 2 | 0% |
| Hepatic vascular thrombosis | 10 | 0% |
| Hepatic vein dilatation | 2 | 0% |
| Hepatic vein occlusion | 2 | 0% |
| Hepatic vein thrombosis | 38 | 0% |
| Hepatic venous pressure gradient | 1 | 0% |
| Hepatitis | 546 | 0.03% |
| Hepatitis A | 69 | 0% |
| Hepatitis A antibody | 136 | 0.01% |
| Hepatitis A antibody negative | 17 | 0% |
| Hepatitis A antibody normal | 4 | 0% |
| Hepatitis A antibody positive | 12 | 0% |
| Hepatitis A antigen negative | 6 | 0% |
| Hepatitis acute | 189 | 0.01% |
| Hepatitis A immunisation | 1 | 0% |
| Hepatitis alcoholic | 20 | 0% |
| Hepatitis A virus test | 283 | 0.02% |
| Hepatitis A virus test positive | 5 | 0% |
| Hepatitis B | 197 | 0.01% |
| Hepatitis B antibody | 148 | 0.01% |
| Hepatitis B antibody negative | 12 | 0% |
| Hepatitis B antibody normal | 2 | 0% |
| Hepatitis B antibody positive | 4 | 0% |
| Hepatitis B antigen | 41 | 0% |
| Hepatitis B antigen positive | 2 | 0% |
| Hepatitis B core antibody | 120 | 0.01% |
| Hepatitis B core antibody negative | 35 | 0% |
| Hepatitis B core antibody positive | 8 | 0% |
| Hepatitis B core antigen | 7 | 0% |
| Hepatitis B DNA assay | 23 | 0% |
| Hepatitis B DNA assay negative | 2 | 0% |
| Hepatitis B DNA assay positive | 3 | 0% |
| Hepatitis B DNA decreased | 1 | 0% |
| Hepatitis B DNA increased | 2 | 0% |
| Hepatitis B e antibody | 5 | 0% |
| Hepatitis B e antigen | 10 | 0% |
| Hepatitis B immunisation | 5 | 0% |
| Hepatitis B reactivation | 12 | 0% |
| Hepatitis B surface antibody | 107 | 0.01% |
| Hepatitis B surface antibody negative | 13 | 0% |
| Hepatitis B surface antibody positive | 13 | 0% |
| Hepatitis B surface antigen | 289 | 0.02% |
| Hepatitis B surface antigen negative | 38 | 0% |
| Hepatitis B surface antigen positive | 6 | 0% |
| Hepatitis B test negative | 83 | 0.01% |
| Hepatitis B virus test | 1,069 | 0.07% |
| Hepatitis B virus test positive | 6 | 0% |
| Hepatitis C | 216 | 0.01% |
| Hepatitis C antibody | 332 | 0.02% |
| Hepatitis C antibody negative | 67 | 0% |
| Hepatitis C antibody positive | 14 | 0% |
| Hepatitis C core antibody | 9 | 0% |
| Hepatitis C core antibody negative | 2 | 0% |
| Hepatitis cholestatic | 41 | 0% |
| Hepatitis chronic active | 2 | 0% |
| Hepatitis C RNA | 60 | 0% |
| Hepatitis C RNA increased | 1 | 0% |
| Hepatitis C RNA negative | 3 | 0% |
| Hepatitis C RNA positive | 2 | 0% |
| Hepatitis C test negative | 105 | 0.01% |
| Hepatitis C virus core antigen | 15 | 0% |
| Hepatitis C virus test | 1,123 | 0.07% |
| Hepatitis C virus test positive | 12 | 0% |
| Hepatitis D | 2 | 0% |
| Hepatitis D antibody | 2 | 0% |
| Hepatitis D virus test | 11 | 0% |
| Hepatitis E | 50 | 0% |
| Hepatitis E antibody | 50 | 0% |
| Hepatitis E antibody negative | 1 | 0% |
| Hepatitis E antigen | 2 | 0% |
| Hepatitis E virus test | 136 | 0.01% |
| Hepatitis E virus test positive | 2 | 0% |
| Hepatitis fulminant | 16 | 0% |
| Hepatitis infectious mononucleosis | 16 | 0% |
| Hepatitis neonatal | 1 | 0% |
| Hepatitis toxic | 22 | 0% |
| Hepatitis viral | 33 | 0% |
| Hepatitis viral test | 222 | 0.01% |
| Hepatitis viral test negative | 130 | 0.01% |
| Hepatitis viral test positive | 3 | 0% |
| Hepato-lenticular degeneration | 1 | 0% |
| Hepatobiliary cyst | 2 | 0% |
| Hepatobiliary disease | 1 | 0% |
| Hepatobiliary scan | 86 | 0.01% |
| Hepatobiliary scan abnormal | 18 | 0% |
| Hepatobiliary scan normal | 10 | 0% |
| Hepatocellular carcinoma | 36 | 0% |
| Hepatocellular injury | 55 | 0% |
| Hepatojugular reflux | 9 | 0% |
| Hepatomegaly | 266 | 0.02% |
| Hepatopulmonary syndrome | 1 | 0% |
| Hepatorenal failure | 2 | 0% |
| Hepatorenal syndrome | 18 | 0% |
| Hepatosplenomegaly | 66 | 0% |
| Hepatotoxicity | 19 | 0% |
| HER2 negative breast cancer | 3 | 0% |
| HER2 positive breast cancer | 12 | 0% |
| HER2 protein overexpression | 1 | 0% |
| Hereditary alpha tryptasaemia | 1 | 0% |
| Hereditary angioedema | 24 | 0% |
| Hereditary angioedema with C1 esterase inhibitor deficiency | 1 | 0% |
| Hereditary angioedema with normal C1 esterase inhibitor | 1 | 0% |
| Hereditary ataxia | 8 | 0% |
| Hereditary haemolytic anaemia | 1 | 0% |
| Hereditary haemorrhagic telangiectasia | 3 | 0% |
| Hereditary motor and sensory neuropathy | 11 | 0% |
| Hereditary neuropathy with liability to pressure palsies | 3 | 0% |
| Hereditary non-polyposis colorectal cancer syndrome | 1 | 0% |
| Hereditary optic atrophy | 4 | 0% |
| Hereditary spherocytosis | 4 | 0% |
| Hernia | 109 | 0.01% |
| Hernia congenital | 1 | 0% |
| Hernia hiatus repair | 4 | 0% |
| Hernial eventration | 1 | 0% |
| Hernia pain | 12 | 0% |
| Hernia perforation | 1 | 0% |
| Hernia repair | 26 | 0% |
| Herpangina | 8 | 0% |
| Herpes dermatitis | 40 | 0% |
| Herpes gestationis | 8 | 0% |
| Herpes oesophagitis | 1 | 0% |
| Herpes ophthalmic | 310 | 0.02% |
| Herpes pharyngitis | 6 | 0% |
| Herpes sepsis | 2 | 0% |
| Herpes simplex | 626 | 0.04% |
| Herpes simplex encephalitis | 34 | 0% |
| Herpes simplex gastritis | 1 | 0% |
| Herpes simplex hepatitis | 3 | 0% |
| Herpes simplex meningitis | 7 | 0% |
| Herpes simplex meningoencephalitis | 5 | 0% |
| Herpes simplex oesophagitis | 2 | 0% |
| Herpes simplex pharyngitis | 2 | 0% |
| Herpes simplex reactivation | 65 | 0% |
| Herpes simplex test | 541 | 0.03% |
| Herpes simplex test negative | 185 | 0.01% |
| Herpes simplex test positive | 78 | 0% |
| Herpes simplex viraemia | 3 | 0% |
| Herpes virus infection | 589 | 0.04% |
| Herpes virus test | 228 | 0.01% |
| Herpes virus test abnormal | 5 | 0% |
| Herpes zoster | 14,522 | 0.88% |
| Herpes zoster cutaneous disseminated | 62 | 0% |
| Herpes zoster disseminated | 27 | 0% |
| Herpes zoster immunisation | 1 | 0% |
| Herpes zoster infection neurological | 37 | 0% |
| Herpes zoster meningitis | 71 | 0% |
| Herpes zoster meningoencephalitis | 38 | 0% |
| Herpes zoster meningomyelitis | 4 | 0% |
| Herpes zoster meningoradiculitis | 8 | 0% |
| Herpes zoster necrotising retinopathy | 1 | 0% |
| Herpes zoster oticus | 334 | 0.02% |
| Herpes zoster pharyngitis | 6 | 0% |
| Herpes zoster reactivation | 147 | 0.01% |
| Herpetic radiculopathy | 4 | 0% |
| Heterogeneous testis | 1 | 0% |
| Heteronymous diplopia | 1 | 0% |
| Heterophoria | 18 | 0% |
| Heterotaxia | 4 | 0% |
| Hiatus hernia | 286 | 0.02% |
| Hiccups | 243 | 0.01% |
| Hidradenitis | 156 | 0.01% |
| High-grade B-cell lymphoma | 3 | 0% |
| High-pitched crying | 4 | 0% |
| High-resolution computerised tomogram of lung | 70 | 0% |
| High density lipoprotein | 1,087 | 0.07% |
| High density lipoprotein abnormal | 1 | 0% |
| High density lipoprotein decreased | 108 | 0.01% |
| High density lipoprotein increased | 32 | 0% |
| High density lipoprotein normal | 63 | 0% |
| High foetal head | 1 | 0% |
| High frequency ablation | 11 | 0% |
| High grade B-cell lymphoma Burkitt-like lymphoma | 1 | 0% |
| High intensity focused ultrasound | 1 | 0% |
| High risk pregnancy | 19 | 0% |
| High risk sexual behaviour | 1 | 0% |
| Hilar lymphadenopathy | 126 | 0.01% |
| Hip arthroplasty | 122 | 0.01% |
| Hip deformity | 4 | 0% |
| Hip disarticulation | 1 | 0% |
| Hip fracture | 232 | 0.01% |
| Hippocampal atrophy | 7 | 0% |
| Hippocampal sclerosis | 5 | 0% |
| Hippus | 1 | 0% |
| Hip surgery | 41 | 0% |
| Hirsutism | 16 | 0% |
| Histamine abnormal | 25 | 0% |
| Histamine intolerance | 185 | 0.01% |
| Histamine level | 100 | 0.01% |
| Histamine level increased | 44 | 0% |
| Histamine normal | 4 | 0% |
| Histamine release test | 8 | 0% |
| Histiocytic necrotising lymphadenitis | 29 | 0% |
| Histiocytosis | 5 | 0% |
| Histology | 871 | 0.05% |
| Histology abnormal | 8 | 0% |
| Histology normal | 6 | 0% |
| Histone antibody | 29 | 0% |
| Histone antibody negative | 2 | 0% |
| Histone antibody positive | 10 | 0% |
| Histoplasmosis | 9 | 0% |
| Histoplasmosis disseminated | 1 | 0% |
| Histrionic personality disorder | 1 | 0% |
| HIV-2 infection | 1 | 0% |
| HIV-associated neurocognitive disorder | 2 | 0% |
| HIV antibody | 326 | 0.02% |
| HIV antibody negative | 57 | 0% |
| HIV antibody positive | 3 | 0% |
| HIV antigen | 79 | 0% |
| HIV antigen negative | 29 | 0% |
| HIV antigen positive | 2 | 0% |
| HIV infection | 58 | 0% |
| HIV infection CDC category C | 1 | 0% |
| HIV peripheral neuropathy | 1 | 0% |
| HIV test | 1,679 | 0.1% |
| HIV test false positive | 19 | 0% |
| HIV test negative | 271 | 0.02% |
| HIV test positive | 32 | 0% |
| HIV viraemia | 1 | 0% |
| HLA-B*27 assay | 168 | 0.01% |
| HLA-B*27 positive | 34 | 0% |
| HLA-B*1502 assay | 3 | 0% |
| HLA-B*5701 assay | 1 | 0% |
| HLA-B*5801 assay | 1 | 0% |
| HLA-B gene status assay | 10 | 0% |
| HLA marker study | 181 | 0.01% |
| HLA marker study positive | 11 | 0% |
| Hodgkin's disease | 89 | 0.01% |
| Hodgkin's disease lymphocyte predominance type stage unspecified | 1 | 0% |
| Hodgkin's disease mixed cellularity stage unspecified | 2 | 0% |
| Hodgkin's disease nodular sclerosis stage II | 1 | 0% |
| Hodgkin's disease nodular sclerosis stage III | 1 | 0% |
| Hodgkin's disease nodular sclerosis stage IV | 1 | 0% |
| Hodgkin's disease recurrent | 2 | 0% |
| Hodgkin's disease stage II | 1 | 0% |
| Hoffmann's sign | 25 | 0% |
| Hollow visceral myopathy | 1 | 0% |
| Holmes-Adie pupil | 9 | 0% |
| Holotranscobalamin test | 6 | 0% |
| Holter valve insertion | 1 | 0% |
| Homans' sign | 32 | 0% |
| Homans' sign negative | 1 | 0% |
| Homans' sign positive | 7 | 0% |
| Homeless | 20 | 0% |
| Homicidal ideation | 14 | 0% |
| Homicide | 1 | 0% |
| Homocysteine urine | 3 | 0% |
| Homocystinaemia | 1 | 0% |
| Homonymous diplopia | 4 | 0% |
| Homosexuality | 1 | 0% |
| Hookworm infection | 2 | 0% |
| Hoover's sign of leg paresis | 2 | 0% |
| Hordeolum | 285 | 0.02% |
| Hormonal contraception | 2 | 0% |
| Hormone analysis | 13 | 0% |
| Hormone level abnormal | 646 | 0.04% |
| Hormone receptor negative HER2 positive breast cancer | 3 | 0% |
| Hormone receptor positive breast cancer | 13 | 0% |
| Hormone receptor positive HER2 negative breast cancer | 2 | 0% |
| Hormone replacement therapy | 13 | 0% |
| Hormone therapy | 21 | 0% |
| Horner's syndrome | 59 | 0% |
| Hospice care | 19 | 0% |
| Hospitalisation | 324 | 0.02% |
| Hostility | 11 | 0% |
| Hot flush | 7,229 | 0.44% |
| Housebound | 49 | 0% |
| HTLV-1 carrier | 1 | 0% |
| HTLV-1 test | 21 | 0% |
| HTLV-1 test positive | 1 | 0% |
| HTLV-2 test | 11 | 0% |
| HTLV-2 test positive | 1 | 0% |
| HTLV test | 20 | 0% |
| Huerthle cell carcinoma | 1 | 0% |
| Human anaplasmosis | 5 | 0% |
| Human anti-human antibody test | 4 | 0% |
| Human anti-mouse antibody test | 1 | 0% |
| Human chorionic gonadotropin | 645 | 0.04% |
| Human chorionic gonadotropin abnormal | 19 | 0% |
| Human chorionic gonadotropin decreased | 55 | 0% |
| Human chorionic gonadotropin increased | 18 | 0% |
| Human chorionic gonadotropin negative | 147 | 0.01% |
| Human chorionic gonadotropin normal | 29 | 0% |
| Human chorionic gonadotropin positive | 37 | 0% |
| Human ehrlichiosis | 6 | 0% |
| Human epidermal growth factor receptor increased | 2 | 0% |
| Human epidermal growth factor receptor negative | 9 | 0% |
| Human epidermal growth factor receptor test | 1 | 0% |
| Human herpesvirus 6 encephalitis | 2 | 0% |
| Human herpesvirus 6 infection | 28 | 0% |
| Human herpesvirus 6 infection reactivation | 7 | 0% |
| Human herpes virus 6 serology | 73 | 0% |
| Human herpes virus 6 serology negative | 22 | 0% |
| Human herpes virus 6 serology positive | 5 | 0% |
| Human herpesvirus 7 infection | 1 | 0% |
| Human herpesvirus 8 infection | 4 | 0% |
| Human herpes virus 8 test | 17 | 0% |
| Human metapneumovirus test | 208 | 0.01% |
| Human metapneumovirus test positive | 17 | 0% |
| Human papilloma virus test | 66 | 0% |
| Human papilloma virus test negative | 8 | 0% |
| Human papilloma virus test positive | 13 | 0% |
| Human rhinovirus test | 213 | 0.01% |
| Human rhinovirus test positive | 57 | 0% |
| Human seminal plasma hypersensitivity | 1 | 0% |
| Human T-cell lymphotropic virus infection | 3 | 0% |
| Human T-cell lymphotropic virus type I infection | 1 | 0% |
| Humerus fracture | 86 | 0.01% |
| Humidity intolerance | 9 | 0% |
| Humoral immune defect | 4 | 0% |
| Hunger | 386 | 0.02% |
| Hunt and Hess scale | 5 | 0% |
| Huntington's disease | 9 | 0% |
| Hyalosis asteroid | 1 | 0% |
| Hyaluronic acid | 2 | 0% |
| Hydranencephaly | 1 | 0% |
| Hydrocele | 23 | 0% |
| Hydrocele operation | 2 | 0% |
| Hydrocephalus | 140 | 0.01% |
| Hydrocholecystis | 16 | 0% |
| Hydrogen breath test | 14 | 0% |
| Hydrogen breath test abnormal | 4 | 0% |
| Hydrogen breath test normal | 5 | 0% |
| Hydrometra | 3 | 0% |
| Hydromyelia | 1 | 0% |
| Hydronephrosis | 155 | 0.01% |
| Hydrophobia | 5 | 0% |
| Hydrops foetalis | 22 | 0% |
| Hydrosalpinx | 11 | 0% |
| Hydrothorax | 17 | 0% |
| Hydroureter | 11 | 0% |
| Hydroxyproline | 2 | 0% |
| Hyperactive pharyngeal reflex | 7 | 0% |
| Hyperacusis | 1,516 | 0.09% |
| Hyperadrenalism | 5 | 0% |
| Hyperadrenocorticism | 3 | 0% |
| Hyperaemia | 92 | 0.01% |
| Hyperaesthesia | 1,483 | 0.09% |
| Hyperaesthesia eye | 3 | 0% |
| Hyperaesthesia teeth | 235 | 0.01% |
| Hyperalbuminaemia | 3 | 0% |
| Hyperaldosteronism | 6 | 0% |
| Hyperammonaemia | 24 | 0% |
| Hyperammonaemic encephalopathy | 2 | 0% |
| Hyperamylasaemia | 1 | 0% |
| Hyperarousal | 7 | 0% |
| Hyperbaric oxygen therapy | 5 | 0% |
| Hyperbilirubinaemia | 113 | 0.01% |
| Hyperbilirubinaemia neonatal | 4 | 0% |
| Hypercalcaemia | 104 | 0.01% |
| Hypercalcaemia of malignancy | 3 | 0% |
| Hypercapnia | 239 | 0.01% |
| Hypercapnic coma | 3 | 0% |
| Hypercarotinaemia | 1 | 0% |
| Hypercatabolism | 1 | 0% |
| Hyperchloraemia | 16 | 0% |
| Hyperchlorhydria | 40 | 0% |
| Hypercholesterolaemia | 142 | 0.01% |
| Hyperchromic anaemia | 4 | 0% |
| Hypercoagulation | 222 | 0.01% |
| Hypercreatinaemia | 2 | 0% |
| Hypercreatininaemia | 7 | 0% |
| Hyperdynamic left ventricle | 20 | 0% |
| Hyperechogenic pancreas | 2 | 0% |
| Hyperemesis gravidarum | 16 | 0% |
| Hypereosinophilic syndrome | 30 | 0% |
| Hyperexplexia | 4 | 0% |
| Hyperferritinaemia | 29 | 0% |
| Hyperfibrinogenaemia | 13 | 0% |
| Hyperfibrinolysis | 3 | 0% |
| Hypergammaglobulinaemia | 41 | 0% |
| Hypergammaglobulinaemia benign monoclonal | 35 | 0% |
| Hypergastrinaemia | 1 | 0% |
| Hypergeusia | 5 | 0% |
| Hyperglobulinaemia | 2 | 0% |
| Hyperglycaemia | 1,091 | 0.07% |
| Hyperglycaemic crisis | 2 | 0% |
| Hyperglycaemic hyperosmolar nonketotic syndrome | 26 | 0% |
| Hyperglycaemic unconsciousness | 2 | 0% |
| Hyperglycinaemia | 2 | 0% |
| Hyperhidrosis | 35,330 | 2.15% |
| Hyperhomocysteinaemia | 39 | 0% |
| Hyperinsulinaemic hypoglycaemia | 1 | 0% |
| Hyperintensity in brain deep nuclei | 19 | 0% |
| Hyperkalaemia | 536 | 0.03% |
| Hyperkeratosis | 66 | 0% |
| Hyperkeratosis follicularis et parafollicularis | 3 | 0% |
| Hyperkeratosis lenticularis perstans | 1 | 0% |
| Hyperkinesia | 6 | 0% |
| Hyperkinetic heart syndrome | 3 | 0% |
| Hyperlactacidaemia | 20 | 0% |
| Hyperleukocytosis | 199 | 0.01% |
| Hyperlipasaemia | 15 | 0% |
| Hyperlipidaemia | 378 | 0.02% |
| Hypermagnesaemia | 8 | 0% |
| Hypermetabolism | 26 | 0% |
| Hypermetropia | 38 | 0% |
| Hypermobility syndrome | 23 | 0% |
| Hypernatraemia | 230 | 0.01% |
| Hyperoestrogenism | 1 | 0% |
| Hyperosmolar state | 11 | 0% |
| Hyperoxia | 3 | 0% |
| Hyperparathyroidism | 26 | 0% |
| Hyperparathyroidism primary | 8 | 0% |
| Hyperparathyroidism secondary | 14 | 0% |
| Hyperparathyroidism tertiary | 1 | 0% |
| Hyperpathia | 1 | 0% |
| Hyperphagia | 45 | 0% |
| Hyperphosphataemia | 11 | 0% |
| Hyperplasia | 21 | 0% |
| Hyperplasia adrenal | 5 | 0% |
| Hyperplasia of thymic epithelium | 2 | 0% |
| Hyperplastic cholecystopathy | 1 | 0% |
| Hyperprolactinaemia | 24 | 0% |
| Hyperproteinaemia | 13 | 0% |
| Hyperprothrombinaemia | 1 | 0% |
| Hyperpyrexia | 2,289 | 0.14% |
| Hyperreflexia | 100 | 0.01% |
| Hyperresponsive to stimuli | 17 | 0% |
| Hypersensitivity | 10,557 | 0.64% |
| Hypersensitivity myocarditis | 10 | 0% |
| Hypersensitivity pneumonitis | 50 | 0% |
| Hypersensitivity vasculitis | 76 | 0% |
| Hypersexuality | 4 | 0% |
| Hypersomnia | 4,373 | 0.27% |
| Hypersomnia-bulimia syndrome | 3 | 0% |
| Hypersplenism | 4 | 0% |
| Hypertelorism | 1 | 0% |
| Hypertension | 19,061 | 1.16% |
| Hypertensive angiopathy | 3 | 0% |
| Hypertensive cardiomegaly | 2 | 0% |
| Hypertensive cardiomyopathy | 9 | 0% |
| Hypertensive cerebrovascular disease | 4 | 0% |
| Hypertensive crisis | 2,123 | 0.13% |
| Hypertensive emergency | 148 | 0.01% |
| Hypertensive encephalopathy | 33 | 0% |
| Hypertensive end-organ damage | 2 | 0% |
| Hypertensive heart disease | 112 | 0.01% |
| Hypertensive hydrocephalus | 1 | 0% |
| Hypertensive nephropathy | 7 | 0% |
| Hypertensive urgency | 180 | 0.01% |
| Hyperthermia | 609 | 0.04% |
| Hyperthermia malignant | 8 | 0% |
| Hyperthermic chemotherapy | 1 | 0% |
| Hyperthyroidism | 1,125 | 0.07% |
| Hypertonia | 175 | 0.01% |
| Hypertonic bladder | 80 | 0% |
| Hypertransaminasaemia | 155 | 0.01% |
| Hypertrichosis | 17 | 0% |
| Hypertriglyceridaemia | 55 | 0% |
| Hypertrophic cardiomyopathy | 80 | 0% |
| Hypertrophic scar | 4 | 0% |
| Hypertrophy | 29 | 0% |
| Hypertrophy of tongue papillae | 13 | 0% |
| Hyperuricaemia | 59 | 0% |
| Hyperventilation | 1,653 | 0.1% |
| Hypervigilance | 63 | 0% |
| Hyperviscosity syndrome | 8 | 0% |
| Hypervitaminosis | 1 | 0% |
| Hypervitaminosis B | 1 | 0% |
| Hypervitaminosis B12 | 4 | 0% |
| Hypervitaminosis D | 2 | 0% |
| Hypervolaemia | 369 | 0.02% |
| Hyphaema | 9 | 0% |
| Hypnagogic hallucination | 19 | 0% |
| Hypnopompic hallucination | 7 | 0% |
| Hypoacusis | 3,325 | 0.2% |
| Hypoaesthesia | 41,873 | 2.55% |
| Hypoaesthesia eye | 228 | 0.01% |
| Hypoaesthesia oral | 6,630 | 0.4% |
| Hypoaesthesia teeth | 22 | 0% |
| Hypoalbuminaemia | 147 | 0.01% |
| Hypobarism | 14 | 0% |
| Hypocalcaemia | 108 | 0.01% |
| Hypocapnia | 12 | 0% |
| Hypochloraemia | 36 | 0% |
| Hypocholesterolaemia | 4 | 0% |
| Hypochondroplasia | 1 | 0% |
| Hypochromasia | 18 | 0% |
| Hypochromic anaemia | 31 | 0% |
| Hypocoagulable state | 4 | 0% |
| Hypocomplementaemia | 9 | 0% |
| Hypoferritinaemia | 4 | 0% |
| Hypofibrinogenaemia | 10 | 0% |
| Hypogammaglobulinaemia | 82 | 0% |
| Hypogeusia | 298 | 0.02% |
| Hypoglossal nerve disorder | 6 | 0% |
| Hypoglossal nerve paralysis | 11 | 0% |
| Hypoglossal nerve paresis | 6 | 0% |
| Hypoglycaemia | 873 | 0.05% |
| Hypoglycaemia neonatal | 3 | 0% |
| Hypoglycaemia unawareness | 1 | 0% |
| Hypoglycaemic coma | 7 | 0% |
| Hypoglycaemic encephalopathy | 1 | 0% |
| Hypoglycaemic seizure | 4 | 0% |
| Hypoglycaemic unconsciousness | 6 | 0% |
| Hypogonadism | 4 | 0% |
| Hypogonadism female | 1 | 0% |
| Hypogonadism male | 2 | 0% |
| Hypohidrosis | 26 | 0% |
| Hypokalaemia | 989 | 0.06% |
| Hypokalaemic syndrome | 6 | 0% |
| Hypokinesia | 2,122 | 0.13% |
| Hypokinetic dysarthria | 1 | 0% |
| Hypolipidaemia | 2 | 0% |
| Hypomagnesaemia | 224 | 0.01% |
| Hypomania | 15 | 0% |
| Hypomenorrhoea | 828 | 0.05% |
| Hypometabolism | 13 | 0% |
| Hyponatraemia | 1,209 | 0.07% |
| Hyponatraemic coma | 1 | 0% |
| Hyponatraemic encephalopathy | 1 | 0% |
| Hyponatraemic syndrome | 5 | 0% |
| Hypoosmolar state | 39 | 0% |
| Hypoparathyroidism | 10 | 0% |
| Hypoperfusion | 46 | 0% |
| Hypophagia | 1,770 | 0.11% |
| Hypophonesis | 1 | 0% |
| Hypophosphataemia | 59 | 0% |
| Hypophosphatasia | 2 | 0% |
| Hypophysectomy | 1 | 0% |
| Hypophysitis | 23 | 0% |
| Hypopigmentation of eyelid | 1 | 0% |
| Hypopituitarism | 29 | 0% |
| Hypoplastic anaemia | 2 | 0% |
| Hypoplastic left heart syndrome | 5 | 0% |
| Hypoplastic right heart syndrome | 1 | 0% |
| Hypopnoea | 955 | 0.06% |
| Hypoproteinaemia | 21 | 0% |
| Hypoprothrombinaemia | 1 | 0% |
| Hypopyon | 1 | 0% |
| Hyporeflexia | 186 | 0.01% |
| Hyporesponsive to stimuli | 298 | 0.02% |
| Hyposmia | 228 | 0.01% |
| Hyposomnia | 7 | 0% |
| Hypospadias | 13 | 0% |
| Hyposplenism | 3 | 0% |
| Hyposthenuria | 2 | 0% |
| Hypotension | 10,698 | 0.65% |
| Hypotensive crisis | 28 | 0% |
| Hypothalamo-pituitary disorder | 25 | 0% |
| Hypothermia | 766 | 0.05% |
| Hypothermia neonatal | 1 | 0% |
| Hypothyroidic goitre | 1 | 0% |
| Hypothyroidism | 1,094 | 0.07% |
| Hypotonia | 1,436 | 0.09% |
| Hypotonia neonatal | 2 | 0% |
| Hypotonic-hyporesponsive episode | 435 | 0.03% |
| Hypotonic urinary bladder | 5 | 0% |
| Hypotony of eye | 4 | 0% |
| Hypotrichosis | 12 | 0% |
| Hypoventilation | 163 | 0.01% |
| Hypovitaminosis | 66 | 0% |
| Hypovolaemia | 188 | 0.01% |
| Hypovolaemic shock | 164 | 0.01% |
| Hypoxia | 6,734 | 0.41% |
| Hypoxic-ischaemic encephalopathy | 81 | 0% |
| Hypozincaemia | 1 | 0% |
| Hysterectomy | 141 | 0.01% |
| Hysterometry | 1 | 0% |
| Hysterosalpingectomy | 1 | 0% |
| Hysterosalpingo-oophorectomy | 3 | 0% |
| Hysterosalpingogram | 11 | 0% |
| Hysteroscopy | 180 | 0.01% |
| Hysteroscopy abnormal | 8 | 0% |
| Hysteroscopy normal | 10 | 0% |
| Hysterotomy | 5 | 0% |
| Iatrogenic injury | 3 | 0% |
| Ichthyosis | 4 | 0% |
| Ichthyosis acquired | 6 | 0% |
| Icterus index | 12 | 0% |
| Ideas of reference | 1 | 0% |
| Idiopathic angioedema | 13 | 0% |
| Idiopathic CD4 lymphocytopenia | 1 | 0% |
| Idiopathic environmental intolerance | 6 | 0% |
| Idiopathic generalised epilepsy | 19 | 0% |
| Idiopathic guttate hypomelanosis | 1 | 0% |
| Idiopathic inflammatory myopathy | 8 | 0% |
| Idiopathic interstitial pneumonia | 3 | 0% |
| Idiopathic intracranial hypertension | 153 | 0.01% |
| Idiopathic neutropenia | 1 | 0% |
| Idiopathic orbital inflammation | 19 | 0% |
| Idiopathic pancreatitis | 1 | 0% |
| Idiopathic partial epilepsy | 7 | 0% |
| Idiopathic pneumonia syndrome | 1 | 0% |
| Idiopathic pulmonary fibrosis | 63 | 0% |
| Idiopathic urticaria | 47 | 0% |
| Idiosyncratic drug reaction | 10 | 0% |
| IgA nephropathy | 302 | 0.02% |
| IgM nephropathy | 1 | 0% |
| IIIrd nerve disorder | 19 | 0% |
| IIIrd nerve injury | 3 | 0% |
| IIIrd nerve paralysis | 146 | 0.01% |
| IIIrd nerve paresis | 33 | 0% |
| IL-2 receptor assay | 37 | 0% |
| Ileal gangrene | 2 | 0% |
| Ileal perforation | 5 | 0% |
| Ileal stenosis | 1 | 0% |
| Ileal ulcer | 4 | 0% |
| Ileectomy | 2 | 0% |
| Ileocaecal resection | 4 | 0% |
| Ileocolectomy | 2 | 0% |
| Ileocolostomy | 2 | 0% |
| Ileostomy | 30 | 0% |
| Ileostomy closure | 2 | 0% |
| Ileus | 152 | 0.01% |
| Ileus paralytic | 56 | 0% |
| Iliac artery arteriosclerosis | 2 | 0% |
| Iliac artery disease | 1 | 0% |
| Iliac artery dissection | 3 | 0% |
| Iliac artery embolism | 4 | 0% |
| Iliac artery occlusion | 28 | 0% |
| Iliac artery rupture | 2 | 0% |
| Iliac artery stenosis | 13 | 0% |
| Iliac bruit | 1 | 0% |
| Iliac vein occlusion | 6 | 0% |
| Iliac vein stenosis | 1 | 0% |
| Iliotibial band syndrome | 9 | 0% |
| Ill-defined disorder | 146 | 0.01% |
| Illiteracy | 23 | 0% |
| Illness | 12,210 | 0.74% |
| Illness anxiety disorder | 11 | 0% |
| Illogical thinking | 5 | 0% |
| Illusion | 177 | 0.01% |
| Imaging procedure | 1,029 | 0.06% |
| Imaging procedure abnormal | 251 | 0.02% |
| Imaging procedure artifact | 26 | 0% |
| Immature granulocyte count | 463 | 0.03% |
| Immature granulocyte count increased | 58 | 0% |
| Immature granulocyte percentage increased | 34 | 0% |
| Immature platelet fraction | 3 | 0% |
| Immediate post-injection reaction | 6,696 | 0.41% |
| Imminent abortion | 3 | 0% |
| Immobile | 363 | 0.02% |
| Immobilisation prolonged | 7 | 0% |
| Immobilisation syndrome | 12 | 0% |
| Immune-mediated adrenal insufficiency | 1 | 0% |
| Immune-mediated adverse reaction | 103 | 0.01% |
| Immune-mediated arthritis | 6 | 0% |
| Immune-mediated cholangitis | 1 | 0% |
| Immune-mediated cholestasis | 1 | 0% |
| Immune-mediated cystitis | 1 | 0% |
| Immune-mediated dermatitis | 5 | 0% |
| Immune-mediated encephalitis | 11 | 0% |
| Immune-mediated encephalopathy | 2 | 0% |
| Immune-mediated enterocolitis | 1 | 0% |
| Immune-mediated hepatic disorder | 6 | 0% |
| Immune-mediated hepatitis | 7 | 0% |
| Immune-mediated hyperthyroidism | 1 | 0% |
| Immune-mediated hypothyroidism | 1 | 0% |
| Immune-mediated lung disease | 8 | 0% |
| Immune-mediated myelitis | 1 | 0% |
| Immune-mediated myocarditis | 6 | 0% |
| Immune-mediated myositis | 32 | 0% |
| Immune-mediated neurological disorder | 6 | 0% |
| Immune-mediated neuropathy | 20 | 0% |
| Immune-mediated pancreatitis | 3 | 0% |
| Immune-mediated renal disorder | 2 | 0% |
| Immune-mediated thyroiditis | 3 | 0% |
| Immune-mediated vasculitis | 1 | 0% |
| Immune agglutinins | 3 | 0% |
| Immune complex assay | 81 | 0% |
| Immune complex level increased | 2 | 0% |
| Immune effector cell encephalopathy score | 1 | 0% |
| Immune enhancement therapy | 1 | 0% |
| Immune reconstitution inflammatory syndrome | 9 | 0% |
| Immune reconstitution inflammatory syndrome associated tuberculosis | 1 | 0% |
| Immune system disorder | 1,254 | 0.08% |
| Immune thrombocytopenia | 1,706 | 0.1% |
| Immune tolerance induction | 4 | 0% |
| Immunisation | 26,232 | 1.6% |
| Immunisation anxiety related reaction | 44 | 0% |
| Immunisation reaction | 3,046 | 0.19% |
| Immunisation stress-related response | 13 | 0% |
| Immunochemotherapy | 3 | 0% |
| Immunodeficiency | 966 | 0.06% |
| Immunodeficiency common variable | 11 | 0% |
| Immunoelectrophoresis | 42 | 0% |
| Immunoglobulin clonality assay | 4 | 0% |
| Immunoglobulin G4 related disease | 27 | 0% |
| Immunoglobulins | 466 | 0.03% |
| Immunoglobulins abnormal | 11 | 0% |
| Immunoglobulins decreased | 27 | 0% |
| Immunoglobulins increased | 28 | 0% |
| Immunoglobulins normal | 27 | 0% |
| Immunoglobulin therapy | 895 | 0.05% |
| Immunohistochemistry | 120 | 0.01% |
| Immunology test | 1,361 | 0.08% |
| Immunology test abnormal | 17 | 0% |
| Immunology test normal | 55 | 0% |
| Immunophenotyping | 116 | 0.01% |
| Immunosuppressant drug level | 9 | 0% |
| Immunosuppressant drug level decreased | 1 | 0% |
| Immunosuppressant drug level increased | 1 | 0% |
| Immunosuppressant drug therapy | 41 | 0% |
| Immunosuppression | 157 | 0.01% |
| Impacted fracture | 4 | 0% |
| Impaired ability to use machinery | 5 | 0% |
| Impaired driving ability | 1,786 | 0.11% |
| Impaired fasting glucose | 8 | 0% |
| Impaired gastric emptying | 174 | 0.01% |
| Impaired healing | 327 | 0.02% |
| Impaired insulin secretion | 5 | 0% |
| Impaired quality of life | 942 | 0.06% |
| Impaired reasoning | 29 | 0% |
| Impaired self-care | 149 | 0.01% |
| Impaired work ability | 10,991 | 0.67% |
| Impatience | 27 | 0% |
| Imperception | 26 | 0% |
| Impetigo | 65 | 0% |
| Implantable cardiac monitor insertion | 97 | 0.01% |
| Implantable cardiac monitor removal | 2 | 0% |
| Implantable defibrillator insertion | 126 | 0.01% |
| Implantable defibrillator removal | 1 | 0% |
| Implantable defibrillator replacement | 2 | 0% |
| Implantation complication | 2 | 0% |
| Implant site extravasation | 3 | 0% |
| Implant site fibrosis | 1 | 0% |
| Implant site haemorrhage | 3 | 0% |
| Implant site hypoaesthesia | 1 | 0% |
| Implant site induration | 1 | 0% |
| Implant site infection | 3 | 0% |
| Implant site inflammation | 3 | 0% |
| Implant site irritation | 1 | 0% |
| Implant site pain | 9 | 0% |
| Implant site pruritus | 2 | 0% |
| Implant site pustules | 1 | 0% |
| Implant site reaction | 2 | 0% |
| Implant site swelling | 3 | 0% |
| Implant site warmth | 3 | 0% |
| Imprisonment | 6 | 0% |
| Impulse-control disorder | 14 | 0% |
| Impulse oscillometry | 5 | 0% |
| Impulsive behaviour | 30 | 0% |
| Inability to afford medication | 8 | 0% |
| Inability to crawl | 11 | 0% |
| Inadequate analgesia | 8 | 0% |
| Inadequate aseptic technique in use of product | 6 | 0% |
| Inadequate diet | 11 | 0% |
| Inappropriate affect | 83 | 0.01% |
| Inappropriate antidiuretic hormone secretion | 85 | 0.01% |
| Inappropriate release of product for distribution | 6 | 0% |
| Inappropriate schedule of product administration | 31,195 | 1.9% |
| Inappropriate schedule of product discontinuation | 3 | 0% |
| Inappropriate sinus tachycardia | 2 | 0% |
| Inborn error of metabolism | 1 | 0% |
| Incarcerated hernia | 6 | 0% |
| Incarcerated hiatus hernia | 1 | 0% |
| Incarcerated incisional hernia | 1 | 0% |
| Incarcerated inguinal hernia | 1 | 0% |
| Incarcerated umbilical hernia | 4 | 0% |
| Incentive spirometry | 38 | 0% |
| Incisional drainage | 82 | 0% |
| Incisional hernia | 4 | 0% |
| Incisional hernia, obstructive | 1 | 0% |
| Incisional hernia repair | 2 | 0% |
| Incision site abscess | 2 | 0% |
| Incision site complication | 12 | 0% |
| Incision site discharge | 5 | 0% |
| Incision site erythema | 7 | 0% |
| Incision site haematoma | 1 | 0% |
| Incision site haemorrhage | 8 | 0% |
| Incision site impaired healing | 3 | 0% |
| Incision site inflammation | 2 | 0% |
| Incision site oedema | 1 | 0% |
| Incision site pain | 22 | 0% |
| Incision site pruritus | 3 | 0% |
| Incision site rash | 3 | 0% |
| Incision site swelling | 8 | 0% |
| Inclusion body myositis | 11 | 0% |
| Incoherent | 478 | 0.03% |
| Incomplete course of vaccination | 591 | 0.04% |
| Incontinence | 713 | 0.04% |
| Incorrect disposal of product | 6 | 0% |
| Incorrect dosage administered | 18 | 0% |
| Incorrect dose administered | 12,204 | 0.74% |
| Incorrect dose administered by device | 14 | 0% |
| Incorrect dose administered by product | 4 | 0% |
| Incorrect drug administration rate | 4 | 0% |
| Incorrect product administration duration | 54 | 0% |
| Incorrect product formulation administered | 8,504 | 0.52% |
| Incorrect route of product administration | 3,152 | 0.19% |
| Increased appetite | 182 | 0.01% |
| Increased bronchial secretion | 117 | 0.01% |
| Increased insulin requirement | 33 | 0% |
| Increased liver stiffness | 1 | 0% |
| Increased need for sleep | 22 | 0% |
| Increased tendency to bruise | 276 | 0.02% |
| Increased upper airway secretion | 228 | 0.01% |
| Increased viscosity of bronchial secretion | 25 | 0% |
| Increased viscosity of upper respiratory secretion | 136 | 0.01% |
| Indeterminate investigation result | 3 | 0% |
| Indeterminate leprosy | 1 | 0% |
| Indeterminate tuberculosis test | 1 | 0% |
| Indifference | 31 | 0% |
| Induced abortion failed | 2 | 0% |
| Induced abortion haemorrhage | 1 | 0% |
| Induced labour | 93 | 0.01% |
| Induction of cervix ripening | 2 | 0% |
| Induration | 2,612 | 0.16% |
| Infant | 1 | 0% |
| Infantile apnoea | 9 | 0% |
| Infantile back arching | 1 | 0% |
| Infantile colic | 1 | 0% |
| Infantile diarrhoea | 2 | 0% |
| Infantile genetic agranulocytosis | 1 | 0% |
| Infantile haemangioma | 1 | 0% |
| Infantile spasms | 6 | 0% |
| Infantile spitting up | 3 | 0% |
| Infantile vomiting | 32 | 0% |
| Infant irritability | 31 | 0% |
| Infant sedation | 2 | 0% |
| Infarction | 313 | 0.02% |
| Infected bite | 21 | 0% |
| Infected bunion | 2 | 0% |
| Infected cyst | 28 | 0% |
| Infected dermal cyst | 8 | 0% |
| Infected fistula | 2 | 0% |
| Infected lymphocele | 2 | 0% |
| Infected neoplasm | 3 | 0% |
| Infected seroma | 4 | 0% |
| Infected skin ulcer | 17 | 0% |
| Infected vasculitis | 2 | 0% |
| Infection | 2,627 | 0.16% |
| Infection in an immunocompromised host | 10 | 0% |
| Infection parasitic | 18 | 0% |
| Infection prophylaxis | 1 | 0% |
| Infection protozoal | 1 | 0% |
| Infection reactivation | 21 | 0% |
| Infection susceptibility increased | 420 | 0.03% |
| Infection via vaccinee | 1 | 0% |
| Infectious disease carrier | 4 | 0% |
| Infectious mononucleosis | 328 | 0.02% |
| Infectious pleural effusion | 45 | 0% |
| Infectious thyroiditis | 6 | 0% |
| Infective aneurysm | 1 | 0% |
| Infective chondritis | 1 | 0% |
| Infective episcleritis | 1 | 0% |
| Infective exacerbation of bronchiectasis | 3 | 0% |
| Infective exacerbation of chronic obstructive airways disease | 7 | 0% |
| Infective glossitis | 2 | 0% |
| Infective iritis | 1 | 0% |
| Infective keratitis | 2 | 0% |
| Infective myositis | 8 | 0% |
| Infective pericardial effusion | 3 | 0% |
| Infective pulmonary exacerbation of cystic fibrosis | 3 | 0% |
| Infective spondylitis | 3 | 0% |
| Infective tenosynovitis | 7 | 0% |
| Infective thrombosis | 2 | 0% |
| Inferiority complex | 1 | 0% |
| Inferior vena cava dilatation | 53 | 0% |
| Inferior vena caval occlusion | 7 | 0% |
| Inferior vena cava stenosis | 1 | 0% |
| Inferior vena cava syndrome | 3 | 0% |
| Infertility | 120 | 0.01% |
| Infertility female | 80 | 0% |
| Infertility male | 7 | 0% |
| Infertility tests | 24 | 0% |
| Infertility tests abnormal | 1 | 0% |
| Infertility tests normal | 1 | 0% |
| Infestation | 2 | 0% |
| Inflammation | 8,489 | 0.52% |
| Inflammation of lacrimal passage | 3 | 0% |
| Inflammation of wound | 14 | 0% |
| Inflammation scan | 43 | 0% |
| Inflammatory bowel disease | 169 | 0.01% |
| Inflammatory carcinoma of the breast | 14 | 0% |
| Inflammatory marker decreased | 18 | 0% |
| Inflammatory marker increased | 855 | 0.05% |
| Inflammatory marker test | 995 | 0.06% |
| Inflammatory myofibroblastic tumour | 1 | 0% |
| Inflammatory pain | 133 | 0.01% |
| Inflammatory pseudotumour | 5 | 0% |
| Influenza | 6,675 | 0.41% |
| Influenza A virus test | 502 | 0.03% |
| Influenza A virus test negative | 1,111 | 0.07% |
| Influenza A virus test positive | 137 | 0.01% |
| Influenza B virus test | 1,461 | 0.09% |
| Influenza B virus test negative | 2 | 0% |
| Influenza B virus test positive | 75 | 0% |
| Influenza C virus test | 1 | 0% |
| Influenza immunisation | 9 | 0% |
| Influenza like illness | 22,297 | 1.36% |
| Influenza virus test | 880 | 0.05% |
| Influenza virus test negative | 1,982 | 0.12% |
| Influenza virus test positive | 178 | 0.01% |
| Infrared therapy | 2 | 0% |
| Infrequent bowel movements | 42 | 0% |
| Infusion | 288 | 0.02% |
| Infusion related hypersensitivity reaction | 7 | 0% |
| Infusion related reaction | 59 | 0% |
| Infusion site abscess | 1 | 0% |
| Infusion site bruising | 5 | 0% |
| Infusion site erythema | 12 | 0% |
| Infusion site extravasation | 9 | 0% |
| Infusion site haemorrhage | 7 | 0% |
| Infusion site induration | 1 | 0% |
| Infusion site joint movement impairment | 2 | 0% |
| Infusion site mass | 1 | 0% |
| Infusion site mobility decreased | 1 | 0% |
| Infusion site pain | 14 | 0% |
| Infusion site pruritus | 6 | 0% |
| Infusion site rash | 1 | 0% |
| Infusion site reaction | 2 | 0% |
| Infusion site streaking | 1 | 0% |
| Infusion site swelling | 3 | 0% |
| Infusion site urticaria | 1 | 0% |
| Infusion site vesicles | 1 | 0% |
| Infusion site warmth | 12 | 0% |
| Ingrowing nail | 9 | 0% |
| Ingrown hair | 11 | 0% |
| Inguinal hernia | 70 | 0% |
| Inguinal hernia repair | 9 | 0% |
| Inguinal mass | 23 | 0% |
| Inhalation therapy | 24 | 0% |
| Inhibiting antibodies | 1 | 0% |
| Inhibiting antibodies positive | 3 | 0% |
| Inhibitory drug interaction | 12 | 0% |
| Initial insomnia | 438 | 0.03% |
| Injectable contraception | 1 | 0% |
| Injected limb mobility decreased | 2,821 | 0.17% |
| Injection | 81 | 0% |
| Injection related reaction | 141 | 0.01% |
| Injection site abscess | 110 | 0.01% |
| Injection site atrophy | 12 | 0% |
| Injection site bruising | 2,663 | 0.16% |
| Injection site calcification | 1 | 0% |
| Injection site cellulitis | 435 | 0.03% |
| Injection site coldness | 27 | 0% |
| Injection site cyst | 15 | 0% |
| Injection site deformation | 2 | 0% |
| Injection site dermatitis | 11 | 0% |
| Injection site discharge | 71 | 0% |
| Injection site discolouration | 664 | 0.04% |
| Injection site discomfort | 1,022 | 0.06% |
| Injection site dryness | 35 | 0% |
| Injection site dysaesthesia | 1 | 0% |
| Injection site eczema | 4 | 0% |
| Injection site erosion | 7 | 0% |
| Injection site erythema | 31,184 | 1.9% |
| Injection site exfoliation | 11 | 0% |
| Injection site extravasation | 152 | 0.01% |
| Injection site fibrosis | 2 | 0% |
| Injection site granuloma | 5 | 0% |
| Injection site haematoma | 193 | 0.01% |
| Injection site haemorrhage | 700 | 0.04% |
| Injection site hyperaesthesia | 2 | 0% |
| Injection site hypersensitivity | 199 | 0.01% |
| Injection site hypertrophy | 3 | 0% |
| Injection site hypoaesthesia | 862 | 0.05% |
| Injection site indentation | 151 | 0.01% |
| Injection site induration | 5,774 | 0.35% |
| Injection site infection | 168 | 0.01% |
| Injection site inflammation | 1,484 | 0.09% |
| Injection site injury | 41 | 0% |
| Injection site irritation | 334 | 0.02% |
| Injection site joint discomfort | 6 | 0% |
| Injection site joint effusion | 1 | 0% |
| Injection site joint erythema | 11 | 0% |
| Injection site joint inflammation | 4 | 0% |
| Injection site joint movement impairment | 47 | 0% |
| Injection site joint pain | 155 | 0.01% |
| Injection site joint swelling | 22 | 0% |
| Injection site joint warmth | 7 | 0% |
| Injection site laceration | 6 | 0% |
| Injection site lymphadenopathy | 112 | 0.01% |
| Injection site macule | 20 | 0% |
| Injection site mass | 3,225 | 0.2% |
| Injection site movement impairment | 160 | 0.01% |
| Injection site muscle atrophy | 16 | 0% |
| Injection site muscle weakness | 118 | 0.01% |
| Injection site necrosis | 16 | 0% |
| Injection site nerve damage | 26 | 0% |
| Injection site nodule | 1,279 | 0.08% |
| Injection site oedema | 271 | 0.02% |
| Injection site pain | 50,620 | 3.08% |
| Injection site pallor | 12 | 0% |
| Injection site panniculitis | 1 | 0% |
| Injection site papule | 66 | 0% |
| Injection site paraesthesia | 734 | 0.04% |
| Injection site phlebitis | 1 | 0% |
| Injection site plaque | 17 | 0% |
| Injection site pruritus | 20,556 | 1.25% |
| Injection site pustule | 49 | 0% |
| Injection site rash | 11,606 | 0.71% |
| Injection site reaction | 6,891 | 0.42% |
| Injection site recall reaction | 1 | 0% |
| Injection site scab | 103 | 0.01% |
| Injection site scar | 57 | 0% |
| Injection site streaking | 63 | 0% |
| Injection site swelling | 26,776 | 1.63% |
| Injection site thrombosis | 15 | 0% |
| Injection site ulcer | 24 | 0% |
| Injection site urticaria | 1,584 | 0.1% |
| Injection site vasculitis | 1 | 0% |
| Injection site vesicles | 410 | 0.02% |
| Injection site warmth | 15,391 | 0.94% |
| Injury | 666 | 0.04% |
| Injury associated with device | 164 | 0.01% |
| Injury corneal | 14 | 0% |
| Injury to brachial plexus due to birth trauma | 2 | 0% |
| Inner ear disorder | 135 | 0.01% |
| Inner ear infarction | 12 | 0% |
| Inner ear inflammation | 66 | 0% |
| Inner ear operation | 1 | 0% |
| Insomnia | 18,595 | 1.13% |
| Inspiratory capacity | 5 | 0% |
| Inspiratory capacity abnormal | 2 | 0% |
| Inspiratory capacity decreased | 27 | 0% |
| Instillation site exfoliation | 2 | 0% |
| Instillation site haemorrhage | 2 | 0% |
| Instillation site induration | 1 | 0% |
| Instillation site pain | 3 | 0% |
| Instillation site paraesthesia | 5 | 0% |
| Instillation site pruritus | 1 | 0% |
| Instillation site warmth | 3 | 0% |
| Insulin-like growth factor | 28 | 0% |
| Insulin-like growth factor increased | 1 | 0% |
| Insulin-requiring type 2 diabetes mellitus | 37 | 0% |
| Insulin autoimmune syndrome | 1 | 0% |
| Insulin C-peptide | 80 | 0% |
| Insulin C-peptide abnormal | 1 | 0% |
| Insulin C-peptide decreased | 8 | 0% |
| Insulin C-peptide increased | 1 | 0% |
| Insulin C-peptide normal | 2 | 0% |
| Insulinoma | 2 | 0% |
| Insulin resistance | 68 | 0% |
| Insulin resistance test | 8 | 0% |
| Insulin resistant diabetes | 6 | 0% |
| Insulin therapy | 89 | 0.01% |
| Insulin tolerance test | 2 | 0% |
| Insulin tolerance test abnormal | 2 | 0% |
| Insurance issue | 29 | 0% |
| Intellectual disability | 47 | 0% |
| Intelligence test | 5 | 0% |
| Intensive care | 4,100 | 0.25% |
| Intensive care unit acquired weakness | 22 | 0% |
| Intensive care unit delirium | 4 | 0% |
| Intentional device use issue | 1 | 0% |
| Intentional dose omission | 133 | 0.01% |
| Intentional medical device removal by patient | 62 | 0% |
| Intentional overdose | 22 | 0% |
| Intentional product misuse | 41 | 0% |
| Intentional product misuse to child | 1 | 0% |
| Intentional product use issue | 220 | 0.01% |
| Intentional removal of drug delivery system by patient | 7 | 0% |
| Intentional self-injury | 56 | 0% |
| Intentional underdose | 7 | 0% |
| Intention tremor | 27 | 0% |
| Intercapillary glomerulosclerosis | 1 | 0% |
| Intercepted medication error | 5 | 0% |
| Intercepted product administration error | 5 | 0% |
| Intercepted product dispensing error | 4 | 0% |
| Intercepted product preparation error | 2 | 0% |
| Intercepted product prescribing error | 1 | 0% |
| Intercepted product selection error | 1 | 0% |
| Intercepted product storage error | 1 | 0% |
| Interchange of vaccine products | 33,912 | 2.06% |
| Intercostal neuralgia | 48 | 0% |
| Interferon alpha level | 13 | 0% |
| Interferon beta level | 5 | 0% |
| Interferon beta level increased | 2 | 0% |
| Interferon gamma decreased | 2 | 0% |
| Interferon gamma level | 73 | 0% |
| Interferon gamma level increased | 3 | 0% |
| Interferon gamma normal | 4 | 0% |
| Interferon gamma release assay | 82 | 0% |
| Interferon gamma release assay positive | 6 | 0% |
| Interleukin-2 receptor assay | 94 | 0.01% |
| Interleukin-2 receptor increased | 17 | 0% |
| Interleukin level | 387 | 0.02% |
| Interleukin level decreased | 3 | 0% |
| Interleukin level increased | 45 | 0% |
| Interleukin therapy | 14 | 0% |
| Intermenstrual bleeding | 4,342 | 0.26% |
| Intermittent claudication | 85 | 0.01% |
| Intermittent explosive disorder | 2 | 0% |
| Intermittent positive pressure breathing | 5 | 0% |
| Internal capsule infarction | 15 | 0% |
| Internal carotid artery deformity | 4 | 0% |
| Internal device exposed | 1 | 0% |
| Internal fixation of fracture | 11 | 0% |
| Internal fixation of spine | 2 | 0% |
| Internal haemorrhage | 408 | 0.02% |
| Internal hernia | 5 | 0% |
| Internal injury | 1 | 0% |
| International normalised ratio | 2,623 | 0.16% |
| International normalised ratio abnormal | 47 | 0% |
| International normalised ratio decreased | 116 | 0.01% |
| International normalised ratio fluctuation | 14 | 0% |
| International normalised ratio increased | 750 | 0.05% |
| International normalised ratio normal | 482 | 0.03% |
| Interspinous osteoarthritis | 2 | 0% |
| Interstitial granulomatous dermatitis | 7 | 0% |
| Interstitial lung abnormality | 3 | 0% |
| Interstitial lung disease | 869 | 0.05% |
| Intertrigo | 20 | 0% |
| Interventional procedure | 21 | 0% |
| Interventricular septum rupture | 4 | 0% |
| Intervertebral disc annular tear | 6 | 0% |
| Intervertebral disc calcification | 1 | 0% |
| Intervertebral disc compression | 13 | 0% |
| Intervertebral disc degeneration | 255 | 0.02% |
| Intervertebral disc disorder | 144 | 0.01% |
| Intervertebral disc displacement | 5 | 0% |
| Intervertebral disc injury | 7 | 0% |
| Intervertebral discitis | 58 | 0% |
| Intervertebral disc operation | 26 | 0% |
| Intervertebral disc protrusion | 503 | 0.03% |
| Intervertebral disc space narrowing | 47 | 0% |
| Intestinal adenocarcinoma | 1 | 0% |
| Intestinal adhesion lysis | 8 | 0% |
| Intestinal anastomosis | 10 | 0% |
| Intestinal angina | 2 | 0% |
| Intestinal angioedema | 6 | 0% |
| Intestinal atony | 3 | 0% |
| Intestinal atresia | 7 | 0% |
| Intestinal barrier dysfunction | 28 | 0% |
| Intestinal congestion | 3 | 0% |
| Intestinal cyst | 3 | 0% |
| Intestinal dilatation | 39 | 0% |
| Intestinal fistula | 1 | 0% |
| Intestinal gangrene | 1 | 0% |
| Intestinal haematoma | 1 | 0% |
| Intestinal haemorrhage | 149 | 0.01% |
| Intestinal infarction | 49 | 0% |
| Intestinal intraepithelial lymphocytes increased | 1 | 0% |
| Intestinal ischaemia | 215 | 0.01% |
| Intestinal malrotation | 1 | 0% |
| Intestinal mass | 35 | 0% |
| Intestinal metaplasia | 2 | 0% |
| Intestinal metastasis | 3 | 0% |
| Intestinal mucosal tear | 3 | 0% |
| Intestinal obstruction | 288 | 0.02% |
| Intestinal operation | 9 | 0% |
| Intestinal perforation | 78 | 0% |
| Intestinal polyp | 5 | 0% |
| Intestinal prolapse | 1 | 0% |
| Intestinal pseudo-obstruction | 18 | 0% |
| Intestinal resection | 36 | 0% |
| Intestinal sepsis | 3 | 0% |
| Intestinal stenosis | 4 | 0% |
| Intestinal stent insertion | 1 | 0% |
| Intestinal strangulation | 5 | 0% |
| Intestinal transit time | 6 | 0% |
| Intestinal transit time abnormal | 4 | 0% |
| Intestinal transit time decreased | 1 | 0% |
| Intestinal tuberculosis | 1 | 0% |
| Intestinal ulcer | 13 | 0% |
| Intestinal vascular disorder | 1 | 0% |
| Intestinal villi atrophy | 1 | 0% |
| Intoxication by breast feeding | 6 | 0% |
| Intra-abdominal fluid collection | 65 | 0% |
| Intra-abdominal haemangioma | 2 | 0% |
| Intra-abdominal haematoma | 31 | 0% |
| Intra-abdominal haemorrhage | 42 | 0% |
| Intra-abdominal pressure increased | 3 | 0% |
| Intra-aortic balloon placement | 22 | 0% |
| Intra-cerebral aneurysm operation | 10 | 0% |
| Intra-ocular injection | 6 | 0% |
| Intra-thoracic aortic aneurysm repair | 1 | 0% |
| Intra-uterine contraceptive device insertion | 15 | 0% |
| Intra-uterine contraceptive device removal | 16 | 0% |
| Intracardiac mass | 10 | 0% |
| Intracardiac pressure increased | 4 | 0% |
| Intracardiac thrombus | 280 | 0.02% |
| Intracerebral haematoma evacuation | 5 | 0% |
| Intracranial aneurysm | 248 | 0.02% |
| Intracranial artery dissection | 5 | 0% |
| Intracranial contrast-enhanced magnetic resonance venography | 4 | 0% |
| Intracranial haematoma | 14 | 0% |
| Intracranial haemorrhage neonatal | 1 | 0% |
| Intracranial hypotension | 21 | 0% |
| Intracranial lipoma | 1 | 0% |
| Intracranial mass | 84 | 0.01% |
| Intracranial pressure increased | 270 | 0.02% |
| Intraductal papillary mucinous neoplasm | 4 | 0% |
| Intraductal papilloma of breast | 4 | 0% |
| Intraductal proliferative breast lesion | 43 | 0% |
| Intrahepatic portal hepatic venous fistula | 1 | 0% |
| Intramedullary rod insertion | 17 | 0% |
| Intranasal hypoaesthesia | 27 | 0% |
| Intranasal paraesthesia | 10 | 0% |
| Intraneural cyst | 1 | 0% |
| Intraocular lens implant | 9 | 0% |
| Intraocular pressure decreased | 5 | 0% |
| Intraocular pressure fluctuation | 1 | 0% |
| Intraocular pressure increased | 187 | 0.01% |
| Intraocular pressure test | 442 | 0.03% |
| Intraocular pressure test abnormal | 25 | 0% |
| Intraocular pressure test normal | 11 | 0% |
| Intraoperative neurophysiologic monitoring | 1 | 0% |
| Intraosseous access placement | 6 | 0% |
| Intrapartum haemorrhage | 5 | 0% |
| Intrapericardial thrombosis | 4 | 0% |
| Intrapulmonary lymphadenopathy | 2 | 0% |
| Intratumoural haematoma | 1 | 0% |
| Intratympanic injection | 2 | 0% |
| Intrauterine contraception | 19 | 0% |
| Intrauterine infection | 5 | 0% |
| Intravascular haemolysis | 2 | 0% |
| Intravascular papillary endothelial hyperplasia | 1 | 0% |
| Intraventricular haemorrhage | 109 | 0.01% |
| Intraventricular haemorrhage neonatal | 3 | 0% |
| Intravesical immunotherapy | 5 | 0% |
| Intrinsic factor antibody | 17 | 0% |
| Intrinsic factor antibody negative | 1 | 0% |
| Intrinsic factor antibody positive | 4 | 0% |
| Intrusive thoughts | 33 | 0% |
| Intussusception | 58 | 0% |
| Invasive breast carcinoma | 17 | 0% |
| Invasive ductal breast carcinoma | 76 | 0% |
| Invasive lobular breast carcinoma | 23 | 0% |
| Invasive papillary breast carcinoma | 2 | 0% |
| Investigation | 19,722 | 1.2% |
| Investigation abnormal | 34 | 0% |
| Investigation noncompliance | 3 | 0% |
| Investigation normal | 20 | 0% |
| In vitro fertilisation | 19 | 0% |
| Involuntary commitment | 1 | 0% |
| Iodine allergy | 9 | 0% |
| Iodine uptake | 10 | 0% |
| Iodine uptake abnormal | 1 | 0% |
| Iodine uptake decreased | 7 | 0% |
| Iodine uptake increased | 6 | 0% |
| Iodine uptake normal | 1 | 0% |
| Iontophoresis | 2 | 0% |
| Iridectomy | 1 | 0% |
| Iridocele | 1 | 0% |
| Iridocorneal endothelial syndrome | 1 | 0% |
| Iridocyclitis | 288 | 0.02% |
| Iridodialysis | 1 | 0% |
| Iridotomy | 3 | 0% |
| Iris adhesions | 12 | 0% |
| Iris bombe | 1 | 0% |
| Iris cyst | 1 | 0% |
| Iris discolouration | 3 | 0% |
| Iris disorder | 6 | 0% |
| Iris hypopigmentation | 1 | 0% |
| Iris injury | 2 | 0% |
| Iris neovascularisation | 2 | 0% |
| Iritis | 198 | 0.01% |
| Iron binding capacity total | 156 | 0.01% |
| Iron binding capacity total abnormal | 6 | 0% |
| Iron binding capacity total decreased | 17 | 0% |
| Iron binding capacity total increased | 10 | 0% |
| Iron binding capacity total normal | 63 | 0% |
| Iron binding capacity unsaturated | 25 | 0% |
| Iron binding capacity unsaturated decreased | 1 | 0% |
| Iron deficiency | 293 | 0.02% |
| Iron deficiency anaemia | 344 | 0.02% |
| Iron metabolism disorder | 2 | 0% |
| Iron overload | 8 | 0% |
| Irregular breathing | 158 | 0.01% |
| Irregular sleep phase | 13 | 0% |
| Irregular sleep wake rhythm disorder | 24 | 0% |
| Irrigation therapy | 1 | 0% |
| Irritability | 1,883 | 0.11% |
| Irritability postvaccinal | 21 | 0% |
| Irritable bowel syndrome | 567 | 0.03% |
| IRVAN syndrome | 1 | 0% |
| Ischaemia | 383 | 0.02% |
| Ischaemic cardiomyopathy | 82 | 0% |
| Ischaemic cerebral infarction | 245 | 0.01% |
| Ischaemic contracture of the left ventricle | 2 | 0% |
| Ischaemic demyelination | 2 | 0% |
| Ischaemic enteritis | 4 | 0% |
| Ischaemic hepatitis | 64 | 0% |
| Ischaemic limb pain | 12 | 0% |
| Ischaemic neuropathy | 5 | 0% |
| Ischaemic skin ulcer | 11 | 0% |
| Ischaemic stroke | 2,690 | 0.16% |
| Isocitrate dehydrogenase gene mutation | 2 | 0% |
| Isoimmune haemolytic disease | 1 | 0% |
| ISTH score for disseminated intravascular coagulation | 4 | 0% |
| Itching scar | 24 | 0% |
| IVth nerve disorder | 5 | 0% |
| IVth nerve injury | 3 | 0% |
| IVth nerve paralysis | 64 | 0% |
| IVth nerve paresis | 12 | 0% |
| Jamais vu | 1 | 0% |
| Janeway lesion | 2 | 0% |
| Janus kinase 2 mutation | 50 | 0% |
| Japanese spotted fever | 1 | 0% |
| Jarisch-Herxheimer reaction | 2 | 0% |
| Jaundice | 561 | 0.03% |
| Jaundice acholuric | 2 | 0% |
| Jaundice cholestatic | 41 | 0% |
| Jaundice hepatocellular | 1 | 0% |
| Jaundice neonatal | 21 | 0% |
| Jaw clicking | 36 | 0% |
| Jaw cyst | 6 | 0% |
| Jaw disorder | 200 | 0.01% |
| Jaw fistula | 1 | 0% |
| Jaw fracture | 38 | 0% |
| Jaw lesion excision | 1 | 0% |
| Jaw operation | 6 | 0% |
| JC polyomavirus test | 25 | 0% |
| JC polyomavirus test negative | 1 | 0% |
| JC polyomavirus test positive | 3 | 0% |
| JC virus infection | 2 | 0% |
| Jealous delusion | 1 | 0% |
| Jejunal perforation | 2 | 0% |
| Jejunostomy | 3 | 0% |
| Jessner's lymphocytic infiltration | 3 | 0% |
| Job change | 1 | 0% |
| Job dissatisfaction | 33 | 0% |
| Joint abscess | 9 | 0% |
| Joint adhesion | 4 | 0% |
| Joint ankylosis | 40 | 0% |
| Joint arthroplasty | 8 | 0% |
| Joint contracture | 112 | 0.01% |
| Joint debridement | 5 | 0% |
| Joint deposit | 3 | 0% |
| Joint destruction | 7 | 0% |
| Joint dislocation | 227 | 0.01% |
| Joint dislocation postoperative | 3 | 0% |
| Joint dislocation reduction | 11 | 0% |
| Joint effusion | 357 | 0.02% |
| Joint fluid drainage | 28 | 0% |
| Joint hyperextension | 19 | 0% |
| Joint impingement | 7 | 0% |
| Joint injection | 44 | 0% |
| Joint injury | 585 | 0.04% |
| Joint instability | 76 | 0% |
| Joint irrigation | 3 | 0% |
| Joint laxity | 9 | 0% |
| Joint lock | 247 | 0.02% |
| Joint manipulation | 1 | 0% |
| Joint microhaemorrhage | 2 | 0% |
| Joint noise | 281 | 0.02% |
| Joint position sense decreased | 2 | 0% |
| Joint prosthesis user | 2 | 0% |
| Joint range of motion decreased | 3,269 | 0.2% |
| Joint range of motion measurement | 17 | 0% |
| Joint space narrowing | 17 | 0% |
| Joint stabilisation | 17 | 0% |
| Joint stiffness | 2,547 | 0.15% |
| Joint swelling | 6,947 | 0.42% |
| Joint vibration | 17 | 0% |
| Joint warmth | 153 | 0.01% |
| Judgement impaired | 22 | 0% |
| Jugular vein distension | 31 | 0% |
| Jugular vein embolism | 3 | 0% |
| Jugular vein haemorrhage | 2 | 0% |
| Jugular vein occlusion | 13 | 0% |
| Jugular vein thrombosis | 191 | 0.01% |
| Juvenile absence epilepsy | 2 | 0% |
| Juvenile chronic myelomonocytic leukaemia | 1 | 0% |
| Juvenile idiopathic arthritis | 59 | 0% |
| Juvenile melanoma benign | 2 | 0% |
| Juvenile myoclonic epilepsy | 8 | 0% |
| Juvenile polymyositis | 3 | 0% |
| Juvenile psoriatic arthritis | 4 | 0% |
| Juvenile spondyloarthritis | 1 | 0% |
| K-ras gene mutation | 1 | 0% |
| Kabuki make-up syndrome | 1 | 0% |
| Kaposi's sarcoma | 19 | 0% |
| Kaposi's sarcoma AIDS related | 1 | 0% |
| Karnofsky scale | 8 | 0% |
| Karyotype analysis | 43 | 0% |
| Karyotype analysis normal | 3 | 0% |
| Kawasaki's disease | 58 | 0% |
| Kearns-Sayre syndrome | 2 | 0% |
| Keloid scar | 15 | 0% |
| Keratic precipitates | 2 | 0% |
| Keratinising squamous cell carcinoma of nasopharynx | 1 | 0% |
| Keratitis | 102 | 0.01% |
| Keratitis bacterial | 2 | 0% |
| Keratitis interstitial | 3 | 0% |
| Keratitis viral | 6 | 0% |
| Keratoacanthoma | 14 | 0% |
| Keratoconus | 18 | 0% |
| Keratoderma blenorrhagica | 1 | 0% |
| Keratolysis exfoliativa acquired | 2 | 0% |
| Keratometry | 1 | 0% |
| Keratomileusis | 5 | 0% |
| Keratoneuralgia | 1 | 0% |
| Keratopathy | 1 | 0% |
| Keratoplasty | 1 | 0% |
| Keratosis follicular | 6 | 0% |
| Keratosis obturans | 1 | 0% |
| Keratosis pilaris | 26 | 0% |
| Keratouveitis | 6 | 0% |
| Kernig's sign | 6 | 0% |
| Ketoacidosis | 66 | 0% |
| Ketogenic diet | 3 | 0% |
| Ketonuria | 18 | 0% |
| Ketosis | 18 | 0% |
| Ketosis-prone diabetes mellitus | 3 | 0% |
| Kidney ablation | 1 | 0% |
| Kidney congestion | 4 | 0% |
| Kidney contusion | 2 | 0% |
| Kidney duplex | 7 | 0% |
| Kidney enlargement | 25 | 0% |
| Kidney fibrosis | 12 | 0% |
| Kidney infection | 360 | 0.02% |
| Kidney malformation | 7 | 0% |
| Kidney rupture | 3 | 0% |
| Kidney small | 4 | 0% |
| Kidney transplant rejection | 12 | 0% |
| Killip classification | 2 | 0% |
| Kinesiophobia | 1 | 0% |
| Kinesitherapy | 5 | 0% |
| KL-6 | 73 | 0% |
| KL-6 increased | 2 | 0% |
| Klebsiella bacteraemia | 9 | 0% |
| Klebsiella infection | 87 | 0.01% |
| Klebsiella sepsis | 5 | 0% |
| Klebsiella test | 20 | 0% |
| Klebsiella test positive | 88 | 0.01% |
| Klebsiella urinary tract infection | 4 | 0% |
| Kleihauer-Betke test | 7 | 0% |
| Kleihauer-Betke test negative | 4 | 0% |
| Klinefelter's syndrome | 1 | 0% |
| Knee arthroplasty | 111 | 0.01% |
| Knee deformity | 11 | 0% |
| Knee impingement syndrome | 1 | 0% |
| Knee operation | 52 | 0% |
| Knuckle pads | 3 | 0% |
| Koebner phenomenon | 5 | 0% |
| Kohler's disease | 1 | 0% |
| Korsakoff's syndrome | 2 | 0% |
| Kounis syndrome | 10 | 0% |
| Kussmaul respiration | 3 | 0% |
| Kyphoscoliosis | 6 | 0% |
| Kyphosis | 33 | 0% |
| Labelled drug-drug interaction issue | 2 | 0% |
| Labelled drug-drug interaction medication error | 1 | 0% |
| Labelled drug-food interaction medication error | 1 | 0% |
| Labia enlarged | 14 | 0% |
| Labial tie | 5 | 0% |
| Labile blood pressure | 111 | 0.01% |
| Labile hypertension | 30 | 0% |
| Laboratory test | 15,386 | 0.94% |
| Laboratory test abnormal | 1,925 | 0.12% |
| Laboratory test interference | 4 | 0% |
| Laboratory test normal | 3,407 | 0.21% |
| Labour augmentation | 2 | 0% |
| Labour complication | 7 | 0% |
| Labour induction | 78 | 0% |
| Labour pain | 171 | 0.01% |
| Labour stimulation | 3 | 0% |
| Labyrinthine fistula | 1 | 0% |
| Labyrinthitis | 324 | 0.02% |
| Lack of administration site rotation | 1 | 0% |
| Lack of injection site rotation | 3 | 0% |
| Lack of satiety | 7 | 0% |
| Lack of spontaneous speech | 65 | 0% |
| Lack of vaccination site rotation | 3 | 0% |
| Lacrimal disorder | 19 | 0% |
| Lacrimal gland enlargement | 5 | 0% |
| Lacrimal gland operation | 1 | 0% |
| Lacrimal haemorrhage | 2 | 0% |
| Lacrimal structural disorder | 1 | 0% |
| Lacrimation decreased | 17 | 0% |
| Lacrimation disorder | 9 | 0% |
| Lacrimation increased | 2,231 | 0.14% |
| Lactase deficiency | 1 | 0% |
| Lactate dehydrogenase urine | 1 | 0% |
| Lactate pyruvate ratio | 1 | 0% |
| Lactation disorder | 76 | 0% |
| Lactation insufficiency | 7 | 0% |
| Lactation puerperal increased | 13 | 0% |
| Lactescent serum | 2 | 0% |
| Lactic acidosis | 428 | 0.03% |
| Lactobacillus infection | 2 | 0% |
| Lactobacillus test positive | 4 | 0% |
| Lactose intolerance | 81 | 0% |
| Lactose tolerance test | 10 | 0% |
| Lactose tolerance test abnormal | 1 | 0% |
| Lacunar infarction | 232 | 0.01% |
| Lacunar stroke | 181 | 0.01% |
| Laevocardia | 1 | 0% |
| Lagophthalmos | 94 | 0.01% |
| Lambl's excrescences | 1 | 0% |
| Laminaplasty | 2 | 0% |
| Langerhans' cell histiocytosis | 8 | 0% |
| Language disorder | 535 | 0.03% |
| Laparoscopic surgery | 146 | 0.01% |
| Laparoscopy | 88 | 0.01% |
| Laparoscopy abnormal | 5 | 0% |
| Laparoscopy normal | 1 | 0% |
| Laparotomy | 27 | 0% |
| Large cell lung cancer | 1 | 0% |
| Large fibre neuropathy | 2 | 0% |
| Large for dates baby | 12 | 0% |
| Large granular lymphocytosis | 3 | 0% |
| Large intestinal haemorrhage | 23 | 0% |
| Large intestinal obstruction | 21 | 0% |
| Large intestinal obstruction reduction | 1 | 0% |
| Large intestinal polypectomy | 9 | 0% |
| Large intestinal stenosis | 13 | 0% |
| Large intestinal ulcer | 23 | 0% |
| Large intestinal ulcer haemorrhage | 5 | 0% |
| Large intestine anastomosis | 6 | 0% |
| Large intestine benign neoplasm | 1 | 0% |
| Large intestine erosion | 2 | 0% |
| Large intestine infection | 39 | 0% |
| Large intestine operation | 2 | 0% |
| Large intestine perforation | 57 | 0% |
| Large intestine polyp | 94 | 0.01% |
| Laryngeal cancer | 11 | 0% |
| Laryngeal cancer stage IV | 2 | 0% |
| Laryngeal discomfort | 79 | 0% |
| Laryngeal disorder | 21 | 0% |
| Laryngeal dyspnoea | 10 | 0% |
| Laryngeal erythema | 3 | 0% |
| Laryngeal haematoma | 3 | 0% |
| Laryngeal haemorrhage | 3 | 0% |
| Laryngeal inflammation | 23 | 0% |
| Laryngeal injury | 4 | 0% |
| Laryngeal mask airway insertion | 2 | 0% |
| Laryngeal mass | 1 | 0% |
| Laryngeal neoplasm | 4 | 0% |
| Laryngeal nerve dysfunction | 1 | 0% |
| Laryngeal nerve palsy | 3 | 0% |
| Laryngeal obstruction | 23 | 0% |
| Laryngeal oedema | 593 | 0.04% |
| Laryngeal pain | 54 | 0% |
| Laryngeal papilloma | 2 | 0% |
| Laryngeal squamous cell carcinoma | 1 | 0% |
| Laryngeal stenosis | 19 | 0% |
| Laryngeal stroboscopy | 6 | 0% |
| Laryngeal tremor | 2 | 0% |
| Laryngeal ulceration | 3 | 0% |
| Laryngeal ventricle prolapse | 1 | 0% |
| Laryngectomy | 1 | 0% |
| Laryngitis | 441 | 0.03% |
| Laryngitis allergic | 4 | 0% |
| Laryngitis bacterial | 1 | 0% |
| Laryngitis viral | 5 | 0% |
| Laryngomalacia | 7 | 0% |
| Laryngopharyngitis | 7 | 0% |
| Laryngoplasty | 1 | 0% |
| Laryngoscopy | 106 | 0.01% |
| Laryngoscopy abnormal | 16 | 0% |
| Laryngoscopy normal | 7 | 0% |
| Laryngospasm | 138 | 0.01% |
| Laryngotracheal oedema | 1 | 0% |
| Laryngotracheobronchoscopy | 1 | 0% |
| Larynx irritation | 39 | 0% |
| Lasegue's test | 30 | 0% |
| Lasegue's test positive | 5 | 0% |
| Laser brain ablation | 1 | 0% |
| Laser doppler flowmetry | 2 | 0% |
| Laser speckle contrast imaging | 2 | 0% |
| Laser therapy | 9 | 0% |
| Latent autoimmune diabetes in adults | 31 | 0% |
| Latent tetany | 1 | 0% |
| Latent tuberculosis | 14 | 0% |
| Lateral medullary syndrome | 32 | 0% |
| Lateral position | 2 | 0% |
| Lateropulsion | 5 | 0% |
| Laziness | 70 | 0% |
| LDL/HDL ratio | 40 | 0% |
| LDL/HDL ratio decreased | 3 | 0% |
| LDL/HDL ratio increased | 2 | 0% |
| Lead dislodgement | 2 | 0% |
| Lead urine increased | 1 | 0% |
| Lead urine normal | 1 | 0% |
| Learning disability | 6 | 0% |
| Learning disorder | 14 | 0% |
| LE cells | 9 | 0% |
| LE cells present | 3 | 0% |
| Left-to-right cardiac shunt | 3 | 0% |
| Left atrial appendage closure implant | 20 | 0% |
| Left atrial dilatation | 81 | 0% |
| Left atrial enlargement | 129 | 0.01% |
| Left atrial hypertrophy | 3 | 0% |
| Left atrial volume increased | 4 | 0% |
| Left ventricle outflow tract obstruction | 4 | 0% |
| Left ventricular dilatation | 99 | 0.01% |
| Left ventricular dysfunction | 461 | 0.03% |
| Left ventricular end-diastolic pressure | 27 | 0% |
| Left ventricular end-diastolic pressure decreased | 3 | 0% |
| Left ventricular end-diastolic pressure increased | 34 | 0% |
| Left ventricular enlargement | 29 | 0% |
| Left ventricular failure | 484 | 0.03% |
| Left ventricular false tendon | 2 | 0% |
| Left ventricular hypertrophy | 293 | 0.02% |
| Legal problem | 1 | 0% |
| Leg amputation | 84 | 0.01% |
| Legionella infection | 14 | 0% |
| Legionella test | 386 | 0.02% |
| Legionella test positive | 5 | 0% |
| Leiomyoma | 28 | 0% |
| Leiomyosarcoma | 16 | 0% |
| Leiomyosarcoma metastatic | 2 | 0% |
| Lemierre syndrome | 4 | 0% |
| Length at birth | 8 | 0% |
| Lennox-Gastaut syndrome | 2 | 0% |
| Lens dislocation | 1 | 0% |
| Lens disorder | 4 | 0% |
| Lens extraction | 2 | 0% |
| Lenticular opacities | 13 | 0% |
| Lentigo | 1 | 0% |
| Lentigo maligna | 6 | 0% |
| Lepromatous leprosy | 1 | 0% |
| Leprosy | 2 | 0% |
| Leptospira test | 49 | 0% |
| Leptospirosis | 15 | 0% |
| Leriche syndrome | 8 | 0% |
| Leser-Trelat sign | 1 | 0% |
| Lesion excision | 8 | 0% |
| Lethargy | 14,143 | 0.86% |
| Leucine aminopeptidase | 7 | 0% |
| Leucine aminopeptidase increased | 1 | 0% |
| Leukaemia | 168 | 0.01% |
| Leukaemia in remission | 1 | 0% |
| Leukaemia monocytic | 3 | 0% |
| Leukaemia recurrent | 10 | 0% |
| Leukaemic infiltration | 1 | 0% |
| Leukaemic lymphoma | 1 | 0% |
| Leukaemoid reaction | 3 | 0% |
| Leukapheresis | 1 | 0% |
| Leukocyte alkaline phosphatase | 4 | 0% |
| Leukocyte alkaline phosphatase increased | 1 | 0% |
| Leukocyte vacuolisation | 1 | 0% |
| Leukocytosis | 1,230 | 0.07% |
| Leukocyturia | 61 | 0% |
| Leukoderma | 3 | 0% |
| Leukoencephalopathy | 56 | 0% |
| Leukoerythroblastic anaemia | 1 | 0% |
| Leukonychia | 3 | 0% |
| Leukopenia | 577 | 0.04% |
| Leukoplakia | 9 | 0% |
| Leukoplakia oral | 17 | 0% |
| Leukostasis syndrome | 3 | 0% |
| Leukotriene increased | 1 | 0% |
| Leukotriene test | 4 | 0% |
| Lewis-Sumner syndrome | 5 | 0% |
| Lhermitte's sign | 39 | 0% |
| Libido decreased | 165 | 0.01% |
| Libido disorder | 17 | 0% |
| Libido increased | 17 | 0% |
| Lice infestation | 5 | 0% |
| Lichenification | 8 | 0% |
| Lichen nitidus | 3 | 0% |
| Lichenoid dysplasia | 1 | 0% |
| Lichenoid keratosis | 78 | 0% |
| Lichen planopilaris | 39 | 0% |
| Lichen planus | 323 | 0.02% |
| Lichen planus pemphigoides | 2 | 0% |
| Lichen sclerosus | 121 | 0.01% |
| Lichen striatus | 3 | 0% |
| Lid lag | 2 | 0% |
| Lid margin discharge | 1 | 0% |
| Lid sulcus deepened | 19 | 0% |
| Life expectancy shortened | 10 | 0% |
| Life support | 178 | 0.01% |
| Ligament calcification | 3 | 0% |
| Ligament disorder | 30 | 0% |
| Ligament injury | 26 | 0% |
| Ligamentitis | 14 | 0% |
| Ligament laxity | 3 | 0% |
| Ligament operation | 7 | 0% |
| Ligament pain | 54 | 0% |
| Ligament rupture | 57 | 0% |
| Ligament sprain | 243 | 0.01% |
| Ligamentum flavum hypertrophy | 4 | 0% |
| Ligase chain reaction test | 2 | 0% |
| Light anaesthesia | 1 | 0% |
| Light chain analysis | 160 | 0.01% |
| Light chain analysis abnormal | 9 | 0% |
| Light chain analysis increased | 22 | 0% |
| Light chain analysis normal | 12 | 0% |
| Light chain disease | 2 | 0% |
| Limbal swelling | 9 | 0% |
| Limb amputation | 6 | 0% |
| Limb asymmetry | 3 | 0% |
| Limb crushing injury | 10 | 0% |
| Limb deformity | 34 | 0% |
| Limb discomfort | 12,223 | 0.74% |
| Limb fracture | 2 | 0% |
| Limb girth decreased | 1 | 0% |
| Limb girth increased | 5 | 0% |
| Limb hypoplasia congenital | 1 | 0% |
| Limbic encephalitis | 49 | 0% |
| Limb immobilisation | 113 | 0.01% |
| Limb injury | 1,262 | 0.08% |
| Limb malformation | 6 | 0% |
| Limb mass | 597 | 0.04% |
| Limb operation | 57 | 0% |
| Limb prosthesis user | 1 | 0% |
| Limb reconstructive surgery | 2 | 0% |
| Limb reduction defect | 5 | 0% |
| Limited symptom panic attack | 1 | 0% |
| Linear IgA disease | 12 | 0% |
| Lipaemic index score | 21 | 0% |
| Lip and/or oral cavity cancer | 15 | 0% |
| Lip and/or oral cavity cancer recurrent | 1 | 0% |
| Lipase | 1,041 | 0.06% |
| Lipase abnormal | 8 | 0% |
| Lipase decreased | 16 | 0% |
| Lipase increased | 273 | 0.02% |
| Lipase normal | 313 | 0.02% |
| Lipase urine | 2 | 0% |
| Lip blister | 385 | 0.02% |
| Lip cosmetic procedure | 3 | 0% |
| Lip discolouration | 146 | 0.01% |
| Lip disorder | 212 | 0.01% |
| Lip dry | 305 | 0.02% |
| Lipectomy | 2 | 0% |
| Lip erosion | 10 | 0% |
| Lip erythema | 208 | 0.01% |
| Lip exfoliation | 81 | 0% |
| Lip haematoma | 5 | 0% |
| Lip haemorrhage | 80 | 0% |
| Lipid metabolism disorder | 6 | 0% |
| Lipids | 698 | 0.04% |
| Lipids abnormal | 29 | 0% |
| Lipids decreased | 4 | 0% |
| Lipids increased | 29 | 0% |
| Lipids normal | 171 | 0.01% |
| Lip infection | 5 | 0% |
| Lip injury | 172 | 0.01% |
| Lip lesion excision | 2 | 0% |
| Lip neoplasm malignant stage unspecified | 3 | 0% |
| Lipoatrophy | 13 | 0% |
| Lipodystrophy acquired | 9 | 0% |
| Lipoedema | 79 | 0% |
| Lip oedema | 470 | 0.03% |
| Lipohypertrophy | 3 | 0% |
| Lipoma | 167 | 0.01% |
| Lipoma excision | 8 | 0% |
| Lipomatosis | 6 | 0% |
| Lip operation | 1 | 0% |
| Lipoprotein (a) | 94 | 0.01% |
| Lipoprotein (a) increased | 9 | 0% |
| Lipoprotein (a) normal | 2 | 0% |
| Lipoprotein-associated phospholipase A2 | 8 | 0% |
| Lipoprotein abnormal | 2 | 0% |
| Lipoprotein deficiency | 1 | 0% |
| Lipoprotein increased | 2 | 0% |
| Liposarcoma | 6 | 0% |
| Liposuction | 1 | 0% |
| Lip pain | 431 | 0.03% |
| Lip pruritus | 487 | 0.03% |
| Lip scab | 10 | 0% |
| Lip swelling | 7,456 | 0.45% |
| Lip ulceration | 59 | 0% |
| Liquid product physical issue | 22 | 0% |
| Lissencephaly | 1 | 0% |
| Listeria test | 40 | 0% |
| Listeria test positive | 3 | 0% |
| Listeriosis | 5 | 0% |
| Listless | 594 | 0.04% |
| Lithiasis | 23 | 0% |
| Lithotripsy | 28 | 0% |
| Live birth | 47 | 0% |
| Livedo reticularis | 375 | 0.02% |
| Liver-kidney microsomal antibody | 33 | 0% |
| Liver-kidney microsomal antibody positive | 1 | 0% |
| Liver abscess | 41 | 0% |
| Liver carcinoma ruptured | 1 | 0% |
| Liver contusion | 3 | 0% |
| Liver disorder | 512 | 0.03% |
| Liver function test | 2,926 | 0.18% |
| Liver function test abnormal | 448 | 0.03% |
| Liver function test decreased | 17 | 0% |
| Liver function test increased | 602 | 0.04% |
| Liver function test normal | 415 | 0.03% |
| Liver induration | 1 | 0% |
| Liver injury | 263 | 0.02% |
| Liver iron concentration decreased | 1 | 0% |
| Liver iron concentration increased | 1 | 0% |
| Liver opacity | 2 | 0% |
| Liver operation | 1 | 0% |
| Liver palpable | 1 | 0% |
| Liver sarcoidosis | 7 | 0% |
| Liver scan | 42 | 0% |
| Liver scan abnormal | 5 | 0% |
| Liver scan normal | 4 | 0% |
| Liver tenderness | 11 | 0% |
| Liver transplant | 18 | 0% |
| Liver transplant failure | 2 | 0% |
| Liver transplant rejection | 13 | 0% |
| Lividity | 64 | 0% |
| Living alone | 5 | 0% |
| Living in residential institution | 2 | 0% |
| Lobular breast carcinoma in situ | 8 | 0% |
| Local anaesthesia | 8 | 0% |
| Localised alternating hot and cold therapy | 3 | 0% |
| Localised infection | 310 | 0.02% |
| Localised oedema | 471 | 0.03% |
| Local reaction | 838 | 0.05% |
| Lochial infection | 1 | 0% |
| Locked-in syndrome | 11 | 0% |
| Locomotive syndrome | 4 | 0% |
| Loeffler's syndrome | 1 | 0% |
| Loefgren syndrome | 32 | 0% |
| Logorrhoea | 50 | 0% |
| Long QT syndrome | 24 | 0% |
| Long thoracic nerve palsy | 7 | 0% |
| Loop electrosurgical excision procedure | 2 | 0% |
| Loopogram | 1 | 0% |
| Loose associations | 1 | 0% |
| Loose body in joint | 7 | 0% |
| Loose tooth | 57 | 0% |
| Lordosis | 19 | 0% |
| Loss of bladder sensation | 44 | 0% |
| Loss of consciousness | 22,599 | 1.37% |
| Loss of control of legs | 209 | 0.01% |
| Loss of dreaming | 5 | 0% |
| Loss of employment | 48 | 0% |
| Loss of libido | 148 | 0.01% |
| Loss of personal independence in daily activities | 9,640 | 0.59% |
| Loss of proprioception | 43 | 0% |
| Loss of therapeutic response | 7 | 0% |
| Loss of visual contrast sensitivity | 4 | 0% |
| Low birth weight baby | 20 | 0% |
| Low carbohydrate diet | 10 | 0% |
| Low cardiac output syndrome | 15 | 0% |
| Low density lipoprotein | 1,689 | 0.1% |
| Low density lipoprotein abnormal | 3 | 0% |
| Low density lipoprotein decreased | 13 | 0% |
| Low density lipoprotein increased | 211 | 0.01% |
| Low density lipoprotein normal | 138 | 0.01% |
| Lower gastrointestinal haemorrhage | 45 | 0% |
| Lower gastrointestinal perforation | 1 | 0% |
| Lower limb artery perforation | 2 | 0% |
| Lower limb fracture | 97 | 0.01% |
| Lower motor neurone lesion | 8 | 0% |
| Lower oesophageal sphincter magnetic augmentation | 1 | 0% |
| Lower respiratory tract congestion | 163 | 0.01% |
| Lower respiratory tract infection | 859 | 0.05% |
| Lower respiratory tract infection bacterial | 4 | 0% |
| Lower respiratory tract infection viral | 3 | 0% |
| Lower respiratory tract inflammation | 3 | 0% |
| Lower urinary tract symptoms | 62 | 0% |
| Low income | 1 | 0% |
| Low lung compliance | 3 | 0% |
| Low set ears | 1 | 0% |
| Ludwig angina | 3 | 0% |
| Lumbar artery embolisation | 1 | 0% |
| Lumbar hernia | 1 | 0% |
| Lumbar puncture | 3,232 | 0.2% |
| Lumbar puncture abnormal | 308 | 0.02% |
| Lumbar puncture normal | 226 | 0.01% |
| Lumbar radiculopathy | 52 | 0% |
| Lumbar spinal drainage complication | 2 | 0% |
| Lumbar spinal stenosis | 77 | 0% |
| Lumbar vertebral fracture | 47 | 0% |
| Lumboperitoneal shunt | 1 | 0% |
| Lumbosacral plexopathy | 10 | 0% |
| Lumbosacral plexus injury | 3 | 0% |
| Lumbosacral radiculopathy | 22 | 0% |
| Lumbosacral radiculoplexus neuropathy | 9 | 0% |
| Lung abscess | 28 | 0% |
| Lung adenocarcinoma | 66 | 0% |
| Lung adenocarcinoma recurrent | 2 | 0% |
| Lung adenocarcinoma stage III | 1 | 0% |
| Lung adenocarcinoma stage IV | 8 | 0% |
| Lung assist device therapy | 52 | 0% |
| Lung cancer metastatic | 53 | 0% |
| Lung carcinoma cell type unspecified recurrent | 11 | 0% |
| Lung carcinoma cell type unspecified stage 0 | 5 | 0% |
| Lung carcinoma cell type unspecified stage I | 1 | 0% |
| Lung carcinoma cell type unspecified stage II | 1 | 0% |
| Lung carcinoma cell type unspecified stage III | 2 | 0% |
| Lung carcinoma cell type unspecified stage IV | 20 | 0% |
| Lung consolidation | 544 | 0.03% |
| Lung cyst | 14 | 0% |
| Lung diffusion disorder | 13 | 0% |
| Lung diffusion test | 52 | 0% |
| Lung diffusion test abnormal | 2 | 0% |
| Lung diffusion test decreased | 3 | 0% |
| Lung disorder | 1,769 | 0.11% |
| Lung hernia | 1 | 0% |
| Lung hyperinflation | 106 | 0.01% |
| Lung hypoinflation | 23 | 0% |
| Lung induration | 1 | 0% |
| Lung infiltration | 1,680 | 0.1% |
| Lung infiltration malignant | 1 | 0% |
| Lung lobectomy | 16 | 0% |
| Lung neoplasm | 16 | 0% |
| Lung neoplasm malignant | 254 | 0.02% |
| Lung neoplasm surgery | 1 | 0% |
| Lung opacity | 2,507 | 0.15% |
| Lung operation | 14 | 0% |
| Lung perforation | 3 | 0% |
| Lung squamous cell carcinoma stage IV | 1 | 0% |
| Lung transplant | 8 | 0% |
| Lung transplant rejection | 5 | 0% |
| Lupus-like syndrome | 46 | 0% |
| Lupus anticoagulant hypoprothrombinaemia syndrome | 2 | 0% |
| Lupus cystitis | 1 | 0% |
| Lupus endocarditis | 2 | 0% |
| Lupus hepatitis | 1 | 0% |
| Lupus miliaris disseminatus faciei | 1 | 0% |
| Lupus myositis | 1 | 0% |
| Lupus nephritis | 43 | 0% |
| Lupus vasculitis | 2 | 0% |
| Lupus vulgaris | 1 | 0% |
| Luteal phase deficiency | 4 | 0% |
| Lyme carditis | 3 | 0% |
| Lyme disease | 529 | 0.03% |
| Lymphadenectomy | 83 | 0.01% |
| Lymphadenitis | 1,226 | 0.07% |
| Lymphadenitis bacterial | 11 | 0% |
| Lymphadenitis viral | 3 | 0% |
| Lymphadenopathy | 43,318 | 2.63% |
| Lymphadenopathy mediastinal | 207 | 0.01% |
| Lymphangiectasia | 2 | 0% |
| Lymphangiogram | 3 | 0% |
| Lymphangioleiomyomatosis | 2 | 0% |
| Lymphangioma | 8 | 0% |
| Lymphangiopathy | 4 | 0% |
| Lymphangiosis carcinomatosa | 3 | 0% |
| Lymphangitis | 249 | 0.02% |
| Lymphatic disorder | 78 | 0% |
| Lymphatic duct injury | 1 | 0% |
| Lymphatic fistula | 9 | 0% |
| Lymphatic insufficiency | 5 | 0% |
| Lymphatic malformation | 3 | 0% |
| Lymphatic mapping | 6 | 0% |
| Lymphatic obstruction | 8 | 0% |
| Lymphatic system neoplasm | 3 | 0% |
| Lymph gland infection | 54 | 0% |
| Lymph node abscess | 55 | 0% |
| Lymph node calcification | 25 | 0% |
| Lymph node fibrosis | 1 | 0% |
| Lymph node haemorrhage | 4 | 0% |
| Lymph node pain | 8,847 | 0.54% |
| Lymph node palpable | 108 | 0.01% |
| Lymph node rupture | 5 | 0% |
| Lymph nodes scan abnormal | 14 | 0% |
| Lymph nodes scan normal | 3 | 0% |
| Lymph node tuberculosis | 4 | 0% |
| Lymph node ulcer | 3 | 0% |
| Lymphoblast count | 9 | 0% |
| Lymphocele | 7 | 0% |
| Lymphocyte count | 3,088 | 0.19% |
| Lymphocyte count abnormal | 22 | 0% |
| Lymphocyte count decreased | 571 | 0.03% |
| Lymphocyte count increased | 224 | 0.01% |
| Lymphocyte count normal | 294 | 0.02% |
| Lymphocyte morphology | 21 | 0% |
| Lymphocyte morphology abnormal | 67 | 0% |
| Lymphocyte percentage | 621 | 0.04% |
| Lymphocyte percentage abnormal | 3 | 0% |
| Lymphocyte percentage decreased | 608 | 0.04% |
| Lymphocyte percentage increased | 86 | 0.01% |
| Lymphocyte stimulation test | 37 | 0% |
| Lymphocyte stimulation test negative | 2 | 0% |
| Lymphocyte stimulation test positive | 2 | 0% |
| Lymphocyte transformation test | 28 | 0% |
| Lymphocytic hypophysitis | 6 | 0% |
| Lymphocytic infiltration | 29 | 0% |
| Lymphocytic leukaemia | 10 | 0% |
| Lymphocytic lymphoma | 2 | 0% |
| Lymphocytosis | 111 | 0.01% |
| Lymphoedema | 838 | 0.05% |
| Lymphoid hyperplasia of intestine | 2 | 0% |
| Lymphoid tissue hyperplasia | 15 | 0% |
| Lymphoid tissue operation | 2 | 0% |
| Lymphoma | 411 | 0.02% |
| Lymphomatoid papulosis | 16 | 0% |
| Lymphopenia | 455 | 0.03% |
| Lymphoplasia | 1 | 0% |
| Lymphoplasmacytoid lymphoma/immunocytoma | 4 | 0% |
| Lymphoplasmacytoid lymphoma/immunocytoma stage IV | 1 | 0% |
| Lymphoproliferative disorder | 19 | 0% |
| Lymphorrhoea | 11 | 0% |
| Lymphostasis | 6 | 0% |
| Lysozyme | 37 | 0% |
| Lysozyme increased | 2 | 0% |
| Macroamylasaemia | 1 | 0% |
| Macroangiopathy | 10 | 0% |
| Macrocephaly | 10 | 0% |
| Macrocytosis | 36 | 0% |
| Macroglossia | 31 | 0% |
| Macrophage activation | 2 | 0% |
| Macrophage count | 20 | 0% |
| Macrophage inflammatory protein-1 alpha decreased | 1 | 0% |
| Macrophage inflammatory protein-1 alpha increased | 1 | 0% |
| Macrophages increased | 3 | 0% |
| Macrosomia | 3 | 0% |
| Macular cherry-red spots | 3 | 0% |
| Macular cyst | 1 | 0% |
| Macular degeneration | 122 | 0.01% |
| Macular detachment | 10 | 0% |
| Macular fibrosis | 10 | 0% |
| Macular hole | 29 | 0% |
| Macular ischaemia | 3 | 0% |
| Macular oedema | 219 | 0.01% |
| Macular opacity | 1 | 0% |
| Macular pseudohole | 1 | 0% |
| Macular rupture | 4 | 0% |
| Macular scar | 3 | 0% |
| Macular telangiectasia | 1 | 0% |
| Macular thickening | 1 | 0% |
| Macula thickness measurement | 9 | 0% |
| Macule | 116 | 0.01% |
| Maculopathy | 44 | 0% |
| Madarosis | 81 | 0% |
| MAGIC syndrome | 3 | 0% |
| Magnesium deficiency | 15 | 0% |
| Magnetic resonance cholangiopancreatography | 123 | 0.01% |
| Magnetic resonance elastography | 7 | 0% |
| Magnetic resonance imaging | 20,748 | 1.26% |
| Magnetic resonance imaging abdominal | 263 | 0.02% |
| Magnetic resonance imaging abdominal abnormal | 61 | 0% |
| Magnetic resonance imaging abdominal normal | 25 | 0% |
| Magnetic resonance imaging abnormal | 1,263 | 0.08% |
| Magnetic resonance imaging brain | 164 | 0.01% |
| Magnetic resonance imaging brain abnormal | 75 | 0% |
| Magnetic resonance imaging brain normal | 67 | 0% |
| Magnetic resonance imaging breast | 34 | 0% |
| Magnetic resonance imaging breast abnormal | 22 | 0% |
| Magnetic resonance imaging breast normal | 6 | 0% |
| Magnetic resonance imaging ear | 6 | 0% |
| Magnetic resonance imaging head | 8,852 | 0.54% |
| Magnetic resonance imaging head abnormal | 1,815 | 0.11% |
| Magnetic resonance imaging head normal | 1,614 | 0.1% |
| Magnetic resonance imaging heart | 3,193 | 0.19% |
| Magnetic resonance imaging heart abnormal | 7 | 0% |
| Magnetic resonance imaging hepatobiliary | 58 | 0% |
| Magnetic resonance imaging hepatobiliary abnormal | 10 | 0% |
| Magnetic resonance imaging joint | 125 | 0.01% |
| Magnetic resonance imaging neck | 979 | 0.06% |
| Magnetic resonance imaging neck normal | 2 | 0% |
| Magnetic resonance imaging normal | 1,740 | 0.11% |
| Magnetic resonance imaging pancreas | 15 | 0% |
| Magnetic resonance imaging pelvic | 23 | 0% |
| Magnetic resonance imaging renal | 12 | 0% |
| Magnetic resonance imaging spinal | 1,400 | 0.09% |
| Magnetic resonance imaging spinal abnormal | 461 | 0.03% |
| Magnetic resonance imaging spinal normal | 292 | 0.02% |
| Magnetic resonance imaging thoracic | 180 | 0.01% |
| Magnetic resonance imaging thoracic abnormal | 59 | 0% |
| Magnetic resonance imaging thoracic normal | 30 | 0% |
| Magnetic resonance imaging whole body | 23 | 0% |
| Magnetic resonance neurography | 40 | 0% |
| Magnetic therapy | 5 | 0% |
| Maisonneuve fracture | 1 | 0% |
| Major depression | 173 | 0.01% |
| Malabsorption | 38 | 0% |
| Malaise | 63,574 | 3.87% |
| Malaria | 16 | 0% |
| Malaria antibody test | 2 | 0% |
| Malaria antibody test negative | 3 | 0% |
| Malaria antibody test positive | 1 | 0% |
| Malaria antigen test | 17 | 0% |
| Malaria recrudescence | 2 | 0% |
| Malaria relapse | 4 | 0% |
| Malassezia infection | 1 | 0% |
| Male genital examination abnormal | 2 | 0% |
| Male genital tract smear | 1 | 0% |
| Male reproductive tract disorder | 2 | 0% |
| Male sexual dysfunction | 6 | 0% |
| Malformation venous | 6 | 0% |
| Malignant ascites | 13 | 0% |
| Malignant atrophic papulosis | 1 | 0% |
| Malignant dysphagia | 2 | 0% |
| Malignant fibrous histiocytoma | 1 | 0% |
| Malignant gastrointestinal obstruction | 1 | 0% |
| Malignant glioma | 1 | 0% |
| Malignant hypertension | 38 | 0% |
| Malignant lymphoid neoplasm | 6 | 0% |
| Malignant melanoma | 87 | 0.01% |
| Malignant melanoma in situ | 16 | 0% |
| Malignant melanoma stage IV | 4 | 0% |
| Malignant middle cerebral artery syndrome | 1 | 0% |
| Malignant neoplasm of ampulla of Vater | 5 | 0% |
| Malignant neoplasm of eye | 1 | 0% |
| Malignant neoplasm of pleura | 2 | 0% |
| Malignant neoplasm of renal pelvis | 2 | 0% |
| Malignant neoplasm of spinal cord | 2 | 0% |
| Malignant neoplasm of thorax | 2 | 0% |
| Malignant neoplasm of unknown primary site | 5 | 0% |
| Malignant neoplasm progression | 34 | 0% |
| Malignant neoplasm removal | 2 | 0% |
| Malignant nervous system neoplasm | 2 | 0% |
| Malignant nipple neoplasm female | 1 | 0% |
| Malignant oligodendroglioma | 1 | 0% |
| Malignant palate neoplasm | 1 | 0% |
| Malignant peritoneal neoplasm | 14 | 0% |
| Malignant pleural effusion | 26 | 0% |
| Malignant respiratory tract neoplasm | 1 | 0% |
| Malignant transformation | 1 | 0% |
| Malignant urinary tract neoplasm metastatic | 1 | 0% |
| Mallampati score | 1 | 0% |
| Mallet finger | 2 | 0% |
| Mallory-Weiss syndrome | 17 | 0% |
| Malnutrition | 325 | 0.02% |
| Malocclusion | 15 | 0% |
| Malpositioned teeth | 3 | 0% |
| Mammary duct ectasia | 8 | 0% |
| Mammary ductectomy | 2 | 0% |
| Mammogram | 1,177 | 0.07% |
| Mammogram abnormal | 352 | 0.02% |
| Mammogram normal | 206 | 0.01% |
| Mammoplasty | 7 | 0% |
| Man-in-the-barrel syndrome | 2 | 0% |
| Mandibular mass | 12 | 0% |
| Manganese | 5 | 0% |
| Mania | 140 | 0.01% |
| Manic symptom | 4 | 0% |
| Manifest refraction | 2 | 0% |
| Manipulation | 5 | 0% |
| Mannose-binding lectin deficiency | 1 | 0% |
| Mantle cell lymphoma | 27 | 0% |
| Mantle cell lymphoma recurrent | 4 | 0% |
| Manual lymphatic drainage | 11 | 0% |
| Manufacturing issue | 12 | 0% |
| Manufacturing laboratory controls issue | 1 | 0% |
| Manufacturing materials issue | 1 | 0% |
| Manufacturing product shipping issue | 31 | 0% |
| Marasmus | 39 | 0% |
| Marcus Gunn syndrome | 1 | 0% |
| Marfan's syndrome | 2 | 0% |
| Marginal zone lymphoma | 7 | 0% |
| Marginal zone lymphoma stage I | 1 | 0% |
| Marital problem | 6 | 0% |
| Marjolin's ulcer | 1 | 0% |
| Marrow hyperplasia | 9 | 0% |
| Mass | 1,723 | 0.1% |
| Massage | 34 | 0% |
| Mass excision | 51 | 0% |
| Mast cell activation syndrome | 353 | 0.02% |
| Mast cell degranulation present | 5 | 0% |
| Mast cell degranulation test | 6 | 0% |
| Mastectomy | 45 | 0% |
| Mastication disorder | 358 | 0.02% |
| Masticatory pain | 6 | 0% |
| Mastitis | 500 | 0.03% |
| Mastitis bacterial | 3 | 0% |
| Mastitis postpartum | 4 | 0% |
| Mastocytic enterocolitis | 1 | 0% |
| Mastocytosis | 24 | 0% |
| Mastoid disorder | 15 | 0% |
| Mastoidectomy | 3 | 0% |
| Mastoid effusion | 14 | 0% |
| Mastoid exploration | 1 | 0% |
| Mastoiditis | 51 | 0% |
| Mastoptosis | 2 | 0% |
| Maternal body mass index | 1 | 0% |
| Maternal condition affecting foetus | 6 | 0% |
| Maternal death during childbirth | 2 | 0% |
| Maternal drugs affecting foetus | 1 | 0% |
| Maternal exposure before pregnancy | 591 | 0.04% |
| Maternal exposure during breast feeding | 1,003 | 0.06% |
| Maternal exposure during delivery | 1 | 0% |
| Maternal exposure during pregnancy | 4,412 | 0.27% |
| Maternal exposure timing unspecified | 410 | 0.02% |
| Maternal exposure via partner during pregnancy | 1 | 0% |
| Maternal therapy to enhance foetal lung maturity | 2 | 0% |
| Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry | 1 | 0% |
| Matrix metalloproteinase-3 | 32 | 0% |
| Matrix metalloproteinase-3 increased | 1 | 0% |
| Maxillofacial operation | 2 | 0% |
| Maxillofacial pain | 5 | 0% |
| Maximal voluntary ventilation | 7 | 0% |
| Maximal voluntary ventilation abnormal | 1 | 0% |
| Maximal voluntary ventilation increased | 1 | 0% |
| Maximum heart rate | 7 | 0% |
| Maximum heart rate increased | 4 | 0% |
| May-Grunwald Giemsa stain | 3 | 0% |
| May-Thurner syndrome | 23 | 0% |
| Mean arterial pressure | 67 | 0% |
| Mean arterial pressure decreased | 12 | 0% |
| Mean arterial pressure increased | 4 | 0% |
| Mean cell haemoglobin | 1,246 | 0.08% |
| Mean cell haemoglobin concentration | 1,028 | 0.06% |
| Mean cell haemoglobin concentration abnormal | 2 | 0% |
| Mean cell haemoglobin concentration decreased | 237 | 0.01% |
| Mean cell haemoglobin concentration increased | 40 | 0% |
| Mean cell haemoglobin concentration normal | 710 | 0.04% |
| Mean cell haemoglobin decreased | 162 | 0.01% |
| Mean cell haemoglobin increased | 250 | 0.02% |
| Mean cell haemoglobin normal | 580 | 0.04% |
| Mean cell volume | 1,874 | 0.11% |
| Mean cell volume abnormal | 17 | 0% |
| Mean cell volume decreased | 136 | 0.01% |
| Mean cell volume increased | 291 | 0.02% |
| Mean cell volume normal | 844 | 0.05% |
| Mean platelet volume | 591 | 0.04% |
| Mean platelet volume decreased | 81 | 0% |
| Mean platelet volume increased | 230 | 0.01% |
| Mean platelet volume normal | 530 | 0.03% |
| Measles | 58 | 0% |
| Measles antibody | 56 | 0% |
| Measles antibody negative | 2 | 0% |
| Measles antibody positive | 4 | 0% |
| Measles post vaccine | 3 | 0% |
| Mechanic's hand | 1 | 0% |
| Mechanical ileus | 3 | 0% |
| Mechanical urticaria | 1,173 | 0.07% |
| Mechanical ventilation | 1,183 | 0.07% |
| Mechanical ventilation complication | 10 | 0% |
| Meconium aspiration syndrome | 4 | 0% |
| Meconium in amniotic fluid | 11 | 0% |
| Meconium peritonitis | 2 | 0% |
| Meconium stain | 4 | 0% |
| Medial tibial stress syndrome | 28 | 0% |
| Median nerve injury | 7 | 0% |
| Mediastinal abscess | 1 | 0% |
| Mediastinal biopsy | 2 | 0% |
| Mediastinal biopsy abnormal | 1 | 0% |
| Mediastinal cyst | 1 | 0% |
| Mediastinal disorder | 13 | 0% |
| Mediastinal effusion | 2 | 0% |
| Mediastinal haematoma | 4 | 0% |
| Mediastinal haemorrhage | 2 | 0% |
| Mediastinal mass | 21 | 0% |
| Mediastinal operation | 1 | 0% |
| Mediastinal shift | 4 | 0% |
| Mediastinitis | 6 | 0% |
| Mediastinoscopy | 27 | 0% |
| Mediastinum neoplasm | 2 | 0% |
| Medical cannabis therapy | 4 | 0% |
| Medical counselling | 15 | 0% |
| Medical device battery replacement | 1 | 0% |
| Medical device change | 8 | 0% |
| Medical device discomfort | 1 | 0% |
| Medical device implantation | 25 | 0% |
| Medical device pain | 5 | 0% |
| Medical device removal | 28 | 0% |
| Medical device site burn | 1 | 0% |
| Medical device site cyst | 1 | 0% |
| Medical device site discomfort | 1 | 0% |
| Medical device site erosion | 1 | 0% |
| Medical device site erythema | 2 | 0% |
| Medical device site fistula | 1 | 0% |
| Medical device site haemorrhage | 4 | 0% |
| Medical device site induration | 1 | 0% |
| Medical device site inflammation | 1 | 0% |
| Medical device site joint infection | 3 | 0% |
| Medical device site joint inflammation | 3 | 0% |
| Medical device site joint pain | 2 | 0% |
| Medical device site joint swelling | 1 | 0% |
| Medical device site pain | 4 | 0% |
| Medical device site pruritus | 1 | 0% |
| Medical device site rash | 1 | 0% |
| Medical device site reaction | 3 | 0% |
| Medical device site scar | 1 | 0% |
| Medical device site swelling | 1 | 0% |
| Medical device site thrombosis | 1 | 0% |
| Medical device site warmth | 1 | 0% |
| Medical diet | 101 | 0.01% |
| Medical induction of coma | 63 | 0% |
| Medical observation | 129 | 0.01% |
| Medical observation normal | 1 | 0% |
| Medical procedure | 21 | 0% |
| Medication dilution | 8 | 0% |
| Medication error | 784 | 0.05% |
| Medication overuse headache | 1 | 0% |
| Medullary thyroid cancer | 3 | 0% |
| Medulloblastoma | 3 | 0% |
| Megacolon | 7 | 0% |
| Megakaryocytes | 8 | 0% |
| Megakaryocytes abnormal | 2 | 0% |
| Megakaryocytes decreased | 1 | 0% |
| Megakaryocytes increased | 2 | 0% |
| Megakaryocytes normal | 2 | 0% |
| Megaloblasts increased | 2 | 0% |
| Meibomian gland dysfunction | 21 | 0% |
| Meibomianitis | 3 | 0% |
| Meige's syndrome | 2 | 0% |
| Melaena | 352 | 0.02% |
| Melanocytic hyperplasia | 1 | 0% |
| Melanocytic naevus | 75 | 0% |
| Melanoderma | 4 | 0% |
| Melanoma recurrent | 7 | 0% |
| MELAS syndrome | 3 | 0% |
| Melkersson-Rosenthal syndrome | 3 | 0% |
| Memory impairment | 5,440 | 0.33% |
| Menarche | 19 | 0% |
| Meniere's disease | 405 | 0.02% |
| Meningeal disorder | 33 | 0% |
| Meningeal neoplasm | 1 | 0% |
| Meningeal thickening | 5 | 0% |
| Meningioma | 92 | 0.01% |
| Meningioma benign | 4 | 0% |
| Meningism | 91 | 0.01% |
| Meningitis | 407 | 0.02% |
| Meningitis aseptic | 228 | 0.01% |
| Meningitis bacterial | 40 | 0% |
| Meningitis chemical | 5 | 0% |
| Meningitis coxsackie viral | 3 | 0% |
| Meningitis cryptococcal | 1 | 0% |
| Meningitis Escherichia | 2 | 0% |
| Meningitis herpes | 13 | 0% |
| Meningitis meningococcal | 1 | 0% |
| Meningitis neonatal | 2 | 0% |
| Meningitis noninfective | 2 | 0% |
| Meningitis pneumococcal | 10 | 0% |
| Meningitis staphylococcal | 1 | 0% |
| Meningitis tuberculous | 3 | 0% |
| Meningitis viral | 115 | 0.01% |
| Meningocele | 1 | 0% |
| Meningococcal bacteraemia | 1 | 0% |
| Meningococcal infection | 5 | 0% |
| Meningococcal sepsis | 1 | 0% |
| Meningoencephalitis bacterial | 6 | 0% |
| Meningoencephalitis herpetic | 61 | 0% |
| Meningoencephalitis viral | 11 | 0% |
| Meningomyelitis herpes | 1 | 0% |
| Meningomyelocele | 2 | 0% |
| Meningoradiculitis | 18 | 0% |
| Meningorrhagia | 13 | 0% |
| Meniscal degeneration | 1 | 0% |
| Meniscus cyst | 1 | 0% |
| Meniscus injury | 85 | 0.01% |
| Meniscus operation | 4 | 0% |
| Meniscus removal | 2 | 0% |
| Menometrorrhagia | 837 | 0.05% |
| Menopausal disorder | 11 | 0% |
| Menopausal symptoms | 185 | 0.01% |
| Menopause | 325 | 0.02% |
| Menopause delayed | 5 | 0% |
| Menorrhagia | 29 | 0% |
| Menstrual clots | 17 | 0% |
| Menstrual cycle management | 29 | 0% |
| Menstrual discomfort | 185 | 0.01% |
| Menstrual disorder | 7,815 | 0.48% |
| Menstrual headache | 5 | 0% |
| Menstruation delayed | 5,003 | 0.3% |
| Menstruation irregular | 9,634 | 0.59% |
| Menstruation normal | 33 | 0% |
| Mental disability | 11 | 0% |
| Mental disorder | 840 | 0.05% |
| Mental disorder due to a general medical condition | 4 | 0% |
| Mental fatigue | 627 | 0.04% |
| Mental impairment | 1,577 | 0.1% |
| Mental status changes | 2,505 | 0.15% |
| Meralgia paraesthetica | 24 | 0% |
| MERS-CoV test | 4 | 0% |
| MERS-CoV test negative | 1 | 0% |
| Merycism | 7 | 0% |
| Mesangioproliferative glomerulonephritis | 6 | 0% |
| Mesenteric abscess | 3 | 0% |
| Mesenteric arterial occlusion | 12 | 0% |
| Mesenteric arteriosclerosis | 4 | 0% |
| Mesenteric artery aneurysm | 3 | 0% |
| Mesenteric artery embolisation | 1 | 0% |
| Mesenteric artery embolism | 5 | 0% |
| Mesenteric artery stenosis | 9 | 0% |
| Mesenteric artery stent insertion | 2 | 0% |
| Mesenteric artery thrombosis | 41 | 0% |
| Mesenteric cyst | 1 | 0% |
| Mesenteric haematoma | 3 | 0% |
| Mesenteric haemorrhage | 6 | 0% |
| Mesenteric lymphadenitis | 3 | 0% |
| Mesenteric neoplasm | 5 | 0% |
| Mesenteric panniculitis | 27 | 0% |
| Mesenteric vascular insufficiency | 1 | 0% |
| Mesenteric vascular occlusion | 6 | 0% |
| Mesenteric vein embolism | 1 | 0% |
| Mesenteric vein thrombosis | 234 | 0.01% |
| Mesenteric venous occlusion | 2 | 0% |
| Mesenteritis | 5 | 0% |
| Mesothelioma | 7 | 0% |
| Mesothelioma malignant | 1 | 0% |
| Metabolic abnormality management | 1 | 0% |
| Metabolic acidosis | 356 | 0.02% |
| Metabolic alkalosis | 12 | 0% |
| Metabolic cardiomyopathy | 1 | 0% |
| Metabolic disorder | 94 | 0.01% |
| Metabolic encephalopathy | 545 | 0.03% |
| Metabolic function test | 6,865 | 0.42% |
| Metabolic function test abnormal | 360 | 0.02% |
| Metabolic function test normal | 1,410 | 0.09% |
| Metabolic myopathy | 1 | 0% |
| Metabolic surgery | 2 | 0% |
| Metabolic syndrome | 14 | 0% |
| Metal poisoning | 7 | 0% |
| Metamorphopsia | 257 | 0.02% |
| Metamyelocyte count | 44 | 0% |
| Metamyelocyte count increased | 4 | 0% |
| Metamyelocyte percentage | 24 | 0% |
| Metamyelocyte percentage increased | 4 | 0% |
| Metanephrine urine | 15 | 0% |
| Metanephrine urine increased | 2 | 0% |
| Metanephrine urine normal | 4 | 0% |
| Metaplasia | 11 | 0% |
| Metaplastic breast carcinoma | 1 | 0% |
| Metapneumovirus infection | 16 | 0% |
| Metapneumovirus pneumonia | 1 | 0% |
| Metastases to abdominal cavity | 7 | 0% |
| Metastases to abdominal wall | 1 | 0% |
| Metastases to adrenals | 5 | 0% |
| Metastases to bladder | 2 | 0% |
| Metastases to bone | 93 | 0.01% |
| Metastases to bone marrow | 4 | 0% |
| Metastases to breast | 2 | 0% |
| Metastases to central nervous system | 63 | 0% |
| Metastases to chest wall | 1 | 0% |
| Metastases to heart | 1 | 0% |
| Metastases to kidney | 2 | 0% |
| Metastases to liver | 110 | 0.01% |
| Metastases to lung | 83 | 0.01% |
| Metastases to lymph nodes | 119 | 0.01% |
| Metastases to meninges | 8 | 0% |
| Metastases to neck | 1 | 0% |
| Metastases to nervous system | 1 | 0% |
| Metastases to oesophagus | 1 | 0% |
| Metastases to ovary | 2 | 0% |
| Metastases to pancreas | 2 | 0% |
| Metastases to pelvis | 5 | 0% |
| Metastases to peritoneum | 30 | 0% |
| Metastases to pituitary gland | 2 | 0% |
| Metastases to pleura | 5 | 0% |
| Metastases to prostate | 1 | 0% |
| Metastases to reproductive organ | 1 | 0% |
| Metastases to skin | 5 | 0% |
| Metastases to soft tissue | 1 | 0% |
| Metastases to spinal cord | 1 | 0% |
| Metastases to spine | 22 | 0% |
| Metastases to spleen | 5 | 0% |
| Metastases to stomach | 1 | 0% |
| Metastases to testicle | 1 | 0% |
| Metastases to the mediastinum | 7 | 0% |
| Metastases to trachea | 1 | 0% |
| Metastases to uterus | 1 | 0% |
| Metastases to vagina | 1 | 0% |
| Metastasis | 65 | 0% |
| Metastatic bronchial carcinoma | 2 | 0% |
| Metastatic carcinoid tumour | 2 | 0% |
| Metastatic carcinoma of the bladder | 3 | 0% |
| Metastatic cutaneous Crohn's disease | 1 | 0% |
| Metastatic gastric cancer | 5 | 0% |
| Metastatic lymphoma | 11 | 0% |
| Metastatic malignant melanoma | 14 | 0% |
| Metastatic neoplasm | 78 | 0% |
| Metastatic renal cell carcinoma | 9 | 0% |
| Metastatic salivary gland cancer | 1 | 0% |
| Metastatic squamous cell carcinoma | 7 | 0% |
| Metastatic uterine cancer | 4 | 0% |
| Metatarsalgia | 9 | 0% |
| Meteoropathy | 4 | 0% |
| Methaemoglobinaemia | 8 | 0% |
| Methaemoglobin urine absent | 2 | 0% |
| Methylenetetrahydrofolate reductase deficiency | 2 | 0% |
| Methylenetetrahydrofolate reductase gene mutation | 35 | 0% |
| Methylmalonic aciduria | 8 | 0% |
| Metrorrhagia | 18 | 0% |
| Metrorrhoea | 2 | 0% |
| Microalbuminuria | 38 | 0% |
| Microangiopathic haemolytic anaemia | 13 | 0% |
| Microangiopathy | 68 | 0% |
| Microbiology test | 311 | 0.02% |
| Microbiology test abnormal | 1 | 0% |
| Microbiology test normal | 7 | 0% |
| Microcephaly | 5 | 0% |
| Micrococcus infection | 1 | 0% |
| Micrococcus test positive | 3 | 0% |
| Microcytic anaemia | 90 | 0.01% |
| Microcytosis | 11 | 0% |
| Microembolism | 43 | 0% |
| Micrognathia | 1 | 0% |
| Micrographia | 2 | 0% |
| Micrographic skin surgery | 12 | 0% |
| Micropenis | 5 | 0% |
| Microphthalmos | 1 | 0% |
| Microscopic enteritis | 1 | 0% |
| Microscopic polyangiitis | 54 | 0% |
| Microscopy | 314 | 0.02% |
| Microsleep | 4 | 0% |
| Microsomia | 1 | 0% |
| Microtia | 2 | 0% |
| Microvascular coronary artery disease | 22 | 0% |
| Microvascular cranial nerve palsy | 15 | 0% |
| Micturition disorder | 101 | 0.01% |
| Micturition frequency decreased | 4 | 0% |
| Micturition urgency | 599 | 0.04% |
| Middle cerebral artery stroke | 12 | 0% |
| Middle ear disorder | 11 | 0% |
| Middle ear effusion | 292 | 0.02% |
| Middle ear inflammation | 34 | 0% |
| Middle East respiratory syndrome | 3 | 0% |
| Middle insomnia | 675 | 0.04% |
| Middle lobe syndrome | 2 | 0% |
| Migraine | 18,661 | 1.13% |
| Migraine-triggered seizure | 5 | 0% |
| Migraine prophylaxis | 2 | 0% |
| Migraine with aura | 815 | 0.05% |
| Migraine without aura | 49 | 0% |
| Milia | 10 | 0% |
| Miliaria | 281 | 0.02% |
| Military service | 3 | 0% |
| Milk allergy | 32 | 0% |
| Milk soy protein intolerance | 2 | 0% |
| Millard-Gubler syndrome | 1 | 0% |
| Miller Fisher syndrome | 167 | 0.01% |
| Mineral deficiency | 11 | 0% |
| Mineral metabolism disorder | 8 | 0% |
| Mineral supplementation | 58 | 0% |
| Mini-tracheostomy | 3 | 0% |
| Minimal residual disease | 3 | 0% |
| Mini mental status examination | 82 | 0% |
| Mini mental status examination abnormal | 3 | 0% |
| Minimum inhibitory concentration | 4 | 0% |
| Minimum inhibitory concentration increased | 1 | 0% |
| Miosis | 96 | 0.01% |
| Misleading laboratory test result | 1 | 0% |
| Misophonia | 10 | 0% |
| Mite allergy | 39 | 0% |
| Mitochondrial cytopathy | 58 | 0% |
| Mitochondrial DNA mutation | 1 | 0% |
| Mitochondrial encephalomyopathy | 4 | 0% |
| Mitochondrial enzyme deficiency | 3 | 0% |
| Mitochondrial myopathy | 18 | 0% |
| Mitochondrial myopathy acquired | 7 | 0% |
| Mitochondrial toxicity | 8 | 0% |
| Mitogen stimulation test | 7 | 0% |
| Mitral perforation | 1 | 0% |
| Mitral valve atresia | 1 | 0% |
| Mitral valve calcification | 33 | 0% |
| Mitral valve disease | 34 | 0% |
| Mitral valve incompetence | 694 | 0.04% |
| Mitral valve prolapse | 113 | 0.01% |
| Mitral valve repair | 15 | 0% |
| Mitral valve replacement | 20 | 0% |
| Mitral valve sclerosis | 2 | 0% |
| Mitral valve stenosis | 35 | 0% |
| Mitral valve thickening | 27 | 0% |
| Mixed anxiety and depressive disorder | 49 | 0% |
| Mixed connective tissue disease | 57 | 0% |
| Mixed deafness | 7 | 0% |
| Mixed delusion | 2 | 0% |
| Mixed dementia | 1 | 0% |
| Mixed incontinence | 4 | 0% |
| Mixed liver injury | 29 | 0% |
| Moaning | 235 | 0.01% |
| Mobility decreased | 15,244 | 0.93% |
| Model for end stage liver disease score | 10 | 0% |
| Model for end stage liver disease score increased | 1 | 0% |
| Modified Rankin score | 49 | 0% |
| Modified Rodnan skin score | 2 | 0% |
| Moebius II syndrome | 1 | 0% |
| Moisture-associated skin damage | 1 | 0% |
| Molar abortion | 3 | 0% |
| Mole excision | 9 | 0% |
| Molluscum contagiosum | 16 | 0% |
| Monkeypox | 4 | 0% |
| Monoblast count | 5 | 0% |
| Monoblast count increased | 1 | 0% |
| Monoclonal antibody immunoconjugate therapy | 8 | 0% |
| Monoclonal antibody unconjugated therapy | 19 | 0% |
| Monoclonal B-cell lymphocytosis | 17 | 0% |
| Monoclonal gammopathy | 63 | 0% |
| Monoclonal immunoglobulin | 8 | 0% |
| Monoclonal immunoglobulin increased | 6 | 0% |
| Monoclonal immunoglobulin present | 20 | 0% |
| Monocyte count | 1,774 | 0.11% |
| Monocyte count abnormal | 11 | 0% |
| Monocyte count decreased | 138 | 0.01% |
| Monocyte count increased | 433 | 0.03% |
| Monocyte count normal | 245 | 0.01% |
| Monocyte morphology | 3 | 0% |
| Monocyte morphology abnormal | 2 | 0% |
| Monocyte percentage | 679 | 0.04% |
| Monocyte percentage abnormal | 3 | 0% |
| Monocyte percentage decreased | 39 | 0% |
| Monocyte percentage increased | 390 | 0.02% |
| Monocytopenia | 3 | 0% |
| Monocytosis | 73 | 0% |
| Monofilament pressure perception test | 6 | 0% |
| Monofilament pressure perception test abnormal | 1 | 0% |
| Mononeuritis | 42 | 0% |
| Mononeuropathy | 42 | 0% |
| Mononeuropathy multiplex | 40 | 0% |
| Mononuclear cell count | 45 | 0% |
| Mononuclear cell count abnormal | 1 | 0% |
| Mononuclear cell count increased | 3 | 0% |
| Mononuclear cell percentage | 5 | 0% |
| Mononucleosis heterophile test | 108 | 0.01% |
| Mononucleosis heterophile test negative | 169 | 0.01% |
| Mononucleosis heterophile test positive | 37 | 0% |
| Mononucleosis syndrome | 6 | 0% |
| Monoparesis | 580 | 0.04% |
| Monoplegia | 1,623 | 0.1% |
| Montreal cognitive assessment | 26 | 0% |
| Montreal cognitive assessment abnormal | 3 | 0% |
| Mood altered | 507 | 0.03% |
| Mood disorder due to a general medical condition | 6 | 0% |
| Mood swings | 594 | 0.04% |
| Moraxella infection | 3 | 0% |
| Moraxella test positive | 4 | 0% |
| Morbid thoughts | 15 | 0% |
| Morganella infection | 10 | 0% |
| Morganella test | 1 | 0% |
| Morganella test positive | 1 | 0% |
| Morning sickness | 78 | 0% |
| Morose | 5 | 0% |
| Morphoea | 66 | 0% |
| Morton's neuralgia | 18 | 0% |
| Morvan syndrome | 2 | 0% |
| Motion sickness | 380 | 0.02% |
| Motor developmental delay | 2 | 0% |
| Motor dysfunction | 1,134 | 0.07% |
| Motor neurone disease | 97 | 0.01% |
| Mouth breathing | 54 | 0% |
| Mouth cyst | 9 | 0% |
| Mouth haemorrhage | 345 | 0.02% |
| Mouth injury | 72 | 0% |
| Mouth swelling | 1,374 | 0.08% |
| Mouth ulceration | 910 | 0.06% |
| Movement disorder | 4,141 | 0.25% |
| Moyamoya disease | 6 | 0% |
| MPL gene mutation | 6 | 0% |
| Mucinous adenocarcinoma of appendix | 1 | 0% |
| Mucinous breast carcinoma | 1 | 0% |
| Mucocutaneous disorder | 6 | 0% |
| Mucocutaneous haemorrhage | 3 | 0% |
| Mucocutaneous rash | 1 | 0% |
| Mucocutaneous ulceration | 2 | 0% |
| Mucopolysaccharidosis I | 1 | 0% |
| Mucormycosis | 2 | 0% |
| Mucosal atrophy | 2 | 0% |
| Mucosal biopsy | 9 | 0% |
| Mucosal discolouration | 41 | 0% |
| Mucosal disorder | 79 | 0% |
| Mucosal dryness | 103 | 0.01% |
| Mucosal erosion | 4 | 0% |
| Mucosal excoriation | 1 | 0% |
| Mucosal exfoliation | 1 | 0% |
| Mucosal haemorrhage | 44 | 0% |
| Mucosal hyperaemia | 3 | 0% |
| Mucosal hypertrophy | 64 | 0% |
| Mucosal infection | 11 | 0% |
| Mucosal inflammation | 94 | 0.01% |
| Mucosal necrosis | 2 | 0% |
| Mucosal pain | 10 | 0% |
| Mucosal ulceration | 16 | 0% |
| Mucosa vesicle | 8 | 0% |
| Mucous membrane pemphigoid | 9 | 0% |
| Mucous stools | 164 | 0.01% |
| Multi-organ disorder | 51 | 0% |
| Multi-vitamin deficiency | 1 | 0% |
| Multifocal micronodular pneumocyte hyperplasia | 2 | 0% |
| Multifocal motor neuropathy | 14 | 0% |
| Multigravida | 7 | 0% |
| Multimorbidity | 56 | 0% |
| Multiparous | 2 | 0% |
| Multipathogen PCR test | 60 | 0% |
| Multipathogen PCR test positive | 1 | 0% |
| Multiple-drug resistance | 7 | 0% |
| Multiple allergies | 117 | 0.01% |
| Multiple chemical sensitivity | 2 | 0% |
| Multiple congenital abnormalities | 6 | 0% |
| Multiple drug therapy | 7 | 0% |
| Multiple fractures | 37 | 0% |
| Multiple gated acquisition scan | 4 | 0% |
| Multiple gated acquisition scan abnormal | 3 | 0% |
| Multiple gated acquisition scan normal | 1 | 0% |
| Multiple injuries | 39 | 0% |
| Multiple organ dysfunction syndrome | 628 | 0.04% |
| Multiple pregnancy | 4 | 0% |
| Multiple sclerosis | 1,351 | 0.08% |
| Multiple sclerosis pseudo relapse | 23 | 0% |
| Multiple sclerosis relapse | 873 | 0.05% |
| Multiple sclerosis relapse prophylaxis | 2 | 0% |
| Multiple system atrophy | 13 | 0% |
| Multiple use of single-use product | 26 | 0% |
| Multisystem inflammatory syndrome | 140 | 0.01% |
| Multisystem inflammatory syndrome in adults | 52 | 0% |
| Multisystem inflammatory syndrome in children | 240 | 0.01% |
| Mumps | 35 | 0% |
| Mumps antibody test | 30 | 0% |
| Mumps antibody test negative | 2 | 0% |
| Murine typhus | 2 | 0% |
| Murphy's sign positive | 1 | 0% |
| Murphy's sign test | 24 | 0% |
| Muscle abscess | 9 | 0% |
| Muscle atrophy | 656 | 0.04% |
| Muscle contractions involuntary | 842 | 0.05% |
| Muscle contracture | 307 | 0.02% |
| Muscle contusion | 7 | 0% |
| Muscle discomfort | 403 | 0.02% |
| Muscle disorder | 510 | 0.03% |
| Muscle electrostimulation therapy | 2 | 0% |
| Muscle enzyme | 31 | 0% |
| Muscle enzyme increased | 12 | 0% |
| Muscle fatigue | 1,328 | 0.08% |
| Muscle fibrosis | 5 | 0% |
| Muscle haemorrhage | 35 | 0% |
| Muscle hernia | 2 | 0% |
| Muscle hypertrophy | 13 | 0% |
| Muscle hypoxia | 6 | 0% |
| Muscle infarction | 2 | 0% |
| Muscle injury | 192 | 0.01% |
| Muscle mass | 52 | 0% |
| Muscle mass percentage | 1 | 0% |
| Muscle necrosis | 22 | 0% |
| Muscle neoplasm | 2 | 0% |
| Muscle oedema | 42 | 0% |
| Muscle operation | 2 | 0% |
| Muscle reattachment | 1 | 0% |
| Muscle release | 1 | 0% |
| Muscle rigidity | 656 | 0.04% |
| Muscle rupture | 159 | 0.01% |
| Muscle spasms | 15,987 | 0.97% |
| Muscle spasticity | 257 | 0.02% |
| Muscle strain | 662 | 0.04% |
| Muscle strength abnormal | 129 | 0.01% |
| Muscle strength normal | 13 | 0% |
| Muscle strength test | 5 | 0% |
| Muscle swelling | 374 | 0.02% |
| Muscle tension dysphonia | 6 | 0% |
| Muscle tightness | 3,312 | 0.2% |
| Muscle tone disorder | 7 | 0% |
| Muscle twitching | 4,928 | 0.3% |
| Muscular dystrophy | 23 | 0% |
| Muscular weakness | 17,478 | 1.06% |
| Musculoskeletal chest pain | 2,725 | 0.17% |
| Musculoskeletal deformity | 3 | 0% |
| Musculoskeletal discomfort | 2,325 | 0.14% |
| Musculoskeletal disorder | 838 | 0.05% |
| Musculoskeletal foreign body | 2 | 0% |
| Musculoskeletal injury | 10 | 0% |
| Musculoskeletal pain | 2,538 | 0.15% |
| Musculoskeletal stiffness | 12,830 | 0.78% |
| Musical ear syndrome | 2 | 0% |
| Mutism | 92 | 0.01% |
| Myalgia | 100,892 | 6.14% |
| Myalgia intercostal | 17 | 0% |
| Myasthenia gravis | 665 | 0.04% |
| Myasthenia gravis crisis | 37 | 0% |
| Myasthenic syndrome | 33 | 0% |
| Mycetoma mycotic | 2 | 0% |
| Mycobacterial infection | 11 | 0% |
| Mycobacterium avium complex infection | 16 | 0% |
| Mycobacterium chelonae infection | 1 | 0% |
| Mycobacterium test | 101 | 0.01% |
| Mycobacterium test negative | 26 | 0% |
| Mycobacterium test positive | 3 | 0% |
| Mycobacterium tuberculosis complex test | 243 | 0.01% |
| Mycobacterium tuberculosis complex test negative | 70 | 0% |
| Mycobacterium tuberculosis complex test positive | 12 | 0% |
| Mycoplasma infection | 11 | 0% |
| Mycoplasma test | 300 | 0.02% |
| Mycoplasma test negative | 192 | 0.01% |
| Mycoplasma test positive | 34 | 0% |
| Mycotic allergy | 20 | 0% |
| Mycotoxicosis | 4 | 0% |
| Mydriasis | 626 | 0.04% |
| Myelin oligodendrocyte glycoprotein antibody-associated disease | 78 | 0% |
| Myelitis | 635 | 0.04% |
| Myelitis transverse | 702 | 0.04% |
| Myeloblast count | 4 | 0% |
| Myeloblast percentage | 1 | 0% |
| Myeloblast percentage increased | 1 | 0% |
| Myeloblast present | 1 | 0% |
| Myelocyte count | 40 | 0% |
| Myelocyte count increased | 9 | 0% |
| Myelocyte percentage | 12 | 0% |
| Myelocyte percentage increased | 2 | 0% |
| Myelocytosis | 4 | 0% |
| Myelodysplastic syndrome | 115 | 0.01% |
| Myelodysplastic syndrome unclassifiable | 1 | 0% |
| Myelofibrosis | 21 | 0% |
| Myeloid leukaemia | 15 | 0% |
| Myelolipoma | 1 | 0% |
| Myeloma cast nephropathy | 1 | 0% |
| Myelomalacia | 6 | 0% |
| Myelopathy | 134 | 0.01% |
| Myeloperoxidase deficiency | 1 | 0% |
| Myeloproliferative neoplasm | 31 | 0% |
| Myelosuppression | 35 | 0% |
| Myocardiac abscess | 1 | 0% |
| Myocardial bridging | 10 | 0% |
| Myocardial calcification | 2 | 0% |
| Myocardial depression | 1 | 0% |
| Myocardial fibrosis | 88 | 0.01% |
| Myocardial haemorrhage | 3 | 0% |
| Myocardial hypoxia | 9 | 0% |
| Myocardial infarction | 5,658 | 0.34% |
| Myocardial injury | 213 | 0.01% |
| Myocardial ischaemia | 550 | 0.03% |
| Myocardial necrosis | 39 | 0% |
| Myocardial necrosis marker | 778 | 0.05% |
| Myocardial necrosis marker decreased | 1 | 0% |
| Myocardial necrosis marker increased | 329 | 0.02% |
| Myocardial necrosis marker normal | 164 | 0.01% |
| Myocardial oedema | 117 | 0.01% |
| Myocardial rupture | 27 | 0% |
| Myocardial strain | 71 | 0% |
| Myocardial strain imaging | 9 | 0% |
| Myocardial strain imaging abnormal | 17 | 0% |
| Myocardial stunning | 1 | 0% |
| Myocarditis | 17,680 | 1.08% |
| Myocarditis bacterial | 3 | 0% |
| Myocarditis infectious | 11 | 0% |
| Myocarditis mycotic | 3 | 0% |
| Myocarditis post infection | 4 | 0% |
| Myocarditis septic | 4 | 0% |
| Myoclonic dystonia | 4 | 0% |
| Myoclonic epilepsy | 38 | 0% |
| Myoclonus | 415 | 0.03% |
| Myofascial pain syndrome | 52 | 0% |
| Myofascial spasm | 2 | 0% |
| Myofascitis | 8 | 0% |
| Myoglobinaemia | 3 | 0% |
| Myoglobin blood | 243 | 0.01% |
| Myoglobin blood decreased | 2 | 0% |
| Myoglobin blood increased | 39 | 0% |
| Myoglobin blood present | 2 | 0% |
| Myoglobinuria | 12 | 0% |
| Myoglobin urine | 5 | 0% |
| Myoglobin urine absent | 1 | 0% |
| Myoglobin urine present | 2 | 0% |
| Myokymia | 64 | 0% |
| Myolipoma | 1 | 0% |
| Myomectomy | 2 | 0% |
| Myopathy | 174 | 0.01% |
| Myopathy toxic | 1 | 0% |
| Myopericarditis | 868 | 0.05% |
| Myopericytoma | 1 | 0% |
| Myopia | 70 | 0% |
| Myopia correction | 1 | 0% |
| Myopic chorioretinal degeneration | 1 | 0% |
| Myosclerosis | 146 | 0.01% |
| Myositis | 795 | 0.05% |
| Myotonia | 6 | 0% |
| Myotonic dystrophy | 4 | 0% |
| Myringitis | 13 | 0% |
| Myringotomy | 4 | 0% |
| Mysophobia | 2 | 0% |
| Myxoedema | 14 | 0% |
| Myxoedema coma | 3 | 0% |
| Myxofibrosarcoma | 5 | 0% |
| Myxoid liposarcoma | 6 | 0% |
| Myxoma | 4 | 0% |
| Myxomatous mitral valve degeneration | 3 | 0% |
| N-ras gene mutation | 1 | 0% |
| N-telopeptide | 2 | 0% |
| N-telopeptide urine | 1 | 0% |
| N-terminal prohormone brain natriuretic peptide | 1,818 | 0.11% |
| N-terminal prohormone brain natriuretic peptide abnormal | 4 | 0% |
| N-terminal prohormone brain natriuretic peptide increased | 409 | 0.02% |
| N-terminal prohormone brain natriuretic peptide normal | 35 | 0% |
| Naevoid melanoma | 1 | 0% |
| Naevus flammeus | 2 | 0% |
| Naevus haemorrhage | 1 | 0% |
| Nail aplasia | 1 | 0% |
| Nail avulsion | 3 | 0% |
| Nail bed bleeding | 14 | 0% |
| Nail bed disorder | 11 | 0% |
| Nail bed infection | 1 | 0% |
| Nail bed inflammation | 6 | 0% |
| Nail bed tenderness | 3 | 0% |
| Nail discolouration | 170 | 0.01% |
| Nail discomfort | 6 | 0% |
| Nail disorder | 84 | 0.01% |
| Nail dystrophy | 5 | 0% |
| Nail fold inflammation | 1 | 0% |
| Nail growth abnormal | 19 | 0% |
| Nail hypertrophy | 3 | 0% |
| Nail infection | 8 | 0% |
| Nail injury | 9 | 0% |
| Nail matrix biopsy | 2 | 0% |
| Nail necrosis | 2 | 0% |
| Nail operation | 8 | 0% |
| Nail pigmentation | 8 | 0% |
| Nail pitting | 3 | 0% |
| Nail psoriasis | 26 | 0% |
| Nail ridging | 22 | 0% |
| Nail toxicity | 1 | 0% |
| Naprapathy | 2 | 0% |
| Narcolepsy | 187 | 0.01% |
| Nasal abscess | 13 | 0% |
| Nasal adhesions | 1 | 0% |
| Nasal aspiration | 1 | 0% |
| Nasal cavity cancer | 4 | 0% |
| Nasal cavity mass | 4 | 0% |
| Nasal cavity packing | 40 | 0% |
| Nasal cavity packing removal | 1 | 0% |
| Nasal congestion | 9,079 | 0.55% |
| Nasal crusting | 25 | 0% |
| Nasal cyst | 3 | 0% |
| Nasal cyst removal | 1 | 0% |
| Nasal discharge discolouration | 43 | 0% |
| Nasal discomfort | 568 | 0.03% |
| Nasal disorder | 110 | 0.01% |
| Nasal dryness | 221 | 0.01% |
| Nasal flaring | 3 | 0% |
| Nasal herpes | 48 | 0% |
| Nasal inflammation | 85 | 0.01% |
| Nasal injury | 91 | 0.01% |
| Nasal irrigation | 4 | 0% |
| Nasal mucosa biopsy | 2 | 0% |
| Nasal mucosal blistering | 17 | 0% |
| Nasal mucosal discolouration | 13 | 0% |
| Nasal mucosal disorder | 18 | 0% |
| Nasal mucosal hypertrophy | 1 | 0% |
| Nasal mucosal ulcer | 3 | 0% |
| Nasal mucosa telangiectasia | 1 | 0% |
| Nasal necrosis | 1 | 0% |
| Nasal obstruction | 84 | 0.01% |
| Nasal odour | 12 | 0% |
| Nasal oedema | 143 | 0.01% |
| Nasal operation | 10 | 0% |
| Nasal polypectomy | 1 | 0% |
| Nasal polyps | 32 | 0% |
| Nasal potential difference test | 1 | 0% |
| Nasal pruritus | 150 | 0.01% |
| Nasal septal operation | 3 | 0% |
| Nasal septum deviation | 28 | 0% |
| Nasal septum disorder | 3 | 0% |
| Nasal septum perforation | 3 | 0% |
| Nasal sinus cancer | 1 | 0% |
| Nasal sinus irrigation | 1 | 0% |
| Nasal turbinate abnormality | 1 | 0% |
| Nasal turbinate hypertrophy | 10 | 0% |
| Nasal ulcer | 24 | 0% |
| Nasal vestibulitis | 14 | 0% |
| Nasoendoscopy | 50 | 0% |
| Nasogastric output abnormal | 1 | 0% |
| Nasolaryngoscopy | 10 | 0% |
| Nasopharyngeal aspiration | 4 | 0% |
| Nasopharyngeal cancer | 3 | 0% |
| Nasopharyngeal cancer metastatic | 2 | 0% |
| Nasopharyngeal reflux | 1 | 0% |
| Nasopharyngeal swab | 400 | 0.02% |
| Nasopharyngeal tumour | 3 | 0% |
| Nasopharyngitis | 10,051 | 0.61% |
| Nasopharyngoscopy | 7 | 0% |
| Natural killer-cell lymphoblastic lymphoma | 1 | 0% |
| Natural killer cell activity decreased | 1 | 0% |
| Natural killer cell activity test | 6 | 0% |
| Natural killer cell count | 66 | 0% |
| Natural killer cell count decreased | 12 | 0% |
| Natural killer cell count increased | 2 | 0% |
| Natural killer T cell count | 12 | 0% |
| Natural killer T cell count decreased | 3 | 0% |
| Natural killer T cell count increased | 3 | 0% |
| Naturopathy | 3 | 0% |
| Nausea | 128,525 | 7.82% |
| Near death experience | 329 | 0.02% |
| Near drowning | 22 | 0% |
| Neck crushing | 2 | 0% |
| Neck deformity | 7 | 0% |
| Neck dissection | 5 | 0% |
| Neck exploration | 4 | 0% |
| Neck injury | 86 | 0.01% |
| Neck lift | 1 | 0% |
| Neck mass | 523 | 0.03% |
| Neck pain | 19,063 | 1.16% |
| Neck surgery | 11 | 0% |
| Necrobiosis | 1 | 0% |
| Necrobiosis lipoidica diabeticorum | 5 | 0% |
| Necrolytic migratory erythema | 2 | 0% |
| Necrosis | 120 | 0.01% |
| Necrosis ischaemic | 6 | 0% |
| Necrosis of artery | 1 | 0% |
| Necrotic angiodermatitis | 2 | 0% |
| Necrotic lymphadenopathy | 19 | 0% |
| Necrotising colitis | 4 | 0% |
| Necrotising enterocolitis neonatal | 1 | 0% |
| Necrotising fasciitis | 37 | 0% |
| Necrotising myositis | 19 | 0% |
| Necrotising retinitis | 18 | 0% |
| Necrotising scleritis | 2 | 0% |
| Necrotising soft tissue infection | 7 | 0% |
| Necrotising ulcerative gingivostomatitis | 5 | 0% |
| Necrotising ulcerative periodontitis | 1 | 0% |
| Needle biopsy site unspecified abnormal | 1 | 0% |
| Needle issue | 390 | 0.02% |
| Needle track marks | 5 | 0% |
| Negative thoughts | 51 | 0% |
| Negativism | 2 | 0% |
| Neglect of personal appearance | 4 | 0% |
| Neisseria test | 78 | 0% |
| Neisseria test negative | 16 | 0% |
| Neisseria test positive | 4 | 0% |
| Nematodiasis | 2 | 0% |
| Neobladder surgery | 1 | 0% |
| Neologism | 2 | 0% |
| Neonatal alloimmune thrombocytopenia | 2 | 0% |
| Neonatal anoxia | 2 | 0% |
| Neonatal asphyxia | 8 | 0% |
| Neonatal aspiration | 3 | 0% |
| Neonatal behavioural syndrome | 1 | 0% |
| Neonatal bradyarrhythmia | 1 | 0% |
| Neonatal candida infection | 1 | 0% |
| Neonatal deafness | 2 | 0% |
| Neonatal disorder | 6 | 0% |
| Neonatal dyspnoea | 18 | 0% |
| Neonatal epileptic seizure | 1 | 0% |
| Neonatal hepatomegaly | 1 | 0% |
| Neonatal hypoacusis | 2 | 0% |
| Neonatal hypotension | 1 | 0% |
| Neonatal hypoxia | 2 | 0% |
| Neonatal infection | 5 | 0% |
| Neonatal insufficient breast milk syndrome | 12 | 0% |
| Neonatal intestinal obstruction | 1 | 0% |
| Neonatal lupus erythematosus | 1 | 0% |
| Neonatal multi-organ failure | 1 | 0% |
| Neonatal pneumonia | 4 | 0% |
| Neonatal pneumothorax | 1 | 0% |
| Neonatal respiratory acidosis | 1 | 0% |
| Neonatal respiratory arrest | 1 | 0% |
| Neonatal respiratory distress | 14 | 0% |
| Neonatal respiratory distress syndrome | 14 | 0% |
| Neonatal respiratory failure | 1 | 0% |
| Neonatal seizure | 7 | 0% |
| Neonatal tachycardia | 1 | 0% |
| Neonatal tachypnoea | 2 | 0% |
| Neoplasm | 277 | 0.02% |
| Neoplasm malignant | 723 | 0.04% |
| Neoplasm of orbit | 1 | 0% |
| Neoplasm of thymus | 1 | 0% |
| Neoplasm progression | 122 | 0.01% |
| Neoplasm prostate | 4 | 0% |
| Neoplasm recurrence | 42 | 0% |
| Neoplasm skin | 39 | 0% |
| Neoplasm swelling | 4 | 0% |
| Neovaginal infection | 1 | 0% |
| Neovaginal pain | 1 | 0% |
| Neovascular age-related macular degeneration | 54 | 0% |
| Neovascularisation | 5 | 0% |
| Nephrectasia | 1 | 0% |
| Nephrectomy | 18 | 0% |
| Nephritic syndrome | 15 | 0% |
| Nephritis | 194 | 0.01% |
| Nephritis allergic | 2 | 0% |
| Nephritis bacterial | 2 | 0% |
| Nephrocalcinosis | 8 | 0% |
| Nephrogenic anaemia | 39 | 0% |
| Nephrogenic diabetes insipidus | 1 | 0% |
| Nephrolithiasis | 825 | 0.05% |
| Nephrological examination | 32 | 0% |
| Nephropathy | 95 | 0.01% |
| Nephropathy toxic | 4 | 0% |
| Nephrosclerosis | 13 | 0% |
| Nephrostomy | 27 | 0% |
| Nephrostomy tube removal | 1 | 0% |
| Nephrotic syndrome | 545 | 0.03% |
| Nephroureterectomy | 1 | 0% |
| Nerve block | 63 | 0% |
| Nerve compression | 437 | 0.03% |
| Nerve conduction studies | 952 | 0.06% |
| Nerve conduction studies abnormal | 135 | 0.01% |
| Nerve conduction studies normal | 117 | 0.01% |
| Nerve degeneration | 15 | 0% |
| Nerve injury | 918 | 0.06% |
| Nerve root injury | 7 | 0% |
| Nerve root injury lumbar | 3 | 0% |
| Nerve root injury thoracic | 1 | 0% |
| Nerve stimulation test | 113 | 0.01% |
| Nerve stimulation test abnormal | 13 | 0% |
| Nerve stimulation test normal | 11 | 0% |
| Nervousness | 3,213 | 0.2% |
| Nervous system cyst | 1 | 0% |
| Nervous system disorder | 1,873 | 0.11% |
| Nervous system injury | 12 | 0% |
| Nervous system neoplasm | 1 | 0% |
| Neuralgia | 6,966 | 0.42% |
| Neuralgic amyotrophy | 754 | 0.05% |
| Neural tube defect | 1 | 0% |
| Neurilemmoma benign | 3 | 0% |
| Neuritic plaques | 2 | 0% |
| Neuritis | 449 | 0.03% |
| Neuritis cranial | 23 | 0% |
| Neuro-ophthalmological test | 13 | 0% |
| Neuro-ophthalmological test abnormal | 2 | 0% |
| Neuroblastoma | 4 | 0% |
| Neuroborreliosis | 34 | 0% |
| Neurodegenerative disorder | 30 | 0% |
| Neurodermatitis | 166 | 0.01% |
| Neurodevelopment test | 6 | 0% |
| Neuroendocrine carcinoma | 11 | 0% |
| Neuroendocrine carcinoma metastatic | 2 | 0% |
| Neuroendocrine carcinoma of the skin | 7 | 0% |
| Neuroendocrine tumour | 15 | 0% |
| Neuroendocrine tumour of the lung | 1 | 0% |
| Neuroendocrine tumour of the lung metastatic | 2 | 0% |
| Neuroendocrine tumour of the rectum | 1 | 0% |
| Neuroendoscopy | 1 | 0% |
| Neurofibroma | 4 | 0% |
| Neurofibromatosis | 7 | 0% |
| Neurogenic bladder | 55 | 0% |
| Neurogenic bowel | 11 | 0% |
| Neurogenic cough | 2 | 0% |
| Neurogenic hypertension | 1 | 0% |
| Neurogenic shock | 52 | 0% |
| Neuroleptic-induced deficit syndrome | 1 | 0% |
| Neuroleptic malignant syndrome | 19 | 0% |
| Neurological complication associated with device | 1 | 0% |
| Neurological decompensation | 53 | 0% |
| Neurological examination | 5,322 | 0.32% |
| Neurological examination abnormal | 179 | 0.01% |
| Neurological examination normal | 230 | 0.01% |
| Neurological eyelid disorder | 5 | 0% |
| Neurological infection | 7 | 0% |
| Neurological procedural complication | 1 | 0% |
| Neurological rehabilitation | 1 | 0% |
| Neurological symptom | 1,587 | 0.1% |
| Neurologic neglect syndrome | 66 | 0% |
| Neurologic somatic symptom disorder | 2 | 0% |
| Neurolysis | 3 | 0% |
| Neuroma | 11 | 0% |
| Neuromuscular blockade | 4 | 0% |
| Neuromuscular pain | 37 | 0% |
| Neuromuscular toxicity | 1 | 0% |
| Neuromyelitis optica spectrum disorder | 151 | 0.01% |
| Neuromyopathy | 67 | 0% |
| Neuromyotonia | 6 | 0% |
| Neuronal intranuclear inclusion disease | 2 | 0% |
| Neuronal neuropathy | 4 | 0% |
| Neurone-specific enolase | 26 | 0% |
| Neurone-specific enolase increased | 7 | 0% |
| Neuronophagia | 1 | 0% |
| Neuropathic arthropathy | 7 | 0% |
| Neuropathic muscular atrophy | 25 | 0% |
| Neuropathic pruritus | 7 | 0% |
| Neuropathic ulcer | 1 | 0% |
| Neuropathy peripheral | 4,576 | 0.28% |
| Neuroprosthesis implantation | 2 | 0% |
| Neuropsychiatric lupus | 1 | 0% |
| Neuropsychiatric symptoms | 18 | 0% |
| Neuropsychiatric syndrome | 2 | 0% |
| Neuropsychological test | 102 | 0.01% |
| Neuropsychological test abnormal | 3 | 0% |
| Neurosarcoidosis | 22 | 0% |
| Neurosensory hypoacusis | 47 | 0% |
| Neurosis | 20 | 0% |
| Neurosurgery | 8 | 0% |
| Neurosyphilis | 5 | 0% |
| Neurotoxicity | 12 | 0% |
| Neurotransmitter level altered | 4 | 0% |
| Neurotrophic keratopathy | 2 | 0% |
| Neurovascular conflict | 1 | 0% |
| Neutralising antibodies | 63 | 0% |
| Neutralising antibodies negative | 1 | 0% |
| Neutralising antibodies positive | 1 | 0% |
| Neutropenia | 500 | 0.03% |
| Neutropenia neonatal | 1 | 0% |
| Neutropenic infection | 1 | 0% |
| Neutropenic sepsis | 9 | 0% |
| Neutrophil/lymphocyte ratio | 31 | 0% |
| Neutrophil/lymphocyte ratio decreased | 1 | 0% |
| Neutrophil/lymphocyte ratio increased | 2 | 0% |
| Neutrophil chemotaxis | 1 | 0% |
| Neutrophil count | 3,574 | 0.22% |
| Neutrophil count abnormal | 20 | 0% |
| Neutrophil count decreased | 366 | 0.02% |
| Neutrophil count increased | 632 | 0.04% |
| Neutrophil count normal | 276 | 0.02% |
| Neutrophil function disorder | 1 | 0% |
| Neutrophil function test | 1 | 0% |
| Neutrophil gelatinase-associated lipocalin | 1 | 0% |
| Neutrophil gelatinase-associated lipocalin increased | 1 | 0% |
| Neutrophil hypersegmented morphology present | 1 | 0% |
| Neutrophilia | 137 | 0.01% |
| Neutrophilic dermatosis | 21 | 0% |
| Neutrophil morphology | 1 | 0% |
| Neutrophil morphology abnormal | 1 | 0% |
| Neutrophil percentage | 620 | 0.04% |
| Neutrophil percentage abnormal | 4 | 0% |
| Neutrophil percentage decreased | 145 | 0.01% |
| Neutrophil percentage increased | 566 | 0.03% |
| Neutrophil toxic granulation present | 7 | 0% |
| Newborn persistent pulmonary hypertension | 1 | 0% |
| New daily persistent headache | 153 | 0.01% |
| New onset refractory status epilepticus | 2 | 0% |
| Next-generation sequencing | 7 | 0% |
| Nicotinamide | 2 | 0% |
| Nicotine dependence | 10 | 0% |
| Nicotine test | 2 | 0% |
| Nicotine test negative | 1 | 0% |
| Night blindness | 37 | 0% |
| Nightmare | 957 | 0.06% |
| Night sweats | 5,469 | 0.33% |
| NIH stroke scale | 451 | 0.03% |
| NIH stroke scale abnormal | 12 | 0% |
| NIH stroke scale score decreased | 4 | 0% |
| NIH stroke scale score increased | 14 | 0% |
| Nikolsky's sign | 13 | 0% |
| Nipple disorder | 30 | 0% |
| Nipple enlargement | 4 | 0% |
| Nipple exudate bloody | 10 | 0% |
| Nipple infection | 3 | 0% |
| Nipple inflammation | 13 | 0% |
| Nipple oedema | 3 | 0% |
| Nipple pain | 235 | 0.01% |
| Nipple resection | 1 | 0% |
| Nipple swelling | 37 | 0% |
| Nitrate compound therapy | 2 | 0% |
| Nitrite urine | 198 | 0.01% |
| Nitrite urine absent | 271 | 0.02% |
| Nitrite urine present | 95 | 0.01% |
| No adverse event | 37,525 | 2.28% |
| Nocardiosis | 3 | 0% |
| Nocturia | 132 | 0.01% |
| Nocturnal dyspnoea | 55 | 0% |
| Nocturnal hypoventilation | 3 | 0% |
| Nodal arrhythmia | 20 | 0% |
| Nodal osteoarthritis | 14 | 0% |
| Nodal rhythm | 35 | 0% |
| Nodular fasciitis | 3 | 0% |
| Nodular lymphocyte predominant Hodgkin lymphoma | 4 | 0% |
| Nodular melanoma | 3 | 0% |
| Nodular rash | 14 | 0% |
| Nodular regenerative hyperplasia | 1 | 0% |
| Nodular vasculitis | 1 | 0% |
| Nodule | 2,046 | 0.12% |
| Non-24-hour sleep-wake disorder | 14 | 0% |
| Non-alcoholic fatty liver | 17 | 0% |
| Non-alcoholic steatohepatitis | 18 | 0% |
| Non-cardiac chest pain | 134 | 0.01% |
| Non-cardiogenic pulmonary oedema | 2 | 0% |
| Non-cirrhotic portal hypertension | 1 | 0% |
| Non-compaction cardiomyopathy | 7 | 0% |
| Non-consummation | 16 | 0% |
| Non-dipping | 2 | 0% |
| Non-high-density lipoprotein cholesterol | 137 | 0.01% |
| Non-high-density lipoprotein cholesterol increased | 10 | 0% |
| Non-Hodgkin's lymphoma | 83 | 0.01% |
| Non-Hodgkin's lymphoma metastatic | 1 | 0% |
| Non-Hodgkin's lymphoma recurrent | 7 | 0% |
| Non-Hodgkin's lymphoma stage III | 1 | 0% |
| Non-Hodgkin's lymphoma stage IV | 5 | 0% |
| Non-Hodgkin's lymphoma unspecified histology indolent | 1 | 0% |
| Non-immune heparin associated thrombocytopenia | 1 | 0% |
| Non-neutralising antibodies negative | 1 | 0% |
| Non-obstructive cardiomyopathy | 3 | 0% |
| Non-pitting oedema | 13 | 0% |
| Non-scarring alopecia | 1 | 0% |
| Non-small cell lung cancer | 23 | 0% |
| Non-small cell lung cancer metastatic | 8 | 0% |
| Non-small cell lung cancer recurrent | 2 | 0% |
| Non-small cell lung cancer stage I | 1 | 0% |
| Non-small cell lung cancer stage III | 2 | 0% |
| Non-small cell lung cancer stage IV | 8 | 0% |
| Non-tobacco user | 13 | 0% |
| Nonalcoholic fatty liver disease | 7 | 0% |
| Noninfectious myelitis | 7 | 0% |
| Noninfectious peritonitis | 1 | 0% |
| Noninfective chorioretinitis | 2 | 0% |
| Noninfective conjunctivitis | 3 | 0% |
| Noninfective encephalitis | 140 | 0.01% |
| Noninfective gingivitis | 200 | 0.01% |
| Noninfective myringitis | 7 | 0% |
| Noninfective oophoritis | 32 | 0% |
| Noninfective retinitis | 1 | 0% |
| Noninfective sialoadenitis | 42 | 0% |
| Nonreassuring foetal heart rate pattern | 1 | 0% |
| Nonspecific reaction | 49 | 0% |
| No reaction on previous exposure to drug | 106 | 0.01% |
| Norepinephrine | 7 | 0% |
| Norepinephrine increased | 6 | 0% |
| Normal foetus | 1 | 0% |
| Normal labour | 66 | 0% |
| Normal newborn | 3 | 0% |
| Normal pressure hydrocephalus | 20 | 0% |
| Normal tension glaucoma | 2 | 0% |
| Normetanephrine urine increased | 2 | 0% |
| Normochromic anaemia | 16 | 0% |
| Normochromic normocytic anaemia | 39 | 0% |
| Normocytic anaemia | 202 | 0.01% |
| Norovirus infection | 25 | 0% |
| Norovirus test | 17 | 0% |
| Norovirus test positive | 9 | 0% |
| Nose deformity | 8 | 0% |
| Nosocomephobia | 1 | 0% |
| Nosocomial infection | 14 | 0% |
| Nosophobia | 4 | 0% |
| Notalgia paraesthetica | 9 | 0% |
| Nothing by mouth order | 63 | 0% |
| NPM1 gene mutation | 4 | 0% |
| Nuchal rigidity | 174 | 0.01% |
| Nucleated red cells | 194 | 0.01% |
| Nucleic acid test | 439 | 0.03% |
| Nulli gravida | 1 | 0% |
| Nulliparous | 1 | 0% |
| Numb chin syndrome | 20 | 0% |
| Nutritional assessment | 22 | 0% |
| Nutritional condition abnormal | 9 | 0% |
| Nutritional condition normal | 1 | 0% |
| Nutritional supplement allergy | 3 | 0% |
| Nutritional supplementation | 4 | 0% |
| Nyctalgia | 4 | 0% |
| NYHA classification | 72 | 0% |
| Nystagmus | 513 | 0.03% |
| Obesity | 271 | 0.02% |
| Obesity cardiomyopathy | 1 | 0% |
| Obliterative bronchiolitis | 2 | 0% |
| Obsessive-compulsive disorder | 56 | 0% |
| Obsessive-compulsive personality disorder | 4 | 0% |
| Obsessive-compulsive symptom | 7 | 0% |
| Obsessive thoughts | 19 | 0% |
| Obstetrical procedure | 2 | 0% |
| Obstructed labour | 3 | 0% |
| Obstruction | 40 | 0% |
| Obstruction gastric | 18 | 0% |
| Obstructive airways disorder | 328 | 0.02% |
| Obstructive nephropathy | 6 | 0% |
| Obstructive pancreatitis | 28 | 0% |
| Obstructive shock | 13 | 0% |
| Obstructive sleep apnoea syndrome | 712 | 0.04% |
| Obturator hernia | 2 | 0% |
| Obturator neuropathy | 1 | 0% |
| Occipital lobe stroke | 1 | 0% |
| Occipital neuralgia | 166 | 0.01% |
| Occult blood | 167 | 0.01% |
| Occult blood negative | 51 | 0% |
| Occult blood positive | 97 | 0.01% |
| Occupational exposure to communicable disease | 2 | 0% |
| Occupational exposure to product | 38 | 0% |
| Occupational exposure to SARS-CoV-2 | 102 | 0.01% |
| Occupational exposure to sunlight | 1 | 0% |
| Occupational problem environmental | 1 | 0% |
| Occupational therapy | 6 | 0% |
| Ocular biometry | 1 | 0% |
| Ocular deposits removal | 1 | 0% |
| Ocular discomfort | 1,794 | 0.11% |
| Ocular dysmetria | 2 | 0% |
| Ocular hyperaemia | 2,673 | 0.16% |
| Ocular hypertension | 130 | 0.01% |
| Ocular icterus | 75 | 0% |
| Ocular ischaemic syndrome | 9 | 0% |
| Ocular lymphoma | 1 | 0% |
| Ocular myasthenia | 71 | 0% |
| Ocular neoplasm | 4 | 0% |
| Ocular pemphigoid | 1 | 0% |
| Ocular procedural complication | 1 | 0% |
| Ocular rosacea | 13 | 0% |
| Ocular sarcoidosis | 11 | 0% |
| Ocular toxicity | 1 | 0% |
| Ocular vascular disorder | 143 | 0.01% |
| Ocular vasculitis | 11 | 0% |
| Oculoauriculovertebral dysplasia | 1 | 0% |
| Oculocephalogyric reflex absent | 2 | 0% |
| Oculofacial paralysis | 13 | 0% |
| Oculogyric crisis | 29 | 0% |
| Oculomotor study | 14 | 0% |
| Oculomotor study abnormal | 2 | 0% |
| Oculomucocutaneous syndrome | 57 | 0% |
| Oculopneumoplethysmogram | 1 | 0% |
| Oculorespiratory syndrome | 1 | 0% |
| Odynophagia | 937 | 0.06% |
| Oedema | 2,393 | 0.15% |
| Oedema blister | 7 | 0% |
| Oedema due to cardiac disease | 11 | 0% |
| Oedema due to hepatic disease | 2 | 0% |
| Oedema due to renal disease | 1 | 0% |
| Oedema genital | 18 | 0% |
| Oedema mouth | 75 | 0% |
| Oedema mucosal | 61 | 0% |
| Oedema peripheral | 5,416 | 0.33% |
| Oedematous kidney | 7 | 0% |
| Oedematous pancreatitis | 16 | 0% |
| Oesophageal achalasia | 49 | 0% |
| Oesophageal adenocarcinoma | 12 | 0% |
| Oesophageal atresia | 3 | 0% |
| Oesophageal cancer metastatic | 5 | 0% |
| Oesophageal candidiasis | 21 | 0% |
| Oesophageal carcinoma | 33 | 0% |
| Oesophageal compression | 4 | 0% |
| Oesophageal dilatation | 18 | 0% |
| Oesophageal dilation procedure | 9 | 0% |
| Oesophageal discomfort | 36 | 0% |
| Oesophageal disorder | 78 | 0% |
| Oesophageal food impaction | 12 | 0% |
| Oesophageal haemorrhage | 13 | 0% |
| Oesophageal hypomotility | 1 | 0% |
| Oesophageal infection | 1 | 0% |
| Oesophageal injury | 4 | 0% |
| Oesophageal irritation | 11 | 0% |
| Oesophageal manometry | 15 | 0% |
| Oesophageal mass | 2 | 0% |
| Oesophageal motility disorder | 15 | 0% |
| Oesophageal motility test | 11 | 0% |
| Oesophageal mucosa erythema | 1 | 0% |
| Oesophageal mucosal tear | 1 | 0% |
| Oesophageal neoplasm | 2 | 0% |
| Oesophageal obstruction | 6 | 0% |
| Oesophageal oedema | 11 | 0% |
| Oesophageal pain | 116 | 0.01% |
| Oesophageal papilloma | 1 | 0% |
| Oesophageal perforation | 6 | 0% |
| Oesophageal pH | 1 | 0% |
| Oesophageal polyp | 3 | 0% |
| Oesophageal rupture | 16 | 0% |
| Oesophageal spasm | 90 | 0.01% |
| Oesophageal squamous cell carcinoma | 3 | 0% |
| Oesophageal stenosis | 34 | 0% |
| Oesophageal ulcer | 28 | 0% |
| Oesophageal ulcer haemorrhage | 5 | 0% |
| Oesophageal variceal ligation | 4 | 0% |
| Oesophageal varices haemorrhage | 20 | 0% |
| Oesophageal wall hypertrophy | 4 | 0% |
| Oesophagectomy | 5 | 0% |
| Oesophagitis | 200 | 0.01% |
| Oesophagitis chemical | 1 | 0% |
| Oesophagitis ulcerative | 7 | 0% |
| Oesophagobronchial fistula | 1 | 0% |
| Oesophagocardiomyotomy | 1 | 0% |
| Oesophagogastric fundoplasty | 3 | 0% |
| Oesophagogastroduodenoscopy | 313 | 0.02% |
| Oesophagogastroduodenoscopy abnormal | 157 | 0.01% |
| Oesophagogastroduodenoscopy normal | 49 | 0% |
| Oesophagogastroscopy | 21 | 0% |
| Oesophagogastroscopy abnormal | 1 | 0% |
| Oesophagogastroscopy normal | 1 | 0% |
| Oesophagoscopy | 5 | 0% |
| Oesophagoscopy abnormal | 1 | 0% |
| Oesophagoscopy normal | 1 | 0% |
| Oesophagostomy | 1 | 0% |
| Oesophagram | 18 | 0% |
| Oestradiol | 151 | 0.01% |
| Oestradiol abnormal | 5 | 0% |
| Oestradiol decreased | 8 | 0% |
| Oestradiol increased | 14 | 0% |
| Oestradiol normal | 13 | 0% |
| Oestrogen deficiency | 2 | 0% |
| Oestrogenic effect | 1 | 0% |
| Oestrogen receptor assay | 19 | 0% |
| Oestrogen receptor assay negative | 2 | 0% |
| Oestrogen receptor assay positive | 4 | 0% |
| Oestrogen therapy | 1 | 0% |
| Office visit | 313 | 0.02% |
| Off label use | 26,658 | 1.62% |
| Oil acne | 2 | 0% |
| Olfactory dysfunction | 11 | 0% |
| Olfactory nerve disorder | 13 | 0% |
| Olfactory test | 9 | 0% |
| Olfactory test abnormal | 1 | 0% |
| Oligoarthritis | 39 | 0% |
| Oligoasthenoteratozoospermia | 2 | 0% |
| Oligodendroglioma | 3 | 0% |
| Oligodipsia | 10 | 0% |
| Oligohydramnios | 31 | 0% |
| Oligomenorrhoea | 1,693 | 0.1% |
| Oligospermia | 2 | 0% |
| Oliguria | 114 | 0.01% |
| Omental haemorrhage | 3 | 0% |
| Omental infarction | 23 | 0% |
| Omental necrosis | 1 | 0% |
| Omental patching | 1 | 0% |
| Omentectomy | 5 | 0% |
| Omentoplasty | 1 | 0% |
| Omphalitis | 14 | 0% |
| On and off phenomenon | 36 | 0% |
| Oncocytoma | 1 | 0% |
| Oncological evaluation | 15 | 0% |
| Oncologic complication | 3 | 0% |
| Oncotype test | 2 | 0% |
| Onychalgia | 33 | 0% |
| Onychoclasis | 75 | 0% |
| Onycholysis | 30 | 0% |
| Onychomadesis | 48 | 0% |
| Onychomycosis | 15 | 0% |
| Onychophagia | 1 | 0% |
| Oocyte harvest | 3 | 0% |
| Oophorectomy | 24 | 0% |
| Oophorectomy bilateral | 1 | 0% |
| Oophoritis | 10 | 0% |
| Open angle glaucoma | 11 | 0% |
| Open fracture | 11 | 0% |
| Open globe injury | 4 | 0% |
| Open reduction of fracture | 48 | 0% |
| Ophthalmia neonatorum | 1 | 0% |
| Ophthalmic artery aneurysm | 3 | 0% |
| Ophthalmic artery occlusion | 11 | 0% |
| Ophthalmic artery thrombosis | 22 | 0% |
| Ophthalmic fluid-air exchange procedure | 3 | 0% |
| Ophthalmic fluid drainage | 2 | 0% |
| Ophthalmic herpes simplex | 68 | 0% |
| Ophthalmic herpes zoster | 1,065 | 0.06% |
| Ophthalmic migraine | 287 | 0.02% |
| Ophthalmic scan | 49 | 0% |
| Ophthalmic vascular thrombosis | 16 | 0% |
| Ophthalmic vein thrombosis | 261 | 0.02% |
| Ophthalmological examination | 2,389 | 0.15% |
| Ophthalmological examination abnormal | 231 | 0.01% |
| Ophthalmological examination normal | 115 | 0.01% |
| Ophthalmoplegia | 192 | 0.01% |
| Ophthalmoplegic migraine | 5 | 0% |
| Opiates | 9 | 0% |
| Opiates negative | 13 | 0% |
| Opiates positive | 11 | 0% |
| Opisthotonus | 23 | 0% |
| Opitz trigonocephaly syndrome | 1 | 0% |
| Opportunistic infection | 5 | 0% |
| Oppositional defiant disorder | 1 | 0% |
| Opsoclonus myoclonus | 11 | 0% |
| Optical coherence tomography | 462 | 0.03% |
| Optical coherence tomography abnormal | 22 | 0% |
| Optical coherence tomography normal | 8 | 0% |
| Optic atrophy | 44 | 0% |
| Optic disc disorder | 8 | 0% |
| Optic disc drusen | 1 | 0% |
| Optic disc haemorrhage | 13 | 0% |
| Optic disc hyperaemia | 3 | 0% |
| Optic disc pit | 2 | 0% |
| Optic discs blurred | 4 | 0% |
| Optic glioma | 1 | 0% |
| Optic ischaemic neuropathy | 299 | 0.02% |
| Optic nerve compression | 5 | 0% |
| Optic nerve cup/disc ratio | 2 | 0% |
| Optic nerve cup/disc ratio increased | 1 | 0% |
| Optic nerve cup/disc ratio normal | 1 | 0% |
| Optic nerve cupping | 2 | 0% |
| Optic nerve disorder | 92 | 0.01% |
| Optic nerve infarction | 17 | 0% |
| Optic nerve injury | 70 | 0% |
| Optic nerve sheath haemorrhage | 6 | 0% |
| Optic neuritis | 869 | 0.05% |
| Optic neuropathy | 63 | 0% |
| Opticokinetic nystagmus tests | 9 | 0% |
| Opticokinetic nystagmus tests abnormal | 3 | 0% |
| Optic perineuritis | 10 | 0% |
| Optometric therapy | 1 | 0% |
| Oral administration complication | 3 | 0% |
| Oral allergy syndrome | 20 | 0% |
| Oral appliance application | 2 | 0% |
| Oral bacterial infection | 2 | 0% |
| Oral blood blister | 78 | 0% |
| Oral candidiasis | 238 | 0.01% |
| Oral cavity examination | 15 | 0% |
| Oral contraception | 23 | 0% |
| Oral contusion | 42 | 0% |
| Oral discharge | 9 | 0% |
| Oral discomfort | 1,205 | 0.07% |
| Oral disorder | 335 | 0.02% |
| Oral dysaesthesia | 37 | 0% |
| Oral dysplasia | 1 | 0% |
| Oral fibroma | 2 | 0% |
| Oral fungal infection | 55 | 0% |
| Oral haemangioma | 1 | 0% |
| Oral herpes | 2,323 | 0.14% |
| Oral herpes zoster | 7 | 0% |
| Oral hyperaesthesia | 1 | 0% |
| Oral infection | 23 | 0% |
| Oral lichenoid reaction | 10 | 0% |
| Oral lichen planus | 89 | 0.01% |
| Oral mucosa atrophy | 1 | 0% |
| Oral mucosa erosion | 22 | 0% |
| Oral mucosa haematoma | 6 | 0% |
| Oral mucosal blistering | 583 | 0.04% |
| Oral mucosal discolouration | 15 | 0% |
| Oral mucosal eruption | 233 | 0.01% |
| Oral mucosal erythema | 142 | 0.01% |
| Oral mucosal exfoliation | 50 | 0% |
| Oral mucosal hypertrophy | 1 | 0% |
| Oral mucosal roughening | 16 | 0% |
| Oral mucosal scar | 3 | 0% |
| Oral neoplasm | 5 | 0% |
| Oral pain | 1,176 | 0.07% |
| Oral papilloma | 3 | 0% |
| Oral papule | 3 | 0% |
| Oral pigmentation | 2 | 0% |
| Oral pruritus | 669 | 0.04% |
| Oral purpura | 6 | 0% |
| Oral pustule | 21 | 0% |
| Oral soft tissue biopsy | 20 | 0% |
| Oral surgery | 18 | 0% |
| Oral viral infection | 5 | 0% |
| Orbital apex syndrome | 3 | 0% |
| Orbital cyst | 4 | 0% |
| Orbital decompression | 1 | 0% |
| Orbital haematoma | 11 | 0% |
| Orbital haemorrhage | 1 | 0% |
| Orbital infection | 1 | 0% |
| Orbital myositis | 22 | 0% |
| Orbital oedema | 28 | 0% |
| Orbital space occupying lesion | 3 | 0% |
| Orbital swelling | 24 | 0% |
| Orbit atrophy | 1 | 0% |
| Orbitotomy | 1 | 0% |
| Orchidectomy | 8 | 0% |
| Orchidopexy | 3 | 0% |
| Orchitis | 61 | 0% |
| Orchitis noninfective | 15 | 0% |
| Orexin | 2 | 0% |
| Orf | 1 | 0% |
| Organ donor | 4 | 0% |
| Organ failure | 151 | 0.01% |
| Organic acid analysis | 1 | 0% |
| Organic acid analysis abnormal | 2 | 0% |
| Organic brain syndrome | 18 | 0% |
| Organic erectile dysfunction | 31 | 0% |
| Organising pneumonia | 164 | 0.01% |
| Organ transplant | 2 | 0% |
| Orgasm abnormal | 5 | 0% |
| Orgasmic sensation decreased | 2 | 0% |
| Ornithine transcarbamoylase deficiency | 1 | 0% |
| Orofacial granulomatosis | 1 | 0% |
| Oromandibular dystonia | 9 | 0% |
| Oropharyngeal blistering | 137 | 0.01% |
| Oropharyngeal cancer | 3 | 0% |
| Oropharyngeal candidiasis | 11 | 0% |
| Oropharyngeal cobble stone mucosa | 7 | 0% |
| Oropharyngeal discolouration | 8 | 0% |
| Oropharyngeal discomfort | 3,036 | 0.18% |
| Oropharyngeal neoplasm | 1 | 0% |
| Oropharyngeal oedema | 21 | 0% |
| Oropharyngeal pain | 26,006 | 1.58% |
| Oropharyngeal plaque | 20 | 0% |
| Oropharyngeal spasm | 23 | 0% |
| Oropharyngeal squamous cell carcinoma | 4 | 0% |
| Oropharyngeal stenosis | 1 | 0% |
| Oropharyngeal suctioning | 14 | 0% |
| Oropharyngeal swelling | 38 | 0% |
| Oropharyngitis fungal | 1 | 0% |
| Orthodontic procedure | 1 | 0% |
| Orthopaedic examination | 170 | 0.01% |
| Orthopaedic examination abnormal | 10 | 0% |
| Orthopaedic examination normal | 1 | 0% |
| Orthopaedic procedure | 9 | 0% |
| Orthopnoea | 330 | 0.02% |
| Orthosis user | 72 | 0% |
| Orthostatic heart rate response increased | 7 | 0% |
| Orthostatic heart rate test | 17 | 0% |
| Orthostatic hypertension | 43 | 0% |
| Orthostatic hypotension | 535 | 0.03% |
| Orthostatic intolerance | 147 | 0.01% |
| Orthostatic tremor | 3 | 0% |
| Oscillopsia | 22 | 0% |
| Osler's nodes | 1 | 0% |
| Osmophobia | 3 | 0% |
| Osmotic demyelination syndrome | 3 | 0% |
| Osteitis | 101 | 0.01% |
| Osteitis condensans | 1 | 0% |
| Osteitis deformans | 2 | 0% |
| Osteo-meningeal breaches | 1 | 0% |
| Osteoarthritis | 999 | 0.06% |
| Osteoarthropathy | 2 | 0% |
| Osteocalcin | 2 | 0% |
| Osteochondral fracture | 1 | 0% |
| Osteochondritis | 3 | 0% |
| Osteochondrodysplasia | 1 | 0% |
| Osteochondrosis | 41 | 0% |
| Osteogenesis imperfecta | 3 | 0% |
| Osteolysis | 23 | 0% |
| Osteoma | 8 | 0% |
| Osteomyelitis | 150 | 0.01% |
| Osteomyelitis acute | 13 | 0% |
| Osteomyelitis bacterial | 1 | 0% |
| Osteomyelitis chronic | 10 | 0% |
| Osteonecrosis | 82 | 0% |
| Osteonecrosis of jaw | 6 | 0% |
| Osteopathic treatment | 2 | 0% |
| Osteopenia | 86 | 0.01% |
| Osteophyte fracture | 1 | 0% |
| Osteoporosis | 152 | 0.01% |
| Osteoporosis postmenopausal | 3 | 0% |
| Osteoporotic fracture | 14 | 0% |
| Osteosarcoma | 9 | 0% |
| Osteosclerosis | 8 | 0% |
| Osteosis | 1 | 0% |
| Osteotomy | 5 | 0% |
| Ostomy bag placement | 5 | 0% |
| Otic examination | 60 | 0% |
| Otic examination normal | 3 | 0% |
| Otitis externa | 99 | 0.01% |
| Otitis externa bacterial | 2 | 0% |
| Otitis externa fungal | 3 | 0% |
| Otitis media | 175 | 0.01% |
| Otitis media acute | 38 | 0% |
| Otitis media chronic | 17 | 0% |
| Otoacoustic emissions test | 9 | 0% |
| Otoacoustic emissions test abnormal | 2 | 0% |
| Otoendoscopy | 1 | 0% |
| Otolithiasis | 19 | 0% |
| Otoplasty | 1 | 0% |
| Otorhinolaryngological surgery | 2 | 0% |
| Otorrhoea | 139 | 0.01% |
| Otosalpingitis | 9 | 0% |
| Otosclerosis | 10 | 0% |
| Otoscopy | 196 | 0.01% |
| Otoscopy abnormal | 3 | 0% |
| Otoscopy normal | 7 | 0% |
| Ototoxicity | 8 | 0% |
| Out of specification product use | 14 | 0% |
| Ovarian abscess | 3 | 0% |
| Ovarian atrophy | 2 | 0% |
| Ovarian bacterial infection | 1 | 0% |
| Ovarian calcification | 1 | 0% |
| Ovarian cancer | 51 | 0% |
| Ovarian cancer metastatic | 4 | 0% |
| Ovarian cancer recurrent | 1 | 0% |
| Ovarian cancer stage I | 1 | 0% |
| Ovarian cancer stage II | 1 | 0% |
| Ovarian cancer stage III | 5 | 0% |
| Ovarian cancer stage IV | 5 | 0% |
| Ovarian clear cell carcinoma | 2 | 0% |
| Ovarian cyst | 477 | 0.03% |
| Ovarian cystectomy | 5 | 0% |
| Ovarian cyst ruptured | 103 | 0.01% |
| Ovarian cyst torsion | 3 | 0% |
| Ovarian disorder | 46 | 0% |
| Ovarian dysgerminoma stage unspecified | 2 | 0% |
| Ovarian enlargement | 25 | 0% |
| Ovarian epithelial cancer | 4 | 0% |
| Ovarian failure | 27 | 0% |
| Ovarian fibroma | 2 | 0% |
| Ovarian fibrosis | 1 | 0% |
| Ovarian germ cell cancer | 1 | 0% |
| Ovarian germ cell teratoma | 1 | 0% |
| Ovarian germ cell teratoma benign | 8 | 0% |
| Ovarian germ cell tumour | 4 | 0% |
| Ovarian granulosa cell tumour | 4 | 0% |
| Ovarian haematoma | 2 | 0% |
| Ovarian haemorrhage | 21 | 0% |
| Ovarian hyperfunction | 1 | 0% |
| Ovarian hyperstimulation syndrome | 3 | 0% |
| Ovarian low malignant potential tumour | 1 | 0% |
| Ovarian mass | 31 | 0% |
| Ovarian necrosis | 3 | 0% |
| Ovarian neoplasm | 10 | 0% |
| Ovarian neoplasm surgery | 1 | 0% |
| Ovarian oedema | 1 | 0% |
| Ovarian operation | 7 | 0% |
| Ovarian prolapse | 2 | 0% |
| Ovarian repair | 1 | 0% |
| Ovarian rupture | 3 | 0% |
| Ovarian vein thrombosis | 34 | 0% |
| Ovariocentesis | 1 | 0% |
| Overdose | 1,277 | 0.08% |
| Overflow diarrhoea | 2 | 0% |
| Overgrowth bacterial | 7 | 0% |
| Overgrowth fungal | 10 | 0% |
| Overlap syndrome | 16 | 0% |
| Oversensing | 84 | 0.01% |
| Overweight | 55 | 0% |
| Overwork | 9 | 0% |
| Ovulation delayed | 61 | 0% |
| Ovulation disorder | 84 | 0.01% |
| Ovulation induction | 3 | 0% |
| Ovulation pain | 193 | 0.01% |
| Oxidative stress | 9 | 0% |
| Oxygenation index | 45 | 0% |
| Oxygen consumption | 77 | 0% |
| Oxygen consumption decreased | 48 | 0% |
| Oxygen consumption increased | 9 | 0% |
| Oxygen saturation | 15,412 | 0.94% |
| Oxygen saturation abnormal | 227 | 0.01% |
| Oxygen saturation decreased | 5,449 | 0.33% |
| Oxygen saturation immeasurable | 13 | 0% |
| Oxygen saturation increased | 35 | 0% |
| Oxygen saturation normal | 89 | 0.01% |
| Oxygen therapy | 115 | 0.01% |
| Ozone therapy | 3 | 0% |
| Pacemaker generated arrhythmia | 8 | 0% |
| Pacemaker generated rhythm | 31 | 0% |
| Pacemaker syndrome | 2 | 0% |
| Pachymeningitis | 16 | 0% |
| Pachyonychia congenita | 1 | 0% |
| Packed red blood cell transfusion | 126 | 0.01% |
| Padua prediction score | 1 | 0% |
| Paediatric acute-onset neuropsychiatric syndrome | 2 | 0% |
| Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 4 | 0% |
| Paget's disease of nipple | 2 | 0% |
| Paget's disease of the vulva | 1 | 0% |
| Paget-Schroetter syndrome | 8 | 0% |
| Pain | 137,061 | 8.34% |
| Pain assessment | 1,085 | 0.07% |
| Painful ejaculation | 12 | 0% |
| Painful erection | 13 | 0% |
| Painful respiration | 1,468 | 0.09% |
| Pain in extremity | 117,711 | 7.16% |
| Pain in jaw | 3,687 | 0.22% |
| Pain management | 8 | 0% |
| Pain of skin | 2,957 | 0.18% |
| Pain prophylaxis | 1 | 0% |
| Pain threshold decreased | 6 | 0% |
| Palatal disorder | 38 | 0% |
| Palatal oedema | 132 | 0.01% |
| Palatal palsy | 6 | 0% |
| Palatal swelling | 134 | 0.01% |
| Palatal ulcer | 8 | 0% |
| Palate injury | 9 | 0% |
| Palindromic rheumatism | 35 | 0% |
| Palliative care | 11 | 0% |
| Pallor | 9,168 | 0.56% |
| Palmar-plantar erythrodysaesthesia syndrome | 34 | 0% |
| Palmar erythema | 76 | 0% |
| Palmar fasciitis | 1 | 0% |
| Palmomental reflex | 2 | 0% |
| Palmoplantar keratoderma | 7 | 0% |
| Palmoplantar pustulosis | 30 | 0% |
| Palpable purpura | 26 | 0% |
| Palpatory finding abnormal | 10 | 0% |
| Palpitations | 39,631 | 2.41% |
| Pancoast's syndrome | 1 | 0% |
| Pancoast's tumour | 1 | 0% |
| Pancreas divisum | 1 | 0% |
| Pancreas infection | 13 | 0% |
| Pancreas transplant rejection | 1 | 0% |
| Pancreatectomy | 11 | 0% |
| Pancreatic abscess | 4 | 0% |
| Pancreatic atrophy | 15 | 0% |
| Pancreatic calcification | 5 | 0% |
| Pancreatic carcinoma | 135 | 0.01% |
| Pancreatic carcinoma metastatic | 26 | 0% |
| Pancreatic carcinoma recurrent | 1 | 0% |
| Pancreatic carcinoma stage IV | 1 | 0% |
| Pancreatic cyst | 65 | 0% |
| Pancreatic cystadenoma | 1 | 0% |
| Pancreatic cyst drainage | 1 | 0% |
| Pancreatic disorder | 95 | 0.01% |
| Pancreatic duct dilatation | 10 | 0% |
| Pancreatic duct obstruction | 2 | 0% |
| Pancreatic duct stenosis | 2 | 0% |
| Pancreatic enlargement | 12 | 0% |
| Pancreatic enzyme abnormality | 3 | 0% |
| Pancreatic enzymes | 25 | 0% |
| Pancreatic enzymes abnormal | 1 | 0% |
| Pancreatic enzymes decreased | 4 | 0% |
| Pancreatic enzymes increased | 36 | 0% |
| Pancreatic enzymes normal | 3 | 0% |
| Pancreatic failure | 73 | 0% |
| Pancreatic infarction | 2 | 0% |
| Pancreatic injury | 3 | 0% |
| Pancreatic islets hyperplasia | 1 | 0% |
| Pancreatic lesion excision | 1 | 0% |
| Pancreatic mass | 34 | 0% |
| Pancreatic neoplasm | 11 | 0% |
| Pancreatic neuroendocrine tumour | 1 | 0% |
| Pancreaticoduodenectomy | 7 | 0% |
| Pancreaticogastrostomy | 1 | 0% |
| Pancreatic operation | 2 | 0% |
| Pancreatic pseudoaneurysm | 1 | 0% |
| Pancreatic pseudocyst | 9 | 0% |
| Pancreatic pseudocyst rupture | 1 | 0% |
| Pancreatic steatosis | 14 | 0% |
| Pancreatic stent placement | 3 | 0% |
| Pancreatitis | 670 | 0.04% |
| Pancreatitis acute | 645 | 0.04% |
| Pancreatitis chronic | 43 | 0% |
| Pancreatitis haemorrhagic | 2 | 0% |
| Pancreatitis necrotising | 54 | 0% |
| Pancreatitis relapsing | 7 | 0% |
| Pancreatogenous diabetes | 1 | 0% |
| Pancytopenia | 461 | 0.03% |
| Panel-reactive antibody | 18 | 0% |
| Panendoscopy | 14 | 0% |
| Panic attack | 2,895 | 0.18% |
| Panic disorder | 176 | 0.01% |
| Panic reaction | 557 | 0.03% |
| Panniculitis | 89 | 0.01% |
| Panniculitis lobular | 1 | 0% |
| Panophthalmitis | 5 | 0% |
| Pantoea agglomerans test positive | 1 | 0% |
| PaO2/FiO2 ratio | 36 | 0% |
| PaO2/FiO2 ratio decreased | 3 | 0% |
| Papilla of Vater sclerosis | 1 | 0% |
| Papillary cystadenoma lymphomatosum | 7 | 0% |
| Papillary muscle haemorrhage | 1 | 0% |
| Papillary muscle rupture | 2 | 0% |
| Papillary renal cell carcinoma | 1 | 0% |
| Papillary thyroid cancer | 25 | 0% |
| Papillitis | 15 | 0% |
| Papilloedema | 312 | 0.02% |
| Papilloma | 10 | 0% |
| Papilloma excision | 2 | 0% |
| Papilloma viral infection | 56 | 0% |
| Papillophlebitis | 5 | 0% |
| Papule | 392 | 0.02% |
| Papulopustular rosacea | 5 | 0% |
| Paracentesis | 72 | 0% |
| Paracentesis eye | 3 | 0% |
| Paradoxical drug reaction | 4 | 0% |
| Paradoxical embolism | 14 | 0% |
| Paradoxical pressor response | 2 | 0% |
| Paradoxical psoriasis | 2 | 0% |
| Paraesthesia | 46,912 | 2.85% |
| Paraesthesia ear | 46 | 0% |
| Paraesthesia mucosal | 14 | 0% |
| Paraesthesia oral | 8,870 | 0.54% |
| Paraganglion neoplasm | 5 | 0% |
| Paragonimiasis | 3 | 0% |
| Parainfluenzae viral laryngotracheobronchitis | 1 | 0% |
| Parainfluenzae virus infection | 21 | 0% |
| Parakeratosis | 10 | 0% |
| Paralogism | 1 | 0% |
| Paralysis | 2,832 | 0.17% |
| Paralysis recurrent laryngeal nerve | 21 | 0% |
| Paralytic disability | 4 | 0% |
| Paralytic lagophthalmos | 6 | 0% |
| Parametritis | 1 | 0% |
| Paramnesia | 8 | 0% |
| Paranasal biopsy normal | 1 | 0% |
| Paranasal cyst | 23 | 0% |
| Paranasal sinus abscess | 1 | 0% |
| Paranasal sinus and nasal cavity malignant neoplasm | 1 | 0% |
| Paranasal sinus discomfort | 1,410 | 0.09% |
| Paranasal sinus haemorrhage | 11 | 0% |
| Paranasal sinus hypersecretion | 275 | 0.02% |
| Paranasal sinus hyposecretion | 19 | 0% |
| Paranasal sinus inflammation | 90 | 0.01% |
| Paranasal sinus injury | 1 | 0% |
| Paranasal sinus mass | 2 | 0% |
| Paranasal sinus mucosal hypertrophy | 3 | 0% |
| Paraneoplastic arthritis | 2 | 0% |
| Paraneoplastic dermatomyositis | 2 | 0% |
| Paraneoplastic encephalomyelitis | 2 | 0% |
| Paraneoplastic myelopathy | 1 | 0% |
| Paraneoplastic neurological syndrome | 1 | 0% |
| Paraneoplastic pemphigus | 1 | 0% |
| Paraneoplastic pleural effusion | 1 | 0% |
| Paraneoplastic syndrome | 13 | 0% |
| Paraneoplastic thrombosis | 1 | 0% |
| Paranoia | 250 | 0.02% |
| Paranoid personality disorder | 2 | 0% |
| Paraparesis | 204 | 0.01% |
| Parapharyngeal space infection | 4 | 0% |
| Paraplegia | 157 | 0.01% |
| Paraproteinaemia | 7 | 0% |
| Parapsoriasis | 50 | 0% |
| Parasite blood test | 42 | 0% |
| Parasite blood test positive | 3 | 0% |
| Parasite DNA test | 1 | 0% |
| Parasite stool test | 54 | 0% |
| Parasite stool test negative | 36 | 0% |
| Parasite stool test positive | 3 | 0% |
| Parasite urine test negative | 2 | 0% |
| Parasitic blood test negative | 15 | 0% |
| Parasitic gastroenteritis | 7 | 0% |
| Parasitic test | 42 | 0% |
| Parasitic test positive | 3 | 0% |
| Parasomnia | 5 | 0% |
| Parasystole | 2 | 0% |
| Parathyroid disorder | 7 | 0% |
| Parathyroidectomy | 3 | 0% |
| Parathyroid gland enlargement | 4 | 0% |
| Parathyroid hormone-related protein | 3 | 0% |
| Parathyroid scan abnormal | 1 | 0% |
| Parathyroid tumour | 1 | 0% |
| Parathyroid tumour benign | 4 | 0% |
| Paratracheal lymphadenopathy | 18 | 0% |
| Paravalvular regurgitation | 1 | 0% |
| Parechovirus infection | 5 | 0% |
| Parent-child problem | 1 | 0% |
| Parenteral nutrition | 25 | 0% |
| Paresis | 478 | 0.03% |
| Paresis anal sphincter | 1 | 0% |
| Paresis cranial nerve | 13 | 0% |
| Parietal cell antibody | 14 | 0% |
| Parietal cell antibody normal | 2 | 0% |
| Parietal cell antibody positive | 2 | 0% |
| Parietal lobe stroke | 2 | 0% |
| Parinaud syndrome | 1 | 0% |
| Parity | 3 | 0% |
| Parkinson's disease | 345 | 0.02% |
| Parkinson's disease psychosis | 1 | 0% |
| Parkinsonian crisis | 1 | 0% |
| Parkinsonian gait | 12 | 0% |
| Parkinsonian rest tremor | 6 | 0% |
| Parkinsonism | 92 | 0.01% |
| Paronychia | 26 | 0% |
| Parophthalmia | 7 | 0% |
| Parosmia | 2,393 | 0.15% |
| Parotid abscess | 3 | 0% |
| Parotid duct obstruction | 6 | 0% |
| Parotidectomy | 5 | 0% |
| Parotid gland enlargement | 87 | 0.01% |
| Parotitis | 126 | 0.01% |
| Paroxysmal arrhythmia | 19 | 0% |
| Paroxysmal atrioventricular block | 6 | 0% |
| Paroxysmal autonomic instability with dystonia | 1 | 0% |
| Paroxysmal choreoathetosis | 1 | 0% |
| Paroxysmal extreme pain disorder | 7 | 0% |
| Paroxysmal nocturnal haemoglobinuria | 30 | 0% |
| Paroxysmal sympathetic hyperactivity | 3 | 0% |
| Partial seizures | 378 | 0.02% |
| Partial seizures with secondary generalisation | 11 | 0% |
| Partner stress | 7 | 0% |
| Paruresis | 1 | 0% |
| Parvovirus B19 infection | 13 | 0% |
| Parvovirus B19 infection reactivation | 2 | 0% |
| Parvovirus B19 test | 391 | 0.02% |
| Parvovirus B19 test negative | 52 | 0% |
| Parvovirus B19 test positive | 18 | 0% |
| Parvovirus infection | 14 | 0% |
| Passive smoking | 9 | 0% |
| Past-pointing | 1 | 0% |
| Pasteurella infection | 1 | 0% |
| Pasteurella test positive | 1 | 0% |
| Patella fracture | 23 | 0% |
| Patellofemoral pain syndrome | 8 | 0% |
| Patent ductus arteriosus | 13 | 0% |
| Paternal exposure before pregnancy | 6 | 0% |
| Paternal exposure during pregnancy | 3 | 0% |
| Pathergy reaction | 3 | 0% |
| Pathogen resistance | 59 | 0% |
| Pathological dissection | 1 | 0% |
| Pathological doubt | 3 | 0% |
| Pathological fracture | 23 | 0% |
| Pathology test | 513 | 0.03% |
| Patient-device incompatibility | 3 | 0% |
| Patient dissatisfaction with device | 2 | 0% |
| Patient dissatisfaction with treatment | 6 | 0% |
| Patient elopement | 25 | 0% |
| Patient isolation | 62 | 0% |
| Patient restraint | 38 | 0% |
| Patient uncooperative | 40 | 0% |
| PCO2 | 976 | 0.06% |
| PCO2 abnormal | 2 | 0% |
| PCO2 decreased | 133 | 0.01% |
| PCO2 increased | 168 | 0.01% |
| PCO2 normal | 105 | 0.01% |
| PD-1 test | 1 | 0% |
| PD-L1 test negative | 1 | 0% |
| Peak expiratory flow rate | 128 | 0.01% |
| Peak expiratory flow rate abnormal | 4 | 0% |
| Peak expiratory flow rate decreased | 25 | 0% |
| Peak expiratory flow rate normal | 1 | 0% |
| Peak nasal inspiratory flow test | 5 | 0% |
| Peau d'orange | 9 | 0% |
| Pectus excavatum | 7 | 0% |
| Pedal pulse abnormal | 1 | 0% |
| Pedal pulse decreased | 2 | 0% |
| Pedantic speech | 1 | 0% |
| Peliosis hepatis | 2 | 0% |
| Pelvi-ureteric obstruction | 10 | 0% |
| Pelvic abscess | 15 | 0% |
| Pelvic adhesions | 1 | 0% |
| Pelvic bone injury | 3 | 0% |
| Pelvic congestion | 7 | 0% |
| Pelvic cyst | 3 | 0% |
| Pelvic deformity | 1 | 0% |
| Pelvic discomfort | 50 | 0% |
| Pelvic exenteration | 1 | 0% |
| Pelvic exploration | 1 | 0% |
| Pelvic floor dysfunction | 18 | 0% |
| Pelvic floor muscle training | 2 | 0% |
| Pelvic floor muscle weakness | 9 | 0% |
| Pelvic fluid collection | 27 | 0% |
| Pelvic fluid collection drainage | 2 | 0% |
| Pelvic fracture | 70 | 0% |
| Pelvic girdle pain | 22 | 0% |
| Pelvic haematoma | 8 | 0% |
| Pelvic haemorrhage | 37 | 0% |
| Pelvic infection | 6 | 0% |
| Pelvic inflammatory disease | 58 | 0% |
| Pelvic mass | 19 | 0% |
| Pelvic misalignment | 2 | 0% |
| Pelvic neoplasm | 2 | 0% |
| Pelvic operation | 2 | 0% |
| Pelvic organ prolapse | 6 | 0% |
| Pelvic pain | 1,243 | 0.08% |
| Pelvic prolapse | 1 | 0% |
| Pelvic resection | 1 | 0% |
| Pelvic venous thrombosis | 217 | 0.01% |
| Pemphigoid | 558 | 0.03% |
| Pemphigoid antibody panel | 2 | 0% |
| Pemphigus | 216 | 0.01% |
| Pemphigus disease area index | 2 | 0% |
| Penetrating aortic ulcer | 3 | 0% |
| Penetrating atherosclerotic ulcer | 1 | 0% |
| Penile abscess | 5 | 0% |
| Penile artery occlusion | 1 | 0% |
| Penile blister | 6 | 0% |
| Penile burning sensation | 4 | 0% |
| Penile contusion | 3 | 0% |
| Penile curvature | 10 | 0% |
| Penile dermatitis | 2 | 0% |
| Penile discharge | 1 | 0% |
| Penile discomfort | 7 | 0% |
| Penile erythema | 6 | 0% |
| Penile exfoliation | 1 | 0% |
| Penile haematoma | 1 | 0% |
| Penile haemorrhage | 18 | 0% |
| Penile oedema | 16 | 0% |
| Penile pain | 44 | 0% |
| Penile pigmentation | 1 | 0% |
| Penile rash | 9 | 0% |
| Penile size reduced | 5 | 0% |
| Penile swelling | 33 | 0% |
| Penile ulceration | 2 | 0% |
| Penile vascular disorder | 1 | 0% |
| Penile vein thrombosis | 24 | 0% |
| Penile wart | 2 | 0% |
| Penis disorder | 43 | 0% |
| Penis injury | 5 | 0% |
| Penoscrotal fusion | 2 | 0% |
| Peptic ulcer | 42 | 0% |
| Peptic ulcer haemorrhage | 28 | 0% |
| Peptostreptococcus infection | 2 | 0% |
| Peptostreptococcus test positive | 1 | 0% |
| Percussion test | 16 | 0% |
| Percussion test normal | 1 | 0% |
| Percutaneous coronary intervention | 115 | 0.01% |
| Percutaneous fracture pinning | 1 | 0% |
| Perforated ulcer | 3 | 0% |
| Perforation | 18 | 0% |
| Perforation bile duct | 2 | 0% |
| Performance fear | 2 | 0% |
| Performance status decreased | 944 | 0.06% |
| Perfume sensitivity | 34 | 0% |
| Perfusion brain scan | 57 | 0% |
| Perfusion brain scan abnormal | 24 | 0% |
| Perfusion brain scan normal | 39 | 0% |
| Peri-implantitis | 1 | 0% |
| Peri-spinal heterotopic ossification | 1 | 0% |
| Periarthritis | 1,377 | 0.08% |
| Periarthritis calcarea | 4 | 0% |
| Periarticular disorder | 2 | 0% |
| Pericardial calcification | 4 | 0% |
| Pericardial cyst | 8 | 0% |
| Pericardial cyst resection | 1 | 0% |
| Pericardial disease | 53 | 0% |
| Pericardial drainage | 137 | 0.01% |
| Pericardial drainage test | 15 | 0% |
| Pericardial drainage test abnormal | 1 | 0% |
| Pericardial drainage test normal | 1 | 0% |
| Pericardial effusion | 3,242 | 0.2% |
| Pericardial excision | 49 | 0% |
| Pericardial fibrosis | 79 | 0% |
| Pericardial haemorrhage | 57 | 0% |
| Pericardial injury | 1 | 0% |
| Pericardial lipoma | 1 | 0% |
| Pericardial mass | 6 | 0% |
| Pericardial mesothelioma malignant | 1 | 0% |
| Pericardial operation | 1 | 0% |
| Pericardial repair | 2 | 0% |
| Pericardial rub | 34 | 0% |
| Pericardiotomy | 4 | 0% |
| Pericarditis | 11,810 | 0.72% |
| Pericarditis adhesive | 3 | 0% |
| Pericarditis constrictive | 47 | 0% |
| Pericarditis fungal | 1 | 0% |
| Pericarditis gonococcal | 1 | 0% |
| Pericarditis infective | 17 | 0% |
| Pericarditis lupus | 1 | 0% |
| Pericarditis rheumatic | 3 | 0% |
| Pericarditis uraemic | 1 | 0% |
| Perichondritis | 22 | 0% |
| Pericoronitis | 5 | 0% |
| Perihepatic discomfort | 4 | 0% |
| Perihepatitis | 1 | 0% |
| Perinatal brain damage | 1 | 0% |
| Perinatal depression | 6 | 0% |
| Perinatal stroke | 2 | 0% |
| Perineal abscess | 6 | 0% |
| Perineal cellulitis | 1 | 0% |
| Perineal cyst | 2 | 0% |
| Perineal disorder | 7 | 0% |
| Perineal erythema | 1 | 0% |
| Perineal fistula | 1 | 0% |
| Perineal haematoma | 1 | 0% |
| Perineal injury | 9 | 0% |
| Perineal operation | 1 | 0% |
| Perineal pain | 29 | 0% |
| Perineal rash | 5 | 0% |
| Perineal ulceration | 3 | 0% |
| Perinephric abscess | 3 | 0% |
| Perinephric collection | 3 | 0% |
| Perinephric oedema | 3 | 0% |
| Perinephritis | 1 | 0% |
| Periodic acid Schiff stain | 15 | 0% |
| Periodic limb movement disorder | 6 | 0% |
| Periodontal disease | 8 | 0% |
| Periodontic-endodontic disease | 1 | 0% |
| Periodontitis | 23 | 0% |
| Perioral dermatitis | 37 | 0% |
| Periorbital abscess | 1 | 0% |
| Periorbital cellulitis | 32 | 0% |
| Periorbital dermatitis | 3 | 0% |
| Periorbital discomfort | 14 | 0% |
| Periorbital disorder | 3 | 0% |
| Periorbital fat herniation | 2 | 0% |
| Periorbital haematoma | 27 | 0% |
| Periorbital haemorrhage | 20 | 0% |
| Periorbital infection | 2 | 0% |
| Periorbital inflammation | 10 | 0% |
| Periorbital injury | 1 | 0% |
| Periorbital irritation | 4 | 0% |
| Periorbital oedema | 337 | 0.02% |
| Periorbital pain | 86 | 0.01% |
| Periorbital swelling | 1,130 | 0.07% |
| Periostitis | 11 | 0% |
| Peripancreatic fluid collection | 8 | 0% |
| Peripancreatic varices | 1 | 0% |
| Peripartum cardiomyopathy | 6 | 0% |
| Peripartum haemorrhage | 5 | 0% |
| Peripheral arterial occlusive disease | 151 | 0.01% |
| Peripheral arteriogram | 1 | 0% |
| Peripheral artery aneurysm | 24 | 0% |
| Peripheral artery aneurysm rupture | 2 | 0% |
| Peripheral artery angioplasty | 4 | 0% |
| Peripheral artery bypass | 12 | 0% |
| Peripheral artery dissection | 2 | 0% |
| Peripheral artery haematoma | 2 | 0% |
| Peripheral artery occlusion | 131 | 0.01% |
| Peripheral artery restenosis | 1 | 0% |
| Peripheral artery stenosis | 31 | 0% |
| Peripheral artery stent insertion | 9 | 0% |
| Peripheral artery surgery | 1 | 0% |
| Peripheral artery thrombosis | 279 | 0.02% |
| Peripheral circulatory failure | 85 | 0.01% |
| Peripheral coldness | 3,633 | 0.22% |
| Peripheral embolism | 120 | 0.01% |
| Peripheral endarterectomy | 5 | 0% |
| Peripheral ischaemia | 257 | 0.02% |
| Peripheral motor neuropathy | 48 | 0% |
| Peripheral nerve decompression | 8 | 0% |
| Peripheral nerve destruction | 2 | 0% |
| Peripheral nerve infection | 1 | 0% |
| Peripheral nerve injury | 46 | 0% |
| Peripheral nerve lesion | 52 | 0% |
| Peripheral nerve neurostimulation | 6 | 0% |
| Peripheral nerve operation | 5 | 0% |
| Peripheral nerve palsy | 17 | 0% |
| Peripheral nerve paresis | 23 | 0% |
| Peripheral nerve ultrasound | 4 | 0% |
| Peripheral nervous system function test | 3 | 0% |
| Peripheral nervous system function test abnormal | 4 | 0% |
| Peripheral nervous system neoplasm | 1 | 0% |
| Peripheral paralysis | 62 | 0% |
| Peripheral pulse decreased | 13 | 0% |
| Peripheral revascularisation | 1 | 0% |
| Peripheral sensorimotor neuropathy | 50 | 0% |
| Peripheral sensory neuropathy | 188 | 0.01% |
| Peripheral spondyloarthritis | 8 | 0% |
| Peripheral swelling | 29,816 | 1.81% |
| Peripheral T-cell lymphoma unspecified | 9 | 0% |
| Peripheral vascular disorder | 548 | 0.03% |
| Peripheral vein occlusion | 38 | 0% |
| Peripheral vein stenosis | 4 | 0% |
| Peripheral vein thrombosis | 4 | 0% |
| Peripheral vein thrombus extension | 15 | 0% |
| Peripheral venous disease | 277 | 0.02% |
| Periphlebitis | 7 | 0% |
| Periportal oedema | 12 | 0% |
| Periprosthetic fracture | 16 | 0% |
| Periprosthetic osteolysis | 1 | 0% |
| Perirectal abscess | 5 | 0% |
| Peristalsis visible | 1 | 0% |
| Peritoneal abscess | 1 | 0% |
| Peritoneal adhesions | 3 | 0% |
| Peritoneal cancer index | 1 | 0% |
| Peritoneal candidiasis | 1 | 0% |
| Peritoneal catheter insertion | 3 | 0% |
| Peritoneal dialysis | 15 | 0% |
| Peritoneal dialysis complication | 1 | 0% |
| Peritoneal disorder | 12 | 0% |
| Peritoneal effluent erythrocyte count | 2 | 0% |
| Peritoneal fibrosis | 2 | 0% |
| Peritoneal fluid analysis | 7 | 0% |
| Peritoneal fluid analysis abnormal | 9 | 0% |
| Peritoneal haematoma | 2 | 0% |
| Peritoneal lavage | 2 | 0% |
| Peritoneal lesion | 1 | 0% |
| Peritoneal neoplasm | 2 | 0% |
| Peritoneal perforation | 1 | 0% |
| Peritonectomy | 1 | 0% |
| Peritonitis | 141 | 0.01% |
| Peritonitis bacterial | 14 | 0% |
| Peritonsillar abscess | 67 | 0% |
| Peritonsillitis | 4 | 0% |
| Peritumoural oedema | 2 | 0% |
| Periumbilical abscess | 1 | 0% |
| Perivascular dermatitis | 23 | 0% |
| Perivascular epithelioid cell tumour | 1 | 0% |
| Periventricular leukomalacia | 9 | 0% |
| Pernicious anaemia | 35 | 0% |
| Pernio-like erythema | 31 | 0% |
| Peroneal nerve injury | 9 | 0% |
| Peroneal nerve palsy | 272 | 0.02% |
| Perry syndrome | 1 | 0% |
| Persecutory delusion | 12 | 0% |
| Perseveration | 6 | 0% |
| Persistent complex bereavement disorder | 1 | 0% |
| Persistent corneal epithelial defect | 1 | 0% |
| Persistent depressive disorder | 17 | 0% |
| Persistent foetal circulation | 2 | 0% |
| Persistent generalised lymphadenopathy | 5 | 0% |
| Persistent genital arousal disorder | 5 | 0% |
| Persistent left superior vena cava | 1 | 0% |
| Persistent postural-perceptual dizziness | 57 | 0% |
| Personality change | 185 | 0.01% |
| Personality change due to a general medical condition | 2 | 0% |
| Personality disorder | 36 | 0% |
| Personal relationship issue | 4 | 0% |
| Perthes disease | 1 | 0% |
| Pertussis | 46 | 0% |
| Petechiae | 2,041 | 0.12% |
| Petit mal epilepsy | 271 | 0.02% |
| Petroleum distillate poisoning | 1 | 0% |
| Peyronie's disease | 23 | 0% |
| PFAPA syndrome | 1 | 0% |
| Pfeiffer syndrome | 1 | 0% |
| Phaeochromocytoma | 8 | 0% |
| Phaeochromocytoma crisis | 1 | 0% |
| Phalen's test positive | 4 | 0% |
| Phantom limb syndrome | 57 | 0% |
| Phantom shocks | 1 | 0% |
| Phantom vibration syndrome | 3 | 0% |
| Pharyngeal abscess | 21 | 0% |
| Pharyngeal contusion | 3 | 0% |
| Pharyngeal cyst | 4 | 0% |
| Pharyngeal disorder | 99 | 0.01% |
| Pharyngeal dyskinesia | 1 | 0% |
| Pharyngeal enanthema | 14 | 0% |
| Pharyngeal erythema | 333 | 0.02% |
| Pharyngeal exudate | 3 | 0% |
| Pharyngeal haematoma | 3 | 0% |
| Pharyngeal haemorrhage | 54 | 0% |
| Pharyngeal hypoaesthesia | 608 | 0.04% |
| Pharyngeal inflammation | 107 | 0.01% |
| Pharyngeal lesion | 3 | 0% |
| Pharyngeal leukoplakia | 1 | 0% |
| Pharyngeal mass | 54 | 0% |
| Pharyngeal neoplasm | 7 | 0% |
| Pharyngeal oedema | 331 | 0.02% |
| Pharyngeal operation | 2 | 0% |
| Pharyngeal paraesthesia | 1,173 | 0.07% |
| Pharyngeal pustule | 6 | 0% |
| Pharyngeal stenosis | 22 | 0% |
| Pharyngeal swelling | 5,960 | 0.36% |
| Pharyngeal ulceration | 69 | 0% |
| Pharyngitis | 456 | 0.03% |
| Pharyngitis bacterial | 11 | 0% |
| Pharyngitis streptococcal | 190 | 0.01% |
| Pharyngo-oesophageal diverticulum | 5 | 0% |
| Pharyngolaryngeal abscess | 1 | 0% |
| Pharyngoscopy | 5 | 0% |
| Pharyngotonsillitis | 11 | 0% |
| pH body fluid | 848 | 0.05% |
| pH body fluid abnormal | 4 | 0% |
| pH body fluid increased | 3 | 0% |
| Phelan-McDermid syndrome | 1 | 0% |
| Philadelphia chromosome negative | 3 | 0% |
| Philadelphia chromosome positive | 9 | 0% |
| Philadelphia positive acute lymphocytic leukaemia | 2 | 0% |
| Philadelphia positive chronic myeloid leukaemia | 1 | 0% |
| Phimosis | 11 | 0% |
| Phlebectomy | 5 | 0% |
| Phlebitis | 674 | 0.04% |
| Phlebitis deep | 15 | 0% |
| Phlebitis infective | 2 | 0% |
| Phlebitis superficial | 98 | 0.01% |
| Phlebolith | 8 | 0% |
| Phlebotomy | 14 | 0% |
| Phobia | 31 | 0% |
| Phobia of driving | 2 | 0% |
| Phobic postural vertigo | 17 | 0% |
| Phonophobia | 110 | 0.01% |
| Phospholipase A2 activity increased | 5 | 0% |
| Phospholipidosis | 1 | 0% |
| Photodermatosis | 5 | 0% |
| Photodynamic therapy | 1 | 0% |
| Photokeratitis | 2 | 0% |
| Photon radiation therapy | 1 | 0% |
| Photophobia | 4,227 | 0.26% |
| Photopsia | 1,036 | 0.06% |
| Photorefractive keratectomy | 2 | 0% |
| Photosensitivity reaction | 678 | 0.04% |
| Phototherapy | 3 | 0% |
| Phrenic nerve injury | 2 | 0% |
| Phrenic nerve paralysis | 12 | 0% |
| pH urine | 200 | 0.01% |
| pH urine abnormal | 3 | 0% |
| pH urine increased | 8 | 0% |
| pH urine normal | 230 | 0.01% |
| Phyllodes tumour | 2 | 0% |
| Physical assault | 12 | 0% |
| Physical breast examination | 43 | 0% |
| Physical breast examination abnormal | 2 | 0% |
| Physical breast examination normal | 2 | 0% |
| Physical capacity evaluation | 9 | 0% |
| Physical deconditioning | 573 | 0.03% |
| Physical disability | 130 | 0.01% |
| Physical examination | 6,720 | 0.41% |
| Physical examination abnormal | 19 | 0% |
| Physical examination normal | 44 | 0% |
| Physical examination of joints | 15 | 0% |
| Physical examination of joints abnormal | 1 | 0% |
| Physical fitness training | 3 | 0% |
| Physical product label issue | 4 | 0% |
| Physical thyroid examination | 14 | 0% |
| Physiotherapy | 93 | 0.01% |
| Physiotherapy chest | 5 | 0% |
| Pica | 9 | 0% |
| Pickwickian syndrome | 20 | 0% |
| Picornavirus infection | 4 | 0% |
| Pigmentary glaucoma | 2 | 0% |
| Pigmentation disorder | 160 | 0.01% |
| Pigmentation lip | 2 | 0% |
| Pigment dispersion syndrome | 1 | 0% |
| PIK3CA related overgrowth spectrum | 1 | 0% |
| Piloerection | 269 | 0.02% |
| Pilonidal cyst | 8 | 0% |
| Pilonidal disease | 5 | 0% |
| Pilonidal sinus repair | 1 | 0% |
| Pineal gland cyst | 13 | 0% |
| Pineal neoplasm | 1 | 0% |
| Pinguecula | 6 | 0% |
| Pingueculitis | 3 | 0% |
| Pinprick test | 1 | 0% |
| Pinta | 1 | 0% |
| Piriformis syndrome | 19 | 0% |
| Pituitary-dependent Cushing's syndrome | 8 | 0% |
| Pituitary apoplexy | 13 | 0% |
| Pituitary cancer metastatic | 1 | 0% |
| Pituitary cyst | 4 | 0% |
| Pituitary enlargement | 5 | 0% |
| Pituitary gland operation | 1 | 0% |
| Pituitary haemorrhage | 5 | 0% |
| Pituitary hyperplasia | 1 | 0% |
| Pituitary scan | 22 | 0% |
| Pituitary scan abnormal | 2 | 0% |
| Pituitary tumour | 18 | 0% |
| Pituitary tumour benign | 46 | 0% |
| Pityriasis | 36 | 0% |
| Pityriasis alba | 1 | 0% |
| Pityriasis lichenoides et varioliformis acuta | 24 | 0% |
| Pityriasis rosea | 469 | 0.03% |
| Pityriasis rubra pilaris | 58 | 0% |
| Placenta accreta | 3 | 0% |
| Placenta growth factor | 1 | 0% |
| Placental calcification | 5 | 0% |
| Placental chorioangioma | 1 | 0% |
| Placental cyst | 1 | 0% |
| Placental disorder | 44 | 0% |
| Placental infarction | 11 | 0% |
| Placental insufficiency | 29 | 0% |
| Placental transfusion syndrome | 3 | 0% |
| Placenta praevia | 25 | 0% |
| Placenta praevia haemorrhage | 9 | 0% |
| Plague | 3 | 0% |
| Planning to become pregnant | 3 | 0% |
| Plantar erythema | 12 | 0% |
| Plantar fascial fibromatosis | 10 | 0% |
| Plantar fasciitis | 147 | 0.01% |
| Plaque shift | 1 | 0% |
| Plasmablast count | 1 | 0% |
| Plasmablastic lymphoma | 3 | 0% |
| Plasma cell count | 20 | 0% |
| Plasma cell disorder | 1 | 0% |
| Plasma cell leukaemia | 3 | 0% |
| Plasma cell leukaemia in remission | 1 | 0% |
| Plasma cell mastitis | 8 | 0% |
| Plasma cell myeloma | 180 | 0.01% |
| Plasma cell myeloma recurrent | 7 | 0% |
| Plasma cell myeloma refractory | 1 | 0% |
| Plasma cells decreased | 1 | 0% |
| Plasma cells increased | 3 | 0% |
| Plasma cells present | 1 | 0% |
| Plasmacytoma | 19 | 0% |
| Plasmacytosis | 2 | 0% |
| Plasmapheresis | 143 | 0.01% |
| Plasma viscosity | 11 | 0% |
| Plasma viscosity abnormal | 2 | 0% |
| Plasmin inhibitor | 8 | 0% |
| Plasminogen | 9 | 0% |
| Plasminogen activator inhibitor | 17 | 0% |
| Plasminogen activator inhibitor polymorphism | 3 | 0% |
| Plasminogen activator inhibitor type 1 deficiency | 3 | 0% |
| Plasminogen increased | 1 | 0% |
| Plasminogen normal | 2 | 0% |
| Plasmodium falciparum infection | 1 | 0% |
| Plasmodium vivax infection | 2 | 0% |
| Plastic surgery | 3 | 0% |
| Plastic surgery to the face | 2 | 0% |
| Platelet-derived growth factor receptor gene mutation | 1 | 0% |
| Platelet-large cell ratio | 41 | 0% |
| Platelet aggregation abnormal | 5 | 0% |
| Platelet aggregation decreased | 1 | 0% |
| Platelet aggregation increased | 2 | 0% |
| Platelet aggregation normal | 1 | 0% |
| Platelet aggregation test | 26 | 0% |
| Platelet anisocytosis | 8 | 0% |
| Platelet count | 10,705 | 0.65% |
| Platelet count abnormal | 54 | 0% |
| Platelet count decreased | 3,028 | 0.18% |
| Platelet count increased | 626 | 0.04% |
| Platelet count normal | 1,675 | 0.1% |
| Plateletcrit | 77 | 0% |
| Plateletcrit abnormal | 1 | 0% |
| Plateletcrit decreased | 3 | 0% |
| Platelet destruction increased | 3 | 0% |
| Platelet disorder | 178 | 0.01% |
| Platelet distribution width | 168 | 0.01% |
| Platelet distribution width decreased | 2 | 0% |
| Platelet distribution width increased | 1 | 0% |
| Platelet dysfunction | 2 | 0% |
| Platelet factor 4 | 319 | 0.02% |
| Platelet factor 4 decreased | 1 | 0% |
| Platelet factor 4 increased | 5 | 0% |
| Platelet function test | 29 | 0% |
| Platelet function test abnormal | 5 | 0% |
| Platelet function test normal | 3 | 0% |
| Platelet maturation arrest | 2 | 0% |
| Platelet morphology | 12 | 0% |
| Platelet morphology abnormal | 19 | 0% |
| Platelet morphology normal | 17 | 0% |
| Plateletpheresis | 2 | 0% |
| Platelet production decreased | 2 | 0% |
| Platelet rich plasma therapy | 2 | 0% |
| Platelet storage pool deficiency | 1 | 0% |
| Platelet transfusion | 208 | 0.01% |
| Platypnoea | 1 | 0% |
| Pleocytosis | 83 | 0.01% |
| Pleomorphic adenoma | 7 | 0% |
| Pleomorphic malignant fibrous histiocytoma | 3 | 0% |
| Pleomorphism | 1 | 0% |
| Plethoric face | 1 | 0% |
| Plethysmography | 61 | 0% |
| Pleural adhesion | 4 | 0% |
| Pleural calcification | 6 | 0% |
| Pleural decortication | 6 | 0% |
| Pleural disorder | 16 | 0% |
| Pleural effusion | 2,675 | 0.16% |
| Pleural fibrosis | 21 | 0% |
| Pleural fluid analysis | 35 | 0% |
| Pleural fluid analysis abnormal | 16 | 0% |
| Pleural infection | 6 | 0% |
| Pleural mass | 6 | 0% |
| Pleural mesothelioma | 3 | 0% |
| Pleural neoplasm | 5 | 0% |
| Pleural rub | 8 | 0% |
| Pleural thickening | 61 | 0% |
| Pleurectomy | 1 | 0% |
| Pleurisy | 694 | 0.04% |
| Pleurisy bacterial | 3 | 0% |
| Pleurisy viral | 4 | 0% |
| Pleuritic pain | 675 | 0.04% |
| Pleurodesis | 10 | 0% |
| Pleuroparenchymal fibroelastosis | 1 | 0% |
| Pleuropericarditis | 111 | 0.01% |
| Pleuroscopy | 2 | 0% |
| Pleurothotonus | 2 | 0% |
| Plica syndrome | 1 | 0% |
| Plicated tongue | 22 | 0% |
| Pneumatic compression therapy | 3 | 0% |
| Pneumatosis | 10 | 0% |
| Pneumatosis intestinalis | 7 | 0% |
| Pneumobilia | 5 | 0% |
| Pneumocephalus | 4 | 0% |
| Pneumococcal bacteraemia | 11 | 0% |
| Pneumococcal immunisation | 2 | 0% |
| Pneumococcal infection | 29 | 0% |
| Pneumococcal sepsis | 10 | 0% |
| Pneumoconiosis | 5 | 0% |
| Pneumocystis jirovecii infection | 3 | 0% |
| Pneumocystis jirovecii pneumonia | 41 | 0% |
| Pneumocystis test | 21 | 0% |
| Pneumocystis test negative | 6 | 0% |
| Pneumocystis test positive | 2 | 0% |
| Pneumomediastinum | 75 | 0% |
| Pneumonectomy | 4 | 0% |
| Pneumonia | 9,092 | 0.55% |
| Pneumonia acinetobacter | 3 | 0% |
| Pneumonia adenoviral | 1 | 0% |
| Pneumonia aspiration | 658 | 0.04% |
| Pneumonia bacterial | 699 | 0.04% |
| Pneumonia chlamydial | 16 | 0% |
| Pneumonia cryptococcal | 1 | 0% |
| Pneumonia cytomegaloviral | 5 | 0% |
| Pneumonia escherichia | 5 | 0% |
| Pneumonia fungal | 21 | 0% |
| Pneumonia haemophilus | 8 | 0% |
| Pneumonia influenzal | 6 | 0% |
| Pneumonia klebsiella | 48 | 0% |
| Pneumonia legionella | 16 | 0% |
| Pneumonia moraxella | 2 | 0% |
| Pneumonia mycoplasmal | 38 | 0% |
| Pneumonia necrotising | 12 | 0% |
| Pneumonia pneumococcal | 45 | 0% |
| Pneumonia proteus | 1 | 0% |
| Pneumonia pseudomonal | 41 | 0% |
| Pneumonia respiratory syncytial viral | 6 | 0% |
| Pneumonia serratia | 2 | 0% |
| Pneumonia staphylococcal | 47 | 0% |
| Pneumonia streptococcal | 32 | 0% |
| Pneumonia viral | 302 | 0.02% |
| Pneumonitis | 759 | 0.05% |
| Pneumonitis aspiration | 19 | 0% |
| Pneumonitis chemical | 3 | 0% |
| Pneumonolysis | 1 | 0% |
| Pneumopericardium | 5 | 0% |
| Pneumoperitoneum | 34 | 0% |
| Pneumothorax | 517 | 0.03% |
| Pneumothorax spontaneous | 62 | 0% |
| Pneumothorax traumatic | 3 | 0% |
| Pneumovirus test positive | 2 | 0% |
| PO2 | 1,204 | 0.07% |
| PO2 abnormal | 5 | 0% |
| PO2 decreased | 280 | 0.02% |
| PO2 increased | 62 | 0% |
| PO2 normal | 50 | 0% |
| Pocket erosion | 1 | 0% |
| Podiatric examination | 6 | 0% |
| POEMS syndrome | 6 | 0% |
| Poikilocytosis | 12 | 0% |
| Poikiloderma | 1 | 0% |
| Poisoning | 65 | 0% |
| Poland's syndrome | 1 | 0% |
| Poliomyelitis | 11 | 0% |
| Pollakiuria | 1,702 | 0.1% |
| Polyarteritis nodosa | 30 | 0% |
| Polyarthritis | 686 | 0.04% |
| Polychondritis | 33 | 0% |
| Polychromasia | 28 | 0% |
| Polychromic red blood cells present | 2 | 0% |
| Polycystic ovarian syndrome | 16 | 0% |
| Polycystic ovaries | 127 | 0.01% |
| Polycythaemia | 68 | 0% |
| Polycythaemia neonatorum | 1 | 0% |
| Polycythaemia vera | 39 | 0% |
| Polydactyly | 4 | 0% |
| Polydipsia | 143 | 0.01% |
| Polydipsia psychogenic | 2 | 0% |
| Polyglandular autoimmune syndrome type I | 4 | 0% |
| Polyglandular autoimmune syndrome type II | 3 | 0% |
| Polyglandular disorder | 1 | 0% |
| Polygraph test | 5 | 0% |
| Polyhydramnios | 23 | 0% |
| Polymenorrhagia | 12 | 0% |
| Polymenorrhoea | 2,717 | 0.17% |
| Polymerase chain reaction | 3,033 | 0.18% |
| Polymerase chain reaction negative | 16 | 0% |
| Polymerase chain reaction positive | 150 | 0.01% |
| Polymers allergy | 31 | 0% |
| Polymicrogyria | 2 | 0% |
| Polymorphic eruption of pregnancy | 3 | 0% |
| Polymorphic light eruption | 15 | 0% |
| Polymyalgia rheumatica | 2,161 | 0.13% |
| Polymyositis | 92 | 0.01% |
| Polyneuropathy | 1,177 | 0.07% |
| Polyneuropathy alcoholic | 1 | 0% |
| Polyneuropathy chronic | 7 | 0% |
| Polyneuropathy idiopathic progressive | 4 | 0% |
| Polyneuropathy in malignant disease | 2 | 0% |
| Polyomavirus test | 3 | 0% |
| Polyomavirus viraemia | 1 | 0% |
| Polyp | 93 | 0.01% |
| Polypectomy | 49 | 0% |
| Polypoidal choroidal vasculopathy | 2 | 0% |
| Polypoid cystitis | 1 | 0% |
| Polyradiculoneuropathy | 4 | 0% |
| Polyserositis | 64 | 0% |
| Polyuria | 566 | 0.03% |
| Poor dental condition | 2 | 0% |
| Poor feeding infant | 33 | 0% |
| Poor milk ejection reflex | 2 | 0% |
| Poor peripheral circulation | 337 | 0.02% |
| Poor personal hygiene | 5 | 0% |
| Poor quality product administered | 7,624 | 0.46% |
| Poor quality sleep | 1,570 | 0.1% |
| Poor school attendance | 1 | 0% |
| Poor sucking reflex | 2 | 0% |
| Poor venous access | 24 | 0% |
| Poor weight gain neonatal | 5 | 0% |
| Popliteal artery entrapment syndrome | 1 | 0% |
| Popliteal pulse decreased | 1 | 0% |
| Popliteal pulse increased | 2 | 0% |
| Porencephaly | 3 | 0% |
| Poriomania | 2 | 0% |
| Porokeratosis | 5 | 0% |
| Porphyria | 8 | 0% |
| Porphyria acute | 8 | 0% |
| Porphyria non-acute | 5 | 0% |
| Porphyria screen | 2 | 0% |
| Porphyrins urine | 5 | 0% |
| Porphyrins urine normal | 2 | 0% |
| Portal fibrosis | 2 | 0% |
| Portal hypertension | 37 | 0% |
| Portal hypertensive colopathy | 1 | 0% |
| Portal hypertensive gastropathy | 6 | 0% |
| Portal shunt | 1 | 0% |
| Portal shunt procedure | 5 | 0% |
| Portal tract inflammation | 1 | 0% |
| Portal vein cavernous transformation | 4 | 0% |
| Portal vein dilatation | 3 | 0% |
| Portal vein embolism | 4 | 0% |
| Portal vein occlusion | 10 | 0% |
| Portal vein phlebitis | 3 | 0% |
| Portal vein thrombosis | 359 | 0.02% |
| Portal venous gas | 3 | 0% |
| Portogram | 105 | 0.01% |
| Portosplenomesenteric venous thrombosis | 35 | 0% |
| Positive airway pressure therapy | 1,369 | 0.08% |
| Positive cardiac inotropic effect | 2 | 0% |
| Positive dose response relationship | 1 | 0% |
| Positive end-expiratory pressure | 38 | 0% |
| Positive expiratory pressure therapy | 6 | 0% |
| Positron emission tomogram | 1,507 | 0.09% |
| Positron emission tomogram abnormal | 143 | 0.01% |
| Positron emission tomogram breast | 1 | 0% |
| Positron emission tomogram breast abnormal | 1 | 0% |
| Positron emission tomogram normal | 35 | 0% |
| Positron emission tomography-magnetic resonance imaging | 19 | 0% |
| Post-acute COVID-19 syndrome | 1,264 | 0.08% |
| Post-anaphylaxis mast cell anergy | 1 | 0% |
| Post-anoxic myoclonus | 2 | 0% |
| Post-thoracotomy pain syndrome | 3 | 0% |
| Post-traumatic amnestic disorder | 3 | 0% |
| Post-traumatic epilepsy | 4 | 0% |
| Post-traumatic headache | 3 | 0% |
| Post-traumatic neck syndrome | 23 | 0% |
| Post-traumatic neuralgia | 2 | 0% |
| Post-traumatic pain | 8 | 0% |
| Post-traumatic stress disorder | 134 | 0.01% |
| Post-tussive vomiting | 15 | 0% |
| Post abortion haemorrhage | 6 | 0% |
| Post cardiac arrest syndrome | 5 | 0% |
| Post cholecystectomy syndrome | 1 | 0% |
| Post concussion syndrome | 25 | 0% |
| Posterior capsule opacification | 9 | 0% |
| Posterior capsule rupture | 1 | 0% |
| Posterior cortical atrophy | 4 | 0% |
| Posterior fossa decompression | 5 | 0% |
| Posterior fossa syndrome | 1 | 0% |
| Posterior interosseous syndrome | 4 | 0% |
| Posterior reversible encephalopathy syndrome | 47 | 0% |
| Posterior tibial nerve injury | 2 | 0% |
| Posterior tibial tendon dysfunction | 1 | 0% |
| Posthaemorrhagic hydrocephalus | 4 | 0% |
| Post herpetic neuralgia | 342 | 0.02% |
| Postictal headache | 2 | 0% |
| Postictal paralysis | 21 | 0% |
| Postictal psychosis | 2 | 0% |
| Postictal state | 160 | 0.01% |
| Postinfarction angina | 3 | 0% |
| Post inflammatory pigmentation change | 12 | 0% |
| Post laminectomy syndrome | 3 | 0% |
| Post lumbar puncture syndrome | 30 | 0% |
| Postmature baby | 2 | 0% |
| Postmenopausal haemorrhage | 4,670 | 0.28% |
| Postmenopause | 40 | 0% |
| Post micturition dribble | 1 | 0% |
| Postmortem blood drug level | 1 | 0% |
| Postoperative abscess | 5 | 0% |
| Postoperative adhesion | 2 | 0% |
| Postoperative care | 2 | 0% |
| Postoperative delirium | 4 | 0% |
| Postoperative ileus | 11 | 0% |
| Postoperative respiratory failure | 5 | 0% |
| Postoperative thoracic procedure complication | 1 | 0% |
| Postoperative thrombosis | 8 | 0% |
| Postoperative wound complication | 9 | 0% |
| Postoperative wound infection | 35 | 0% |
| Postpartum anxiety | 1 | 0% |
| Postpartum disorder | 4 | 0% |
| Postpartum haemorrhage | 62 | 0% |
| Postpartum state | 16 | 0% |
| Postpartum stress disorder | 1 | 0% |
| Postpartum thrombosis | 1 | 0% |
| Postpartum venous thrombosis | 3 | 0% |
| Postpericardiotomy syndrome | 1 | 0% |
| Post polio syndrome | 5 | 0% |
| Postprandial hypoglycaemia | 8 | 0% |
| Post procedural bile leak | 1 | 0% |
| Post procedural complication | 70 | 0% |
| Post procedural constipation | 2 | 0% |
| Post procedural contusion | 5 | 0% |
| Post procedural diarrhoea | 5 | 0% |
| Post procedural discharge | 1 | 0% |
| Post procedural discomfort | 2 | 0% |
| Post procedural drainage | 7 | 0% |
| Post procedural erythema | 2 | 0% |
| Post procedural fever | 3 | 0% |
| Post procedural fistula | 2 | 0% |
| Post procedural haematoma | 2 | 0% |
| Post procedural haematuria | 1 | 0% |
| Post procedural haemorrhage | 53 | 0% |
| Post procedural hypotension | 5 | 0% |
| Post procedural hypothyroidism | 6 | 0% |
| Post procedural infection | 30 | 0% |
| Post procedural myocardial infarction | 2 | 0% |
| Post procedural oedema | 3 | 0% |
| Post procedural pneumonia | 1 | 0% |
| Post procedural pulmonary embolism | 3 | 0% |
| Post procedural sepsis | 1 | 0% |
| Post procedural stroke | 2 | 0% |
| Post procedural swelling | 5 | 0% |
| Post procedural urine leak | 3 | 0% |
| Postrenal failure | 1 | 0% |
| Postresuscitation encephalopathy | 3 | 0% |
| Post streptococcal glomerulonephritis | 1 | 0% |
| Post stroke depression | 6 | 0% |
| Post stroke epilepsy | 5 | 0% |
| Post stroke seizure | 3 | 0% |
| Post thrombotic syndrome | 23 | 0% |
| Post transplant lymphoproliferative disorder | 3 | 0% |
| Post treatment Lyme disease syndrome | 3 | 0% |
| Postural orthostatic tachycardia syndrome | 996 | 0.06% |
| Postural reflex impairment | 1 | 0% |
| Postural tremor | 12 | 0% |
| Posture abnormal | 515 | 0.03% |
| Posturing | 32 | 0% |
| Posturography | 9 | 0% |
| Post vaccination autoinoculation | 1 | 0% |
| Post vaccination fever | 3 | 0% |
| Post vaccination syndrome | 572 | 0.03% |
| Post viral fatigue syndrome | 439 | 0.03% |
| Potassium chloride sensitivity test | 3 | 0% |
| Potassium chloride sensitivity test abnormal | 2 | 0% |
| Potassium hydroxide preparation | 6 | 0% |
| Potassium hydroxide preparation negative | 1 | 0% |
| Potassium hydroxide preparation positive | 1 | 0% |
| Potentiating drug interaction | 25 | 0% |
| Potter's syndrome | 1 | 0% |
| Pouchitis | 3 | 0% |
| Poverty of speech | 13 | 0% |
| Poverty of thought content | 1 | 0% |
| Pre-eclampsia | 160 | 0.01% |
| Pre-existing condition improved | 80 | 0% |
| Pre-existing disease | 29 | 0% |
| Prealbumin | 70 | 0% |
| Prealbumin decreased | 7 | 0% |
| Preauricular cyst | 3 | 0% |
| Precancerous cells present | 11 | 0% |
| Precancerous condition | 17 | 0% |
| Precancerous lesion of digestive tract | 4 | 0% |
| Precancerous skin lesion | 8 | 0% |
| Precerebral artery dissection | 1 | 0% |
| Precerebral artery occlusion | 2 | 0% |
| Precerebral artery thrombosis | 2 | 0% |
| Precipitate labour | 2 | 0% |
| Precocious puberty | 4 | 0% |
| Precursor T-lymphoblastic lymphoma/leukaemia | 1 | 0% |
| Precursor T-lymphoblastic lymphoma/leukaemia stage II | 1 | 0% |
| Pregnancy | 390 | 0.02% |
| Pregnancy after post coital contraception | 4 | 0% |
| Pregnancy of unknown location | 4 | 0% |
| Pregnancy on contraceptive | 10 | 0% |
| Pregnancy on oral contraceptive | 15 | 0% |
| Pregnancy test | 1,411 | 0.09% |
| Pregnancy test false positive | 4 | 0% |
| Pregnancy test negative | 462 | 0.03% |
| Pregnancy test positive | 118 | 0.01% |
| Pregnancy test urine | 67 | 0% |
| Pregnancy test urine negative | 80 | 0% |
| Pregnancy test urine positive | 15 | 0% |
| Pregnancy with advanced maternal age | 3 | 0% |
| Pregnancy with contraceptive device | 16 | 0% |
| Pregnancy with implant contraceptive | 1 | 0% |
| Prehypertension | 5 | 0% |
| Preictal state | 1 | 0% |
| Premature ageing | 11 | 0% |
| Premature baby | 274 | 0.02% |
| Premature baby death | 12 | 0% |
| Premature delivery | 168 | 0.01% |
| Premature ejaculation | 8 | 0% |
| Premature labour | 199 | 0.01% |
| Premature menarche | 21 | 0% |
| Premature menopause | 124 | 0.01% |
| Premature ovulation | 11 | 0% |
| Premature rupture of membranes | 116 | 0.01% |
| Premature separation of placenta | 97 | 0.01% |
| Premedication | 1 | 0% |
| Premenstrual dysphoric disorder | 61 | 0% |
| Premenstrual headache | 11 | 0% |
| Premenstrual pain | 284 | 0.02% |
| Premenstrual syndrome | 892 | 0.05% |
| Prenatal care | 3 | 0% |
| Prenatal screening test | 132 | 0.01% |
| Prenatal screening test abnormal | 6 | 0% |
| Preoperative care | 1 | 0% |
| Prepuce dorsal slit | 1 | 0% |
| Prerenal failure | 25 | 0% |
| Presbyacusis | 19 | 0% |
| Presbyastasis | 2 | 0% |
| Presbyoesophagus | 1 | 0% |
| Presbyopia | 21 | 0% |
| Presbyvestibulopathy | 1 | 0% |
| Prescribed overdose | 2 | 0% |
| Prescribed underdose | 4 | 0% |
| Prescription drug used without a prescription | 2 | 0% |
| Presenile dementia | 1 | 0% |
| Pressure of speech | 8 | 0% |
| Presyncope | 8,902 | 0.54% |
| Preterm premature rupture of membranes | 50 | 0% |
| Prevertebral soft tissue swelling of cervical space | 2 | 0% |
| Previous caesarean section | 1 | 0% |
| Priapism | 24 | 0% |
| Primary adrenal insufficiency | 3 | 0% |
| Primary amyloidosis | 5 | 0% |
| Primary biliary cholangitis | 31 | 0% |
| Primary cerebellar degeneration | 1 | 0% |
| Primary coenzyme Q10 deficiency | 1 | 0% |
| Primary cough headache | 6 | 0% |
| Primary cutaneous adenoid cystic carcinoma | 1 | 0% |
| Primary familial brain calcification | 2 | 0% |
| Primary gastrointestinal follicular lymphoma | 1 | 0% |
| Primary headache associated with sexual activity | 16 | 0% |
| Primary hyperaldosteronism | 9 | 0% |
| Primary hyperthyroidism | 10 | 0% |
| Primary hypogonadism | 1 | 0% |
| Primary hypothyroidism | 2 | 0% |
| Primary mediastinal large B-cell lymphoma | 9 | 0% |
| Primary mediastinal large B-cell lymphoma stage IV | 1 | 0% |
| Primary myelofibrosis | 5 | 0% |
| Primary progressive multiple sclerosis | 5 | 0% |
| Primary stabbing headache | 5 | 0% |
| Primigravida | 11 | 0% |
| Primiparous | 1 | 0% |
| Primitive reflex test | 3 | 0% |
| Prinzmetal angina | 69 | 0% |
| Prion disease | 3 | 0% |
| Probiotic therapy | 2 | 0% |
| Procalcitonin | 1,481 | 0.09% |
| Procalcitonin abnormal | 7 | 0% |
| Procalcitonin decreased | 33 | 0% |
| Procalcitonin increased | 368 | 0.02% |
| Procalcitonin normal | 269 | 0.02% |
| Procedural anxiety | 1 | 0% |
| Procedural complication | 24 | 0% |
| Procedural dizziness | 10 | 0% |
| Procedural failure | 26 | 0% |
| Procedural haemorrhage | 20 | 0% |
| Procedural headache | 4 | 0% |
| Procedural hypotension | 1 | 0% |
| Procedural intestinal perforation | 1 | 0% |
| Procedural nausea | 11 | 0% |
| Procedural pain | 89 | 0.01% |
| Procedural pneumothorax | 3 | 0% |
| Procedural shock | 2 | 0% |
| Procedural site reaction | 9 | 0% |
| Procedural vomiting | 5 | 0% |
| Procedure aborted | 8 | 0% |
| Procoagulant therapy | 1 | 0% |
| Procrastination | 1 | 0% |
| Proctalgia | 147 | 0.01% |
| Proctectomy | 7 | 0% |
| Proctitis | 66 | 0% |
| Proctitis gonococcal | 1 | 0% |
| Proctitis haemorrhagic | 4 | 0% |
| Proctitis ulcerative | 32 | 0% |
| Proctocolectomy | 2 | 0% |
| Proctoscopy | 29 | 0% |
| Proctosigmoidoscopy | 12 | 0% |
| Proctosigmoidoscopy abnormal | 1 | 0% |
| Prodromal Alzheimer's disease | 2 | 0% |
| Product administered at inappropriate site | 1,280 | 0.08% |
| Product administered by wrong person | 5 | 0% |
| Product administered to patient of inappropriate age | 14,161 | 0.86% |
| Product administration error | 1,802 | 0.11% |
| Product administration interrupted | 172 | 0.01% |
| Product after taste | 22 | 0% |
| Product appearance confusion | 2 | 0% |
| Product availability issue | 74 | 0% |
| Product barcode issue | 2 | 0% |
| Product blister packaging issue | 1 | 0% |
| Product closure issue | 2 | 0% |
| Product colour issue | 34 | 0% |
| Product communication issue | 8 | 0% |
| Product complaint | 22 | 0% |
| Product confusion | 2 | 0% |
| Product container issue | 23 | 0% |
| Product container seal issue | 2 | 0% |
| Product contamination | 14 | 0% |
| Product contamination chemical | 2 | 0% |
| Product contamination microbial | 2 | 0% |
| Product contamination physical | 42 | 0% |
| Product delivery mechanism issue | 2 | 0% |
| Product design issue | 2 | 0% |
| Product dispensing error | 49 | 0% |
| Product dispensing issue | 33 | 0% |
| Product distribution issue | 3 | 0% |
| Product dosage form confusion | 1 | 0% |
| Product dose confusion | 5 | 0% |
| Product dose omission in error | 34 | 0% |
| Product dose omission issue | 3,004 | 0.18% |
| Product expiration date issue | 80 | 0% |
| Product formulation issue | 11 | 0% |
| Product identification number issue | 12 | 0% |
| Product intolerance | 11 | 0% |
| Productive cough | 4,393 | 0.27% |
| Product label confusion | 91 | 0.01% |
| Product label issue | 64 | 0% |
| Product label on wrong product | 2 | 0% |
| Product leakage | 42 | 0% |
| Product lot number issue | 58 | 0% |
| Product measured potency issue | 5 | 0% |
| Product monitoring error | 8 | 0% |
| Product odour abnormal | 10 | 0% |
| Product origin unknown | 6 | 0% |
| Product packaging confusion | 14 | 0% |
| Product packaging issue | 4 | 0% |
| Product packaging quantity issue | 26 | 0% |
| Product physical issue | 11 | 0% |
| Product preparation error | 1,817 | 0.11% |
| Product preparation issue | 5,727 | 0.35% |
| Product prescribing error | 13 | 0% |
| Product prescribing issue | 4 | 0% |
| Product quality issue | 71 | 0% |
| Product reconstitution quality issue | 60 | 0% |
| Product residue present | 3 | 0% |
| Product selection error | 7 | 0% |
| Product storage error | 38,710 | 2.35% |
| Product substitution | 8 | 0% |
| Product substitution error | 2 | 0% |
| Product substitution issue | 10 | 0% |
| Product supply issue | 12 | 0% |
| Product tampering | 1 | 0% |
| Product taste abnormal | 6 | 0% |
| Product temperature excursion issue | 5,829 | 0.35% |
| Product use complaint | 10 | 0% |
| Product used for unknown indication | 1 | 0% |
| Product use in unapproved indication | 16 | 0% |
| Product use issue | 3,674 | 0.22% |
| Proerythroblast count | 1 | 0% |
| Progesterone | 93 | 0.01% |
| Progesterone abnormal | 5 | 0% |
| Progesterone decreased | 30 | 0% |
| Progesterone deficiency | 1 | 0% |
| Progesterone increased | 1 | 0% |
| Progesterone normal | 11 | 0% |
| Progesterone receptor assay | 24 | 0% |
| Progesterone receptor assay negative | 2 | 0% |
| Progesterone receptor assay positive | 1 | 0% |
| Progestin therapy | 1 | 0% |
| Progressive bulbar palsy | 11 | 0% |
| Progressive facial hemiatrophy | 5 | 0% |
| Progressive familial intrahepatic cholestasis | 1 | 0% |
| Progressive macular hypomelanosis | 3 | 0% |
| Progressive multifocal leukoencephalopathy | 10 | 0% |
| Progressive multiple sclerosis | 9 | 0% |
| Progressive muscular atrophy | 1 | 0% |
| Progressive myoclonic epilepsy | 1 | 0% |
| Progressive supranuclear palsy | 18 | 0% |
| Prohormone brain natriuretic peptide | 124 | 0.01% |
| Prohormone brain natriuretic peptide abnormal | 1 | 0% |
| Prohormone brain natriuretic peptide decreased | 1 | 0% |
| Prohormone brain natriuretic peptide increased | 186 | 0.01% |
| Prolactin-producing pituitary tumour | 9 | 0% |
| Prolapse | 12 | 0% |
| Prolonged expiration | 8 | 0% |
| Prolonged labour | 38 | 0% |
| Prolonged pregnancy | 12 | 0% |
| Prolonged rupture of membranes | 1 | 0% |
| Prolymphocytic leukaemia | 1 | 0% |
| Promotion of peripheral circulation | 1 | 0% |
| Promyelocyte count | 22 | 0% |
| Promyelocyte count increased | 1 | 0% |
| Pronator teres syndrome | 1 | 0% |
| Prone position | 71 | 0% |
| Prophylaxis | 6 | 0% |
| Prophylaxis against gastrointestinal ulcer | 1 | 0% |
| Prophylaxis of nausea and vomiting | 9 | 0% |
| Propionibacterium infection | 1 | 0% |
| Propionibacterium test positive | 2 | 0% |
| Propofol infusion syndrome | 1 | 0% |
| Prosopagnosia | 8 | 0% |
| Prostate ablation | 1 | 0% |
| Prostate cancer | 198 | 0.01% |
| Prostate cancer metastatic | 27 | 0% |
| Prostate cancer recurrent | 5 | 0% |
| Prostate cancer stage I | 1 | 0% |
| Prostate cancer stage IV | 1 | 0% |
| Prostatectomy | 3 | 0% |
| Prostate examination | 28 | 0% |
| Prostate examination abnormal | 2 | 0% |
| Prostate examination normal | 1 | 0% |
| Prostate infection | 22 | 0% |
| Prostate tenderness | 2 | 0% |
| Prostate volume study | 2 | 0% |
| Prostatic abscess | 4 | 0% |
| Prostatic acid phosphatase | 1 | 0% |
| Prostatic adenoma | 5 | 0% |
| Prostatic artery embolisation | 1 | 0% |
| Prostatic calcification | 3 | 0% |
| Prostatic cyst | 2 | 0% |
| Prostatic disorder | 33 | 0% |
| Prostatic haemorrhage | 4 | 0% |
| Prostatic mass | 1 | 0% |
| Prostatic obstruction | 10 | 0% |
| Prostatic operation | 9 | 0% |
| Prostatic pain | 10 | 0% |
| Prostatic specific antigen | 467 | 0.03% |
| Prostatic specific antigen abnormal | 4 | 0% |
| Prostatic specific antigen decreased | 16 | 0% |
| Prostatic specific antigen increased | 153 | 0.01% |
| Prostatic specific antigen normal | 20 | 0% |
| Prostatitis | 135 | 0.01% |
| Prostatomegaly | 86 | 0.01% |
| Prosthesis user | 1 | 0% |
| Prosthetic cardiac valve malfunction | 3 | 0% |
| Prosthetic cardiac valve regurgitation | 4 | 0% |
| Prosthetic cardiac valve stenosis | 2 | 0% |
| Prosthetic cardiac valve thrombosis | 6 | 0% |
| Prosthetic valve endocarditis | 1 | 0% |
| Prosthetic vessel implantation | 2 | 0% |
| Protein-losing gastroenteropathy | 2 | 0% |
| Protein albumin ratio | 44 | 0% |
| Protein albumin ratio abnormal | 1 | 0% |
| Protein albumin ratio increased | 1 | 0% |
| Protein albumin ratio normal | 2 | 0% |
| Protein C | 376 | 0.02% |
| Protein C decreased | 10 | 0% |
| Protein C deficiency | 7 | 0% |
| Protein C increased | 34 | 0% |
| Protein deficiency | 11 | 0% |
| Protein induced by vitamin K absence or antagonist II | 4 | 0% |
| Protein S | 301 | 0.02% |
| Protein S abnormal | 3 | 0% |
| Protein S decreased | 10 | 0% |
| Protein S deficiency | 5 | 0% |
| Protein S increased | 10 | 0% |
| Protein S normal | 36 | 0% |
| Protein total | 1,517 | 0.09% |
| Protein total abnormal | 23 | 0% |
| Protein total decreased | 274 | 0.02% |
| Protein total increased | 164 | 0.01% |
| Protein total normal | 625 | 0.04% |
| Proteinuria | 561 | 0.03% |
| Protein urine | 935 | 0.06% |
| Protein urine absent | 155 | 0.01% |
| Protein urine present | 316 | 0.02% |
| Proteus infection | 18 | 0% |
| Proteus test positive | 34 | 0% |
| Prothrombin consumption time prolonged | 1 | 0% |
| Prothrombin fragment 1.2 | 2 | 0% |
| Prothrombin index | 20 | 0% |
| Prothrombin level | 752 | 0.05% |
| Prothrombin level abnormal | 6 | 0% |
| Prothrombin level decreased | 9 | 0% |
| Prothrombin level increased | 18 | 0% |
| Prothrombin level normal | 58 | 0% |
| Prothrombin time | 2,694 | 0.16% |
| Prothrombin time abnormal | 17 | 0% |
| Prothrombin time normal | 306 | 0.02% |
| Prothrombin time prolonged | 373 | 0.02% |
| Prothrombin time ratio | 318 | 0.02% |
| Prothrombin time ratio abnormal | 2 | 0% |
| Prothrombin time ratio decreased | 6 | 0% |
| Prothrombin time ratio increased | 5 | 0% |
| Prothrombin time shortened | 77 | 0% |
| Protrusion tongue | 12 | 0% |
| Providencia infection | 1 | 0% |
| Proximal focal femoral deficiency | 1 | 0% |
| Prurigo | 54 | 0% |
| Pruritus | 51,615 | 3.14% |
| Pruritus allergic | 29 | 0% |
| Pruritus genital | 83 | 0.01% |
| Pseudarthrosis | 2 | 0% |
| Pseudo-Bartter syndrome | 1 | 0% |
| Pseudo-occlusion of internal carotid artery | 2 | 0% |
| Pseudoallergic reaction | 8 | 0% |
| Pseudoangina | 1 | 0% |
| Pseudobulbar palsy | 1 | 0% |
| Pseudocyst | 7 | 0% |
| Pseudodementia | 5 | 0% |
| Pseudodiverticular disease | 1 | 0% |
| Pseudofolliculitis | 4 | 0% |
| Pseudogynaecomastia | 1 | 0% |
| Pseudohallucination | 4 | 0% |
| Pseudohernia | 2 | 0% |
| Pseudohyponatraemia | 10 | 0% |
| Pseudohypoparathyroidism | 1 | 0% |
| Pseudolymphoma | 25 | 0% |
| Pseudomembranous colitis | 7 | 0% |
| Pseudomonal bacteraemia | 14 | 0% |
| Pseudomonal sepsis | 3 | 0% |
| Pseudomonas infection | 81 | 0% |
| Pseudomonas test | 12 | 0% |
| Pseudomonas test positive | 69 | 0% |
| Pseudomyopia | 2 | 0% |
| Pseudopapilloedema | 1 | 0% |
| Pseudoparalysis | 1 | 0% |
| Pseudophakia | 2 | 0% |
| Pseudophakic bullous keratopathy | 1 | 0% |
| Pseudopolyp | 1 | 0% |
| Pseudoporphyria | 1 | 0% |
| Pseudoradicular syndrome | 2 | 0% |
| Pseudostroke | 14 | 0% |
| Pseudothrombophlebitis | 1 | 0% |
| Psittacosis | 2 | 0% |
| Psoas abscess | 10 | 0% |
| Psoriasis | 1,971 | 0.12% |
| Psoriasis area severity index | 37 | 0% |
| Psoriasis area severity index decreased | 1 | 0% |
| Psoriasis area severity index increased | 1 | 0% |
| Psoriatic arthropathy | 603 | 0.04% |
| Psychiatric care | 1 | 0% |
| Psychiatric decompensation | 12 | 0% |
| Psychiatric evaluation | 75 | 0% |
| Psychiatric evaluation abnormal | 3 | 0% |
| Psychiatric evaluation normal | 1 | 0% |
| Psychiatric investigation | 21 | 0% |
| Psychiatric symptom | 106 | 0.01% |
| Psychogenic blindness | 1 | 0% |
| Psychogenic movement disorder | 5 | 0% |
| Psychogenic pseudosyncope | 4 | 0% |
| Psychogenic seizure | 132 | 0.01% |
| Psychogenic tremor | 1 | 0% |
| Psychogenic visual disorder | 2 | 0% |
| Psychological factor affecting medical condition | 5 | 0% |
| Psychological trauma | 23 | 0% |
| Psychomotor disadaptation syndrome | 4 | 0% |
| Psychomotor hyperactivity | 278 | 0.02% |
| Psychomotor retardation | 31 | 0% |
| Psychomotor skills impaired | 62 | 0% |
| Psychotherapy | 4 | 0% |
| Psychotic behaviour | 9 | 0% |
| Psychotic disorder | 345 | 0.02% |
| Psychotic disorder due to a general medical condition | 3 | 0% |
| Psychotic symptom | 25 | 0% |
| Psychotic symptom rating scale | 1 | 0% |
| PTEN gene mutation | 1 | 0% |
| Pterygium | 1 | 0% |
| Pubic pain | 25 | 0% |
| Pudendal canal syndrome | 21 | 0% |
| Puerperal pyrexia | 2 | 0% |
| Pulmonary ablation | 1 | 0% |
| Pulmonary air leakage | 7 | 0% |
| Pulmonary alveolar haemorrhage | 74 | 0% |
| Pulmonary amyloidosis | 3 | 0% |
| Pulmonary angioplasty | 1 | 0% |
| Pulmonary aplasia | 1 | 0% |
| Pulmonary arterial hypertension | 73 | 0% |
| Pulmonary arterial pressure | 123 | 0.01% |
| Pulmonary arterial pressure abnormal | 13 | 0% |
| Pulmonary arterial pressure increased | 32 | 0% |
| Pulmonary arterial pressure normal | 4 | 0% |
| Pulmonary arterial wedge pressure | 23 | 0% |
| Pulmonary arterial wedge pressure decreased | 1 | 0% |
| Pulmonary arterial wedge pressure increased | 4 | 0% |
| Pulmonary arteriopathy | 1 | 0% |
| Pulmonary arteriovenous fistula | 1 | 0% |
| Pulmonary artery aneurysm | 2 | 0% |
| Pulmonary artery compression | 6 | 0% |
| Pulmonary artery dilatation | 43 | 0% |
| Pulmonary artery occlusion | 23 | 0% |
| Pulmonary artery stenosis | 5 | 0% |
| Pulmonary artery stenosis congenital | 2 | 0% |
| Pulmonary artery thrombosis | 72 | 0% |
| Pulmonary artery wall hypertrophy | 3 | 0% |
| Pulmonary blastomycosis | 1 | 0% |
| Pulmonary calcification | 45 | 0% |
| Pulmonary cavitation | 12 | 0% |
| Pulmonary congestion | 953 | 0.06% |
| Pulmonary contusion | 10 | 0% |
| Pulmonary embolism | 14,828 | 0.9% |
| Pulmonary endarterectomy | 5 | 0% |
| Pulmonary eosinophilia | 6 | 0% |
| Pulmonary fibrosis | 413 | 0.03% |
| Pulmonary fistula | 1 | 0% |
| Pulmonary function challenge test | 7 | 0% |
| Pulmonary function challenge test abnormal | 3 | 0% |
| Pulmonary function challenge test normal | 2 | 0% |
| Pulmonary function test | 1,194 | 0.07% |
| Pulmonary function test abnormal | 98 | 0.01% |
| Pulmonary function test decreased | 122 | 0.01% |
| Pulmonary function test normal | 123 | 0.01% |
| Pulmonary granuloma | 59 | 0% |
| Pulmonary haematoma | 2 | 0% |
| Pulmonary haemorrhage | 99 | 0.01% |
| Pulmonary haemosiderosis | 3 | 0% |
| Pulmonary hilar enlargement | 14 | 0% |
| Pulmonary hilum mass | 24 | 0% |
| Pulmonary histoplasmosis | 1 | 0% |
| Pulmonary hypertension | 472 | 0.03% |
| Pulmonary hypertensive crisis | 2 | 0% |
| Pulmonary hypoperfusion | 6 | 0% |
| Pulmonary imaging procedure | 44 | 0% |
| Pulmonary imaging procedure abnormal | 48 | 0% |
| Pulmonary imaging procedure normal | 7 | 0% |
| Pulmonary infarction | 492 | 0.03% |
| Pulmonary interstitial emphysema syndrome | 2 | 0% |
| Pulmonary malformation | 4 | 0% |
| Pulmonary mass | 802 | 0.05% |
| Pulmonary microemboli | 21 | 0% |
| Pulmonary necrosis | 8 | 0% |
| Pulmonary nocardiosis | 1 | 0% |
| Pulmonary nodular lymphoid hyperplasia | 1 | 0% |
| Pulmonary oedema | 1,511 | 0.09% |
| Pulmonary pain | 1,253 | 0.08% |
| Pulmonary physical examination | 312 | 0.02% |
| Pulmonary physical examination abnormal | 3 | 0% |
| Pulmonary physical examination normal | 2 | 0% |
| Pulmonary pneumatocele | 4 | 0% |
| Pulmonary renal syndrome | 9 | 0% |
| Pulmonary resection | 6 | 0% |
| Pulmonary sarcoidosis | 69 | 0% |
| Pulmonary sensitisation | 3 | 0% |
| Pulmonary sepsis | 24 | 0% |
| Pulmonary septal thickening | 9 | 0% |
| Pulmonary sequestration | 1 | 0% |
| Pulmonary thrombosis | 1,217 | 0.07% |
| Pulmonary toxicity | 17 | 0% |
| Pulmonary tuberculoma | 1 | 0% |
| Pulmonary tuberculosis | 57 | 0% |
| Pulmonary valve disease | 5 | 0% |
| Pulmonary valve incompetence | 49 | 0% |
| Pulmonary valve replacement | 1 | 0% |
| Pulmonary valve stenosis | 12 | 0% |
| Pulmonary valve stenosis congenital | 4 | 0% |
| Pulmonary valve thickening | 3 | 0% |
| Pulmonary vascular disorder | 32 | 0% |
| Pulmonary vascular resistance abnormality | 1 | 0% |
| Pulmonary vasculitis | 12 | 0% |
| Pulmonary vein occlusion | 1 | 0% |
| Pulmonary vein stenosis | 1 | 0% |
| Pulmonary veno-occlusive disease | 1 | 0% |
| Pulmonary venous hypertension | 7 | 0% |
| Pulmonary venous thrombosis | 15 | 0% |
| Pulpitis dental | 69 | 0% |
| Pulpless tooth | 2 | 0% |
| Pulse abnormal | 710 | 0.04% |
| Pulse absent | 579 | 0.04% |
| Pulseless electrical activity | 359 | 0.02% |
| Pulse pressure abnormal | 4 | 0% |
| Pulse pressure decreased | 9 | 0% |
| Pulse pressure increased | 19 | 0% |
| Pulse pressure normal | 3 | 0% |
| Pulse volume decreased | 5 | 0% |
| Pulse waveform | 8 | 0% |
| Pulse waveform abnormal | 10 | 0% |
| Pulse waveform normal | 1 | 0% |
| Pulse wave velocity | 4 | 0% |
| Punctal plug insertion | 3 | 0% |
| Punctate basophilia | 1 | 0% |
| Punctate keratitis | 23 | 0% |
| Puncture site bruise | 17 | 0% |
| Puncture site discharge | 1 | 0% |
| Puncture site erythema | 2 | 0% |
| Puncture site haematoma | 4 | 0% |
| Puncture site haemorrhage | 7 | 0% |
| Puncture site induration | 1 | 0% |
| Puncture site infection | 1 | 0% |
| Puncture site inflammation | 1 | 0% |
| Puncture site oedema | 10 | 0% |
| Puncture site pain | 50 | 0% |
| Puncture site pruritus | 1 | 0% |
| Puncture site reaction | 9 | 0% |
| Puncture site swelling | 8 | 0% |
| Pupil dilation procedure | 38 | 0% |
| Pupil fixed | 135 | 0.01% |
| Pupillary deformity | 1 | 0% |
| Pupillary disorder | 33 | 0% |
| Pupillary light reflex tests | 71 | 0% |
| Pupillary light reflex tests abnormal | 38 | 0% |
| Pupillary reflex impaired | 84 | 0.01% |
| Pupillotonia | 3 | 0% |
| Pupils unequal | 83 | 0.01% |
| Purging | 4 | 0% |
| Purple glove syndrome | 2 | 0% |
| Purpura | 811 | 0.05% |
| Purpura fulminans | 4 | 0% |
| Purpura non-thrombocytopenic | 11 | 0% |
| Purpura senile | 4 | 0% |
| Purtscher retinopathy | 1 | 0% |
| Purulence | 42 | 0% |
| Purulent discharge | 95 | 0.01% |
| Purulent pericarditis | 5 | 0% |
| Pus in stool | 3 | 0% |
| Pustular psoriasis | 62 | 0% |
| Pustule | 399 | 0.02% |
| Putamen haemorrhage | 36 | 0% |
| Pyelitis | 24 | 0% |
| Pyelocaliectasis | 13 | 0% |
| Pyelonephritis | 361 | 0.02% |
| Pyelonephritis acute | 76 | 0% |
| Pyelonephritis chronic | 3 | 0% |
| Pyelonephritis fungal | 1 | 0% |
| Pyeloplasty | 2 | 0% |
| Pyloric sphincter insufficiency | 1 | 0% |
| Pyloric stenosis | 2 | 0% |
| Pyloroplasty | 1 | 0% |
| Pyoderma | 11 | 0% |
| Pyoderma gangrenosum | 61 | 0% |
| Pyoderma streptococcal | 1 | 0% |
| Pyogenic granuloma | 5 | 0% |
| Pyometra | 1 | 0% |
| Pyomyositis | 1 | 0% |
| Pyonephrosis | 2 | 0% |
| Pyramidal tract syndrome | 27 | 0% |
| Pyrexia | 197,934 | 12.04% |
| Pyroglutamic acidosis | 1 | 0% |
| Pyruvate dehydrogenase complex deficiency | 2 | 0% |
| Pyruvate kinase | 19 | 0% |
| Pyruvate kinase increased | 1 | 0% |
| Pyuria | 77 | 0% |
| Q fever | 81 | 0% |
| QRS axis | 36 | 0% |
| QRS axis abnormal | 67 | 0% |
| QRS axis normal | 6 | 0% |
| Quadrantanopia | 23 | 0% |
| Quadriparesis | 178 | 0.01% |
| Quadriplegia | 106 | 0.01% |
| Quality of life decreased | 894 | 0.05% |
| Quantitative sensory testing | 19 | 0% |
| Quantitative sudomotor axon reflex test | 20 | 0% |
| Quarantine | 79 | 0% |
| Rabies | 3 | 0% |
| Radial head dislocation | 1 | 0% |
| Radial nerve compression | 5 | 0% |
| Radial nerve injury | 24 | 0% |
| Radial nerve palsy | 69 | 0% |
| Radial pulse | 38 | 0% |
| Radial pulse abnormal | 33 | 0% |
| Radial pulse decreased | 8 | 0% |
| Radial pulse increased | 6 | 0% |
| Radiation associated pain | 6 | 0% |
| Radiation dysphagia | 1 | 0% |
| Radiation inflammation | 2 | 0% |
| Radiation injury | 3 | 0% |
| Radiation mastitis | 1 | 0% |
| Radiation neuropathy | 1 | 0% |
| Radiation oesophagitis | 2 | 0% |
| Radiation pneumonitis | 7 | 0% |
| Radiation proctitis | 2 | 0% |
| Radiation sickness syndrome | 3 | 0% |
| Radiation skin injury | 2 | 0% |
| Radical cystectomy | 1 | 0% |
| Radical hysterectomy | 3 | 0% |
| Radical prostatectomy | 4 | 0% |
| Radicular pain | 33 | 0% |
| Radiculitis brachial | 117 | 0.01% |
| Radiculopathy | 265 | 0.02% |
| Radiculotomy | 1 | 0% |
| Radioactive iodine therapy | 3 | 0% |
| Radioallergosorbent test | 23 | 0% |
| Radioallergosorbent test negative | 1 | 0% |
| Radiochemotherapy | 1 | 0% |
| Radioembolisation | 2 | 0% |
| Radioimmunotherapy | 1 | 0% |
| Radioisotope scan | 496 | 0.03% |
| Radioisotope scan abnormal | 1 | 0% |
| Radioisotope uptake increased | 2 | 0% |
| Radiologically isolated syndrome | 7 | 0% |
| Radiologic pelvimetry | 1 | 0% |
| Radiotherapy | 174 | 0.01% |
| Radiotherapy to brain | 2 | 0% |
| Radiotherapy to breast | 1 | 0% |
| Radiotherapy to ear | 1 | 0% |
| Radiotherapy to eye | 1 | 0% |
| Radiotherapy to lymph nodes | 1 | 0% |
| Radiotherapy to pharynx | 1 | 0% |
| Radius fracture | 34 | 0% |
| Rales | 369 | 0.02% |
| Ranula | 3 | 0% |
| Rapid alternating movement test abnormal | 1 | 0% |
| Rapid eye movement sleep behaviour disorder | 7 | 0% |
| Rapid eye movements sleep abnormal | 8 | 0% |
| Rash | 57,097 | 3.47% |
| Rash erythematous | 13,270 | 0.81% |
| Rash follicular | 10 | 0% |
| Rash macular | 5,764 | 0.35% |
| Rash maculo-papular | 716 | 0.04% |
| Rash maculovesicular | 5 | 0% |
| Rash morbilliform | 303 | 0.02% |
| Rash neonatal | 5 | 0% |
| Rash papular | 4,133 | 0.25% |
| Rash papulosquamous | 7 | 0% |
| Rash pruritic | 12,233 | 0.74% |
| Rash pustular | 264 | 0.02% |
| Rash rubelliform | 13 | 0% |
| Rash scarlatiniform | 10 | 0% |
| Rash vesicular | 1,117 | 0.07% |
| Rathke's cleft cyst | 4 | 0% |
| Raynaud's phenomenon | 625 | 0.04% |
| Reaction to azo-dyes | 1 | 0% |
| Reaction to colouring | 8 | 0% |
| Reaction to excipient | 88 | 0.01% |
| Reaction to food additive | 7 | 0% |
| Reaction to preservatives | 46 | 0% |
| Reaction to previous exposure to any vaccine | 101 | 0.01% |
| Reactive airways dysfunction syndrome | 1 | 0% |
| Reactive angioendotheliomatosis | 1 | 0% |
| Reactive capillary endothelial proliferation | 1 | 0% |
| Reactive gastropathy | 19 | 0% |
| Reactive perforating collagenosis | 1 | 0% |
| Reactogenicity event | 38 | 0% |
| Reading disorder | 167 | 0.01% |
| Rebound eczema | 2 | 0% |
| Rebound effect | 23 | 0% |
| Rebound nasal congestion | 1 | 0% |
| Rebound psoriasis | 1 | 0% |
| Rebound tachycardia | 1 | 0% |
| Recalled product | 4 | 0% |
| Recalled product administered | 66 | 0% |
| Recall phenomenon | 9 | 0% |
| Rectal abscess | 8 | 0% |
| Rectal adenocarcinoma | 5 | 0% |
| Rectal cancer | 29 | 0% |
| Rectal cancer metastatic | 5 | 0% |
| Rectal cancer stage III | 1 | 0% |
| Rectal cancer stage IV | 3 | 0% |
| Rectal discharge | 24 | 0% |
| Rectal examination | 83 | 0.01% |
| Rectal examination abnormal | 4 | 0% |
| Rectal examination normal | 5 | 0% |
| Rectal fissure | 5 | 0% |
| Rectal haemorrhage | 970 | 0.06% |
| Rectal injury | 4 | 0% |
| Rectal lesion | 4 | 0% |
| Rectal neoplasm | 1 | 0% |
| Rectal obstruction | 1 | 0% |
| Rectal polyp | 7 | 0% |
| Rectal polypectomy | 1 | 0% |
| Rectal prolapse | 10 | 0% |
| Rectal prolapse repair | 4 | 0% |
| Rectal spasm | 9 | 0% |
| Rectal swab | 3 | 0% |
| Rectal tenesmus | 31 | 0% |
| Rectal tube insertion | 5 | 0% |
| Rectal ulcer | 5 | 0% |
| Rectal ulcer haemorrhage | 1 | 0% |
| Rectal ultrasound | 3 | 0% |
| Rectal ultrasound normal | 1 | 0% |
| Rectocele | 1 | 0% |
| Rectosigmoid cancer | 2 | 0% |
| Rectourethral fistula | 1 | 0% |
| Recurrent cancer | 23 | 0% |
| Recurrent subareolar breast abscess | 1 | 0% |
| Red blood cell abnormality | 94 | 0.01% |
| Red blood cell acanthocytes present | 2 | 0% |
| Red blood cell agglutination | 6 | 0% |
| Red blood cell agglutination present | 1 | 0% |
| Red blood cell analysis | 170 | 0.01% |
| Red blood cell analysis abnormal | 2 | 0% |
| Red blood cell analysis normal | 2 | 0% |
| Red blood cell anisocytes | 3 | 0% |
| Red blood cell anisocytes present | 9 | 0% |
| Red blood cell burr cells present | 3 | 0% |
| Red blood cell count | 2,350 | 0.14% |
| Red blood cell count abnormal | 34 | 0% |
| Red blood cell count decreased | 960 | 0.06% |
| Red blood cell count increased | 204 | 0.01% |
| Red blood cell count normal | 596 | 0.04% |
| Red blood cell elliptocytes present | 5 | 0% |
| Red blood cell enzymes abnormal | 1 | 0% |
| Red blood cell Heinz bodies present | 1 | 0% |
| Red blood cell hyperchromic morphology | 2 | 0% |
| Red blood cell hyperchromic morphology present | 2 | 0% |
| Red blood cell hypochromic morphology present | 8 | 0% |
| Red blood cell macrocytes | 3 | 0% |
| Red blood cell macrocytes present | 3 | 0% |
| Red blood cell microcytes | 7 | 0% |
| Red blood cell microcytes present | 9 | 0% |
| Red blood cell morphology | 26 | 0% |
| Red blood cell morphology abnormal | 10 | 0% |
| Red blood cell morphology normal | 22 | 0% |
| Red blood cell nucleated morphology | 249 | 0.02% |
| Red blood cell nucleated morphology present | 17 | 0% |
| Red blood cell poikilocytes | 3 | 0% |
| Red blood cell poikilocytes present | 5 | 0% |
| Red blood cell rouleaux formation present | 3 | 0% |
| Red blood cell scan | 71 | 0% |
| Red blood cell schistocytes | 44 | 0% |
| Red blood cell schistocytes present | 13 | 0% |
| Red blood cell sedimentation rate | 3,244 | 0.2% |
| Red blood cell sedimentation rate abnormal | 73 | 0% |
| Red blood cell sedimentation rate decreased | 40 | 0% |
| Red blood cell sedimentation rate increased | 1,671 | 0.1% |
| Red blood cell sedimentation rate normal | 1,071 | 0.07% |
| Red blood cell spherocytes | 3 | 0% |
| Red blood cell spherocytes present | 1 | 0% |
| Red blood cells urine | 313 | 0.02% |
| Red blood cells urine negative | 48 | 0% |
| Red blood cells urine positive | 213 | 0.01% |
| Red blood cell transfusion | 203 | 0.01% |
| Red blood cell vacuolisation | 2 | 0% |
| Red breast syndrome | 1 | 0% |
| Red cell distribution width | 823 | 0.05% |
| Red cell distribution width abnormal | 4 | 0% |
| Red cell distribution width decreased | 19 | 0% |
| Red cell distribution width increased | 463 | 0.03% |
| Red cell distribution width normal | 628 | 0.04% |
| Red ear syndrome | 13 | 0% |
| Red light therapy | 1 | 0% |
| Red man syndrome | 1 | 0% |
| Reduced facial expression | 81 | 0% |
| Reduced parasympathetic activity | 1 | 0% |
| Reduction of increased intracranial pressure | 3 | 0% |
| Reexpansion pulmonary oedema | 1 | 0% |
| Refeeding syndrome | 2 | 0% |
| Reflexes abnormal | 41 | 0% |
| Reflexology | 3 | 0% |
| Reflex test | 166 | 0.01% |
| Reflex test abnormal | 10 | 0% |
| Reflex test normal | 22 | 0% |
| Reflux gastritis | 54 | 0% |
| Reflux laryngitis | 27 | 0% |
| Refraction disorder | 5 | 0% |
| Refractory anaemia with an excess of blasts | 2 | 0% |
| Refractory cancer | 1 | 0% |
| Refractory cytopenia with unilineage dysplasia | 1 | 0% |
| Refusal of examination | 7 | 0% |
| Refusal of treatment by patient | 239 | 0.01% |
| Refusal of treatment by relative | 9 | 0% |
| Refusal of vaccination | 30 | 0% |
| Regenerative siderotic hepatic nodule | 2 | 0% |
| Regressive behaviour | 3 | 0% |
| Regurgitation | 87 | 0.01% |
| Rehabilitation therapy | 13 | 0% |
| Reinfusion | 1 | 0% |
| Relapsing-remitting multiple sclerosis | 57 | 0% |
| Relapsing fever | 26 | 0% |
| Relapsing multiple sclerosis | 21 | 0% |
| Removal of external fixation | 2 | 0% |
| Removal of foreign body | 1 | 0% |
| Removal of foreign body from oesophagus | 1 | 0% |
| Renal-limited thrombotic microangiopathy | 6 | 0% |
| Renal abscess | 14 | 0% |
| Renal adenoma | 1 | 0% |
| Renal amyloidosis | 2 | 0% |
| Renal aneurysm | 5 | 0% |
| Renal aplasia | 4 | 0% |
| Renal arteriosclerosis | 3 | 0% |
| Renal arteritis | 1 | 0% |
| Renal artery arteriosclerosis | 3 | 0% |
| Renal artery dissection | 4 | 0% |
| Renal artery embolisation | 2 | 0% |
| Renal artery fibromuscular dysplasia | 1 | 0% |
| Renal artery occlusion | 5 | 0% |
| Renal artery restenosis | 1 | 0% |
| Renal artery stenosis | 21 | 0% |
| Renal artery stent placement | 10 | 0% |
| Renal artery stent removal | 1 | 0% |
| Renal artery thrombosis | 35 | 0% |
| Renal atrophy | 38 | 0% |
| Renal cancer | 72 | 0% |
| Renal cancer metastatic | 7 | 0% |
| Renal cancer recurrent | 3 | 0% |
| Renal cancer stage I | 1 | 0% |
| Renal cancer stage IV | 2 | 0% |
| Renal cell carcinoma | 22 | 0% |
| Renal cell carcinoma recurrent | 1 | 0% |
| Renal colic | 131 | 0.01% |
| Renal cortical necrosis | 3 | 0% |
| Renal cyst | 246 | 0.01% |
| Renal cyst haemorrhage | 2 | 0% |
| Renal cyst ruptured | 1 | 0% |
| Renal disorder | 616 | 0.04% |
| Renal dysplasia | 3 | 0% |
| Renal embolism | 14 | 0% |
| Renal exploration | 7 | 0% |
| Renal failure | 1,507 | 0.09% |
| Renal function test | 1,656 | 0.1% |
| Renal function test abnormal | 118 | 0.01% |
| Renal function test normal | 273 | 0.02% |
| Renal fusion anomaly | 5 | 0% |
| Renal graft infection | 2 | 0% |
| Renal haemangioma | 2 | 0% |
| Renal haematoma | 6 | 0% |
| Renal haemorrhage | 38 | 0% |
| Renal hamartoma | 6 | 0% |
| Renal hypertension | 1 | 0% |
| Renal hypertrophy | 8 | 0% |
| Renal impairment | 1,218 | 0.07% |
| Renal infarct | 167 | 0.01% |
| Renal injury | 89 | 0.01% |
| Renal ischaemia | 12 | 0% |
| Renal lithiasis prophylaxis | 1 | 0% |
| Renal mass | 67 | 0% |
| Renal necrosis | 10 | 0% |
| Renal neoplasm | 24 | 0% |
| Renal pain | 1,947 | 0.12% |
| Renal procedural complication | 1 | 0% |
| Renal replacement therapy | 32 | 0% |
| Renal scan | 42 | 0% |
| Renal scan abnormal | 1 | 0% |
| Renal scan normal | 4 | 0% |
| Renal stone removal | 32 | 0% |
| Renal surgery | 9 | 0% |
| Renal transplant | 35 | 0% |
| Renal transplant failure | 5 | 0% |
| Renal tubular atrophy | 4 | 0% |
| Renal tubular disorder | 7 | 0% |
| Renal tubular injury | 12 | 0% |
| Renal tubular necrosis | 88 | 0.01% |
| Renal tumour excision | 2 | 0% |
| Renal vascular thrombosis | 16 | 0% |
| Renal vasculitis | 19 | 0% |
| Renal vein compression | 2 | 0% |
| Renal vein occlusion | 3 | 0% |
| Renal vein thrombosis | 48 | 0% |
| Renal vessel disorder | 2 | 0% |
| Renin | 28 | 0% |
| Renin-angiotensin system inhibition | 1 | 0% |
| Renin abnormal | 1 | 0% |
| Renin decreased | 3 | 0% |
| Renin increased | 3 | 0% |
| Renin normal | 3 | 0% |
| Renovascular hypertension | 1 | 0% |
| Reocclusion | 1 | 0% |
| Reperfusion arrhythmia | 2 | 0% |
| Reperfusion injury | 1 | 0% |
| Repetitive speech | 38 | 0% |
| Repetitive strain injury | 6 | 0% |
| Reproductive hormone | 2 | 0% |
| Reproductive tract disorder | 10 | 0% |
| Residual urine volume | 14 | 0% |
| Residual urine volume increased | 4 | 0% |
| Resorption bone increased | 6 | 0% |
| Respiration abnormal | 1,051 | 0.06% |
| Respiratory acidosis | 125 | 0.01% |
| Respiratory alkalosis | 64 | 0% |
| Respiratory arrest | 878 | 0.05% |
| Respiratory depression | 161 | 0.01% |
| Respiratory depth decreased | 11 | 0% |
| Respiratory disorder | 1,671 | 0.1% |
| Respiratory disorder neonatal | 5 | 0% |
| Respiratory distress | 3,934 | 0.24% |
| Respiratory failure | 3,820 | 0.23% |
| Respiratory fatigue | 56 | 0% |
| Respiratory fremitus | 2 | 0% |
| Respiratory fume inhalation disorder | 3 | 0% |
| Respiratory gas exchange disorder | 7 | 0% |
| Respiratory moniliasis | 1 | 0% |
| Respiratory muscle weakness | 29 | 0% |
| Respiratory paralysis | 4 | 0% |
| Respiratory pathogen panel | 42 | 0% |
| Respiratory rate | 3,401 | 0.21% |
| Respiratory rate decreased | 206 | 0.01% |
| Respiratory rate increased | 887 | 0.05% |
| Respiratory sinus arrhythmia magnitude | 2 | 0% |
| Respiratory sinus arrhythmia magnitude abnormal | 4 | 0% |
| Respiratory symptom | 888 | 0.05% |
| Respiratory syncytial virus bronchiolitis | 2 | 0% |
| Respiratory syncytial virus bronchitis | 4 | 0% |
| Respiratory syncytial virus infection | 114 | 0.01% |
| Respiratory syncytial virus test | 402 | 0.02% |
| Respiratory syncytial virus test negative | 850 | 0.05% |
| Respiratory syncytial virus test positive | 125 | 0.01% |
| Respiratory therapy | 5 | 0% |
| Respiratory tract chlamydial infection | 2 | 0% |
| Respiratory tract congestion | 8,566 | 0.52% |
| Respiratory tract haemorrhage | 34 | 0% |
| Respiratory tract infection | 458 | 0.03% |
| Respiratory tract infection bacterial | 6 | 0% |
| Respiratory tract infection viral | 30 | 0% |
| Respiratory tract inflammation | 24 | 0% |
| Respiratory tract irritation | 118 | 0.01% |
| Respiratory tract malformation | 1 | 0% |
| Respiratory tract oedema | 87 | 0.01% |
| Respiratory tract ulceration | 1 | 0% |
| Respiratory viral panel | 674 | 0.04% |
| Respirovirus test | 28 | 0% |
| Respirovirus test positive | 3 | 0% |
| Respite care | 1 | 0% |
| Resting tremor | 32 | 0% |
| Restless arm syndrome | 28 | 0% |
| Restless legs syndrome | 776 | 0.05% |
| Restlessness | 2,545 | 0.15% |
| Rest regimen | 8 | 0% |
| Restrictive cardiomyopathy | 7 | 0% |
| Restrictive pulmonary disease | 22 | 0% |
| Resuscitation | 1,215 | 0.07% |
| Retained placenta operation | 5 | 0% |
| Retained placenta or membranes | 13 | 0% |
| Retained products of conception | 7 | 0% |
| Retching | 2,403 | 0.15% |
| Retention cyst | 9 | 0% |
| Reticular cell count | 5 | 0% |
| Reticulocyte count | 302 | 0.02% |
| Reticulocyte count abnormal | 3 | 0% |
| Reticulocyte count decreased | 13 | 0% |
| Reticulocyte count increased | 41 | 0% |
| Reticulocyte count normal | 10 | 0% |
| Reticulocyte haemoglobin equivalent | 11 | 0% |
| Reticulocyte haemoglobin increased | 2 | 0% |
| Reticulocyte percentage | 26 | 0% |
| Reticulocyte percentage decreased | 1 | 0% |
| Reticulocyte percentage increased | 5 | 0% |
| Reticulocyte percentage normal | 3 | 0% |
| Reticulocytopenia | 1 | 0% |
| Reticulocytosis | 7 | 0% |
| Retinal aneurysm | 10 | 0% |
| Retinal aneurysm rupture | 2 | 0% |
| Retinal artery embolism | 27 | 0% |
| Retinal artery occlusion | 442 | 0.03% |
| Retinal artery stenosis | 1 | 0% |
| Retinal artery thrombosis | 50 | 0% |
| Retinal cryoablation | 1 | 0% |
| Retinal cyst | 3 | 0% |
| Retinal degeneration | 30 | 0% |
| Retinal depigmentation | 2 | 0% |
| Retinal deposits | 1 | 0% |
| Retinal detachment | 469 | 0.03% |
| Retinal disorder | 56 | 0% |
| Retinal drusen | 2 | 0% |
| Retinal dystrophy | 2 | 0% |
| Retinal exudates | 52 | 0% |
| Retinal fibrosis | 2 | 0% |
| Retinal fovea disorder | 3 | 0% |
| Retinal function test abnormal | 10 | 0% |
| Retinal function test normal | 3 | 0% |
| Retinal haemorrhage | 272 | 0.02% |
| Retinal infarction | 17 | 0% |
| Retinal infiltrates | 1 | 0% |
| Retinal injury | 30 | 0% |
| Retinal ischaemia | 42 | 0% |
| Retinal laser coagulation | 3 | 0% |
| Retinal microangiopathy | 2 | 0% |
| Retinal migraine | 92 | 0.01% |
| Retinal neovascularisation | 5 | 0% |
| Retinal occlusive vasculitis | 4 | 0% |
| Retinal oedema | 55 | 0% |
| Retinal operation | 22 | 0% |
| Retinal pallor | 1 | 0% |
| Retinal pigment epitheliopathy | 19 | 0% |
| Retinal scar | 7 | 0% |
| Retinal tear | 177 | 0.01% |
| Retinal thickening | 1 | 0% |
| Retinal toxicity | 3 | 0% |
| Retinal vascular disorder | 28 | 0% |
| Retinal vascular occlusion | 81 | 0% |
| Retinal vascular thrombosis | 122 | 0.01% |
| Retinal vasculitis | 47 | 0% |
| Retinal vein occlusion | 783 | 0.05% |
| Retinal vein thrombosis | 231 | 0.01% |
| Retinal vessel avulsion | 1 | 0% |
| Retinal white dots syndrome | 35 | 0% |
| Retinitis | 18 | 0% |
| Retinitis pigmentosa | 6 | 0% |
| Retinitis viral | 1 | 0% |
| Retinogram | 66 | 0% |
| Retinogram abnormal | 12 | 0% |
| Retinogram normal | 3 | 0% |
| Retinopathy | 42 | 0% |
| Retinopathy hypertensive | 14 | 0% |
| Retinopathy proliferative | 2 | 0% |
| Retinopexy | 17 | 0% |
| Retinoschisis | 6 | 0% |
| Retinoscopy | 1 | 0% |
| Retirement | 8 | 0% |
| Retracted nipple | 5 | 0% |
| Retrognathia | 1 | 0% |
| Retrograde amnesia | 51 | 0% |
| Retrograde ejaculation | 1 | 0% |
| Retrograde menstruation | 3 | 0% |
| Retroperitoneal abscess | 4 | 0% |
| Retroperitoneal cancer | 1 | 0% |
| Retroperitoneal disorder | 1 | 0% |
| Retroperitoneal effusion | 2 | 0% |
| Retroperitoneal fibrosis | 6 | 0% |
| Retroperitoneal haematoma | 23 | 0% |
| Retroperitoneal haemorrhage | 27 | 0% |
| Retroperitoneal lymphadenopathy | 25 | 0% |
| Retroperitoneal mass | 6 | 0% |
| Retroperitoneal neoplasm | 2 | 0% |
| Retroperitoneal neoplasm metastatic | 1 | 0% |
| Retroperitoneal oedema | 2 | 0% |
| Retroperitonitis | 1 | 0% |
| Retroplacental haematoma | 18 | 0% |
| Revascularisation procedure | 8 | 0% |
| Reversal of opiate activity | 1 | 0% |
| Reversed hot-cold sensation | 20 | 0% |
| Reverse tri-iodothyronine | 1 | 0% |
| Reverse tri-iodothyronine increased | 1 | 0% |
| Reversible airways obstruction | 4 | 0% |
| Reversible cerebral vasoconstriction syndrome | 48 | 0% |
| Reversible ischaemic neurological deficit | 28 | 0% |
| Reversible splenial lesion syndrome | 4 | 0% |
| Reynold's syndrome | 17 | 0% |
| Rhabdoid tumour | 1 | 0% |
| Rhabdomyolysis | 796 | 0.05% |
| Rhabdomyoma | 1 | 0% |
| Rhabdomyosarcoma | 4 | 0% |
| Rhegmatogenous retinal detachment | 6 | 0% |
| Rhesus antibodies | 15 | 0% |
| Rhesus antibodies positive | 4 | 0% |
| Rhesus antigen | 13 | 0% |
| Rhesus antigen negative | 11 | 0% |
| Rhesus antigen positive | 16 | 0% |
| Rhesus incompatibility | 1 | 0% |
| Rheumatic disorder | 486 | 0.03% |
| Rheumatic fever | 28 | 0% |
| Rheumatic heart disease | 6 | 0% |
| Rheumatoid arthritis | 3,573 | 0.22% |
| Rheumatoid arthritis-associated interstitial lung disease | 3 | 0% |
| Rheumatoid bursitis | 1 | 0% |
| Rheumatoid factor | 1,804 | 0.11% |
| Rheumatoid factor decreased | 4 | 0% |
| Rheumatoid factor increased | 167 | 0.01% |
| Rheumatoid factor negative | 372 | 0.02% |
| Rheumatoid factor positive | 101 | 0.01% |
| Rheumatoid factor quantitative | 15 | 0% |
| Rheumatoid factor quantitative increased | 1 | 0% |
| Rheumatoid lung | 1 | 0% |
| Rheumatoid nodule | 9 | 0% |
| Rheumatoid vasculitis | 4 | 0% |
| Rheumatological examination | 406 | 0.02% |
| Rhinalgia | 230 | 0.01% |
| Rhinitis | 704 | 0.04% |
| Rhinitis allergic | 157 | 0.01% |
| Rhinitis atrophic | 1 | 0% |
| Rhinitis perennial | 1 | 0% |
| Rhinolaryngitis | 1 | 0% |
| Rhinophyma | 3 | 0% |
| Rhinorrhoea | 14,375 | 0.87% |
| Rhinoscopy | 21 | 0% |
| Rhinotracheitis | 2 | 0% |
| Rhinovirus infection | 63 | 0% |
| Rhonchi | 149 | 0.01% |
| Rhythm idioventricular | 9 | 0% |
| Rib deformity | 7 | 0% |
| Rib excision | 1 | 0% |
| Rib fracture | 309 | 0.02% |
| Richter's syndrome | 3 | 0% |
| Rickets | 1 | 0% |
| Rickettsiosis | 7 | 0% |
| Right-to-left cardiac shunt | 2 | 0% |
| Right aortic arch | 2 | 0% |
| Right atrial dilatation | 38 | 0% |
| Right atrial enlargement | 48 | 0% |
| Right atrial hypertrophy | 1 | 0% |
| Right atrial pressure increased | 6 | 0% |
| Right atrial volume abnormal | 1 | 0% |
| Right atrial volume decreased | 1 | 0% |
| Right hemisphere deficit syndrome | 7 | 0% |
| Right ventricular diastolic collapse | 6 | 0% |
| Right ventricular dilatation | 112 | 0.01% |
| Right ventricular dysfunction | 151 | 0.01% |
| Right ventricular ejection fraction decreased | 27 | 0% |
| Right ventricular enlargement | 48 | 0% |
| Right ventricular failure | 131 | 0.01% |
| Right ventricular hypertension | 2 | 0% |
| Right ventricular hypertrophy | 26 | 0% |
| Right ventricular systolic pressure | 51 | 0% |
| Right ventricular systolic pressure decreased | 7 | 0% |
| Right ventricular systolic pressure increased | 18 | 0% |
| Rinne tuning fork test | 17 | 0% |
| Rippling muscle disease | 2 | 0% |
| Risk of future pregnancy miscarriage | 2 | 0% |
| Road traffic accident | 478 | 0.03% |
| Robotic surgery | 12 | 0% |
| Robust take following exposure to vaccinia virus | 2 | 0% |
| Rocky mountain spotted fever | 10 | 0% |
| Romberg test | 225 | 0.01% |
| Romberg test positive | 28 | 0% |
| Root canal infection | 11 | 0% |
| Rosacea | 244 | 0.01% |
| Rosai-Dorfman syndrome | 5 | 0% |
| Roseola | 12 | 0% |
| Roseolovirus test | 8 | 0% |
| Roseolovirus test positive | 2 | 0% |
| Rotator cuff injury of hip | 1 | 0% |
| Rotator cuff repair | 16 | 0% |
| Rotator cuff syndrome | 531 | 0.03% |
| Rotator cuff tear arthropathy | 1 | 0% |
| Rotavirus infection | 5 | 0% |
| Rotavirus test | 12 | 0% |
| Rotavirus test negative | 6 | 0% |
| Rotavirus test positive | 1 | 0% |
| Rouleaux formation | 3 | 0% |
| Routine health maintenance | 2 | 0% |
| Routine immunisation schedule not administered | 1 | 0% |
| Rubber sensitivity | 21 | 0% |
| Rubella | 41 | 0% |
| Rubella antibody negative | 1 | 0% |
| Rubella antibody positive | 3 | 0% |
| Rubella antibody test | 86 | 0.01% |
| Rubella immunity confirmed | 2 | 0% |
| Rubella in pregnancy | 2 | 0% |
| Rubivirus test positive | 4 | 0% |
| Rubulavirus test | 8 | 0% |
| Rubulavirus test positive | 2 | 0% |
| RUNX1 gene mutation | 3 | 0% |
| Ruptured cerebral aneurysm | 82 | 0% |
| Ruptured ectopic pregnancy | 6 | 0% |
| Russell's viper venom time | 39 | 0% |
| Russell's viper venom time abnormal | 3 | 0% |
| Russell's viper venom time normal | 12 | 0% |
| Saccadic eye movement | 6 | 0% |
| Sacralisation | 1 | 0% |
| Sacral pain | 88 | 0.01% |
| Sacral radiculopathy | 2 | 0% |
| Sacroiliac fracture | 1 | 0% |
| Sacroiliac fusion | 1 | 0% |
| Sacroiliac joint dysfunction | 25 | 0% |
| Sacroiliitis | 55 | 0% |
| Saline infusion sonogram | 14 | 0% |
| Saliva alcohol test | 2 | 0% |
| Saliva alcohol test positive | 1 | 0% |
| Saliva altered | 48 | 0% |
| Saliva analysis | 22 | 0% |
| Saliva analysis normal | 1 | 0% |
| Saliva discolouration | 13 | 0% |
| Salivary duct obstruction | 4 | 0% |
| Salivary duct stenosis | 1 | 0% |
| Salivary gland adenoma | 5 | 0% |
| Salivary gland calculus | 5 | 0% |
| Salivary gland cancer | 8 | 0% |
| Salivary gland cancer stage III | 1 | 0% |
| Salivary gland cyst | 3 | 0% |
| Salivary gland disorder | 27 | 0% |
| Salivary gland enlargement | 93 | 0.01% |
| Salivary gland induration | 1 | 0% |
| Salivary gland mass | 11 | 0% |
| Salivary gland mucocoele | 7 | 0% |
| Salivary gland neoplasm | 17 | 0% |
| Salivary gland operation | 1 | 0% |
| Salivary gland pain | 57 | 0% |
| Salivary hypersecretion | 498 | 0.03% |
| Salivary scan | 5 | 0% |
| Saliva testosterone | 1 | 0% |
| Salmonella bacteraemia | 1 | 0% |
| Salmonella sepsis | 3 | 0% |
| Salmonella test | 21 | 0% |
| Salmonella test negative | 20 | 0% |
| Salmonella test positive | 10 | 0% |
| Salmonellosis | 23 | 0% |
| Salpingectomy | 28 | 0% |
| Salpingitis | 12 | 0% |
| Salpingo-oophorectomy | 2 | 0% |
| Salpingo-oophorectomy bilateral | 5 | 0% |
| Salpingo-oophorectomy unilateral | 2 | 0% |
| Salpingo-oophoritis | 3 | 0% |
| Salpingogram | 1 | 0% |
| Salpingostomy | 1 | 0% |
| Salt craving | 16 | 0% |
| Salt intoxication | 3 | 0% |
| SAPHO syndrome | 8 | 0% |
| Sapovirus test positive | 1 | 0% |
| Sarcoid-like reaction | 4 | 0% |
| Sarcoidosis | 419 | 0.03% |
| Sarcoidosis of lymph node | 6 | 0% |
| Sarcoma | 17 | 0% |
| Sarcoma excision | 1 | 0% |
| Sarcoma metastatic | 2 | 0% |
| Sarcoma of skin | 1 | 0% |
| Sarcoma uterus | 1 | 0% |
| Sarcopenia | 13 | 0% |
| SARS-CoV-1 test | 292 | 0.02% |
| SARS-CoV-1 test negative | 17 | 0% |
| SARS-CoV-1 test positive | 36 | 0% |
| SARS-CoV-2 antibody test | 5,656 | 0.34% |
| SARS-CoV-2 antibody test negative | 571 | 0.03% |
| SARS-CoV-2 antibody test positive | 576 | 0.04% |
| SARS-CoV-2 carrier | 3 | 0% |
| SARS-CoV-2 RNA | 400 | 0.02% |
| SARS-CoV-2 RNA fluctuation | 3 | 0% |
| SARS-CoV-2 RNA increased | 35 | 0% |
| SARS-CoV-2 RNA undetectable | 18 | 0% |
| SARS-CoV-2 sepsis | 10 | 0% |
| SARS-CoV-2 test | 246,240 | 14.98% |
| SARS-CoV-2 test false negative | 8 | 0% |
| SARS-CoV-2 test false positive | 39 | 0% |
| SARS-CoV-2 test negative | 12,404 | 0.75% |
| SARS-CoV-2 test positive | 63,063 | 3.84% |
| SARS-CoV-2 viraemia | 4 | 0% |
| Satoyoshi syndrome | 3 | 0% |
| Scab | 606 | 0.04% |
| Scalloped tongue | 16 | 0% |
| Scalp haematoma | 9 | 0% |
| Scan | 2,654 | 0.16% |
| Scan abdomen abnormal | 12 | 0% |
| Scan abnormal | 96 | 0.01% |
| Scan adrenal gland | 9 | 0% |
| Scan adrenal gland abnormal | 1 | 0% |
| Scan bone marrow | 12 | 0% |
| Scan bone marrow abnormal | 2 | 0% |
| Scan bone marrow normal | 2 | 0% |
| Scan brain | 1,091 | 0.07% |
| Scan gallium | 6 | 0% |
| Scan gallium abnormal | 1 | 0% |
| Scan lymph nodes | 25 | 0% |
| Scan myocardial perfusion | 303 | 0.02% |
| Scan myocardial perfusion abnormal | 15 | 0% |
| Scan myocardial perfusion normal | 23 | 0% |
| Scan normal | 99 | 0.01% |
| Scan parathyroid | 2 | 0% |
| Scan spleen | 8 | 0% |
| Scan thyroid gland | 117 | 0.01% |
| Scan with contrast | 1,283 | 0.08% |
| Scan with contrast abnormal | 830 | 0.05% |
| Scan with contrast normal | 439 | 0.03% |
| Scaphocephaly | 1 | 0% |
| Scapholunate dissociation | 2 | 0% |
| Scapula fracture | 4 | 0% |
| Scapular dyskinesis | 3 | 0% |
| Scar | 558 | 0.03% |
| Scar discomfort | 4 | 0% |
| Scar excision | 1 | 0% |
| Scar inflammation | 16 | 0% |
| Scarlet fever | 14 | 0% |
| Scar pain | 65 | 0% |
| Scedosporium infection | 1 | 0% |
| Schellong test | 30 | 0% |
| Schirmer's test | 32 | 0% |
| Schirmer's test abnormal | 4 | 0% |
| Schistocytosis | 8 | 0% |
| Schistosoma test | 4 | 0% |
| Schistosoma test negative | 1 | 0% |
| Schistosomiasis | 2 | 0% |
| Schistosomiasis cutaneous | 1 | 0% |
| Schizoaffective disorder | 14 | 0% |
| Schizoaffective disorder bipolar type | 3 | 0% |
| Schizoid personality disorder | 1 | 0% |
| Schizophrenia | 69 | 0% |
| Schizophreniform disorder | 5 | 0% |
| Schnitzler's syndrome | 2 | 0% |
| School refusal | 1 | 0% |
| Schwannoma | 9 | 0% |
| Sciatica | 1,127 | 0.07% |
| Sciatic hernia | 1 | 0% |
| Sciatic nerve injury | 23 | 0% |
| Sciatic nerve neuropathy | 19 | 0% |
| Sciatic nerve palsy | 5 | 0% |
| Scimitar syndrome | 1 | 0% |
| Scintillating scotoma | 56 | 0% |
| Scleral buckling surgery | 2 | 0% |
| Scleral cyst | 1 | 0% |
| Scleral discolouration | 17 | 0% |
| Scleral disorder | 13 | 0% |
| Scleral haemorrhage | 26 | 0% |
| Scleral hyperaemia | 2 | 0% |
| Scleral oedema | 8 | 0% |
| Scleral thinning | 1 | 0% |
| Scleritis | 130 | 0.01% |
| Scleritis allergic | 1 | 0% |
| Sclerodactylia | 3 | 0% |
| Scleroderma | 124 | 0.01% |
| Scleroderma-like reaction | 4 | 0% |
| Scleroderma associated digital ulcer | 1 | 0% |
| Scleroderma renal crisis | 5 | 0% |
| Scleroedema | 4 | 0% |
| Sclerotherapy | 7 | 0% |
| Sclerotylosis | 1 | 0% |
| Scoliosis | 99 | 0.01% |
| Scoliosis surgery | 1 | 0% |
| SCORTEN score | 2 | 0% |
| Scratch | 496 | 0.03% |
| Screaming | 278 | 0.02% |
| Scrotal abscess | 3 | 0% |
| Scrotal angiokeratoma | 1 | 0% |
| Scrotal cancer | 1 | 0% |
| Scrotal cellulitis | 7 | 0% |
| Scrotal cyst | 3 | 0% |
| Scrotal dermatitis | 4 | 0% |
| Scrotal discomfort | 2 | 0% |
| Scrotal disorder | 8 | 0% |
| Scrotal erythema | 11 | 0% |
| Scrotal exfoliation | 3 | 0% |
| Scrotal exploration | 2 | 0% |
| Scrotal gangrene | 1 | 0% |
| Scrotal haematoma | 2 | 0% |
| Scrotal haemorrhage | 2 | 0% |
| Scrotal infection | 1 | 0% |
| Scrotal inflammation | 1 | 0% |
| Scrotal mass | 4 | 0% |
| Scrotal oedema | 18 | 0% |
| Scrotal operation | 1 | 0% |
| Scrotal pain | 58 | 0% |
| Scrotal swelling | 63 | 0% |
| Scrotal ulcer | 2 | 0% |
| Scrotum erosion | 1 | 0% |
| Scrub typhus | 5 | 0% |
| Seasonal affective disorder | 2 | 0% |
| Seasonal allergy | 475 | 0.03% |
| Sebaceous cyst excision | 2 | 0% |
| Sebaceous gland disorder | 1 | 0% |
| Sebaceous gland infection | 1 | 0% |
| Sebaceous hyperplasia | 3 | 0% |
| Sebaceous naevus | 1 | 0% |
| Seborrhoea | 39 | 0% |
| Seborrhoeic alopecia | 1 | 0% |
| Seborrhoeic dermatitis | 55 | 0% |
| Seborrhoeic keratosis | 24 | 0% |
| Secondary adrenocortical insufficiency | 6 | 0% |
| Secondary cerebellar degeneration | 3 | 0% |
| Secondary hypertension | 10 | 0% |
| Secondary hyperthyroidism | 3 | 0% |
| Secondary hypogonadism | 2 | 0% |
| Secondary hypothyroidism | 2 | 0% |
| Secondary immunodeficiency | 6 | 0% |
| Secondary progressive multiple sclerosis | 6 | 0% |
| Secondary syphilis | 4 | 0% |
| Secondary thrombocytosis | 2 | 0% |
| Secondary tic | 1 | 0% |
| Secondary transmission | 4 | 0% |
| Second primary malignancy | 7 | 0% |
| Second trimester pregnancy | 12 | 0% |
| Secretion discharge | 1,041 | 0.06% |
| Sedation | 628 | 0.04% |
| Sedation complication | 9 | 0% |
| Sedative therapy | 27 | 0% |
| Segmental arterial mediolysis | 3 | 0% |
| Segmental diverticular colitis | 3 | 0% |
| Segmented hyalinising vasculitis | 20 | 0% |
| Seizure | 12,083 | 0.73% |
| Seizure anoxic | 9 | 0% |
| Seizure cluster | 20 | 0% |
| Seizure like phenomena | 678 | 0.04% |
| Seizure prophylaxis | 1 | 0% |
| Selective eating disorder | 10 | 0% |
| Selective IgA immunodeficiency | 8 | 0% |
| Selective IgG subclass deficiency | 5 | 0% |
| Selective IgM immunodeficiency | 1 | 0% |
| Selective mutism | 1 | 0% |
| Selenium deficiency | 7 | 0% |
| Self-consciousness | 5 | 0% |
| Self-destructive behaviour | 2 | 0% |
| Self-induced vomiting | 3 | 0% |
| Self-injurious ideation | 43 | 0% |
| Self-medication | 6 | 0% |
| Self esteem decreased | 25 | 0% |
| Semen analysis | 9 | 0% |
| Semen analysis abnormal | 3 | 0% |
| Semen discolouration | 5 | 0% |
| Semen liquefaction | 1 | 0% |
| Semen volume decreased | 8 | 0% |
| Seminal vesicular infection | 1 | 0% |
| Seminoma | 3 | 0% |
| Senile dementia | 13 | 0% |
| Senile osteoporosis | 1 | 0% |
| Senile pruritus | 2 | 0% |
| Sensation of blood flow | 90 | 0.01% |
| Sensation of foreign body | 1,891 | 0.12% |
| Sense of a foreshortened future | 5 | 0% |
| Sense of oppression | 240 | 0.01% |
| Sensitisation | 77 | 0% |
| Sensitive skin | 3,179 | 0.19% |
| Sensitivity to weather change | 41 | 0% |
| Sensorimotor disorder | 109 | 0.01% |
| Sensory disturbance | 3,382 | 0.21% |
| Sensory ganglionitis | 1 | 0% |
| Sensory integrative dysfunction | 3 | 0% |
| Sensory level | 48 | 0% |
| Sensory level abnormal | 154 | 0.01% |
| Sensory loss | 1,546 | 0.09% |
| Sensory neuropathy hereditary | 3 | 0% |
| Sensory overload | 68 | 0% |
| Sensory processing disorder | 22 | 0% |
| Sensory processing sensitivity | 12 | 0% |
| Separation anxiety disorder | 2 | 0% |
| Sepsis | 3,266 | 0.2% |
| Sepsis neonatal | 5 | 0% |
| Sepsis syndrome | 7 | 0% |
| Septal panniculitis | 2 | 0% |
| Septic arthritis staphylococcal | 5 | 0% |
| Septic arthritis streptococcal | 1 | 0% |
| Septic cerebral embolism | 3 | 0% |
| Septic coagulopathy | 1 | 0% |
| Septic embolus | 11 | 0% |
| Septic encephalopathy | 16 | 0% |
| Septic necrosis | 2 | 0% |
| Septic pulmonary embolism | 8 | 0% |
| Septic rash | 7 | 0% |
| Septic screen | 17 | 0% |
| Septic shock | 921 | 0.06% |
| Septum pellucidum agenesis | 1 | 0% |
| Seroconversion test | 5 | 0% |
| Seroconversion test negative | 4 | 0% |
| Serology abnormal | 6 | 0% |
| Serology negative | 29 | 0% |
| Serology normal | 11 | 0% |
| Serology positive | 10 | 0% |
| Serology test | 1,402 | 0.09% |
| Seroma | 20 | 0% |
| Seroma drainage | 2 | 0% |
| Seronegative arthritis | 86 | 0.01% |
| Serositis | 28 | 0% |
| Serotonin syndrome | 18 | 0% |
| Serous cystadenocarcinoma ovary | 1 | 0% |
| Serous retinal detachment | 9 | 0% |
| Serous retinopathy | 2 | 0% |
| Serpiginous choroiditis | 2 | 0% |
| Serratia bacteraemia | 3 | 0% |
| Serratia infection | 10 | 0% |
| Serratia sepsis | 1 | 0% |
| Serratia test positive | 10 | 0% |
| Serum amyloid A protein | 15 | 0% |
| Serum amyloid A protein increased | 3 | 0% |
| Serum colour abnormal | 1 | 0% |
| Serum ferritin | 1,851 | 0.11% |
| Serum ferritin abnormal | 10 | 0% |
| Serum ferritin decreased | 166 | 0.01% |
| Serum ferritin increased | 570 | 0.03% |
| Serum ferritin normal | 219 | 0.01% |
| Serum serotonin | 12 | 0% |
| Serum serotonin decreased | 1 | 0% |
| Serum serotonin increased | 1 | 0% |
| Serum sickness | 57 | 0% |
| Serum sickness-like reaction | 32 | 0% |
| Severe acute respiratory syndrome | 78 | 0% |
| Severe asthma with fungal sensitisation | 2 | 0% |
| Severe cutaneous adverse reaction | 6 | 0% |
| Severe fever with thrombocytopenia syndrome | 2 | 0% |
| Severe invasive streptococcal infection | 2 | 0% |
| Sex hormone binding globulin | 17 | 0% |
| Sex hormone binding globulin decreased | 1 | 0% |
| Sex hormone binding globulin increased | 1 | 0% |
| Sexual dysfunction | 75 | 0% |
| Sexual inhibition | 2 | 0% |
| Sexual life impairment | 1 | 0% |
| Sexually active | 1 | 0% |
| Sexually inappropriate behaviour | 2 | 0% |
| Sexually transmitted disease | 20 | 0% |
| Sexually transmitted disease test | 150 | 0.01% |
| Sezary cell count | 3 | 0% |
| Shared psychotic disorder | 2 | 0% |
| Shift to the left | 53 | 0% |
| Shift to the right | 1 | 0% |
| Shigella infection | 5 | 0% |
| Shigella test positive | 1 | 0% |
| Shock | 923 | 0.06% |
| Shock haemorrhagic | 97 | 0.01% |
| Shock hypoglycaemic | 7 | 0% |
| Shock symptom | 68 | 0% |
| Short-bowel syndrome | 5 | 0% |
| Short-chain acyl-coenzyme A dehydrogenase deficiency | 2 | 0% |
| Shortened cervix | 11 | 0% |
| Short interpregnancy interval | 1 | 0% |
| Short stature | 1 | 0% |
| Shoshin beriberi | 1 | 0% |
| Shoulder arthroplasty | 20 | 0% |
| Shoulder deformity | 14 | 0% |
| Shoulder dystocia | 2 | 0% |
| Shoulder fracture | 4 | 0% |
| Shoulder girdle pain | 8 | 0% |
| Shoulder injury related to vaccine administration | 649 | 0.04% |
| Shoulder operation | 39 | 0% |
| Shunt blood flow excessive | 1 | 0% |
| Shunt infection | 1 | 0% |
| Shunt malfunction | 2 | 0% |
| Shunt occlusion | 4 | 0% |
| Shunt stenosis | 1 | 0% |
| Shunt thrombosis | 2 | 0% |
| Sialoadenitis | 96 | 0.01% |
| Sialometry | 1 | 0% |
| Sick building syndrome | 1 | 0% |
| Sick leave | 362 | 0.02% |
| Sickle cell anaemia | 5 | 0% |
| Sickle cell anaemia with crisis | 67 | 0% |
| Sickle cell disease | 9 | 0% |
| Sickle cell trait | 3 | 0% |
| Sick relative | 97 | 0.01% |
| Sideroblastic anaemia | 1 | 0% |
| Sight disability | 36 | 0% |
| Sigmoid-shaped ventricular septum | 4 | 0% |
| Sigmoidectomy | 12 | 0% |
| Sigmoidoscopy | 61 | 0% |
| Sigmoidoscopy abnormal | 18 | 0% |
| Sigmoidoscopy normal | 3 | 0% |
| Sigmoid sinus thrombosis | 12 | 0% |
| Silent myocardial infarction | 13 | 0% |
| Silent thyroiditis | 13 | 0% |
| Silicosis | 1 | 0% |
| Similar reaction on previous exposure to drug | 63 | 0% |
| Simple partial seizures | 16 | 0% |
| Single atrium | 1 | 0% |
| Single component of a two-component product administered | 2 | 0% |
| Single functional kidney | 12 | 0% |
| Single photon emission computerised tomogram | 27 | 0% |
| Single photon emission computerised tomogram abnormal | 1 | 0% |
| Single photon emission computerised tomogram normal | 3 | 0% |
| Single umbilical artery | 8 | 0% |
| Sinoatrial block | 18 | 0% |
| Sinobronchitis | 4 | 0% |
| Sinonasal obstruction | 53 | 0% |
| Sinoscopy | 3 | 0% |
| Sinuplasty | 2 | 0% |
| Sinus arrest | 58 | 0% |
| Sinus arrhythmia | 253 | 0.02% |
| Sinus bradycardia | 390 | 0.02% |
| Sinus congestion | 2,031 | 0.12% |
| Sinus disorder | 1,075 | 0.07% |
| Sinus headache | 933 | 0.06% |
| Sinusitis | 2,844 | 0.17% |
| Sinusitis aspergillus | 2 | 0% |
| Sinusitis bacterial | 23 | 0% |
| Sinusitis fungal | 5 | 0% |
| Sinus node dysfunction | 96 | 0.01% |
| Sinus operation | 297 | 0.02% |
| Sinus pain | 1,069 | 0.07% |
| Sinus polyp | 8 | 0% |
| Sinus polyp degeneration | 1 | 0% |
| Sinus rhythm | 704 | 0.04% |
| Sinus tachycardia | 1,622 | 0.1% |
| Sitophobia | 4 | 0% |
| Sitting disability | 302 | 0.02% |
| Sjogren's syndrome | 395 | 0.02% |
| Sjogren-Larsson syndrome | 2 | 0% |
| SJS-TEN overlap | 3 | 0% |
| Skeletal dysplasia | 2 | 0% |
| Skeletal injury | 25 | 0% |
| Skeletal muscle enzymes | 7 | 0% |
| Skeletal survey | 4 | 0% |
| Skin abrasion | 425 | 0.03% |
| Skin atrophy | 61 | 0% |
| Skin bacterial infection | 32 | 0% |
| Skin burning sensation | 2,612 | 0.16% |
| Skin cancer | 83 | 0.01% |
| Skin candida | 14 | 0% |
| Skin cosmetic procedure | 2 | 0% |
| Skin culture | 25 | 0% |
| Skin culture positive | 7 | 0% |
| Skin cyst excision | 2 | 0% |
| Skin degenerative disorder | 1 | 0% |
| Skin depigmentation | 69 | 0% |
| Skin discharge | 22 | 0% |
| Skin discolouration | 3,900 | 0.24% |
| Skin discomfort | 201 | 0.01% |
| Skin disorder | 1,896 | 0.12% |
| Skin dystrophy | 2 | 0% |
| Skin erosion | 152 | 0.01% |
| Skin exfoliation | 1,805 | 0.11% |
| Skin fibrosis | 4 | 0% |
| Skin fissures | 178 | 0.01% |
| Skin flap necrosis | 1 | 0% |
| Skin fragility | 8 | 0% |
| Skin graft | 18 | 0% |
| Skin graft infection | 1 | 0% |
| Skin haemorrhage | 305 | 0.02% |
| Skin hyperpigmentation | 107 | 0.01% |
| Skin hyperplasia | 2 | 0% |
| Skin hypertrophy | 94 | 0.01% |
| Skin hypopigmentation | 28 | 0% |
| Skin hypoplasia | 1 | 0% |
| Skin implant | 1 | 0% |
| Skin indentation | 64 | 0% |
| Skin induration | 243 | 0.01% |
| Skin infection | 228 | 0.01% |
| Skin injury | 86 | 0.01% |
| Skin irritation | 1,021 | 0.06% |
| Skin laceration | 619 | 0.04% |
| Skin laxity | 20 | 0% |
| Skin lesion | 1,458 | 0.09% |
| Skin lesion inflammation | 12 | 0% |
| Skin lesion removal | 5 | 0% |
| Skin maceration | 5 | 0% |
| Skin malformation | 1 | 0% |
| Skin mass | 589 | 0.04% |
| Skin necrosis | 68 | 0% |
| Skin neoplasm excision | 14 | 0% |
| Skin odour abnormal | 193 | 0.01% |
| Skin oedema | 44 | 0% |
| Skin operation | 8 | 0% |
| Skin papilloma | 117 | 0.01% |
| Skin perfusion pressure test | 3 | 0% |
| Skin plaque | 163 | 0.01% |
| Skin pressure mark | 2 | 0% |
| Skin procedural complication | 1 | 0% |
| Skin reaction | 1,323 | 0.08% |
| Skin sensitisation | 245 | 0.01% |
| Skin squamous cell carcinoma metastatic | 1 | 0% |
| Skin striae | 31 | 0% |
| Skin swelling | 975 | 0.06% |
| Skin temperature | 54 | 0% |
| Skin test | 551 | 0.03% |
| Skin test negative | 50 | 0% |
| Skin test positive | 75 | 0% |
| Skin texture abnormal | 95 | 0.01% |
| Skin tightness | 696 | 0.04% |
| Skin turgor decreased | 6 | 0% |
| Skin ulcer | 420 | 0.03% |
| Skin ulcer excision | 1 | 0% |
| Skin ulcer haemorrhage | 9 | 0% |
| Skin warm | 10,010 | 0.61% |
| Skin weeping | 229 | 0.01% |
| Skin wound | 73 | 0% |
| Skin wrinkling | 89 | 0.01% |
| Skull base tumour | 1 | 0% |
| Skull fracture | 57 | 0% |
| Skull fractured base | 18 | 0% |
| Skull malformation | 1 | 0% |
| Skull X-ray | 68 | 0% |
| Skull X-ray abnormal | 8 | 0% |
| Skull X-ray normal | 8 | 0% |
| SLE arthritis | 5 | 0% |
| Sleep-related eating disorder | 1 | 0% |
| Sleep apnoea syndrome | 495 | 0.03% |
| Sleep attacks | 20 | 0% |
| Sleep deficit | 241 | 0.01% |
| Sleep disorder | 13,482 | 0.82% |
| Sleep disorder due to a general medical condition | 150 | 0.01% |
| Sleep disorder due to general medical condition, hypersomnia type | 1 | 0% |
| Sleep disorder due to general medical condition, insomnia type | 103 | 0.01% |
| Sleep disorder therapy | 1 | 0% |
| Sleep inertia | 6 | 0% |
| Sleep paralysis | 86 | 0.01% |
| Sleep study | 206 | 0.01% |
| Sleep study abnormal | 35 | 0% |
| Sleep study normal | 21 | 0% |
| Sleep talking | 39 | 0% |
| Sleep terror | 115 | 0.01% |
| Slipping rib syndrome | 9 | 0% |
| Slit-lamp examination | 174 | 0.01% |
| Slit-lamp tests abnormal | 5 | 0% |
| Slit-lamp tests normal | 3 | 0% |
| Slow response to stimuli | 207 | 0.01% |
| Slow speech | 301 | 0.02% |
| Sluggishness | 1,069 | 0.07% |
| Small airways disease | 13 | 0% |
| Small cell carcinoma | 6 | 0% |
| Small cell lung cancer | 21 | 0% |
| Small cell lung cancer extensive stage | 3 | 0% |
| Small cell lung cancer metastatic | 5 | 0% |
| Small fibre neuropathy | 475 | 0.03% |
| Small fontanelle | 1 | 0% |
| Small for dates baby | 13 | 0% |
| Small intestinal anastomosis | 7 | 0% |
| Small intestinal haemorrhage | 27 | 0% |
| Small intestinal intussusception reduction | 1 | 0% |
| Small intestinal obstruction | 224 | 0.01% |
| Small intestinal obstruction reduction | 1 | 0% |
| Small intestinal perforation | 7 | 0% |
| Small intestinal resection | 37 | 0% |
| Small intestinal stenosis | 1 | 0% |
| Small intestinal ulcer haemorrhage | 1 | 0% |
| Small intestine adenocarcinoma | 4 | 0% |
| Small intestine carcinoma | 12 | 0% |
| Small intestine carcinoma metastatic | 1 | 0% |
| Small intestine gangrene | 1 | 0% |
| Small intestine neuroendocrine tumour | 1 | 0% |
| Small intestine operation | 1 | 0% |
| Small intestine ulcer | 2 | 0% |
| Smallpox | 10 | 0% |
| Small size placenta | 5 | 0% |
| Smear buccal | 4 | 0% |
| Smear buccal abnormal | 1 | 0% |
| Smear cervix | 379 | 0.02% |
| Smear cervix abnormal | 41 | 0% |
| Smear cervix normal | 71 | 0% |
| Smear site unspecified abnormal | 1 | 0% |
| Smear site unspecified normal | 13 | 0% |
| Smear test | 472 | 0.03% |
| Smear vagina | 46 | 0% |
| Smear vaginal abnormal | 3 | 0% |
| Smear vaginal normal | 9 | 0% |
| Smegma accumulation | 1 | 0% |
| Smoke sensitivity | 7 | 0% |
| Smoking cessation therapy | 1 | 0% |
| Smooth muscle antibody | 154 | 0.01% |
| Smooth muscle antibody negative | 9 | 0% |
| Smooth muscle antibody positive | 18 | 0% |
| Snake bite | 3 | 0% |
| Snapping hip syndrome | 3 | 0% |
| Sneddon's syndrome | 1 | 0% |
| Sneezing | 3,854 | 0.23% |
| Snoring | 172 | 0.01% |
| Social (pragmatic) communication disorder | 1 | 0% |
| Social alcohol drinker | 3 | 0% |
| Social anxiety disorder | 25 | 0% |
| Social avoidant behaviour | 57 | 0% |
| Social fear | 3 | 0% |
| Social problem | 56 | 0% |
| Sodium retention | 1 | 0% |
| Soft tissue atrophy | 3 | 0% |
| Soft tissue disorder | 37 | 0% |
| Soft tissue haemorrhage | 6 | 0% |
| Soft tissue infection | 28 | 0% |
| Soft tissue inflammation | 20 | 0% |
| Soft tissue injury | 18 | 0% |
| Soft tissue mass | 28 | 0% |
| Soft tissue necrosis | 12 | 0% |
| Soft tissue neoplasm | 3 | 0% |
| Soft tissue sarcoma | 9 | 0% |
| Soft tissue swelling | 108 | 0.01% |
| Solar dermatitis | 14 | 0% |
| Solar lentigo | 17 | 0% |
| Solar urticaria | 11 | 0% |
| Solid organ transplant | 1 | 0% |
| Solid pseudopapillary tumour of the pancreas | 1 | 0% |
| Soliloquy | 32 | 0% |
| Solitary fibrous tumour | 2 | 0% |
| Soluble fibrin monomer complex | 8 | 0% |
| Soluble fibrin monomer complex increased | 1 | 0% |
| Somatic delusion | 2 | 0% |
| Somatic dysfunction | 14 | 0% |
| Somatic hallucination | 3 | 0% |
| Somatic symptom disorder | 176 | 0.01% |
| Somatic symptom disorder of pregnancy | 6 | 0% |
| Somatosensory evoked potentials | 143 | 0.01% |
| Somatosensory evoked potentials abnormal | 1 | 0% |
| Somatostatin receptor scan | 1 | 0% |
| Somatotropin stimulation test | 4 | 0% |
| Somnambulism | 75 | 0% |
| Somniphobia | 2 | 0% |
| Somnolence | 13,807 | 0.84% |
| Sopor | 61 | 0% |
| Spasmodic dysphonia | 10 | 0% |
| Specialist consultation | 4,995 | 0.3% |
| Specific gravity body fluid | 7 | 0% |
| Specific gravity body fluid normal | 1 | 0% |
| Specific gravity urine | 129 | 0.01% |
| Specific gravity urine abnormal | 4 | 0% |
| Specific gravity urine decreased | 12 | 0% |
| Specific gravity urine increased | 30 | 0% |
| Specific gravity urine normal | 227 | 0.01% |
| Speech disorder | 4,215 | 0.26% |
| Speech disorder developmental | 45 | 0% |
| Speech rehabilitation | 8 | 0% |
| Speech sound disorder | 27 | 0% |
| Sperm analysis | 11 | 0% |
| Sperm analysis abnormal | 1 | 0% |
| Spermatic cord cyst | 1 | 0% |
| Spermatic cord funiculitis | 1 | 0% |
| Spermatic cord haemorrhage | 1 | 0% |
| Spermatic cord inflammation | 2 | 0% |
| Spermatocele | 3 | 0% |
| Spermatogenesis abnormal | 2 | 0% |
| Spermatozoa abnormal | 4 | 0% |
| Spermatozoa morphology abnormal | 3 | 0% |
| Spermatozoa progressive motility decreased | 3 | 0% |
| Sperm concentration | 13 | 0% |
| Sperm concentration abnormal | 2 | 0% |
| Sperm concentration decreased | 12 | 0% |
| Sperm concentration increased | 1 | 0% |
| Sphenoid sinus operation | 1 | 0% |
| Sphenopalatine neuralgia | 1 | 0% |
| Spherocytic anaemia | 2 | 0% |
| Sphincter of Oddi dysfunction | 6 | 0% |
| Spider naevus | 3 | 0% |
| Spider vein | 79 | 0% |
| Spina bifida | 10 | 0% |
| Spinal anaesthesia | 2 | 0% |
| Spinal artery embolism | 1 | 0% |
| Spinal artery thrombosis | 1 | 0% |
| Spinal claudication | 12 | 0% |
| Spinal column injury | 36 | 0% |
| Spinal compression fracture | 130 | 0.01% |
| Spinal cord abscess | 10 | 0% |
| Spinal cord compression | 53 | 0% |
| Spinal cord disorder | 115 | 0.01% |
| Spinal cord drainage | 4 | 0% |
| Spinal cord haematoma | 5 | 0% |
| Spinal cord haemorrhage | 15 | 0% |
| Spinal cord herniation | 2 | 0% |
| Spinal cord infarction | 43 | 0% |
| Spinal cord infection | 19 | 0% |
| Spinal cord injury | 60 | 0% |
| Spinal cord injury cauda equina | 2 | 0% |
| Spinal cord injury cervical | 18 | 0% |
| Spinal cord injury lumbar | 4 | 0% |
| Spinal cord injury thoracic | 14 | 0% |
| Spinal cord ischaemia | 28 | 0% |
| Spinal cord lipoma | 1 | 0% |
| Spinal cord neoplasm | 11 | 0% |
| Spinal cord oedema | 15 | 0% |
| Spinal cord operation | 5 | 0% |
| Spinal cord paralysis | 2 | 0% |
| Spinal corpectomy | 1 | 0% |
| Spinal decompression | 15 | 0% |
| Spinal deformity | 39 | 0% |
| Spinal disorder | 188 | 0.01% |
| Spinal epidural haematoma | 10 | 0% |
| Spinal epidural haemorrhage | 1 | 0% |
| Spinal flattening | 5 | 0% |
| Spinal fracture | 107 | 0.01% |
| Spinal fusion acquired | 3 | 0% |
| Spinal fusion surgery | 53 | 0% |
| Spinal instability | 13 | 0% |
| Spinal laminectomy | 38 | 0% |
| Spinal ligament ossification | 1 | 0% |
| Spinal manipulation | 1 | 0% |
| Spinal meningeal cyst | 11 | 0% |
| Spinal meningioma benign | 2 | 0% |
| Spinal muscular atrophy | 5 | 0% |
| Spinal myelogram | 205 | 0.01% |
| Spinal myelogram abnormal | 5 | 0% |
| Spinal myelogram normal | 6 | 0% |
| Spinal nerve stimulator implantation | 8 | 0% |
| Spinal operation | 68 | 0% |
| Spinal osteoarthritis | 408 | 0.02% |
| Spinal pain | 1,738 | 0.11% |
| Spinal retrolisthesis | 15 | 0% |
| Spinal rod insertion | 1 | 0% |
| Spinal segmental dysfunction | 1 | 0% |
| Spinal shock | 2 | 0% |
| Spinal stabilisation | 2 | 0% |
| Spinal stenosis | 185 | 0.01% |
| Spinal stroke | 10 | 0% |
| Spinal subarachnoid haemorrhage | 1 | 0% |
| Spinal subdural haematoma | 1 | 0% |
| Spinal subdural haemorrhage | 1 | 0% |
| Spinal support | 5 | 0% |
| Spinal synovial cyst | 4 | 0% |
| Spinal vascular disorder | 5 | 0% |
| Spinal vessel congenital anomaly | 1 | 0% |
| Spinal X-ray | 508 | 0.03% |
| Spinal X-ray abnormal | 121 | 0.01% |
| Spinal X-ray normal | 90 | 0.01% |
| Spindle cell sarcoma | 5 | 0% |
| Spine malformation | 4 | 0% |
| Spinocerebellar disorder | 1 | 0% |
| Spirochaetal infection | 1 | 0% |
| Spirometry | 307 | 0.02% |
| Spirometry abnormal | 12 | 0% |
| Spirometry normal | 14 | 0% |
| Spleen atrophy | 1 | 0% |
| Spleen congestion | 1 | 0% |
| Spleen contusion | 2 | 0% |
| Spleen disorder | 56 | 0% |
| Spleen follicular hyperplasia | 1 | 0% |
| Spleen ischaemia | 6 | 0% |
| Spleen palpable | 1 | 0% |
| Spleen scan abnormal | 1 | 0% |
| Spleen scan normal | 3 | 0% |
| Splenectomy | 23 | 0% |
| Splenic abscess | 1 | 0% |
| Splenic artery aneurysm | 14 | 0% |
| Splenic artery embolisation | 4 | 0% |
| Splenic artery thrombosis | 16 | 0% |
| Splenic calcification | 12 | 0% |
| Splenic cyst | 10 | 0% |
| Splenic embolism | 3 | 0% |
| Splenic flexure mobilisation | 1 | 0% |
| Splenic granuloma | 14 | 0% |
| Splenic haematoma | 6 | 0% |
| Splenic haemorrhage | 14 | 0% |
| Splenic infarction | 169 | 0.01% |
| Splenic infection | 2 | 0% |
| Splenic injury | 8 | 0% |
| Splenic lesion | 15 | 0% |
| Splenic marginal zone lymphoma | 4 | 0% |
| Splenic necrosis | 3 | 0% |
| Splenic neoplasm malignancy unspecified | 2 | 0% |
| Splenic rupture | 36 | 0% |
| Splenic thrombosis | 30 | 0% |
| Splenic varices | 3 | 0% |
| Splenic vein occlusion | 3 | 0% |
| Splenic vein thrombosis | 53 | 0% |
| Splenitis | 5 | 0% |
| Splenomegaly | 443 | 0.03% |
| Splenorenal shunt | 1 | 0% |
| Splint application | 26 | 0% |
| Splinter | 4 | 0% |
| Splinter haemorrhages | 16 | 0% |
| Spondylitis | 195 | 0.01% |
| Spondyloarthropathy | 17 | 0% |
| Spondylolisthesis | 40 | 0% |
| Spondylolysis | 4 | 0% |
| Spontaneous bacterial peritonitis | 15 | 0% |
| Spontaneous cerebrospinal fluid leak syndrome | 2 | 0% |
| Spontaneous ejaculation | 1 | 0% |
| Spontaneous haematoma | 106 | 0.01% |
| Spontaneous haemorrhage | 33 | 0% |
| Spontaneous heparin-induced thrombocytopenia syndrome | 1 | 0% |
| Spontaneous hyphaema | 3 | 0% |
| Spontaneous intrahepatic portosystemic venous shunt | 1 | 0% |
| Spontaneous penile erection | 13 | 0% |
| Spontaneous rupture of membranes | 12 | 0% |
| Spontaneous splenic rupture | 1 | 0% |
| Sporotrichosis | 1 | 0% |
| Sports injury | 4 | 0% |
| Spotted fever rickettsia test positive | 2 | 0% |
| Spousal abuse | 1 | 0% |
| Sputum abnormal | 45 | 0% |
| Sputum culture | 250 | 0.02% |
| Sputum culture positive | 144 | 0.01% |
| Sputum decreased | 4 | 0% |
| Sputum discoloured | 630 | 0.04% |
| Sputum increased | 98 | 0.01% |
| Sputum normal | 4 | 0% |
| Sputum purulent | 42 | 0% |
| Sputum retention | 38 | 0% |
| Sputum test | 70 | 0% |
| Squamous cell carcinoma | 79 | 0% |
| Squamous cell carcinoma antigen | 8 | 0% |
| Squamous cell carcinoma of head and neck | 1 | 0% |
| Squamous cell carcinoma of lung | 17 | 0% |
| Squamous cell carcinoma of pharynx | 1 | 0% |
| Squamous cell carcinoma of skin | 37 | 0% |
| Squamous cell carcinoma of the cervix | 1 | 0% |
| Squamous cell carcinoma of the oral cavity | 9 | 0% |
| Squamous cell carcinoma of the tongue | 9 | 0% |
| SRSF2 gene mutation | 1 | 0% |
| Stab wound | 10 | 0% |
| Stag horn calculus | 1 | 0% |
| Staphylococcal abscess | 4 | 0% |
| Staphylococcal bacteraemia | 121 | 0.01% |
| Staphylococcal impetigo | 1 | 0% |
| Staphylococcal infection | 351 | 0.02% |
| Staphylococcal scalded skin syndrome | 4 | 0% |
| Staphylococcal sepsis | 53 | 0% |
| Staphylococcal skin infection | 14 | 0% |
| Staphylococcus test | 99 | 0.01% |
| Staphylococcus test negative | 190 | 0.01% |
| Staphylococcus test positive | 258 | 0.02% |
| Staphyloma | 1 | 0% |
| Stargardt's disease | 1 | 0% |
| Staring | 272 | 0.02% |
| Starvation | 13 | 0% |
| Starvation ketoacidosis | 7 | 0% |
| Stasis dermatitis | 27 | 0% |
| Stasis syndrome | 2 | 0% |
| Status asthmaticus | 17 | 0% |
| Status epilepticus | 401 | 0.02% |
| Status migrainosus | 55 | 0% |
| Steal syndrome | 1 | 0% |
| Steatohepatitis | 5 | 0% |
| Steatorrhoea | 19 | 0% |
| Stem cell therapy | 3 | 0% |
| Stem cell transplant | 14 | 0% |
| Stenocephaly | 1 | 0% |
| Stenosis | 102 | 0.01% |
| Stenotrophomonas infection | 4 | 0% |
| Stenotrophomonas test | 1 | 0% |
| Stenotrophomonas test positive | 8 | 0% |
| Stent-graft endoleak | 8 | 0% |
| Stent malfunction | 1 | 0% |
| Stent placement | 349 | 0.02% |
| Stent removal | 9 | 0% |
| Stereotactic electroencephalography | 6 | 0% |
| Stereotypy | 9 | 0% |
| Sterile pyuria | 5 | 0% |
| Sterilisation | 2 | 0% |
| Sternal fracture | 10 | 0% |
| Sternal injury | 3 | 0% |
| Sternitis | 5 | 0% |
| Sternotomy | 22 | 0% |
| Steroid activity | 1 | 0% |
| Steroid dependence | 4 | 0% |
| Steroid diabetes | 7 | 0% |
| Steroid therapy | 50 | 0% |
| Steroid withdrawal syndrome | 1 | 0% |
| Stertor | 16 | 0% |
| Stevens-Johnson syndrome | 169 | 0.01% |
| Sticky skin | 28 | 0% |
| Stiff leg syndrome | 12 | 0% |
| Stiff person syndrome | 25 | 0% |
| Stiff skin syndrome | 1 | 0% |
| Stiff tongue | 36 | 0% |
| Still's disease | 160 | 0.01% |
| Stillbirth | 171 | 0.01% |
| Stomach mass | 14 | 0% |
| Stomach scan | 24 | 0% |
| Stomach scan normal | 1 | 0% |
| Stoma closure | 2 | 0% |
| Stoma complication | 1 | 0% |
| Stoma creation | 3 | 0% |
| Stomal hernia | 1 | 0% |
| Stoma obstruction | 1 | 0% |
| Stoma prolapse | 1 | 0% |
| Stoma site discharge | 7 | 0% |
| Stoma site erythema | 2 | 0% |
| Stoma site extravasation | 2 | 0% |
| Stoma site haemorrhage | 12 | 0% |
| Stoma site hypergranulation | 3 | 0% |
| Stoma site infection | 1 | 0% |
| Stoma site inflammation | 1 | 0% |
| Stoma site irritation | 3 | 0% |
| Stoma site mucocutaneous separation | 1 | 0% |
| Stoma site pain | 7 | 0% |
| Stoma site rash | 3 | 0% |
| Stomatitis | 1,253 | 0.08% |
| Stomatitis haemorrhagic | 1 | 0% |
| Stomatitis necrotising | 1 | 0% |
| Stomatocytes present | 5 | 0% |
| Stool analysis | 732 | 0.04% |
| Stool analysis abnormal | 55 | 0% |
| Stool analysis normal | 168 | 0.01% |
| Stool DNA test | 3 | 0% |
| Stool DNA test negative | 1 | 0% |
| Stool DNA test positive | 1 | 0% |
| Stool pH increased | 2 | 0% |
| Stool reducing substances test | 1 | 0% |
| Strabismus | 166 | 0.01% |
| Strangulated hernia | 4 | 0% |
| Strangury | 8 | 0% |
| Strawberry tongue | 12 | 0% |
| Streptobacillary fever | 1 | 0% |
| Streptobacillus infection | 7 | 0% |
| Streptobacillus test positive | 4 | 0% |
| Streptococcal abscess | 3 | 0% |
| Streptococcal bacteraemia | 26 | 0% |
| Streptococcal endocarditis | 3 | 0% |
| Streptococcal infection | 154 | 0.01% |
| Streptococcal sepsis | 25 | 0% |
| Streptococcal urinary tract infection | 11 | 0% |
| Streptococcus test | 757 | 0.05% |
| Streptococcus test negative | 1,307 | 0.08% |
| Streptococcus test positive | 232 | 0.01% |
| Stress | 1,650 | 0.1% |
| Stress at work | 26 | 0% |
| Stress cardiomyopathy | 271 | 0.02% |
| Stress echocardiogram | 232 | 0.01% |
| Stress echocardiogram abnormal | 29 | 0% |
| Stress echocardiogram normal | 42 | 0% |
| Stress fracture | 24 | 0% |
| Stress management | 1 | 0% |
| Stress polycythaemia | 1 | 0% |
| Stress ulcer | 2 | 0% |
| Stress urinary incontinence | 22 | 0% |
| Stricturoplasty | 1 | 0% |
| Stridor | 336 | 0.02% |
| Stroke-like migraine attacks after radiation therapy | 1 | 0% |
| Stroke in evolution | 9 | 0% |
| Stroke volume | 20 | 0% |
| Stroke volume decreased | 3 | 0% |
| Strongyloides test positive | 3 | 0% |
| Strongyloidiasis | 3 | 0% |
| Struck by lightning | 2 | 0% |
| Stubbornness | 1 | 0% |
| Stump appendicitis | 1 | 0% |
| Stupor | 89 | 0.01% |
| Subacute combined cord degeneration | 3 | 0% |
| Subacute cutaneous lupus erythematosus | 31 | 0% |
| Subacute endocarditis | 3 | 0% |
| Subacute hepatic failure | 5 | 0% |
| Subacute inflammatory demyelinating polyneuropathy | 22 | 0% |
| Subacute kidney injury | 2 | 0% |
| Subacute pancreatitis | 1 | 0% |
| Subacute sclerosing panencephalitis | 3 | 0% |
| Subarachnoid haematoma | 5 | 0% |
| Subarachnoid haemorrhage | 724 | 0.04% |
| Subcapsular hepatic haematoma | 2 | 0% |
| Subcapsular renal haematoma | 4 | 0% |
| Subcapsular splenic haematoma | 3 | 0% |
| Subchondral insufficiency fracture | 1 | 0% |
| Subchorionic haematoma | 20 | 0% |
| Subchorionic haemorrhage | 22 | 0% |
| Subclavian artery aneurysm | 1 | 0% |
| Subclavian artery dissection | 3 | 0% |
| Subclavian artery embolism | 5 | 0% |
| Subclavian artery occlusion | 12 | 0% |
| Subclavian artery stenosis | 6 | 0% |
| Subclavian artery thrombosis | 18 | 0% |
| Subclavian steal syndrome | 8 | 0% |
| Subclavian vein occlusion | 8 | 0% |
| Subclavian vein stenosis | 2 | 0% |
| Subclavian vein thrombosis | 182 | 0.01% |
| Subcorneal pustular dermatosis | 3 | 0% |
| Subcutaneous abscess | 129 | 0.01% |
| Subcutaneous biopsy | 6 | 0% |
| Subcutaneous biopsy abnormal | 1 | 0% |
| Subcutaneous drug absorption impaired | 1 | 0% |
| Subcutaneous emphysema | 33 | 0% |
| Subcutaneous haematoma | 68 | 0% |
| Subdiaphragmatic abscess | 1 | 0% |
| Subdural abscess | 4 | 0% |
| Subdural effusion | 1 | 0% |
| Subdural haematoma | 371 | 0.02% |
| Subdural haematoma evacuation | 12 | 0% |
| Subdural haemorrhage | 87 | 0.01% |
| Subdural hygroma | 15 | 0% |
| Subendocardial ischaemia | 5 | 0% |
| Subgaleal haematoma | 2 | 0% |
| Subgaleal haemorrhage | 1 | 0% |
| Subglottic laryngitis | 1 | 0% |
| Subileus | 22 | 0% |
| Submaxillary gland enlargement | 43 | 0% |
| Subperiosteal abscess | 3 | 0% |
| Subretinal fibrosis | 1 | 0% |
| Subretinal fluid | 8 | 0% |
| Subretinal haematoma | 3 | 0% |
| Substance-induced psychotic disorder | 11 | 0% |
| Substance abuse | 10 | 0% |
| Substance abuser | 1 | 0% |
| Substance dependence | 2 | 0% |
| Substance use | 58 | 0% |
| Substance use disorder | 3 | 0% |
| Suck-swallow breathing coordination disturbance | 2 | 0% |
| Sucrase-isomaltase deficiency | 1 | 0% |
| Sucrose intolerance | 1 | 0% |
| Sudden cardiac death | 171 | 0.01% |
| Sudden death | 1,203 | 0.07% |
| Sudden hearing loss | 1,804 | 0.11% |
| Sudden infant death syndrome | 3 | 0% |
| Sudden onset of sleep | 108 | 0.01% |
| Sudden visual loss | 60 | 0% |
| Suffocation feeling | 312 | 0.02% |
| Suggestibility | 1 | 0% |
| Suicidal behaviour | 22 | 0% |
| Suicidal ideation | 982 | 0.06% |
| Suicide attempt | 119 | 0.01% |
| Suicide threat | 10 | 0% |
| Sulphur dioxide test | 17 | 0% |
| Sunburn | 214 | 0.01% |
| SUNCT syndrome | 1 | 0% |
| Sunscreen sensitivity | 3 | 0% |
| Superficial inflammatory dermatosis | 9 | 0% |
| Superficial injury of eye | 3 | 0% |
| Superficial spreading melanoma stage unspecified | 1 | 0% |
| Superficial vein prominence | 45 | 0% |
| Superficial vein thrombosis | 618 | 0.04% |
| Superimposed pre-eclampsia | 2 | 0% |
| Superinfection | 288 | 0.02% |
| Superinfection bacterial | 54 | 0% |
| Superinfection viral | 1 | 0% |
| Superior mesenteric artery dissection | 5 | 0% |
| Superior mesenteric artery syndrome | 3 | 0% |
| Superior sagittal sinus thrombosis | 98 | 0.01% |
| Superior semicircular canal dehiscence | 4 | 0% |
| Superior vena cava occlusion | 3 | 0% |
| Superior vena cava syndrome | 18 | 0% |
| Supernumerary nipple | 1 | 0% |
| Supernumerary rib | 1 | 0% |
| Superovulation | 3 | 0% |
| Supine hypertension | 2 | 0% |
| Supine position | 23 | 0% |
| Supplementation therapy | 1 | 0% |
| Supportive care | 6 | 0% |
| Suppressed lactation | 239 | 0.01% |
| Supra-aortic trunk stenosis | 1 | 0% |
| Supraclavicular fossa pain | 6 | 0% |
| Supranuclear palsy | 3 | 0% |
| Suprapubic pain | 36 | 0% |
| Supraventricular extrasystoles | 658 | 0.04% |
| Supraventricular tachyarrhythmia | 11 | 0% |
| Supraventricular tachycardia | 1,152 | 0.07% |
| Surfactant protein | 34 | 0% |
| Surfactant protein increased | 1 | 0% |
| Surgery | 816 | 0.05% |
| Surgical failure | 8 | 0% |
| Surgical fixation of rib fracture | 2 | 0% |
| Surgical procedure repeated | 7 | 0% |
| Surgical stapling | 3 | 0% |
| Susac's syndrome | 16 | 0% |
| Suspected counterfeit product | 12 | 0% |
| Suspected COVID-19 | 9,583 | 0.58% |
| Suspected product contamination | 5 | 0% |
| Suspected product quality issue | 7 | 0% |
| Suspected product tampering | 1 | 0% |
| Suspected suicide | 1 | 0% |
| Suspected suicide attempt | 1 | 0% |
| Suspiciousness | 7 | 0% |
| Sustained viral response | 1 | 0% |
| Suture insertion | 114 | 0.01% |
| Suture related complication | 3 | 0% |
| Suture removal | 14 | 0% |
| Suture rupture | 3 | 0% |
| Swallow study | 75 | 0% |
| Swallow study abnormal | 37 | 0% |
| Swan ganz catheter placement | 2 | 0% |
| Sweat discolouration | 5 | 0% |
| Sweat gland disorder | 10 | 0% |
| Sweat gland infection | 4 | 0% |
| Sweat gland tumour | 1 | 0% |
| Sweating fever | 226 | 0.01% |
| Sweat test | 12 | 0% |
| Sweat test abnormal | 2 | 0% |
| Swelling | 19,703 | 1.2% |
| Swelling face | 11,040 | 0.67% |
| Swelling of eyelid | 1,772 | 0.11% |
| Swollen joint count | 9 | 0% |
| Swollen joint count increased | 1 | 0% |
| Swollen tear duct | 5 | 0% |
| Swollen tongue | 6,330 | 0.38% |
| Sydenham's chorea | 1 | 0% |
| Symblepharon | 1 | 0% |
| Symmetrical drug-related intertriginous and flexural exanthema | 15 | 0% |
| Sympathetic nerve injury | 2 | 0% |
| Sympathetic ophthalmia | 2 | 0% |
| Sympathetic posterior cervical syndrome | 4 | 0% |
| Sympathicotonia | 4 | 0% |
| Symphysiolysis | 8 | 0% |
| Symptom masked | 2 | 0% |
| Symptom recurrence | 1,140 | 0.07% |
| Synaesthesia | 3 | 0% |
| Syncope | 38,208 | 2.32% |
| Syndactyly | 8 | 0% |
| Synkinesis | 9 | 0% |
| Synovial biopsy | 2 | 0% |
| Synovial biopsy abnormal | 1 | 0% |
| Synovial cyst | 275 | 0.02% |
| Synovial disorder | 6 | 0% |
| Synovial fluid analysis | 25 | 0% |
| Synovial fluid analysis abnormal | 9 | 0% |
| Synovial fluid analysis normal | 1 | 0% |
| Synovial fluid cell count | 5 | 0% |
| Synovial fluid crystal | 4 | 0% |
| Synovial fluid crystal present | 8 | 0% |
| Synovial fluid glucose | 1 | 0% |
| Synovial fluid protein | 2 | 0% |
| Synovial fluid red blood cells positive | 3 | 0% |
| Synovial fluid white blood cells | 5 | 0% |
| Synovial fluid white blood cells positive | 9 | 0% |
| Synovial rupture | 14 | 0% |
| Synovitis | 170 | 0.01% |
| Syphilis | 146 | 0.01% |
| Syphilis genital | 1 | 0% |
| Syringe issue | 1,340 | 0.08% |
| Syringomyelia | 14 | 0% |
| Systemic bacterial infection | 1 | 0% |
| Systemic candida | 9 | 0% |
| Systemic immune activation | 13 | 0% |
| Systemic infection | 12 | 0% |
| Systemic inflammatory response syndrome | 449 | 0.03% |
| Systemic leakage | 1 | 0% |
| Systemic lupus erythematosus | 835 | 0.05% |
| Systemic lupus erythematosus disease activity index abnormal | 4 | 0% |
| Systemic lupus erythematosus disease activity index decreased | 1 | 0% |
| Systemic lupus erythematosus disease activity index increased | 1 | 0% |
| Systemic lupus erythematosus rash | 28 | 0% |
| Systemic mastocytosis | 8 | 0% |
| Systemic mycosis | 1 | 0% |
| Systemic scleroderma | 61 | 0% |
| Systemic sclerosis pulmonary | 2 | 0% |
| Systemic toxicity | 1 | 0% |
| Systemic viral infection | 6 | 0% |
| Systolic anterior motion of mitral valve | 1 | 0% |
| Systolic dysfunction | 95 | 0.01% |
| Systolic hypertension | 31 | 0% |
| T-cell lymphoma | 23 | 0% |
| T-cell lymphoma recurrent | 3 | 0% |
| T-cell lymphoma stage III | 1 | 0% |
| T-cell lymphoma stage IV | 1 | 0% |
| T-cell prolymphocytic leukaemia | 3 | 0% |
| T-cell receptor gene rearrangement test | 16 | 0% |
| T-cell type acute leukaemia | 8 | 0% |
| T-lymphocyte count | 137 | 0.01% |
| T-lymphocyte count abnormal | 4 | 0% |
| T-lymphocyte count decreased | 32 | 0% |
| T-lymphocyte count increased | 23 | 0% |
| T-lymphocyte count normal | 1 | 0% |
| Tachyarrhythmia | 228 | 0.01% |
| Tachycardia | 23,876 | 1.45% |
| Tachycardia foetal | 30 | 0% |
| Tachycardia induced cardiomyopathy | 15 | 0% |
| Tachycardia paroxysmal | 94 | 0.01% |
| Tachyphrenia | 118 | 0.01% |
| Tachypnoea | 1,693 | 0.1% |
| Taciturnity | 1 | 0% |
| Taeniasis | 1 | 0% |
| Takayasu's arteritis | 12 | 0% |
| Talipes | 6 | 0% |
| Tandem gait test | 9 | 0% |
| Tandem gait test abnormal | 2 | 0% |
| Tangentiality | 7 | 0% |
| Tanning | 2 | 0% |
| Tardive dyskinesia | 43 | 0% |
| Targeted cancer therapy | 2 | 0% |
| Target skin lesion | 20 | 0% |
| Tarsal tunnel decompression | 1 | 0% |
| Tarsal tunnel syndrome | 6 | 0% |
| Tartrate-resistant acid phosphatase increased | 1 | 0% |
| Taste disorder | 3,525 | 0.21% |
| Tattoo | 5 | 0% |
| Tattoo excision | 1 | 0% |
| Tear discolouration | 1 | 0% |
| Tearfulness | 257 | 0.02% |
| Teeth brittle | 8 | 0% |
| Teething | 37 | 0% |
| Telangiectasia | 53 | 0% |
| Telemedicine | 8 | 0% |
| Temperature difference of extremities | 40 | 0% |
| Temperature intolerance | 577 | 0.04% |
| Temperature perception test abnormal | 12 | 0% |
| Temperature perception test decreased | 3 | 0% |
| Temperature perception test increased | 9 | 0% |
| Temperature perception test normal | 9 | 0% |
| Temperature regulation disorder | 272 | 0.02% |
| TEMPI syndrome | 1 | 0% |
| Temporal lobe epilepsy | 28 | 0% |
| Temporary mechanical circulatory support | 3 | 0% |
| Temporary transvenous pacing | 4 | 0% |
| Temporomandibular joint surgery | 1 | 0% |
| Temporomandibular joint syndrome | 238 | 0.01% |
| Temporomandibular pain and dysfunction syndrome | 3 | 0% |
| Tender joint count | 7 | 0% |
| Tenderness | 6,547 | 0.4% |
| Tendinous contracture | 2 | 0% |
| Tendon calcification | 16 | 0% |
| Tendon discomfort | 43 | 0% |
| Tendon dislocation | 2 | 0% |
| Tendon disorder | 315 | 0.02% |
| Tendon injury | 73 | 0% |
| Tendonitis | 854 | 0.05% |
| Tendon laxity | 2 | 0% |
| Tendon operation | 5 | 0% |
| Tendon pain | 484 | 0.03% |
| Tendon rupture | 176 | 0.01% |
| Tendon sheath disorder | 6 | 0% |
| Tendon sheath effusion | 3 | 0% |
| Tendon sheath incision | 4 | 0% |
| Tenodesis | 2 | 0% |
| Tenoplasty | 9 | 0% |
| Tenosynovitis | 145 | 0.01% |
| Tenosynovitis stenosans | 26 | 0% |
| Tenotomy | 2 | 0% |
| Tensilon test | 11 | 0% |
| Tension | 586 | 0.04% |
| Tension headache | 1,386 | 0.08% |
| Tensor fasciae latae syndrome | 2 | 0% |
| Teratogenicity | 1 | 0% |
| Teratoma | 1 | 0% |
| Teratospermia | 1 | 0% |
| Term baby | 3 | 0% |
| Term birth | 8 | 0% |
| Terminal agitation | 1 | 0% |
| Terminal ileitis | 24 | 0% |
| Terminal insomnia | 60 | 0% |
| Terminal state | 50 | 0% |
| Tertiary syphilis | 1 | 0% |
| Tessellated fundus | 2 | 0% |
| Testes exploration | 1 | 0% |
| Testicular abscess | 3 | 0% |
| Testicular appendage torsion | 1 | 0% |
| Testicular atrophy | 5 | 0% |
| Testicular cancer metastatic | 1 | 0% |
| Testicular cyst | 8 | 0% |
| Testicular disorder | 42 | 0% |
| Testicular embryonal carcinoma | 1 | 0% |
| Testicular failure | 1 | 0% |
| Testicular germ cell cancer | 1 | 0% |
| Testicular haemorrhage | 4 | 0% |
| Testicular infarction | 4 | 0% |
| Testicular injury | 2 | 0% |
| Testicular mass | 9 | 0% |
| Testicular microlithiasis | 1 | 0% |
| Testicular necrosis | 4 | 0% |
| Testicular neoplasm | 2 | 0% |
| Testicular oedema | 6 | 0% |
| Testicular operation | 2 | 0% |
| Testicular pain | 490 | 0.03% |
| Testicular retraction | 2 | 0% |
| Testicular scan | 4 | 0% |
| Testicular scan abnormal | 1 | 0% |
| Testicular seminoma (pure) | 1 | 0% |
| Testicular swelling | 199 | 0.01% |
| Testicular torsion | 16 | 0% |
| Testis cancer | 40 | 0% |
| Testis discomfort | 19 | 0% |
| Tetanus | 24 | 0% |
| Tetanus immunisation | 5 | 0% |
| Tetany | 111 | 0.01% |
| Tethered oral tissue | 2 | 0% |
| Thalamic infarction | 191 | 0.01% |
| Thalamic stroke | 30 | 0% |
| Thalamus haemorrhage | 72 | 0% |
| Thalassaemia | 9 | 0% |
| Thalassaemia alpha | 2 | 0% |
| Thalassaemia minor | 9 | 0% |
| Thanatophobia | 3 | 0% |
| Thanatophoric dysplasia | 1 | 0% |
| Thecal sac compression | 4 | 0% |
| Therapeutic aspiration | 10 | 0% |
| Therapeutic embolisation | 17 | 0% |
| Therapeutic gargle | 1 | 0% |
| Therapeutic hypothermia | 14 | 0% |
| Therapeutic nerve ablation | 4 | 0% |
| Therapeutic procedure | 14 | 0% |
| Therapeutic product effect decreased | 122 | 0.01% |
| Therapeutic product effect delayed | 7 | 0% |
| Therapeutic product effect incomplete | 46 | 0% |
| Therapeutic product effect increased | 2 | 0% |
| Therapeutic product effect prolonged | 2 | 0% |
| Therapeutic product effect variable | 1 | 0% |
| Therapeutic product ineffective | 41 | 0% |
| Therapeutic reaction time decreased | 2 | 0% |
| Therapeutic response changed | 8 | 0% |
| Therapeutic response decreased | 29 | 0% |
| Therapeutic response delayed | 6 | 0% |
| Therapeutic response increased | 2 | 0% |
| Therapeutic response shortened | 70 | 0% |
| Therapeutic response unexpected | 1,345 | 0.08% |
| Therapeutic skin care topical | 1 | 0% |
| Therapy cessation | 29 | 0% |
| Therapy change | 102 | 0.01% |
| Therapy interrupted | 25 | 0% |
| Therapy non-responder | 522 | 0.03% |
| Therapy partial responder | 31 | 0% |
| Thermal burn | 206 | 0.01% |
| Thermal burns of eye | 79 | 0% |
| Thermoanaesthesia | 5 | 0% |
| Thermogram | 2 | 0% |
| Thermohyperaesthesia | 2 | 0% |
| Thermohypoaesthesia | 10 | 0% |
| Thermometry | 47 | 0% |
| Thermometry abnormal | 1 | 0% |
| Thermophobia | 3 | 0% |
| Thinking abnormal | 809 | 0.05% |
| Thiopurine methyltransferase | 5 | 0% |
| Thiopurine methyltransferase polymorphism | 2 | 0% |
| Third stage postpartum haemorrhage | 3 | 0% |
| Third trimester pregnancy | 19 | 0% |
| Thirst | 2,561 | 0.16% |
| Thirst decreased | 75 | 0% |
| Thoracic cavity drainage | 32 | 0% |
| Thoracic cavity drainage test | 2 | 0% |
| Thoracic haemorrhage | 2 | 0% |
| Thoracic operation | 21 | 0% |
| Thoracic outlet surgery | 2 | 0% |
| Thoracic outlet syndrome | 36 | 0% |
| Thoracic radiculopathy | 2 | 0% |
| Thoracic spinal cord paralysis | 1 | 0% |
| Thoracic spinal stenosis | 4 | 0% |
| Thoracic vertebral fracture | 51 | 0% |
| Thoracotomy | 14 | 0% |
| Thought blocking | 13 | 0% |
| Thought broadcasting | 2 | 0% |
| Thought insertion | 3 | 0% |
| Thought withdrawal | 1 | 0% |
| Threatened labour | 20 | 0% |
| Threat of redundancy | 2 | 0% |
| Throat cancer | 17 | 0% |
| Throat clearing | 498 | 0.03% |
| Throat irritation | 8,901 | 0.54% |
| Throat lesion | 22 | 0% |
| Throat tightness | 8,651 | 0.53% |
| Thrombectomy | 477 | 0.03% |
| Thrombin-antithrombin III complex | 9 | 0% |
| Thrombin-antithrombin III complex normal | 3 | 0% |
| Thrombin time | 106 | 0.01% |
| Thrombin time normal | 5 | 0% |
| Thrombin time prolonged | 2 | 0% |
| Thrombin time shortened | 3 | 0% |
| Thromboangiitis obliterans | 11 | 0% |
| Thrombocytopenia | 4,010 | 0.24% |
| Thrombocytopenia neonatal | 1 | 0% |
| Thrombocytopenic purpura | 175 | 0.01% |
| Thrombocytosis | 197 | 0.01% |
| Thromboelastogram | 10 | 0% |
| Thromboembolectomy | 56 | 0% |
| Thrombolysis | 72 | 0% |
| Thrombomodulin | 1 | 0% |
| Thrombophlebitis | 848 | 0.05% |
| Thrombophlebitis migrans | 2 | 0% |
| Thrombophlebitis septic | 6 | 0% |
| Thrombophlebitis superficial | 544 | 0.03% |
| Thrombopoietin level abnormal | 4 | 0% |
| Thrombosed varicose vein | 11 | 0% |
| Thrombosis | 11,122 | 0.68% |
| Thrombosis corpora cavernosa | 3 | 0% |
| Thrombosis in device | 30 | 0% |
| Thrombosis mesenteric vessel | 16 | 0% |
| Thrombosis prophylaxis | 7 | 0% |
| Thrombosis with thrombocytopenia syndrome | 240 | 0.01% |
| Thrombotic cerebral infarction | 48 | 0% |
| Thrombotic microangiopathy | 64 | 0% |
| Thrombotic stroke | 72 | 0% |
| Thrombotic thrombocytopenic purpura | 227 | 0.01% |
| Thumb sucking | 1 | 0% |
| Thunderclap headache | 84 | 0.01% |
| Thymectomy | 8 | 0% |
| Thymic cyst | 1 | 0% |
| Thymoma | 11 | 0% |
| Thymoma benign | 1 | 0% |
| Thymus disorder | 12 | 0% |
| Thymus enlargement | 10 | 0% |
| Thyroglobulin | 110 | 0.01% |
| Thyroglobulin increased | 12 | 0% |
| Thyroglobulin present | 1 | 0% |
| Thyroglossal cyst | 5 | 0% |
| Thyroglossal cyst excision | 1 | 0% |
| Thyroid adenoma | 6 | 0% |
| Thyroid atrophy | 6 | 0% |
| Thyroid calcification | 8 | 0% |
| Thyroid cancer | 50 | 0% |
| Thyroid cancer metastatic | 4 | 0% |
| Thyroid cancer recurrent | 2 | 0% |
| Thyroid cancer stage IV | 2 | 0% |
| Thyroid cyst | 47 | 0% |
| Thyroid dermatopathy | 3 | 0% |
| Thyroid disorder | 464 | 0.03% |
| Thyroidectomy | 34 | 0% |
| Thyroid fibrosis | 1 | 0% |
| Thyroid function test | 1,306 | 0.08% |
| Thyroid function test abnormal | 157 | 0.01% |
| Thyroid function test normal | 444 | 0.03% |
| Thyroid gland abscess | 1 | 0% |
| Thyroid gland injury | 2 | 0% |
| Thyroid gland scan abnormal | 21 | 0% |
| Thyroid gland scan normal | 5 | 0% |
| Thyroid haemorrhage | 3 | 0% |
| Thyroid hormone replacement therapy | 1 | 0% |
| Thyroid hormones decreased | 14 | 0% |
| Thyroid hormones increased | 49 | 0% |
| Thyroid hormones test | 161 | 0.01% |
| Thyroiditis | 314 | 0.02% |
| Thyroiditis acute | 81 | 0% |
| Thyroiditis chronic | 4 | 0% |
| Thyroiditis subacute | 322 | 0.02% |
| Thyroid mass | 298 | 0.02% |
| Thyroid neoplasm | 21 | 0% |
| Thyroid nodule removal | 1 | 0% |
| Thyroid operation | 7 | 0% |
| Thyroid pain | 91 | 0.01% |
| Thyroid releasing hormone challenge test | 6 | 0% |
| Thyroid size decreased | 1 | 0% |
| Thyroid stimulating hormone deficiency | 2 | 0% |
| Thyroid stimulating immunoglobulin | 254 | 0.02% |
| Thyroid stimulating immunoglobulin increased | 15 | 0% |
| Thyroid therapy | 1 | 0% |
| Thyroplasty | 1 | 0% |
| Thyrotoxic cardiomyopathy | 1 | 0% |
| Thyrotoxic crisis | 54 | 0% |
| Thyrotoxic periodic paralysis | 2 | 0% |
| Thyroxin binding globulin | 4 | 0% |
| Thyroxine | 646 | 0.04% |
| Thyroxine abnormal | 4 | 0% |
| Thyroxine decreased | 25 | 0% |
| Thyroxine free | 814 | 0.05% |
| Thyroxine free abnormal | 3 | 0% |
| Thyroxine free decreased | 42 | 0% |
| Thyroxine free increased | 73 | 0% |
| Thyroxine free normal | 214 | 0.01% |
| Thyroxine increased | 60 | 0% |
| Thyroxine normal | 119 | 0.01% |
| Tibia fracture | 50 | 0% |
| Tic | 283 | 0.02% |
| Tick-borne viral encephalitis | 8 | 0% |
| Tick paralysis | 1 | 0% |
| Tidal volume | 9 | 0% |
| Tidal volume abnormal | 2 | 0% |
| Tidal volume decreased | 4 | 0% |
| Tilt table test | 147 | 0.01% |
| Tilt table test normal | 14 | 0% |
| Tilt table test positive | 54 | 0% |
| Time perception altered | 36 | 0% |
| Tinea capitis | 3 | 0% |
| Tinea cruris | 6 | 0% |
| Tinea infection | 17 | 0% |
| Tinea pedis | 24 | 0% |
| Tinea versicolour | 14 | 0% |
| Tinel's sign | 14 | 0% |
| Tinetti test | 1 | 0% |
| Tinnitus | 26,308 | 1.6% |
| Tissue discolouration | 3 | 0% |
| Tissue expansion procedure | 1 | 0% |
| Tissue infiltration | 12 | 0% |
| Tissue injury | 39 | 0% |
| Tissue irritation | 9 | 0% |
| Tissue polypeptide antigen | 1 | 0% |
| Tissue rupture | 4 | 0% |
| Tobacco abuse | 33 | 0% |
| Tobacco user | 75 | 0% |
| Tobacco withdrawal symptoms | 1 | 0% |
| Toe amputation | 41 | 0% |
| Toe operation | 5 | 0% |
| Toe walking | 1 | 0% |
| Tolosa-Hunt syndrome | 24 | 0% |
| Tongue abscess | 8 | 0% |
| Tongue atrophy | 8 | 0% |
| Tongue biting | 211 | 0.01% |
| Tongue blistering | 214 | 0.01% |
| Tongue cancer metastatic | 1 | 0% |
| Tongue cancer recurrent | 2 | 0% |
| Tongue carcinoma stage II | 1 | 0% |
| Tongue coated | 99 | 0.01% |
| Tongue cyst | 7 | 0% |
| Tongue discolouration | 278 | 0.02% |
| Tongue discomfort | 882 | 0.05% |
| Tongue disorder | 749 | 0.05% |
| Tongue dry | 158 | 0.01% |
| Tongue dysplasia | 1 | 0% |
| Tongue eruption | 103 | 0.01% |
| Tongue erythema | 191 | 0.01% |
| Tongue exfoliation | 14 | 0% |
| Tongue fungal infection | 6 | 0% |
| Tongue geographic | 35 | 0% |
| Tongue haematoma | 13 | 0% |
| Tongue haemorrhage | 37 | 0% |
| Tongue induration | 3 | 0% |
| Tongue injury | 33 | 0% |
| Tongue movement disturbance | 104 | 0.01% |
| Tongue necrosis | 1 | 0% |
| Tongue neoplasm | 2 | 0% |
| Tongue neoplasm malignant stage unspecified | 6 | 0% |
| Tongue oedema | 372 | 0.02% |
| Tongue paralysis | 120 | 0.01% |
| Tongue pigmentation | 4 | 0% |
| Tongue polyp | 2 | 0% |
| Tongue pruritus | 602 | 0.04% |
| Tongue rough | 23 | 0% |
| Tongue spasm | 34 | 0% |
| Tongue thrust | 2 | 0% |
| Tongue ulceration | 207 | 0.01% |
| Tonic clonic movements | 188 | 0.01% |
| Tonic convulsion | 178 | 0.01% |
| Tonic posturing | 11 | 0% |
| Tonsil cancer | 14 | 0% |
| Tonsil cancer metastatic | 1 | 0% |
| Tonsillar cyst | 4 | 0% |
| Tonsillar disorder | 61 | 0% |
| Tonsillar erythema | 42 | 0% |
| Tonsillar exudate | 5 | 0% |
| Tonsillar haemorrhage | 14 | 0% |
| Tonsillar hypertrophy | 432 | 0.03% |
| Tonsillar inflammation | 72 | 0% |
| Tonsillar neoplasm | 1 | 0% |
| Tonsillar ulcer | 10 | 0% |
| Tonsillectomy | 14 | 0% |
| Tonsillitis | 467 | 0.03% |
| Tonsillitis bacterial | 31 | 0% |
| Tonsillitis streptococcal | 7 | 0% |
| Tonsillolith | 20 | 0% |
| Tooth abscess | 120 | 0.01% |
| Toothache | 1,823 | 0.11% |
| Tooth avulsion | 6 | 0% |
| Tooth demineralisation | 1 | 0% |
| Tooth deposit | 2 | 0% |
| Tooth development disorder | 3 | 0% |
| Tooth discolouration | 18 | 0% |
| Tooth dislocation | 1 | 0% |
| Tooth disorder | 178 | 0.01% |
| Tooth erosion | 6 | 0% |
| Tooth extraction | 91 | 0.01% |
| Tooth fracture | 165 | 0.01% |
| Tooth impacted | 4 | 0% |
| Tooth infection | 161 | 0.01% |
| Tooth injury | 90 | 0.01% |
| Tooth loss | 98 | 0.01% |
| Tooth malformation | 3 | 0% |
| Tooth repair | 1 | 0% |
| Tooth resorption | 4 | 0% |
| Tooth restoration | 9 | 0% |
| Tooth socket haemorrhage | 2 | 0% |
| Topography corneal | 7 | 0% |
| Topography corneal abnormal | 2 | 0% |
| TORCH infection | 2 | 0% |
| Torsade de pointes | 29 | 0% |
| Torticollis | 144 | 0.01% |
| Torus fracture | 2 | 0% |
| Total bile acids | 11 | 0% |
| Total bile acids increased | 7 | 0% |
| Total cholesterol/HDL ratio | 136 | 0.01% |
| Total cholesterol/HDL ratio abnormal | 1 | 0% |
| Total cholesterol/HDL ratio decreased | 3 | 0% |
| Total cholesterol/HDL ratio increased | 7 | 0% |
| Total cholesterol/HDL ratio normal | 4 | 0% |
| Total complement activity decreased | 3 | 0% |
| Total complement activity increased | 9 | 0% |
| Total complement activity test | 170 | 0.01% |
| Total fluid output | 3 | 0% |
| Total lung capacity | 64 | 0% |
| Total lung capacity abnormal | 6 | 0% |
| Total lung capacity decreased | 164 | 0.01% |
| Total lung capacity normal | 2 | 0% |
| Total neuropathy score | 1 | 0% |
| Tourette's disorder | 37 | 0% |
| Toxic anterior segment syndrome | 1 | 0% |
| Toxic cardiomyopathy | 3 | 0% |
| Toxic encephalopathy | 122 | 0.01% |
| Toxic epidermal necrolysis | 50 | 0% |
| Toxic goitre | 5 | 0% |
| Toxicity to various agents | 96 | 0.01% |
| Toxic leukoencephalopathy | 1 | 0% |
| Toxic neuropathy | 6 | 0% |
| Toxic nodular goitre | 16 | 0% |
| Toxicologic test | 154 | 0.01% |
| Toxicologic test abnormal | 18 | 0% |
| Toxicologic test normal | 77 | 0% |
| Toxic optic neuropathy | 1 | 0% |
| Toxic shock syndrome | 21 | 0% |
| Toxic skin eruption | 170 | 0.01% |
| Toxocariasis | 22 | 0% |
| Toxoplasma serology | 239 | 0.01% |
| Toxoplasma serology negative | 22 | 0% |
| Toxoplasma serology positive | 1 | 0% |
| Toxoplasmosis | 105 | 0.01% |
| TP53 gene mutation | 2 | 0% |
| Trabeculoplasty | 2 | 0% |
| Trace element deficiency | 1 | 0% |
| Tracheal aspirate culture | 21 | 0% |
| Tracheal aspiration procedure | 4 | 0% |
| Tracheal cancer | 2 | 0% |
| Tracheal compression | 5 | 0% |
| Tracheal deviation | 7 | 0% |
| Tracheal dilatation | 1 | 0% |
| Tracheal disorder | 13 | 0% |
| Tracheal diverticulum | 1 | 0% |
| Tracheal fistula repair | 1 | 0% |
| Tracheal haemorrhage | 5 | 0% |
| Tracheal inflammation | 14 | 0% |
| Tracheal injury | 2 | 0% |
| Tracheal neoplasm | 1 | 0% |
| Tracheal obstruction | 11 | 0% |
| Tracheal oedema | 11 | 0% |
| Tracheal pain | 22 | 0% |
| Tracheal stenosis | 26 | 0% |
| Tracheitis | 45 | 0% |
| Tracheo-oesophageal fistula | 3 | 0% |
| Tracheobronchial stent insertion | 1 | 0% |
| Tracheobronchitis | 9 | 0% |
| Tracheobronchitis bacterial | 3 | 0% |
| Tracheomalacia | 8 | 0% |
| Tracheoscopy | 4 | 0% |
| Tracheostomy | 157 | 0.01% |
| Tracheostomy infection | 1 | 0% |
| Tracheostomy malfunction | 6 | 0% |
| Tracheostomy tube removal | 7 | 0% |
| Trachoma | 1 | 0% |
| Traction | 4 | 0% |
| Tractional retinal detachment | 1 | 0% |
| Trance | 12 | 0% |
| Trans-sexualism | 1 | 0% |
| Transaminases | 466 | 0.03% |
| Transaminases abnormal | 8 | 0% |
| Transaminases decreased | 2 | 0% |
| Transaminases increased | 398 | 0.02% |
| Transcatheter aortic valve implantation | 18 | 0% |
| Transcranial electrical motor evoked potential monitoring | 23 | 0% |
| Transcranial electrical motor evoked potential monitoring abnormal | 1 | 0% |
| Transcranial magnetic stimulation | 6 | 0% |
| Transcription medication error | 26 | 0% |
| Transcutaneous pacing | 8 | 0% |
| Transfer factor reduced | 1 | 0% |
| Transferrin | 242 | 0.01% |
| Transferrin abnormal | 2 | 0% |
| Transferrin decreased | 15 | 0% |
| Transferrin increased | 8 | 0% |
| Transferrin normal | 9 | 0% |
| Transferrin receptor assay | 10 | 0% |
| Transferrin saturation | 283 | 0.02% |
| Transferrin saturation abnormal | 1 | 0% |
| Transferrin saturation decreased | 62 | 0% |
| Transferrin saturation increased | 8 | 0% |
| Transfusion | 629 | 0.04% |
| Transfusion-related acute lung injury | 2 | 0% |
| Transfusion-related circulatory overload | 2 | 0% |
| Transfusion reaction | 2 | 0% |
| Transfusion related complication | 1 | 0% |
| Transient acantholytic dermatosis | 28 | 0% |
| Transient aphasia | 37 | 0% |
| Transient elastography | 10 | 0% |
| Transient epileptic amnesia | 3 | 0% |
| Transient global amnesia | 243 | 0.01% |
| Transient ischaemic attack | 3,333 | 0.2% |
| Transient lingual papillitis | 8 | 0% |
| Transient psychosis | 1 | 0% |
| Transient tachypnoea of the newborn | 3 | 0% |
| Transillumination | 2 | 0% |
| Transitional cell cancer of the renal pelvis and ureter | 2 | 0% |
| Transitional cell carcinoma | 20 | 0% |
| Transitional cell carcinoma metastatic | 1 | 0% |
| Transitional cell carcinoma urethra | 2 | 0% |
| Transmembrane receptor tyrosine kinase assay | 1 | 0% |
| Transplant | 9 | 0% |
| Transplantation complication | 1 | 0% |
| Transplant dysfunction | 3 | 0% |
| Transplant evaluation | 5 | 0% |
| Transplant failure | 5 | 0% |
| Transplant rejection | 61 | 0% |
| Transposition of the great vessels | 9 | 0% |
| Transsphenoidal surgery | 1 | 0% |
| Transurethral bladder resection | 9 | 0% |
| Transurethral incision of prostate | 1 | 0% |
| Transurethral prostatectomy | 9 | 0% |
| Transvalvular pressure gradient | 7 | 0% |
| Transvalvular pressure gradient abnormal | 1 | 0% |
| Transvalvular pressure gradient increased | 2 | 0% |
| Transverse sinus stenosis | 15 | 0% |
| Transverse sinus thrombosis | 142 | 0.01% |
| Traumatic delivery | 2 | 0% |
| Traumatic fracture | 8 | 0% |
| Traumatic haematoma | 28 | 0% |
| Traumatic haemorrhage | 18 | 0% |
| Traumatic haemothorax | 14 | 0% |
| Traumatic heart injury | 6 | 0% |
| Traumatic intracranial haemorrhage | 17 | 0% |
| Traumatic liver injury | 2 | 0% |
| Traumatic lumbar puncture | 1 | 0% |
| Traumatic lung injury | 43 | 0% |
| Traumatic renal injury | 1 | 0% |
| Traumatic shock | 3 | 0% |
| Traumatic spinal cord compression | 1 | 0% |
| Traumatic tooth displacement | 1 | 0% |
| Treatment delayed | 3 | 0% |
| Treatment failure | 47 | 0% |
| Treatment noncompliance | 144 | 0.01% |
| Trematode infection | 4 | 0% |
| Tremor | 24,255 | 1.48% |
| Tremor neonatal | 1 | 0% |
| Trendelenburg's symptom | 3 | 0% |
| Trendelenburg position | 11 | 0% |
| Treponema test | 873 | 0.05% |
| Treponema test false positive | 9 | 0% |
| Treponema test negative | 209 | 0.01% |
| Treponema test positive | 17 | 0% |
| Tri-iodothyronine | 385 | 0.02% |
| Tri-iodothyronine abnormal | 3 | 0% |
| Tri-iodothyronine decreased | 37 | 0% |
| Tri-iodothyronine free | 318 | 0.02% |
| Tri-iodothyronine free abnormal | 2 | 0% |
| Tri-iodothyronine free decreased | 6 | 0% |
| Tri-iodothyronine free increased | 24 | 0% |
| Tri-iodothyronine free normal | 28 | 0% |
| Tri-iodothyronine increased | 59 | 0% |
| Tri-iodothyronine normal | 57 | 0% |
| Tri-iodothyronine uptake | 4 | 0% |
| Tri-iodothyronine uptake decreased | 1 | 0% |
| Tri-iodothyronine uptake increased | 2 | 0% |
| Trial of void | 13 | 0% |
| Trichiasis | 1 | 0% |
| Trichiniasis | 6 | 0% |
| Trichodynia | 10 | 0% |
| Trichoglossia | 30 | 0% |
| Trichomoniasis | 5 | 0% |
| Trichophytosis | 3 | 0% |
| Trichorrhexis | 48 | 0% |
| Trichuriasis | 1 | 0% |
| Tricuspid valve calcification | 3 | 0% |
| Tricuspid valve disease | 11 | 0% |
| Tricuspid valve incompetence | 419 | 0.03% |
| Tricuspid valve prolapse | 2 | 0% |
| Tricuspid valve repair | 2 | 0% |
| Tricuspid valve replacement | 2 | 0% |
| Tricuspid valve stenosis | 2 | 0% |
| Tricuspid valve thickening | 1 | 0% |
| Trifascicular block | 4 | 0% |
| Trigeminal nerve disorder | 116 | 0.01% |
| Trigeminal nerve injection | 2 | 0% |
| Trigeminal nerve paresis | 14 | 0% |
| Trigeminal neuralgia | 876 | 0.05% |
| Trigeminal neuritis | 29 | 0% |
| Trigeminal neuropathy | 12 | 0% |
| Trigeminal palsy | 28 | 0% |
| Trigger finger | 237 | 0.01% |
| Trigger points | 4 | 0% |
| Triple negative breast cancer | 33 | 0% |
| Triple positive breast cancer | 7 | 0% |
| Triplopia | 1 | 0% |
| Trismus | 502 | 0.03% |
| Trisomy 8 | 1 | 0% |
| Trisomy 13 | 5 | 0% |
| Trisomy 15 | 1 | 0% |
| Trisomy 16 | 1 | 0% |
| Trisomy 18 | 10 | 0% |
| Trisomy 21 | 25 | 0% |
| Trisomy 22 | 2 | 0% |
| Trombidiasis | 1 | 0% |
| Tropical spastic paresis | 1 | 0% |
| Troponin | 9,010 | 0.55% |
| Troponin abnormal | 127 | 0.01% |
| Troponin C | 19 | 0% |
| Troponin C increased | 2 | 0% |
| Troponin decreased | 31 | 0% |
| Troponin I | 2,642 | 0.16% |
| Troponin I abnormal | 12 | 0% |
| Troponin I decreased | 8 | 0% |
| Troponin I increased | 696 | 0.04% |
| Troponin increased | 4,601 | 0.28% |
| Troponin I normal | 342 | 0.02% |
| Troponin normal | 1,460 | 0.09% |
| Troponin T | 1,731 | 0.11% |
| Troponin T increased | 318 | 0.02% |
| Troponin T normal | 67 | 0% |
| Trousseau's sign | 5 | 0% |
| TRPV4 gene mutation | 1 | 0% |
| Truncus arteriosus persistent | 1 | 0% |
| Truncus coeliacus thrombosis | 10 | 0% |
| Trunk injury | 3 | 0% |
| Tryptase | 590 | 0.04% |
| Tryptase decreased | 1 | 0% |
| Tryptase increased | 16 | 0% |
| Tubal rupture | 1 | 0% |
| Tuberculin test | 83 | 0.01% |
| Tuberculin test false positive | 2 | 0% |
| Tuberculin test negative | 12 | 0% |
| Tuberculin test positive | 9 | 0% |
| Tuberculoma of central nervous system | 1 | 0% |
| Tuberculosis | 89 | 0.01% |
| Tuberculosis gastrointestinal | 1 | 0% |
| Tuberculosis of central nervous system | 1 | 0% |
| Tuberculosis of eye | 2 | 0% |
| Tuberculous pleurisy | 1 | 0% |
| Tuberous sclerosis complex | 1 | 0% |
| Tubo-ovarian abscess | 3 | 0% |
| Tubular breast carcinoma | 1 | 0% |
| Tubulointerstitial nephritis | 154 | 0.01% |
| Tubulointerstitial nephritis and uveitis syndrome | 8 | 0% |
| Tularaemia | 8 | 0% |
| Tumefactive multiple sclerosis | 8 | 0% |
| Tumour ablation | 1 | 0% |
| Tumour biopsy | 5 | 0% |
| Tumour excision | 38 | 0% |
| Tumour flare | 2 | 0% |
| Tumour haemorrhage | 10 | 0% |
| Tumour inflammation | 1 | 0% |
| Tumour invasion | 1 | 0% |
| Tumour lysis syndrome | 7 | 0% |
| Tumour marker abnormal | 4 | 0% |
| Tumour marker decreased | 4 | 0% |
| Tumour marker increased | 36 | 0% |
| Tumour marker test | 244 | 0.01% |
| Tumour necrosis | 6 | 0% |
| Tumour necrosis factor receptor-associated periodic syndrome | 2 | 0% |
| Tumour pain | 13 | 0% |
| Tumour perforation | 2 | 0% |
| Tumour pseudoprogression | 1 | 0% |
| Tumour rupture | 3 | 0% |
| Tumour thrombosis | 2 | 0% |
| Tumour ulceration | 1 | 0% |
| Tunnel vision | 637 | 0.04% |
| Turbinectomy | 1 | 0% |
| Turner's syndrome | 9 | 0% |
| Twiddler's syndrome | 1 | 0% |
| Twin pregnancy | 18 | 0% |
| Twin reversed arterial perfusion sequence malformation | 1 | 0% |
| Tympanic membrane disorder | 32 | 0% |
| Tympanic membrane hyperaemia | 12 | 0% |
| Tympanic membrane perforation | 66 | 0% |
| Tympanometry | 122 | 0.01% |
| Tympanometry abnormal | 21 | 0% |
| Tympanometry normal | 14 | 0% |
| Tympanoplasty | 3 | 0% |
| Tympanosclerosis | 1 | 0% |
| Tympanoscopy | 5 | 0% |
| Type 1 diabetes mellitus | 680 | 0.04% |
| Type 2 diabetes mellitus | 732 | 0.04% |
| Type 2 lepra reaction | 2 | 0% |
| Type 3 diabetes mellitus | 4 | 0% |
| Type I hypersensitivity | 217 | 0.01% |
| Type IIa hyperlipidaemia | 11 | 0% |
| Type IIb hyperlipidaemia | 2 | 0% |
| Type II hypersensitivity | 5 | 0% |
| Type III immune complex mediated reaction | 57 | 0% |
| Type IV hypersensitivity reaction | 231 | 0.01% |
| Type V hyperlipidaemia | 34 | 0% |
| Typhoid fever | 4 | 0% |
| Typhus | 1 | 0% |
| Typhus rickettsia test | 37 | 0% |
| Typical aura without headache | 36 | 0% |
| Tyrosine kinase mutation assay | 8 | 0% |
| Ubiquinone | 5 | 0% |
| Ubiquinone decreased | 2 | 0% |
| Uhthoff's phenomenon | 20 | 0% |
| Ulcer | 247 | 0.02% |
| Ulcerative duodenitis | 1 | 0% |
| Ulcerative gastritis | 3 | 0% |
| Ulcerative keratitis | 51 | 0% |
| Ulcer haemorrhage | 33 | 0% |
| Ulna fracture | 17 | 0% |
| Ulnar nerve injury | 23 | 0% |
| Ulnar nerve palsy | 24 | 0% |
| Ulnar neuritis | 21 | 0% |
| Ulnar tunnel syndrome | 7 | 0% |
| Ulnocarpal abutment syndrome | 1 | 0% |
| Ultrasonic angiogram | 21 | 0% |
| Ultrasonic angiogram normal | 2 | 0% |
| Ultrasound abdomen | 2,159 | 0.13% |
| Ultrasound abdomen abnormal | 298 | 0.02% |
| Ultrasound abdomen normal | 219 | 0.01% |
| Ultrasound antenatal screen | 156 | 0.01% |
| Ultrasound antenatal screen abnormal | 218 | 0.01% |
| Ultrasound antenatal screen normal | 35 | 0% |
| Ultrasound biliary tract | 133 | 0.01% |
| Ultrasound biliary tract abnormal | 17 | 0% |
| Ultrasound biliary tract normal | 12 | 0% |
| Ultrasound bladder | 71 | 0% |
| Ultrasound bladder abnormal | 8 | 0% |
| Ultrasound bladder normal | 21 | 0% |
| Ultrasound breast | 412 | 0.03% |
| Ultrasound breast abnormal | 118 | 0.01% |
| Ultrasound breast normal | 52 | 0% |
| Ultrasound chest | 380 | 0.02% |
| Ultrasound Doppler | 7,118 | 0.43% |
| Ultrasound Doppler abnormal | 1,591 | 0.1% |
| Ultrasound Doppler normal | 777 | 0.05% |
| Ultrasound eye | 52 | 0% |
| Ultrasound eye abnormal | 11 | 0% |
| Ultrasound eye normal | 7 | 0% |
| Ultrasound foetal | 272 | 0.02% |
| Ultrasound foetal abnormal | 120 | 0.01% |
| Ultrasound head | 52 | 0% |
| Ultrasound head abnormal | 5 | 0% |
| Ultrasound head normal | 3 | 0% |
| Ultrasound joint | 178 | 0.01% |
| Ultrasound joint abnormal | 3 | 0% |
| Ultrasound kidney | 357 | 0.02% |
| Ultrasound kidney abnormal | 89 | 0.01% |
| Ultrasound kidney normal | 108 | 0.01% |
| Ultrasound liver | 199 | 0.01% |
| Ultrasound liver abnormal | 46 | 0% |
| Ultrasound liver normal | 37 | 0% |
| Ultrasound lymph nodes | 70 | 0% |
| Ultrasound neck | 11 | 0% |
| Ultrasound ovary | 47 | 0% |
| Ultrasound ovary abnormal | 16 | 0% |
| Ultrasound pancreas | 25 | 0% |
| Ultrasound pancreas abnormal | 7 | 0% |
| Ultrasound pancreas normal | 7 | 0% |
| Ultrasound pelvis | 568 | 0.03% |
| Ultrasound pelvis abnormal | 72 | 0% |
| Ultrasound pelvis normal | 91 | 0.01% |
| Ultrasound penis | 7 | 0% |
| Ultrasound prostate | 6 | 0% |
| Ultrasound prostate abnormal | 1 | 0% |
| Ultrasound prostate normal | 1 | 0% |
| Ultrasound scan | 13,150 | 0.8% |
| Ultrasound scan abnormal | 1,127 | 0.07% |
| Ultrasound scan normal | 1,054 | 0.06% |
| Ultrasound scan vagina | 526 | 0.03% |
| Ultrasound scan vagina abnormal | 64 | 0% |
| Ultrasound scan vagina normal | 51 | 0% |
| Ultrasound skull | 14 | 0% |
| Ultrasound skull normal | 1 | 0% |
| Ultrasound spleen | 27 | 0% |
| Ultrasound testes | 140 | 0.01% |
| Ultrasound testes abnormal | 20 | 0% |
| Ultrasound testes normal | 9 | 0% |
| Ultrasound therapy | 12 | 0% |
| Ultrasound thyroid | 518 | 0.03% |
| Ultrasound thyroid abnormal | 104 | 0.01% |
| Ultrasound thyroid normal | 30 | 0% |
| Ultrasound urinary system | 32 | 0% |
| Ultrasound uterus | 192 | 0.01% |
| Ultrasound uterus abnormal | 56 | 0% |
| Ultrasound uterus normal | 30 | 0% |
| Umbilical cord abnormality | 15 | 0% |
| Umbilical cord around neck | 5 | 0% |
| Umbilical cord blood pH | 18 | 0% |
| Umbilical cord prolapse | 3 | 0% |
| Umbilical cord short | 2 | 0% |
| Umbilical cord thrombosis | 9 | 0% |
| Umbilical discharge | 1 | 0% |
| Umbilical erythema | 2 | 0% |
| Umbilical granuloma | 1 | 0% |
| Umbilical haematoma | 2 | 0% |
| Umbilical haemorrhage | 1 | 0% |
| Umbilical hernia | 38 | 0% |
| Umbilical hernia repair | 4 | 0% |
| Underdose | 7,560 | 0.46% |
| Underimmunisation | 3 | 0% |
| Undersensing | 11 | 0% |
| Underweight | 32 | 0% |
| Undifferentiated connective tissue disease | 17 | 0% |
| Undifferentiated nasopharyngeal carcinoma | 1 | 0% |
| Undifferentiated sarcoma | 1 | 0% |
| Undifferentiated spondyloarthritis | 5 | 0% |
| Unemployment | 6 | 0% |
| Unevaluable event | 10,428 | 0.63% |
| Unevaluable investigation | 4 | 0% |
| Unevaluable specimen | 2 | 0% |
| Unhealthy diet | 2 | 0% |
| Unhealthy lifestyle | 2 | 0% |
| Unintended pregnancy | 17 | 0% |
| Unintentional medical device removal | 14 | 0% |
| Univentricular heart | 1 | 0% |
| Unmasking of previously unidentified disease | 19 | 0% |
| Unresponsive to stimuli | 6,129 | 0.37% |
| Unwanted pregnancy | 3 | 0% |
| Upper-airway cough syndrome | 1,134 | 0.07% |
| Upper airway obstruction | 30 | 0% |
| Upper gastrointestinal haemorrhage | 175 | 0.01% |
| Upper limb fracture | 141 | 0.01% |
| Upper motor neurone lesion | 35 | 0% |
| Upper respiratory tract congestion | 260 | 0.02% |
| Upper respiratory tract endoscopy | 9 | 0% |
| Upper respiratory tract infection | 708 | 0.04% |
| Upper respiratory tract infection bacterial | 4 | 0% |
| Upper respiratory tract inflammation | 27 | 0% |
| Upper respiratory tract irritation | 12 | 0% |
| Urachal abnormality | 1 | 0% |
| Urachal sinus infection | 1 | 0% |
| Uraemic encephalopathy | 2 | 0% |
| Uraemic gastropathy | 1 | 0% |
| Urate nephropathy | 1 | 0% |
| Ureaplasma infection | 2 | 0% |
| Urea renal clearance | 8 | 0% |
| Urea urine | 23 | 0% |
| Urea urine abnormal | 2 | 0% |
| Urea urine decreased | 2 | 0% |
| Urea urine increased | 1 | 0% |
| Ureteral catheterisation | 2 | 0% |
| Ureteral disorder | 7 | 0% |
| Ureteral neoplasm | 1 | 0% |
| Ureteral stent insertion | 59 | 0% |
| Ureteral stent removal | 2 | 0% |
| Ureteral wall thickening | 2 | 0% |
| Ureteric calculus removal | 2 | 0% |
| Ureteric cancer | 4 | 0% |
| Ureteric compression | 3 | 0% |
| Ureteric dilatation | 12 | 0% |
| Ureteric haemorrhage | 1 | 0% |
| Ureteric injury | 2 | 0% |
| Ureteric obstruction | 15 | 0% |
| Ureteric stenosis | 5 | 0% |
| Ureteritis | 7 | 0% |
| Ureterocele | 1 | 0% |
| Ureterolithiasis | 45 | 0% |
| Ureterolithotomy | 1 | 0% |
| Ureteroscopy | 13 | 0% |
| Ureteroscopy abnormal | 7 | 0% |
| Urethral atresia | 1 | 0% |
| Urethral atrophy | 1 | 0% |
| Urethral bulking agent injection | 1 | 0% |
| Urethral cancer | 1 | 0% |
| Urethral carbuncle | 1 | 0% |
| Urethral caruncle | 2 | 0% |
| Urethral cyst | 1 | 0% |
| Urethral dilation procedure | 1 | 0% |
| Urethral discharge | 4 | 0% |
| Urethral disorder | 10 | 0% |
| Urethral fistula | 1 | 0% |
| Urethral haemorrhage | 21 | 0% |
| Urethral injury | 6 | 0% |
| Urethral intrinsic sphincter deficiency | 2 | 0% |
| Urethral meatotomy | 1 | 0% |
| Urethral meatus stenosis | 2 | 0% |
| Urethral obstruction | 8 | 0% |
| Urethral pain | 40 | 0% |
| Urethral polyp | 1 | 0% |
| Urethral repair | 1 | 0% |
| Urethral spasm | 6 | 0% |
| Urethral stenosis | 9 | 0% |
| Urethral syndrome | 2 | 0% |
| Urethral ulcer | 1 | 0% |
| Urethral valves | 3 | 0% |
| Urethritis | 24 | 0% |
| Urethritis noninfective | 15 | 0% |
| Urge incontinence | 26 | 0% |
| Urinary assistance device user | 1 | 0% |
| Urinary bladder abscess | 1 | 0% |
| Urinary bladder haematoma | 1 | 0% |
| Urinary bladder haemorrhage | 55 | 0% |
| Urinary bladder polyp | 4 | 0% |
| Urinary bladder rupture | 4 | 0% |
| Urinary bladder suspension | 2 | 0% |
| Urinary bladder toxicity | 1 | 0% |
| Urinary casts | 87 | 0.01% |
| Urinary casts absent | 9 | 0% |
| Urinary casts present | 12 | 0% |
| Urinary cystectomy | 1 | 0% |
| Urinary hesitation | 55 | 0% |
| Urinary incontinence | 1,966 | 0.12% |
| Urinary lipids present | 1 | 0% |
| Urinary nitrogen increased | 1 | 0% |
| Urinary occult blood | 94 | 0.01% |
| Urinary occult blood negative | 16 | 0% |
| Urinary occult blood positive | 25 | 0% |
| Urinary retention | 957 | 0.06% |
| Urinary retention postoperative | 2 | 0% |
| Urinary sediment | 134 | 0.01% |
| Urinary sediment abnormal | 4 | 0% |
| Urinary sediment present | 195 | 0.01% |
| Urinary squamous epithelial cells increased | 4 | 0% |
| Urinary stone analysis | 3 | 0% |
| Urinary straining | 6 | 0% |
| Urinary system X-ray | 62 | 0% |
| Urinary system x-ray abnormal | 8 | 0% |
| Urinary system x-ray normal | 4 | 0% |
| Urinary tract candidiasis | 9 | 0% |
| Urinary tract discomfort | 45 | 0% |
| Urinary tract disorder | 95 | 0.01% |
| Urinary tract imaging | 2 | 0% |
| Urinary tract imaging abnormal | 4 | 0% |
| Urinary tract imaging normal | 1 | 0% |
| Urinary tract infection | 4,302 | 0.26% |
| Urinary tract infection bacterial | 68 | 0% |
| Urinary tract infection enterococcal | 14 | 0% |
| Urinary tract infection fungal | 10 | 0% |
| Urinary tract infection neonatal | 1 | 0% |
| Urinary tract infection pseudomonal | 11 | 0% |
| Urinary tract infection staphylococcal | 3 | 0% |
| Urinary tract infection viral | 1 | 0% |
| Urinary tract inflammation | 53 | 0% |
| Urinary tract malformation | 1 | 0% |
| Urinary tract neoplasm | 2 | 0% |
| Urinary tract obstruction | 45 | 0% |
| Urinary tract operation | 1 | 0% |
| Urinary tract pain | 39 | 0% |
| Urinary tract stoma complication | 5 | 0% |
| Urinary tract toxicity | 3 | 0% |
| Urine abnormality | 276 | 0.02% |
| Urine albumin/creatinine ratio | 101 | 0.01% |
| Urine albumin/creatinine ratio increased | 8 | 0% |
| Urine albumin/creatinine ratio normal | 1 | 0% |
| Urine alcohol test | 5 | 0% |
| Urine alcohol test negative | 2 | 0% |
| Urine alcohol test positive | 2 | 0% |
| Urine alkalinisation therapy | 1 | 0% |
| Urine amphetamine | 1 | 0% |
| Urine amphetamine negative | 12 | 0% |
| Urine amphetamine positive | 3 | 0% |
| Urine analysis | 6,819 | 0.41% |
| Urine analysis abnormal | 1,128 | 0.07% |
| Urine analysis normal | 1,698 | 0.1% |
| Urine antigen test | 68 | 0% |
| Urine arsenic | 1 | 0% |
| Urine barbiturates | 8 | 0% |
| Urine bilirubin decreased | 8 | 0% |
| Urine bilirubin increased | 2 | 0% |
| Urine calcium | 11 | 0% |
| Urine calcium/creatinine ratio | 4 | 0% |
| Urine calcium increased | 2 | 0% |
| Urine cannabinoids decreased | 1 | 0% |
| Urine cannabinoids increased | 7 | 0% |
| Urine chloride | 19 | 0% |
| Urine chromium | 1 | 0% |
| Urine chromium increased | 1 | 0% |
| Urine copper | 11 | 0% |
| Urine copper increased | 1 | 0% |
| Urine cytology | 70 | 0% |
| Urine cytology abnormal | 3 | 0% |
| Urine cytology normal | 4 | 0% |
| Urine delta aminolevulinate | 2 | 0% |
| Urine delta aminolevulinate normal | 1 | 0% |
| Urine electrolytes | 36 | 0% |
| Urine electrolytes abnormal | 2 | 0% |
| Urine electrolytes decreased | 1 | 0% |
| Urine electrolytes normal | 8 | 0% |
| Urine electrophoresis | 12 | 0% |
| Urine electrophoresis abnormal | 1 | 0% |
| Urine electrophoresis normal | 1 | 0% |
| Urine flow decreased | 54 | 0% |
| Urine homocystine | 5 | 0% |
| Urine iron | 1 | 0% |
| Urine ketone body | 169 | 0.01% |
| Urine ketone body absent | 191 | 0.01% |
| Urine ketone body present | 196 | 0.01% |
| Urine lactic acid | 1 | 0% |
| Urine lactic acid increased | 1 | 0% |
| Urine leukocyte esterase | 283 | 0.02% |
| Urine leukocyte esterase positive | 204 | 0.01% |
| Urine magnesium | 4 | 0% |
| Urine mercury abnormal | 1 | 0% |
| Urine mercury normal | 1 | 0% |
| Urine nitrogen | 10 | 0% |
| Urine odour abnormal | 196 | 0.01% |
| Urine organic acid test | 3 | 0% |
| Urine osmolarity | 55 | 0% |
| Urine osmolarity decreased | 8 | 0% |
| Urine osmolarity increased | 4 | 0% |
| Urine osmolarity normal | 4 | 0% |
| Urine output | 163 | 0.01% |
| Urine output decreased | 314 | 0.02% |
| Urine output increased | 68 | 0% |
| Urine oxalate | 3 | 0% |
| Urine oxalate increased | 1 | 0% |
| Urine phosphorus | 5 | 0% |
| Urine phosphorus normal | 3 | 0% |
| Urine porphobilinogen increased | 4 | 0% |
| Urine potassium | 44 | 0% |
| Urine potassium decreased | 4 | 0% |
| Urine potassium normal | 1 | 0% |
| Urine protein/creatinine ratio | 235 | 0.01% |
| Urine protein/creatinine ratio abnormal | 4 | 0% |
| Urine protein/creatinine ratio decreased | 2 | 0% |
| Urine protein/creatinine ratio increased | 15 | 0% |
| Urine protein/creatinine ratio normal | 7 | 0% |
| Urine retinol binding protein increased | 1 | 0% |
| Urine sodium | 69 | 0% |
| Urine sodium abnormal | 3 | 0% |
| Urine sodium decreased | 8 | 0% |
| Urine sodium increased | 6 | 0% |
| Urine sodium normal | 9 | 0% |
| Urine transitional cells present | 1 | 0% |
| Urine uric acid | 5 | 0% |
| Urine uric acid abnormal | 1 | 0% |
| Urine uric acid decreased | 2 | 0% |
| Urine uric acid increased | 3 | 0% |
| Urine uric acid normal | 2 | 0% |
| Urinoma | 2 | 0% |
| Urobilinogen urine | 352 | 0.02% |
| Urobilinogen urine decreased | 32 | 0% |
| Urobilinogen urine increased | 37 | 0% |
| Urodynamics measurement | 29 | 0% |
| Urodynamics measurement abnormal | 1 | 0% |
| Urogenital disorder | 6 | 0% |
| Urogenital fistula | 2 | 0% |
| Urogenital haemorrhage | 4 | 0% |
| Urogenital infection bacterial | 3 | 0% |
| Urogram | 51 | 0% |
| Urogram abnormal | 12 | 0% |
| Urogram normal | 5 | 0% |
| Urological examination | 148 | 0.01% |
| Urological examination abnormal | 1 | 0% |
| Urosepsis | 135 | 0.01% |
| Urostomy | 4 | 0% |
| Urostomy complication | 1 | 0% |
| Urothelial papilloma | 1 | 0% |
| Urothelium erosion | 1 | 0% |
| Urticaria | 34,233 | 2.08% |
| Urticaria aquagenic | 5 | 0% |
| Urticaria cholinergic | 27 | 0% |
| Urticaria chronic | 605 | 0.04% |
| Urticaria contact | 7 | 0% |
| Urticarial dermatitis | 6 | 0% |
| Urticarial vasculitis | 113 | 0.01% |
| Urticaria papular | 29 | 0% |
| Urticaria physical | 7 | 0% |
| Urticaria pigmentosa | 3 | 0% |
| Urticaria pressure | 16 | 0% |
| Urticaria thermal | 16 | 0% |
| Urticaria vesiculosa | 4 | 0% |
| Urticaria vibratory | 1 | 0% |
| Useless hand syndrome | 1 | 0% |
| Use of accessory respiratory muscles | 83 | 0.01% |
| Uterine abscess | 1 | 0% |
| Uterine adhesions | 2 | 0% |
| Uterine artery embolisation | 3 | 0% |
| Uterine atony | 6 | 0% |
| Uterine atrophy | 1 | 0% |
| Uterine cancer | 40 | 0% |
| Uterine cervical laceration | 1 | 0% |
| Uterine cervical pain | 2 | 0% |
| Uterine cervix dilation procedure | 2 | 0% |
| Uterine cervix hyperplasia | 3 | 0% |
| Uterine cervix stenosis | 3 | 0% |
| Uterine contractions abnormal | 49 | 0% |
| Uterine contractions during pregnancy | 150 | 0.01% |
| Uterine cyst | 27 | 0% |
| Uterine dilation and curettage | 286 | 0.02% |
| Uterine dilation and evacuation | 19 | 0% |
| Uterine disorder | 46 | 0% |
| Uterine enlargement | 27 | 0% |
| Uterine fibrosis | 1 | 0% |
| Uterine haematoma | 5 | 0% |
| Uterine haemorrhage | 662 | 0.04% |
| Uterine hypertonus | 29 | 0% |
| Uterine hypotonus | 4 | 0% |
| Uterine infection | 13 | 0% |
| Uterine inflammation | 45 | 0% |
| Uterine injury | 2 | 0% |
| Uterine inversion | 1 | 0% |
| Uterine irritability | 4 | 0% |
| Uterine leiomyoma | 311 | 0.02% |
| Uterine leiomyoma embolisation | 1 | 0% |
| Uterine malposition | 4 | 0% |
| Uterine mass | 23 | 0% |
| Uterine myoma expulsion | 2 | 0% |
| Uterine neoplasm | 4 | 0% |
| Uterine obstruction | 1 | 0% |
| Uterine operation | 8 | 0% |
| Uterine pain | 336 | 0.02% |
| Uterine polyp | 93 | 0.01% |
| Uterine polypectomy | 3 | 0% |
| Uterine prolapse | 9 | 0% |
| Uterine rupture | 5 | 0% |
| Uterine scar | 1 | 0% |
| Uterine spasm | 233 | 0.01% |
| Uterine tenderness | 6 | 0% |
| Uveal melanoma | 1 | 0% |
| Uveal prolapse | 1 | 0% |
| Uveitic glaucoma | 2 | 0% |
| Uveitis | 746 | 0.05% |
| Uveitis-glaucoma-hyphaema syndrome | 2 | 0% |
| UV light therapy | 6 | 0% |
| Uvula deviation | 3 | 0% |
| Uvulitis | 24 | 0% |
| Vaccination complication | 5,451 | 0.33% |
| Vaccination error | 614 | 0.04% |
| Vaccination failure | 81,666 | 4.97% |
| Vaccination site abscess | 63 | 0% |
| Vaccination site abscess sterile | 7 | 0% |
| Vaccination site anaesthesia | 39 | 0% |
| Vaccination site atrophy | 13 | 0% |
| Vaccination site bruising | 1,133 | 0.07% |
| Vaccination site calcification | 6 | 0% |
| Vaccination site cellulitis | 230 | 0.01% |
| Vaccination site coldness | 45 | 0% |
| Vaccination site cyst | 7 | 0% |
| Vaccination site dermatitis | 17 | 0% |
| Vaccination site discharge | 92 | 0.01% |
| Vaccination site discolouration | 523 | 0.03% |
| Vaccination site discomfort | 711 | 0.04% |
| Vaccination site dryness | 14 | 0% |
| Vaccination site dysaesthesia | 46 | 0% |
| Vaccination site eczema | 15 | 0% |
| Vaccination site erosion | 3 | 0% |
| Vaccination site erythema | 11,615 | 0.71% |
| Vaccination site eschar | 1 | 0% |
| Vaccination site exfoliation | 20 | 0% |
| Vaccination site extravasation | 35 | 0% |
| Vaccination site fibrosis | 3 | 0% |
| Vaccination site granuloma | 8 | 0% |
| Vaccination site haematoma | 365 | 0.02% |
| Vaccination site haemorrhage | 582 | 0.04% |
| Vaccination site hyperaesthesia | 61 | 0% |
| Vaccination site hypersensitivity | 101 | 0.01% |
| Vaccination site hypertrichosis | 1 | 0% |
| Vaccination site hypertrophy | 6 | 0% |
| Vaccination site hypoaesthesia | 327 | 0.02% |
| Vaccination site induration | 1,925 | 0.12% |
| Vaccination site infection | 111 | 0.01% |
| Vaccination site inflammation | 1,326 | 0.08% |
| Vaccination site injury | 44 | 0% |
| Vaccination site irritation | 134 | 0.01% |
| Vaccination site ischaemia | 3 | 0% |
| Vaccination site joint discomfort | 12 | 0% |
| Vaccination site joint effusion | 4 | 0% |
| Vaccination site joint erythema | 45 | 0% |
| Vaccination site joint infection | 3 | 0% |
| Vaccination site joint inflammation | 16 | 0% |
| Vaccination site joint movement impairment | 201 | 0.01% |
| Vaccination site joint pain | 180 | 0.01% |
| Vaccination site joint swelling | 43 | 0% |
| Vaccination site joint warmth | 6 | 0% |
| Vaccination site laceration | 1 | 0% |
| Vaccination site lymphadenopathy | 602 | 0.04% |
| Vaccination site macule | 21 | 0% |
| Vaccination site mass | 2,289 | 0.14% |
| Vaccination site movement impairment | 1,284 | 0.08% |
| Vaccination site necrosis | 37 | 0% |
| Vaccination site nerve damage | 38 | 0% |
| Vaccination site nodule | 220 | 0.01% |
| Vaccination site oedema | 673 | 0.04% |
| Vaccination site pain | 40,439 | 2.46% |
| Vaccination site pallor | 6 | 0% |
| Vaccination site papule | 41 | 0% |
| Vaccination site paraesthesia | 377 | 0.02% |
| Vaccination site phlebitis | 3 | 0% |
| Vaccination site photosensitivity reaction | 1 | 0% |
| Vaccination site plaque | 22 | 0% |
| Vaccination site pruritus | 6,305 | 0.38% |
| Vaccination site pustule | 23 | 0% |
| Vaccination site rash | 3,762 | 0.23% |
| Vaccination site reaction | 5,384 | 0.33% |
| Vaccination site recall reaction | 2 | 0% |
| Vaccination site scab | 47 | 0% |
| Vaccination site scar | 60 | 0% |
| Vaccination site streaking | 17 | 0% |
| Vaccination site swelling | 11,349 | 0.69% |
| Vaccination site thrombosis | 20 | 0% |
| Vaccination site ulcer | 16 | 0% |
| Vaccination site urticaria | 546 | 0.03% |
| Vaccination site vasculitis | 5 | 0% |
| Vaccination site vesicles | 206 | 0.01% |
| Vaccination site warmth | 5,521 | 0.34% |
| Vaccine associated enhanced disease | 39 | 0% |
| Vaccine associated enhanced respiratory disease | 20 | 0% |
| Vaccine associated paralytic poliomyelitis | 2 | 0% |
| Vaccine bacteria shedding | 1 | 0% |
| Vaccine breakthrough infection | 8,626 | 0.52% |
| Vaccine coadministration | 1 | 0% |
| Vaccine induced antibody absent | 20 | 0% |
| Vaccine interaction | 2 | 0% |
| Vaccine positive rechallenge | 2,107 | 0.13% |
| Vaccine virus shedding | 4 | 0% |
| Vaccinia virus infection | 2 | 0% |
| VACTERL syndrome | 3 | 0% |
| Vacuum aspiration | 5 | 0% |
| Vacuum extractor delivery | 5 | 0% |
| Vagal nerve stimulator implantation | 3 | 0% |
| Vagal nerve stimulator removal | 1 | 0% |
| Vaginal abscess | 7 | 0% |
| Vaginal cancer | 2 | 0% |
| Vaginal cancer recurrent | 1 | 0% |
| Vaginal cancer stage 0 | 1 | 0% |
| Vaginal cellulitis | 1 | 0% |
| Vaginal cyst | 13 | 0% |
| Vaginal dilation procedure | 1 | 0% |
| Vaginal discharge | 381 | 0.02% |
| Vaginal disorder | 20 | 0% |
| Vaginal erosion | 2 | 0% |
| Vaginal fistula | 4 | 0% |
| Vaginal haematoma | 1 | 0% |
| Vaginal haemorrhage | 3,933 | 0.24% |
| Vaginal infection | 87 | 0.01% |
| Vaginal lesion | 22 | 0% |
| Vaginal mucosal blistering | 10 | 0% |
| Vaginal odour | 26 | 0% |
| Vaginal oedema | 2 | 0% |
| Vaginal pH abnormal | 2 | 0% |
| Vaginal polyp | 4 | 0% |
| Vaginal prolapse | 3 | 0% |
| Vaginal removal of intrauterine foreign body | 1 | 0% |
| Vaginal stricture | 1 | 0% |
| Vaginal ulceration | 88 | 0.01% |
| Vaginitis gardnerella | 4 | 0% |
| Vagotomy | 2 | 0% |
| Vagus nerve disorder | 51 | 0% |
| Vagus nerve paralysis | 6 | 0% |
| Valsalva maneuver | 22 | 0% |
| Valvuloplasty cardiac | 5 | 0% |
| Vanillyl mandelic acid urine | 1 | 0% |
| Vanishing bile duct syndrome | 1 | 0% |
| Vanishing twin syndrome | 2 | 0% |
| Variant Creutzfeldt-Jakob disease | 1 | 0% |
| Varicella | 171 | 0.01% |
| Varicella encephalitis | 1 | 0% |
| Varicella immunisation | 1 | 0% |
| Varicella meningitis | 9 | 0% |
| Varicella post vaccine | 3 | 0% |
| Varicella virus test | 373 | 0.02% |
| Varicella virus test negative | 99 | 0.01% |
| Varicella virus test positive | 118 | 0.01% |
| Varicella zoster oesophagitis | 1 | 0% |
| Varicella zoster pneumonia | 2 | 0% |
| Varicella zoster virus infection | 198 | 0.01% |
| Varices oesophageal | 35 | 0% |
| Varicocele | 41 | 0% |
| Varicophlebitis | 49 | 0% |
| Varicose ulceration | 8 | 0% |
| Varicose vein | 473 | 0.03% |
| Varicose vein operation | 2 | 0% |
| Varicose vein ruptured | 13 | 0% |
| Varicose veins of abdominal wall | 1 | 0% |
| Varicose veins pelvic | 6 | 0% |
| Varicose veins vaginal | 2 | 0% |
| Vasa praevia | 4 | 0% |
| Vascular access complication | 3 | 0% |
| Vascular access device culture | 1 | 0% |
| Vascular access malfunction | 4 | 0% |
| Vascular access placement | 2 | 0% |
| Vascular access site bruising | 4 | 0% |
| Vascular access site discolouration | 1 | 0% |
| Vascular access site dissection | 1 | 0% |
| Vascular access site extravasation | 1 | 0% |
| Vascular access site infection | 1 | 0% |
| Vascular access site pain | 1 | 0% |
| Vascular access site swelling | 2 | 0% |
| Vascular access site thrombosis | 4 | 0% |
| Vascular anastomosis | 1 | 0% |
| Vascular calcification | 33 | 0% |
| Vascular catheterisation | 22 | 0% |
| Vascular catheter specimen collection | 1 | 0% |
| Vascular cauterisation | 16 | 0% |
| Vascular cognitive impairment | 2 | 0% |
| Vascular compression | 13 | 0% |
| Vascular compression therapy | 3 | 0% |
| Vascular dementia | 50 | 0% |
| Vascular device infection | 8 | 0% |
| Vascular device occlusion | 1 | 0% |
| Vascular device user | 17 | 0% |
| Vascular dissection | 5 | 0% |
| Vascular encephalopathy | 23 | 0% |
| Vascular endothelial growth factor assay | 38 | 0% |
| Vascular endothelial growth factor overexpression | 3 | 0% |
| Vascular fragility | 3 | 0% |
| Vascular graft | 33 | 0% |
| Vascular graft complication | 2 | 0% |
| Vascular graft infection | 1 | 0% |
| Vascular graft occlusion | 12 | 0% |
| Vascular graft stenosis | 3 | 0% |
| Vascular graft thrombosis | 13 | 0% |
| Vascular headache | 33 | 0% |
| Vascular imaging | 39 | 0% |
| Vascular injury | 66 | 0% |
| Vascular insufficiency | 8 | 0% |
| Vascular malformation | 9 | 0% |
| Vascular occlusion | 109 | 0.01% |
| Vascular operation | 19 | 0% |
| Vascular pain | 391 | 0.02% |
| Vascular parkinsonism | 3 | 0% |
| Vascular procedure complication | 4 | 0% |
| Vascular pseudoaneurysm | 31 | 0% |
| Vascular pseudoaneurysm ruptured | 1 | 0% |
| Vascular purpura | 81 | 0% |
| Vascular resistance pulmonary | 6 | 0% |
| Vascular resistance pulmonary decreased | 1 | 0% |
| Vascular resistance pulmonary increased | 2 | 0% |
| Vascular resistance systemic | 6 | 0% |
| Vascular resistance systemic decreased | 1 | 0% |
| Vascular resistance systemic increased | 2 | 0% |
| Vascular rupture | 69 | 0% |
| Vascular shunt | 3 | 0% |
| Vascular skin disorder | 2 | 0% |
| Vascular stenosis | 15 | 0% |
| Vascular stent insertion | 4 | 0% |
| Vascular stent occlusion | 13 | 0% |
| Vascular stent stenosis | 17 | 0% |
| Vascular stent thrombosis | 36 | 0% |
| Vascular test | 116 | 0.01% |
| Vascular test abnormal | 7 | 0% |
| Vascular test normal | 11 | 0% |
| Vascular wall hypertrophy | 1 | 0% |
| Vasculitic rash | 66 | 0% |
| Vasculitic ulcer | 7 | 0% |
| Vasculitis | 1,171 | 0.07% |
| Vasculitis gastrointestinal | 4 | 0% |
| Vasculitis necrotising | 24 | 0% |
| Vasectomy | 1 | 0% |
| Vasoactive intestinal polypeptide test | 3 | 0% |
| Vasoconstriction | 42 | 0% |
| Vasodilatation | 391 | 0.02% |
| Vasodilation procedure | 10 | 0% |
| Vasogenic cerebral oedema | 42 | 0% |
| Vasoligation | 1 | 0% |
| Vasomotor rhinitis | 5 | 0% |
| Vasoplegia syndrome | 7 | 0% |
| Vasopressin challenge test | 2 | 0% |
| Vasopressive therapy | 11 | 0% |
| Vasospasm | 63 | 0% |
| Vegan | 2 | 0% |
| Vein collapse | 23 | 0% |
| Vein discolouration | 74 | 0% |
| Vein disorder | 332 | 0.02% |
| Vein dissection | 1 | 0% |
| Vein rupture | 95 | 0.01% |
| Velopharyngeal incompetence | 1 | 0% |
| Vena cava embolism | 4 | 0% |
| Vena cava filter insertion | 75 | 0% |
| Vena cava filter removal | 5 | 0% |
| Vena cava injury | 3 | 0% |
| Vena cava thrombosis | 94 | 0.01% |
| Venipuncture | 10 | 0% |
| Venogram | 316 | 0.02% |
| Venogram abnormal | 87 | 0.01% |
| Venogram normal | 83 | 0.01% |
| Venoocclusive disease | 2 | 0% |
| Venoocclusive liver disease | 3 | 0% |
| Venous aneurysm | 6 | 0% |
| Venous angioma of brain | 9 | 0% |
| Venous angioplasty | 9 | 0% |
| Venous arterialisation | 1 | 0% |
| Venous bruit | 1 | 0% |
| Venous haemorrhage | 18 | 0% |
| Venous hypertension | 2 | 0% |
| Venous injury | 25 | 0% |
| Venous occlusion | 115 | 0.01% |
| Venous operation | 5 | 0% |
| Venous oxygen partial pressure | 10 | 0% |
| Venous oxygen partial pressure decreased | 2 | 0% |
| Venous oxygen saturation | 49 | 0% |
| Venous oxygen saturation abnormal | 4 | 0% |
| Venous oxygen saturation decreased | 21 | 0% |
| Venous oxygen saturation increased | 1 | 0% |
| Venous oxygen saturation normal | 2 | 0% |
| Venous perforation | 2 | 0% |
| Venous pressure | 5 | 0% |
| Venous pressure jugular | 20 | 0% |
| Venous pressure jugular increased | 10 | 0% |
| Venous pressure jugular normal | 1 | 0% |
| Venous recanalisation | 4 | 0% |
| Venous repair | 2 | 0% |
| Venous stasis retinopathy | 4 | 0% |
| Venous stenosis | 4 | 0% |
| Venous stent insertion | 11 | 0% |
| Venous thrombosis | 670 | 0.04% |
| Venous thrombosis in pregnancy | 2 | 0% |
| Venous thrombosis limb | 967 | 0.06% |
| Venous ulcer pain | 1 | 0% |
| Venous valve ruptured | 2 | 0% |
| Ventilation/perfusion scan | 416 | 0.03% |
| Ventilation/perfusion scan abnormal | 38 | 0% |
| Ventilation/perfusion scan normal | 37 | 0% |
| Ventilation perfusion mismatch | 3 | 0% |
| Ventricle rupture | 5 | 0% |
| Ventricular arrhythmia | 126 | 0.01% |
| Ventricular assist device insertion | 26 | 0% |
| Ventricular asystole | 1 | 0% |
| Ventricular cisternostomy | 7 | 0% |
| Ventricular drainage | 33 | 0% |
| Ventricular dysfunction | 64 | 0% |
| Ventricular dyskinesia | 14 | 0% |
| Ventricular dyssynchrony | 11 | 0% |
| Ventricular enlargement | 22 | 0% |
| Ventricular extrasystoles | 2,039 | 0.12% |
| Ventricular failure | 12 | 0% |
| Ventricular fibrillation | 588 | 0.04% |
| Ventricular flutter | 5 | 0% |
| Ventricular hypertrophy | 72 | 0% |
| Ventricular hypokinesia | 318 | 0.02% |
| Ventricular hypoplasia | 3 | 0% |
| Ventricular internal diameter | 37 | 0% |
| Ventricular internal diameter abnormal | 6 | 0% |
| Ventricular internal diameter normal | 2 | 0% |
| Ventricular pre-excitation | 5 | 0% |
| Ventricular remodelling | 6 | 0% |
| Ventricular septal defect | 49 | 0% |
| Ventricular septal defect acquired | 1 | 0% |
| Ventricular tachyarrhythmia | 12 | 0% |
| Ventricular tachycardia | 780 | 0.05% |
| Ventriculo-cardiac shunt | 1 | 0% |
| Ventriculo-peritoneal shunt | 13 | 0% |
| Verbal abuse | 1 | 0% |
| Vertebral artery aneurysm | 9 | 0% |
| Vertebral artery arteriosclerosis | 5 | 0% |
| Vertebral artery dissection | 91 | 0.01% |
| Vertebral artery hypoplasia | 4 | 0% |
| Vertebral artery occlusion | 43 | 0% |
| Vertebral artery stenosis | 44 | 0% |
| Vertebral artery thrombosis | 19 | 0% |
| Vertebral column mass | 1 | 0% |
| Vertebral end plate inflammation | 2 | 0% |
| Vertebral foraminal stenosis | 86 | 0.01% |
| Vertebral lateral recess stenosis | 4 | 0% |
| Vertebral lesion | 23 | 0% |
| Vertebral osteophyte | 37 | 0% |
| Vertebral wedging | 5 | 0% |
| Vertebrobasilar artery dissection | 10 | 0% |
| Vertebrobasilar dolichoectasia | 1 | 0% |
| Vertebrobasilar infarction | 1 | 0% |
| Vertebrobasilar insufficiency | 18 | 0% |
| Vertebrobasilar stroke | 25 | 0% |
| Vertebroplasty | 9 | 0% |
| Vertical infection transmission | 8 | 0% |
| Vertigo | 16,708 | 1.02% |
| Vertigo CNS origin | 15 | 0% |
| Vertigo labyrinthine | 21 | 0% |
| Vertigo positional | 833 | 0.05% |
| Very long-chain acyl-coenzyme A dehydrogenase deficiency | 1 | 0% |
| Very low density lipoprotein | 41 | 0% |
| Very low density lipoprotein decreased | 2 | 0% |
| Very low density lipoprotein increased | 5 | 0% |
| Very low density lipoprotein normal | 8 | 0% |
| Vesicoureteric reflux | 4 | 0% |
| Vesicourethral fistula | 1 | 0% |
| Vessel harvesting | 6 | 0% |
| Vessel perforation | 4 | 0% |
| Vessel puncture site bruise | 4 | 0% |
| Vessel puncture site erythema | 1 | 0% |
| Vessel puncture site haematoma | 3 | 0% |
| Vessel puncture site haemorrhage | 4 | 0% |
| Vessel puncture site inflammation | 1 | 0% |
| Vessel puncture site injury | 1 | 0% |
| Vessel puncture site reaction | 1 | 0% |
| Vessel puncture site swelling | 1 | 0% |
| Vestibular ataxia | 6 | 0% |
| Vestibular disorder | 348 | 0.02% |
| Vestibular function test | 142 | 0.01% |
| Vestibular function test abnormal | 21 | 0% |
| Vestibular function test normal | 20 | 0% |
| Vestibular ischaemia | 5 | 0% |
| Vestibular migraine | 140 | 0.01% |
| Vestibular neuronitis | 902 | 0.05% |
| Vestibular nystagmus | 6 | 0% |
| Vestibular paroxysmia | 5 | 0% |
| Vestibulitis | 11 | 0% |
| Vestibulocerebellar syndrome | 3 | 0% |
| VEXAS syndrome | 9 | 0% |
| Vibration syndrome | 12 | 0% |
| Vibration test | 8 | 0% |
| Vibration test abnormal | 2 | 0% |
| Vibratory sense increased | 161 | 0.01% |
| Vibrio vulnificus infection | 1 | 0% |
| Victim of abuse | 4 | 0% |
| Victim of crime | 2 | 0% |
| Victim of sexual abuse | 1 | 0% |
| Videooculogram | 2 | 0% |
| VIIIth nerve injury | 24 | 0% |
| VIIIth nerve lesion | 4 | 0% |
| VIIth nerve injury | 8 | 0% |
| Violence-related symptom | 9 | 0% |
| Viraemia | 12 | 0% |
| Viral cardiomyopathy | 11 | 0% |
| Viral corneal ulcer | 1 | 0% |
| Viral diarrhoea | 3 | 0% |
| Viral hepatitis carrier | 2 | 0% |
| Viral infection | 840 | 0.05% |
| Viral keratouveitis | 2 | 0% |
| Viral labyrinthitis | 13 | 0% |
| Viral load | 104 | 0.01% |
| Viral load abnormal | 2 | 0% |
| Viral load increased | 8 | 0% |
| Viral mutation identified | 13 | 0% |
| Viral myelitis | 5 | 0% |
| Viral myocarditis | 95 | 0.01% |
| Viral myositis | 6 | 0% |
| Viral parotitis | 4 | 0% |
| Viral pericarditis | 67 | 0% |
| Viral pharyngitis | 45 | 0% |
| Viral rash | 102 | 0.01% |
| Viral sepsis | 43 | 0% |
| Viral sinusitis | 3 | 0% |
| Viral skin infection | 4 | 0% |
| Viral test | 1,074 | 0.07% |
| Viral test negative | 284 | 0.02% |
| Viral test positive | 51 | 0% |
| Viral titre | 63 | 0% |
| Viral titre decreased | 4 | 0% |
| Viral titre increased | 7 | 0% |
| Viral tonsillitis | 4 | 0% |
| Viral tracheitis | 1 | 0% |
| Viral upper respiratory tract infection | 55 | 0% |
| Viral uveitis | 5 | 0% |
| Viral vasculitis | 2 | 0% |
| Virilism | 1 | 0% |
| Virologic failure | 2 | 0% |
| Visceral congestion | 6 | 0% |
| Visceral leishmaniasis | 2 | 0% |
| Visceral oedema | 1 | 0% |
| Visceral pain | 31 | 0% |
| Visceral venous thrombosis | 17 | 0% |
| Visceroptosis | 1 | 0% |
| Vision blurred | 13,930 | 0.85% |
| Visual acuity reduced | 674 | 0.04% |
| Visual acuity reduced transiently | 10 | 0% |
| Visual acuity tests | 703 | 0.04% |
| Visual acuity tests abnormal | 13 | 0% |
| Visual acuity tests normal | 13 | 0% |
| Visual agnosia | 4 | 0% |
| Visual analogue scale | 376 | 0.02% |
| Visual brightness | 48 | 0% |
| Visual evoked potentials | 148 | 0.01% |
| Visual evoked potentials abnormal | 7 | 0% |
| Visual evoked potentials normal | 3 | 0% |
| Visual field defect | 957 | 0.06% |
| Visual field tests | 267 | 0.02% |
| Visual field tests abnormal | 27 | 0% |
| Visual field tests normal | 8 | 0% |
| Visual impairment | 11,074 | 0.67% |
| Visual pathway disorder | 8 | 0% |
| Visual perseveration | 17 | 0% |
| Visual processing disorder | 2 | 0% |
| Visual snow syndrome | 59 | 0% |
| Visual tracking test | 9 | 0% |
| Visual tracking test abnormal | 7 | 0% |
| Visuospatial deficit | 8 | 0% |
| Vital capacity | 42 | 0% |
| Vital capacity abnormal | 1 | 0% |
| Vital capacity decreased | 7 | 0% |
| Vital capacity normal | 3 | 0% |
| Vital dye staining cornea present | 1 | 0% |
| Vital functions abnormal | 45 | 0% |
| Vital signs measurement | 2,446 | 0.15% |
| Vitamin A | 16 | 0% |
| Vitamin A normal | 2 | 0% |
| Vitamin B1 | 133 | 0.01% |
| Vitamin B1 decreased | 4 | 0% |
| Vitamin B1 deficiency | 8 | 0% |
| Vitamin B2 | 11 | 0% |
| Vitamin B2 decreased | 1 | 0% |
| Vitamin B2 deficiency | 1 | 0% |
| Vitamin B6 | 107 | 0.01% |
| Vitamin B6 abnormal | 1 | 0% |
| Vitamin B6 decreased | 3 | 0% |
| Vitamin B6 deficiency | 5 | 0% |
| Vitamin B6 increased | 12 | 0% |
| Vitamin B6 normal | 18 | 0% |
| Vitamin B12 | 1,249 | 0.08% |
| Vitamin B12 abnormal | 12 | 0% |
| Vitamin B12 absorption test | 11 | 0% |
| Vitamin B12 decreased | 153 | 0.01% |
| Vitamin B12 deficiency | 142 | 0.01% |
| Vitamin B12 increased | 79 | 0% |
| Vitamin B12 normal | 391 | 0.02% |
| Vitamin B complex deficiency | 19 | 0% |
| Vitamin C | 27 | 0% |
| Vitamin C decreased | 3 | 0% |
| Vitamin C deficiency | 4 | 0% |
| Vitamin C increased | 1 | 0% |
| Vitamin C normal | 2 | 0% |
| Vitamin D | 1,011 | 0.06% |
| Vitamin D abnormal | 7 | 0% |
| Vitamin D decreased | 326 | 0.02% |
| Vitamin D deficiency | 317 | 0.02% |
| Vitamin D increased | 12 | 0% |
| Vitamin E | 32 | 0% |
| Vitamin K | 11 | 0% |
| Vitamin K decreased | 3 | 0% |
| Vitamin K deficiency | 2 | 0% |
| Vitamin supplementation | 22 | 0% |
| Vitamin test | 14 | 0% |
| Vitello-intestinal duct remnant | 2 | 0% |
| VIth nerve disorder | 21 | 0% |
| VIth nerve injury | 3 | 0% |
| VIth nerve paralysis | 265 | 0.02% |
| VIth nerve paresis | 10 | 0% |
| Vitiligo | 277 | 0.02% |
| Vitrectomy | 15 | 0% |
| Vitreoretinal traction syndrome | 6 | 0% |
| Vitreous adhesions | 5 | 0% |
| Vitreous degeneration | 14 | 0% |
| Vitreous detachment | 418 | 0.03% |
| Vitreous disorder | 24 | 0% |
| Vitreous floaters | 1,038 | 0.06% |
| Vitreous haematoma | 1 | 0% |
| Vitreous haemorrhage | 158 | 0.01% |
| Vitreous haze | 13 | 0% |
| Vitreous injury | 3 | 0% |
| Vitreous loss | 1 | 0% |
| Vitreous opacities | 30 | 0% |
| Vitreous prolapse | 1 | 0% |
| Vitritis | 17 | 0% |
| Vitritis infective | 1 | 0% |
| Vocal cord atrophy | 3 | 0% |
| Vocal cord augmentation | 2 | 0% |
| Vocal cord bowing | 1 | 0% |
| Vocal cord cyst | 3 | 0% |
| Vocal cord disorder | 74 | 0% |
| Vocal cord dysfunction | 43 | 0% |
| Vocal cord erythema | 2 | 0% |
| Vocal cord inflammation | 23 | 0% |
| Vocal cord nodule removal | 1 | 0% |
| Vocal cord paralysis | 118 | 0.01% |
| Vocal cord paresis | 20 | 0% |
| Vocal cord polyp | 3 | 0% |
| Vocal cord polypectomy | 1 | 0% |
| Vocal cord scarring | 1 | 0% |
| Vocal cord thickening | 8 | 0% |
| Vogt-Koyanagi-Harada disease | 55 | 0% |
| Volume blood | 9 | 0% |
| Volume blood decreased | 13 | 0% |
| Volume blood increased | 1 | 0% |
| Volvulus | 41 | 0% |
| Volvulus of small bowel | 3 | 0% |
| Volvulus repair | 2 | 0% |
| Vomiting | 57,945 | 3.52% |
| Vomiting projectile | 371 | 0.02% |
| Vomiting psychogenic | 2 | 0% |
| Von Willebrand's disease | 25 | 0% |
| Von Willebrand's factor activity abnormal | 1 | 0% |
| Von Willebrand's factor activity decreased | 2 | 0% |
| Von Willebrand's factor activity increased | 4 | 0% |
| Von Willebrand's factor activity normal | 7 | 0% |
| Von Willebrand's factor activity test | 61 | 0% |
| Von Willebrand's factor antibody | 7 | 0% |
| Von Willebrand's factor antigen abnormal | 1 | 0% |
| Von Willebrand's factor antigen increased | 6 | 0% |
| Von Willebrand's factor antigen normal | 3 | 0% |
| Von Willebrand's factor antigen test | 30 | 0% |
| Von Willebrand's factor multimers test | 8 | 0% |
| Vth nerve injury | 5 | 0% |
| Vulva cyst | 10 | 0% |
| Vulval abscess | 12 | 0% |
| Vulval cancer | 7 | 0% |
| Vulval cancer metastatic | 1 | 0% |
| Vulval cellulitis | 1 | 0% |
| Vulval disorder | 40 | 0% |
| Vulval eczema | 3 | 0% |
| Vulval haematoma | 1 | 0% |
| Vulval haemorrhage | 45 | 0% |
| Vulval oedema | 5 | 0% |
| Vulval ulceration | 107 | 0.01% |
| Vulvar dysplasia | 1 | 0% |
| Vulvar erosion | 5 | 0% |
| Vulvar squamous cell hyperplasia | 1 | 0% |
| Vulvectomy | 1 | 0% |
| Vulvitis | 9 | 0% |
| Vulvovaginal burning sensation | 80 | 0% |
| Vulvovaginal candidiasis | 69 | 0% |
| Vulvovaginal discomfort | 98 | 0.01% |
| Vulvovaginal dryness | 55 | 0% |
| Vulvovaginal erythema | 25 | 0% |
| Vulvovaginal exfoliation | 2 | 0% |
| Vulvovaginal inflammation | 23 | 0% |
| Vulvovaginal injury | 18 | 0% |
| Vulvovaginal mycotic infection | 100 | 0.01% |
| Vulvovaginal pain | 269 | 0.02% |
| Vulvovaginal pruritus | 113 | 0.01% |
| Vulvovaginal rash | 26 | 0% |
| Vulvovaginal swelling | 77 | 0% |
| Vulvovaginal ulceration | 17 | 0% |
| Vulvovaginitis | 8 | 0% |
| Vulvovaginitis trichomonal | 1 | 0% |
| Wagner's disease | 1 | 0% |
| Waist circumference | 16 | 0% |
| Waist circumference increased | 17 | 0% |
| Waldenstrom's macroglobulinaemia | 18 | 0% |
| Waldenstrom's macroglobulinaemia stage III | 1 | 0% |
| Walking aid user | 948 | 0.06% |
| Walking disability | 261 | 0.02% |
| Walking distance test | 67 | 0% |
| Walking distance test abnormal | 32 | 0% |
| Walking distance test normal | 42 | 0% |
| Wallerian degeneration | 3 | 0% |
| Wall motion score index | 10 | 0% |
| Wall motion score index abnormal | 51 | 0% |
| Wall motion score index normal | 13 | 0% |
| Wandering pacemaker | 2 | 0% |
| Warm autoimmune haemolytic anaemia | 14 | 0% |
| Warm type haemolytic anaemia | 14 | 0% |
| Water deprivation test | 3 | 0% |
| Waterhouse-Friderichsen syndrome | 1 | 0% |
| Water intoxication | 4 | 0% |
| Water loading test | 4 | 0% |
| Water pollution | 24 | 0% |
| Waxy flexibility | 1 | 0% |
| Wean from ventilator | 6 | 0% |
| Weaning failure | 23 | 0% |
| Weber's syndrome | 1 | 0% |
| Weber tuning fork test | 19 | 0% |
| Weber tuning fork test abnormal | 1 | 0% |
| Weight | 3,465 | 0.21% |
| Weight abnormal | 16 | 0% |
| Weight bearing difficulty | 946 | 0.06% |
| Weight control | 6 | 0% |
| Weight decreased | 5,972 | 0.36% |
| Weight decrease neonatal | 2 | 0% |
| Weight fluctuation | 50 | 0% |
| Weight gain poor | 22 | 0% |
| Weight increased | 1,544 | 0.09% |
| Weight loss diet | 1 | 0% |
| Weight loss poor | 16 | 0% |
| Weil's disease | 1 | 0% |
| Wellens' syndrome | 1 | 0% |
| Wernicke's encephalopathy | 7 | 0% |
| West Nile viral infection | 3 | 0% |
| West Nile virus test | 44 | 0% |
| West Nile virus test negative | 36 | 0% |
| West Nile virus test positive | 4 | 0% |
| Wheat-free diet | 1 | 0% |
| Wheelchair user | 404 | 0.02% |
| Wheezing | 5,926 | 0.36% |
| Whipple's disease | 4 | 0% |
| White blood cell agglutination present | 54 | 0% |
| White blood cell analysis | 45 | 0% |
| White blood cell analysis normal | 3 | 0% |
| White blood cell count | 9,782 | 0.59% |
| White blood cell count abnormal | 89 | 0.01% |
| White blood cell count decreased | 1,318 | 0.08% |
| White blood cell count increased | 3,548 | 0.22% |
| White blood cell count normal | 1,421 | 0.09% |
| White blood cell disorder | 166 | 0.01% |
| White blood cell morphology | 2 | 0% |
| White blood cell morphology abnormal | 5 | 0% |
| White blood cell morphology normal | 4 | 0% |
| White blood cell scan | 16 | 0% |
| White blood cells stool | 1 | 0% |
| White blood cells stool negative | 2 | 0% |
| White blood cells stool positive | 5 | 0% |
| White blood cells urine | 268 | 0.02% |
| White blood cells urine abnormal | 3 | 0% |
| White blood cells urine negative | 108 | 0.01% |
| White blood cells urine positive | 305 | 0.02% |
| White coat hypertension | 23 | 0% |
| White matter lesion | 262 | 0.02% |
| Whole-genome sequencing | 31 | 0% |
| Whole body scan | 50 | 0% |
| Widal test | 1 | 0% |
| Wig wearer | 4 | 0% |
| Winged scapula | 31 | 0% |
| Wisdom teeth removal | 14 | 0% |
| Withdrawal bleed | 17 | 0% |
| Withdrawal hypertension | 4 | 0% |
| Withdrawal of life support | 34 | 0% |
| Withdrawal syndrome | 53 | 0% |
| Wolf-Hirschhorn syndrome | 2 | 0% |
| Wolff-Parkinson-White syndrome | 29 | 0% |
| Wolff-Parkinson-White syndrome congenital | 1 | 0% |
| Wound | 632 | 0.04% |
| Wound abscess | 4 | 0% |
| Wound closure | 55 | 0% |
| Wound complication | 66 | 0% |
| Wound contamination | 1 | 0% |
| Wound decomposition | 1 | 0% |
| Wound dehiscence | 22 | 0% |
| Wound drainage | 29 | 0% |
| Wound evisceration | 1 | 0% |
| Wound haematoma | 5 | 0% |
| Wound haemorrhage | 116 | 0.01% |
| Wound healing normal | 1 | 0% |
| Wound infection | 86 | 0.01% |
| Wound infection bacterial | 4 | 0% |
| Wound infection pseudomonas | 1 | 0% |
| Wound infection staphylococcal | 9 | 0% |
| Wound necrosis | 10 | 0% |
| Wound secretion | 87 | 0.01% |
| Wound sepsis | 5 | 0% |
| Wound treatment | 70 | 0% |
| Wrist deformity | 9 | 0% |
| Wrist fracture | 72 | 0% |
| Wrist surgery | 9 | 0% |
| Writer's cramp | 6 | 0% |
| Wrong device used | 7 | 0% |
| Wrong dosage formulation | 10 | 0% |
| Wrong dose | 6 | 0% |
| Wrong drug | 1 | 0% |
| Wrong patient | 70 | 0% |
| Wrong patient received product | 50 | 0% |
| Wrong product administered | 4,931 | 0.3% |
| Wrong route | 8 | 0% |
| Wrong schedule | 8 | 0% |
| Wrong technique in device usage process | 79 | 0% |
| Wrong technique in product usage process | 716 | 0.04% |
| X-linked lymphoproliferative syndrome | 1 | 0% |
| X-ray | 9,398 | 0.57% |
| X-ray abnormal | 489 | 0.03% |
| X-ray dental | 98 | 0.01% |
| X-ray dental abnormal | 24 | 0% |
| X-ray dental normal | 44 | 0% |
| X-ray gastrointestinal tract | 12 | 0% |
| X-ray gastrointestinal tract abnormal | 13 | 0% |
| X-ray gastrointestinal tract normal | 7 | 0% |
| X-ray hepatobiliary | 2 | 0% |
| X-ray limb | 965 | 0.06% |
| X-ray limb abnormal | 330 | 0.02% |
| X-ray limb normal | 334 | 0.02% |
| X-ray normal | 1,044 | 0.06% |
| X-ray of pelvis and hip | 259 | 0.02% |
| X-ray of pelvis and hip abnormal | 81 | 0% |
| X-ray of pelvis and hip normal | 95 | 0.01% |
| X-ray therapy to blood | 2 | 0% |
| X-ray therapy to joint | 1 | 0% |
| X-ray therapy to lung | 13 | 0% |
| X-ray treatment | 3 | 0% |
| X-ray with contrast | 13 | 0% |
| X-ray with contrast lower gastrointestinal tract | 8 | 0% |
| X-ray with contrast upper gastrointestinal tract | 28 | 0% |
| X-ray with contrast upper gastrointestinal tract normal | 1 | 0% |
| Xanthelasma | 2 | 0% |
| Xanthochromia | 11 | 0% |
| Xanthogranuloma | 1 | 0% |
| Xanthoma | 1 | 0% |
| Xanthomatosis | 1 | 0% |
| Xanthopsia | 16 | 0% |
| Xeroderma | 1 | 0% |
| Xeroderma pigmentosum | 9 | 0% |
| Xerophthalmia | 18 | 0% |
| Xerosis | 16 | 0% |
| XXX syndrome | 1 | 0% |
| Yawning | 196 | 0.01% |
| Yellow fever | 3 | 0% |
| Yellow fever immunisation | 1 | 0% |
| Yellow skin | 176 | 0.01% |
| Yergason's test | 1 | 0% |
| Yersinia bacteraemia | 1 | 0% |
| Yersinia infection | 7 | 0% |
| Yersinia test | 26 | 0% |
| Yersinia test negative | 4 | 0% |
| Yolk sac tumour site unspecified | 1 | 0% |
| Young's syndrome | 1 | 0% |
| Young mania rating scale | 4 | 0% |
| Zika virus infection | 1 | 0% |
| Zinc deficiency | 10 | 0% |
| Zoonotic bacterial infection | 1 | 0% |
| TOTAL | † 7,524,641 | † 457.63% |
| † Because VAERS cases can have multiple vaccinations, symptoms, and event outcomes, a single case can account for multiple entries in this table. This is why the Total Count is greater than 1,644,249 (the number of cases found), and the Total Percent is greater than 100. | ||
| Case Details |
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient experienced mild numbness traveling from injection site up and down arm that subsided over 20 minutes. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: C/O Headache | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: felt warm, hot and face and ears were red and flushed. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: within 15 minutes progressive light-headedness leading to near-syncope and diaphoresis. After 20 minutes symptoms subsided. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Pt felt wave come over body @ 1218 starting in head and going down. Bad taste in mouth, tingling in body , legs, back , across stomach, BP 150/100 P 120@ 1219, EMS activated. BP 120/80, P 80 Pt alert and oriented, Pt declined transport and Benadryl. Symptoms come and go, pt feels better but then bad taste in mouth starts, shaking of hands, tingling starts again in stomach and back. @ 1300 pt requests Benadryl, 25 mg administered. Pt notified family by phone of circumstances and family in transit.@1324 BP 120/80, P 84, tongue tingling and pt reports smelling chemical smell. @1345 Pt complained of mouth itching, EMS activated and will transport to Medical Center. Pt oriented and transported at @13 | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Within 1 minute, patient complained of symptoms of lightheadedness, flushing, asked for water. Symptoms persisted, reported vagal and "spacey", vitals were 117/91, HR 67, O2 sat 99% on room air. Reported chest heaviness, shortness of breath and within 5 minutes developed rigors and urge to defecate. 911 called, repeat vital 150/89 HR 113 O2sat 97%, continues to want to defecate. 1 loose BM, transferred to ED | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: rPfizer-BionNTech COVID-19 Vaccine EUA 5-7 minutes after the vaccine Associate stated she did not feel right, mentioned chest pain. "My chest feels funny. It feels like when you have really bad heartburn coming on". "I feel flushed like when you get contrast for a CT". Pulse 90 BP 160/90 checked later 130/90 | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Headache, body ache | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Within a few minutes of receiving the COVID 19 vaccination, patient developed lightheadedness, shortness of breath, headache, and some nausea. She did get some redness to her neck and upper chest. No recent illness. Had elevated BPs ranged from 158/103 to 207/126 . HR ranged from 82-106. O2 sats always $g 96%. Temp 37.1 C. Received Tylenol 1000 mg PO, Dexamethasone 10 mg IV, diphenhydramine 50 mg IV, famotidine 20 mg IV, ketorolac 30 mg IV, ondansetron 4 mg IV, and 1 L NS. Patient prescribed EpiPen and prednisone and discharged. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: About 25 minutes after receiving vaccine complained of dizziness and being hot and nauseated. No difficulty breathing. No chest pain. B/P was 130/90 and was monitored. It went down to 124/80 after he started feeling better. He was wearing sweater over shirt and it was warm in building. Took sweater off. Cool wet cloth applied to back of neck. States he had only had a donut and cup of hot chocolate before receiving vaccine. Sprite and peanut butter crackers given. Became nauseated after eating peanut butter crackers Blood pressure monitored monitored. He laid on exam table for about 15 minutes. He felt better. Stood up and walked to conference room for another 15 minutes. Stated he felt much better and was ready to leave. Coworker drove him back. Received email from him letting us know he had made it back and they had stopped and eaten pizza on the way. Received text from coworker that he was dizzy and seeing spots and that his blood pressure had been 120/80 and then spiked to 160/100. Coworkers taking him to ER at Hospital for evaluation. | ||||||||||||||||
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=SYM&EVENTS=ON&VAX[]=COVID19&VAX[]=COVID19-2
Copyright ©
2024 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166